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Abstract  
 
Fluorinated compounds make up a large proportion of the output from both the 
pharmaceutical and agrochemical industries. However, there are still a limited number of 
methodologies involving the synthesis of such molecules. Six-membered nitrogen 
containing heterocycles such as pyridines and lactams are key compounds for medicinal 
chemistry. Therefore, there is much interest into the synthesis of fluorinated nitrogen 
heterocycle libraries which can be utilised effectively for numerous substrate screens.  
 
This thesis aims to produce a novel route for the generation of a host of fluorinated 
pyridines, lactams and piperidines. Work on non-fluorinated analogues has lead to a rapid 
two-pot process for the production of dihydropyridones, a potential intermediate for the 
above targets, starting from common aldehydes.  
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This methodology has been utilised in the synthesis of fluorinated lactams through an 
efficient ring-closing metathesis protocol of vinyl fluoride compounds. A variety of 
aldehydes, including aromatic, aliphatic and heterocyclic examples, could be converted in 
6 efficient steps into novel fluorinated δ-lactams. The final hydrogenation occurred on the 
opposite face to the R groups giving a single diasteromer in all cases. 
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Taking inspiration from the δ-lactams series, a synthetic route was designed and 
implemented to grant access to an array of fluorinated polysubstituted pyrroles. The final 
step involved a novel addition-aromatisation reaction which allowed late-stage variation of 
the resulting fluorinated pyrroles. Installation of a hydride, n-butyl, phenyl and allyl 
moieties could be achieved, all in high yields of 75-93%. 
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Finally the synthesis of a number of interesting benzoxazole containing compounds was 
undertaken to produce a range of novel fluorinated poly(ADP-ribose) polymerase (PARP) 
inhibitors, yielding a group of potential anti-cancer agents.  
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1. Introduction  
 
1.1: Fluorine in organic chemistry 
 
It has been well documented that the installation of fluorine atoms into organic molecules 
greatly changes their physical and pharmacological properties.1 Fluorinated molecules 
are, therefore, highly sought after in industry, especially by medicinal and materials 
chemists hoping to fine tune the properties of their target molecules.2 
 
Cholesterol lowering drugs atorvastatin 1 (the worlds best-selling pharmaceutical between 
1996 and 2012),3 fluvastatin and rosuvastatin all have C-F bonds in their structures which 
is paramount to their efficiency.4 Many other examples of fluorinated pharmaceuticals 
exist including the antibiotic ciprofloxacin 2 produced by Bayer and Roche’s anti-malarial 
treatment mefloquine 3 (Figure 1).5, 6  
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Figure 1. Cholesterol lowering drug atorvastatin 1, antibiotic ciprofloxacin 2 and anti-malarial agent 
mefloquine 3.3, 6 
 
However, the installation of fluorine atoms is not a trivial matter for organic chemists. This 
is exemplified in nature, with little more than 30 naturally occurring organofluorine 
compounds and only one isolated enzyme, adenosyl-fluoride synthase, known to catalyse 
the production of C-F bonds (Figure 2).7,8 In contrast, around 30% of all agrochemicals 
and 20% of all pharmaceuticals contain a C-F bond in their structure.3 This shows the 
importance of the C-F bond in modern bio-organic chemistry as well as the significant 
need for new, efficient ways to install fluorine atoms into a large variety of environments 
with little inspiration from nature to guide the design of methodology.   
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Figure 2. The chemical structures of two naturally occurring fluorinated compounds: 1-fluoro-
propan-2-one 4 and 3-carboxy-2-fluoro-3-hydroxy-pentanedioic acid 5.7,8 
 
Fluorine is the most common halogen in the earth’s crust contributing to 0.065% of the 
overall make up, this is significantly more than other halogens such as chlorine and 
bromine, which have abundances of 0.017% and 0.0003% respectively.7 It is, therefore, 
surprising that there are upwards of 4,500 natural products containing these less common 
halogens compared to the 30 natural products containing fluorine.9 Fluorine may be 
relatively abundant as an element, however the uptake of fluorine into biological systems 
is compromised by a number of factors. The naturally forming fluorine-containing 
minerals, such as fluorite, have poor solubility in aqueous media due to strong ionic bonds 
between the fluorine and the metal.8 Once a fluorine atom is present in water, a very tight 
solvation shell means the anion has poor nucleophilicity.8 Oxidation of halogens from X- to 
X+ is an important process in their incorporation into natural compounds. However, as the 
oxidation potential of fluoride (-2.87 eV) which is higher than hydrogen peroxide (-1.87 
eV), this process can not take place.8  
 
Even with these obstacles, nature has managed to incorporate fluorine into a limited 
number of natural products. Adenosyl-fluoride synthase, an enzyme identified from the 
bacteria Streptomyces cattleya was found to convert S-adenosylmethionine (SAM) 6 to 5’-
fluoro-5’deoxyfluoroadenosine (5’-FDA) 7 (Scheme 1).8 This transformation involves the 
nucleophilic attack of the fluoride ion onto the 5’ carbon on the ribose ring eliminating the 
amino acid, methionine. 5’-FDA 7 can then be readily transformed into the fluorinated 
building blocks 4-fluorothreonine 8 and fluoroacetate 9.8 
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Scheme 1. Nucleophilic fluorination reaction catalysed by enzyme, adenosyl-fluoride synthase. 
The resulting fluorinated sugar 5’-FDA 7 is further metabolised to produce fluorinated natural 
products, 8 and 9.8  
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The special properties of organofluorine molecules that make them integral for medicinal 
chemistry are largely determined by the size and electronegativity of the fluorine atom.1 
Apart from hydrogen, fluorine has the smallest Van der Waals radius of any atom that can 
form a covalent bond with carbon. This generates a bond with very low steric strain, which 
coupled with a partial ionic nature produces very strong, short C-F interactions. The C-F 
bond can replace a C-H bond with very little change to the molecular sterics, which is 
important when modifying a drug candidate for a particular enzyme active site.1  
 
The high electronegativity of the fluorine atom causes the C-F bond to be highly polarised, 
pulling electrons towards the fluorine and lowering the electron density of surrounding 
atoms.1 This lowers the pKa of α-hydrogen atoms and nearby acid functionalities as well 
as reducing the reactivity towards oxidising agents.2,10 The lone pair of electrons on the 
fluorine atom is too strongly attracted to the electronegative centre to form any noteworthy 
hydrogen bonding interactions with proton donating functionalities.1 This lack of 
polarisability of the fluorine atom leads to the general increase in the lipophilicity of 
molecules upon fluorination.2,10 The physical properties, stated above, have a profound 
effect on the pharmacological properties of organofluorine compounds making them key 
compounds in the pharmaceutical industry.  
 
As a consequence of the inclusion of fluorine atoms, organic molecules display an 
increase in metabolic stability. When administered to the body a lipophillic drug molecule 
will be modified by enzymes involved in the metabolic processes, changing the molecular 
structure. This often involves oxidation, which not only decreases the biological activity but 
can also lead to an increase in the hydrophilic nature of the compound causing an 
increased rate of expulsion from the body through urination.11 The inclusion of fluorine 
atoms can be used to block such degradation by deactivating the labile sites prone to 
oxidation, by reducing the availability of electrons in the molecule which can interact with 
the metabolic enzymes.  
 
An important example is the oxidation of phenyl groups by enzyme cytochrome P450. 
Cytochrome P450 oxidises phenyl rings at the para position which leads to an increase in 
the hydrophilic nature of the drug candidate. However, the inclusion of a fluorine atom at 
the para position deactivates the phenyl ring towards oxidation, hence slowing metabolism 
without changing the sterics of the drug molecule significantly.11 This strategy was utilised 
in the production of the cholesterol-absorption inhibitor 11. Compound 10 was identified 
as a lead compound for the inhibition of cholesterol-absorption mechanisms, however in 
vivo metabolism at certain labile sites hindered the activity of the compound. Fluorination 
at the para position of two of the phenyl rings was used to block the action of metabolic 
13 
enzymes and drastically improve the activity in vivo using a hamster model. This resulted 
in lowering the ED50 value from 2.20 mg Kg-1 for 10 to 0.04 mg Kg-1 for 11 (Figure 3).11  
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Figure 3. Cholesterol-absorption inhibitor: SCH 48461, 10, undergoes oxidation of the phenyl ring 
during metabolism, which reduces the drug activity in vivo. However, addition of fluorine atoms, as 
shown in structure 11, increases activity 400 fold by blocking this oxidation.11 
 
Another crucial function of the C-F bond is to increase the ability of drug-like molecules to 
cross the lipid bilayer surrounding cells. Many biologically active molecules have modes of 
action that are carried out inside cells, targeting enzymes, DNA etc.12 If a molecule is too 
lipophobic, it will not be able to diffuse through the internal lipid layer of the cell membrane 
and will have to enter the cell by other means, or be rendered ineffective. The increase in 
lipophilicity caused by the fluorination of drug-like molecules facilitates their transport into 
cells, therefore increasing the intracellular drug concentration.12 Fluorination can also be 
used to make a drug viable for oral administration instead of less practical approaches. 
The increase in lipophilicity can be enough to facilitate transport across the gut and 
stomach linings and also make compounds more chemically stable towards the highly 
acidic environment of the stomach.2,13 
 
The alteration of the pKa of a molecule is another way the introduction of fluorine atoms 
can be used to tune potential drug candidates. If one of the forms, protonated or non-
protonated, is the active form, then the change in pKa can be used to shift the equilibrium 
to favour one isoform. Installation of fluorine can lower the pKa of surrounding protons, so 
addition of a number of fluorine atoms can be used to tune the pKa to favour the active 
form of a compound.2,10 The change of basicity of nearby sites upon fluorination was 
demonstrated eloquently by van Niel and coworkers.14 They found that fluorination of 
human 5-HT1D receptor 12 reduced the pKa, favouring the un-ionised species, and so 
significantly increased the compounds bioavailability and viability for oral administration 
(Figure 4).14  
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Figure 4. Fluorinated analogue 13 of human 5-HT1D receptor 12 has a lower pKa (9.7 for 12 and 
8.7 for 13) and improved bioavailability to a medium value (F = 14%).14   
 
In summary, organofluorine compounds are of paramount importance in medicinal 
chemistry where the properties of the C-F bond are often used to turn highly active 
compounds into potential drug candidates that can survive in a biological environment.  
 
1.2: Fluorinated nitrogen heterocycles 
 
Nitrogen containing heterocycles are abundant in nature and increasingly, in synthetically 
produced molecules. They have diverse applications and are used as pharmaceutical 
drugs, pesticides and in the materials industry.  
 
As previously discussed, the fluorination of certain molecules is highly desirable. 
Therefore, there is a high demand for cost-effective methodology for the construction of 
fluorinated nitrogen heterocycles. Although much progress has been made in this area 
there is still scope for improvement to make these compounds readily available and 
economically viable targets.  
 
This thesis will focus on 5- and 6- membered fluorinated heterocycles such as pyridines, 
lactams and pyrroles. On the market there are already significant examples with both key 
agrochemicals and pharmaceuticals comprising such functionality. The herbicide 
fluroxypyr 14 is a prime example possessing a fluorine atom in the 2 position of a fully 
substituted pyridine unit (Figure 5).15 Lansoprazole 15 is a proton pump inhibitor used in 
the treatment of stomach ulcers and gastric reflux disease (Figure 5).16 Another important 
example discussed previously is atorvastatin 1 (Section 1.1), which has a p-fluorobenzene 
substituent on a pyrrole ring system (Figure 1).3 
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Figure 5. Herbicide fluroxypyr, 14, and proton pump inhibitor lansoprazole, 15.15, 16 
 
1.3: Synthesis of fluorinated nitrogen heterocycles 
 
As fluorinated compounds have become major targets for medicinal chemists,2 there has 
been significant research dedicated to the synthesis of fluorinated nitrogen heterocycles. 
In the following sections, significant developments regarding fluorinated pyridines, δ- and 
γ-lactams, and finally pyrroles will be described.  
 
1.3.1: Pyridines 
 
The pyridine unit is a motif of high biological relevance and features in many naturally-
occurring compounds, with examples including the human enzyme cofactor pyridoxyl 
phosphate (active form of vitamin B6),17 the NAD and NADP precursor niacin (vitamin 
B3),18 and the plant alkaloid nicotine.19 Pyridines are also extensively used in medicinal 
chemistry as both key functional groups and scaffold structures.20 They are also used in 
the pharmaceutical and material industries as solvents, bases, ligands and even 
components in molecular devices.21 Thus, it is not surprising that the pyridine moiety 
features in several high selling pharmaceutical drugs such as the proton pump inhibitor 
Nexium® 16, the anti-tuberculosis drug Isoniazid® 17 and the diabetes treatment  Actos® 
18 (Figure 6).21, 22, 33, 24   
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Figure 6. Heartburn relief drug nexium® 16, anti-tuberculosis agent isoniazid® 17 and diabetes 
treatment actos® 18.21, 22, 23, 24 
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1.3.1.1: Direct fluorination of pyridine ring 
 
An important reaction in the synthesis of fluorinated aromatics is the Balz-Schiemann 
reaction.25 This reaction involves the direct production of a C-F bond from an amine 
starting material using HNO2 and HBF4 (Scheme 2). Timperley and co-workers used this 
approach to form an array of mono- and perfluorinated pyridine aldoximes as potential 
lead compounds for the treatment of organophosphorous nerve-agent poisoning.26 
Although Timperley was successful in producing a variety of different compounds for 
testing, the reported yields were low and one of the most problematic steps was the 
fluorination reaction which occurred in moderate yields (41-66%) (Scheme 2).26 
 
N NH2
Me
N F
Me
NaNO2
40% aq HBF4
4 steps
N F
19 20 21
4%41%
N
OH
 
Scheme 2. The Balz-Schiemann reaction for the synthesis of fluorinated aldoximes such as 21.26  
 
 Another approach for producing fluorinated pyridine units is the direct fluorination of 
pyridine with strong fluorinating agents. One example is elemental fluorine, F2, which was 
reported by Van Der Puy to react with a number of pyridine derivatives producing 2-fluoro 
analogues in low to moderate yields (Scheme 3).27  
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22 23  
Scheme 3. Fluorination of 4-methylpyridine 22 with elemental fluorine occurring at the 2 position to 
yield 23.27  
 
A more successful outcome can be achieved using cesium fluoroxysulfate (Scheme 4) 
which was shown by Stavber and Zupan to yield 2-fluoropyridine 25 with a 70% yield.28 
However, these types of reagents are not easy to handle, and their use is hindered by the 
intolerance of different functionalities in more complex pyridine systems.  
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Scheme 4. The direct fluorination of pyridine 24 with CsSO4F to form 2-fluoropyridne 25 as 
reported by Zupan et al.28  
 
Fluorinated analogues of the herbicide aminopyralid have received some interest in recent 
years as there is the possibility of producing new active compounds with lower toxicity. 
Brewster managed to achieve an electrophilic fluorination using Selectfluor® producing the 
fluorinated analogue 27 in 31% yield (Scheme 5).29  
 
N
N
F
Cl
2BF4
N
NH2
Cl
OH
O
Cl
F
N
NH2
Cl
OH
O
Cl H2O
65 oC, 6 h
26 2731%  
Scheme 5. The fluorination of aminopyralid 26, by Selectfluor® producing compound 27.29 
 
A popular route for the synthesis of fluorinated pyridine derivatives involves the lithium-
halogen exchange of halopyridines to install the fluorine atom. One example, as 
developed by Shin and co-workers, involves bromine-lithium exchange followed by the 
addition of N-fluorobenzenesulfonimide (NFSI) (Scheme 6). Using this methodology, 3,5-
difluoropyridine 28 was produced from the 3,5-dibromo-precursor  29 in  a yield of 78%.30  
 
N
BrBr
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N
FF
OO1) n-BuLi, -120 oC
2)
28 2978%
THF
[PhSO2]2NF
THF
 
Scheme 6. Lithium-halogen exchange followed by addition of electrophilic fluorine source to 
produce difluoropyridines such as 29.30 
 
Another halogen exchange route, in which KF or Bu4NF are used as sources of the 
fluoride anion to undergo nucleophilic substitution with halo-precursors, has been well 
documented in the literature. Shestopalov and co-workers used this approach for the 
synthesis of different 3-cyano-2-fluoropyridines as potential kinase inhibitors, K+ channel 
inhibitors as well as acetylcholine receptor ligands.31 It was demonstrated that starting 
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from 2-halo-3-cyanopyridnes, fluorination could be achieved in good yield (52-76%) using 
KF (Scheme 7). Increased yields were obtained using Bu4NF and it was proposed that this 
was due to the increase in the organic solubility of the reagent. The authors also showed 
that the same method could be applied to substrates with a sulfonyl group or a 
tetrahydrothiophenium salt in the pyridine 2 position (Scheme 7).31   
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Scheme 7. Shestopalov approach for the production of 3-cyano-2-fluoropyridines 31 and 33.31 
 
1.3.1.2: Pyridine synthesis via cyclisation of fluorinated precursors 
 
All the examples detailed so far have involved reactions on a preformed or pre-
functionalised pyridine ring to install the fluorine atom. However, this is not always the 
most efficient route as this often requires the installation of a group, which may not be 
facile, just for it to be removed in favour of the fluorine. A more streamlined and expedient 
method could be achieved by the incorporation of the fluorination step into the pyridine 
ring synthesis.   
 
This approach was elegantly demonstrated by Arimitsu, who used a β-fluorinated 
vinamidinium salt as a building block in their pyridine synthesis (Scheme 8).32 Reaction of 
the vinamidinium salt 34 with a Horner-Wadsworth-Emmons reagent produced the 
organophosphorus compound 35, which was then cyclised to form the fluorinated pyridine 
36 in the presence of 25% aq. ammonia.32 
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F P(OEt)2
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r.t., 3 h34 35 36
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Scheme 8. Synthesis of fluorinated pyridine 36 as reported by Arimitsu et al. 32 
 
In 2011, Gong and co-workers reported a cascade process to produce fluorinated pyridine 
analogues 38 from the reaction of fluoroalkyl alkynylimines 37, with primary amines 
(Scheme 9).33 The reaction involves the loss of two of the three fluorine atoms leaving one 
still intact on the pyridine backbone. The process worked in good to excellent yields, and 
the scope of the reaction was extended to the synthesis of other nitrogen based 
heterocycles such as pyrimidines.33   
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Scheme 9. Gong’s synthesis of fluorinated pyridine 38.33 
 
1.3.2: Lactams 
 
Lactam moieties are present in a large number of biologically active molecules. It has 
been estimated that 25% of all pharmaceuticals contain an amide bond, and many of 
these are cyclic.34 The production of fluorinated lactams is, therefore, of significant interest 
to the scientific community, with the aim of combining the lucrative pharmacological 
properties of the fluorine with this key scaffold.  
 
1.3.2.1: Ring-closing metathesis routes to fluorinated nitrogen ring systems  
 
Fluorinated δ and γ-lactams are both species with limited documentation in the literature 
and at the time of writing there are still very few synthetic routes for such compounds. The 
most expedient method for the generation of these molecules proceeds via the ring-
closing metathesis (RCM) of vinyl fluoride compounds to form the α,β-unsaturated 
lactams; however, there are only a few reported examples.   
 
The first ring-closing metathesis reaction utilising a vinyl fluoride moiety in the production 
of nitrogen heterocycles was reported by two separate groups independently within a 
margin of 13 days. Haufe and co-workers found that Grubbs 2nd generation catalyst (2 
mol%) could be used in the formation of fluorinated γ and δ-lactams, 41 and 42, in high 
yields (Scheme 10).35  
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Scheme 10. RCM reaction to form γ and δ-lactams, 41 and 42.35 
 
Rutjes and co-workers also utilised Grubbs 2nd generation catalyst for the synthesis of 
fluorinated lactams.36 Using the same RCM precursor as Haufe and co-workers, they 
could generate γ and δ-lactams, 41 and 42, in 68 and 80% yield respectively (Scheme 
11). An excellent yield of 99% was also reported for a triene analogue 44 which 
demonstrated a selective route for forming 6-membered rings over 7-membered variants 
(Scheme 11).  
 
39 n = 1
40 n = 2
41 n = 1
42 n = 2
N
O
F
N
O
n
F
7 mol% Grubbs II
100 oC, 4 h
n = 1 = 68%
n = 2 = 80%
ntoluene
 
NO
F
NO
4 mol% Grubbs II
100 oC, 4 h
O O
F
F
O
F
O
99%
43 44
toluene
 
Scheme 11. RCM reaction, identical to Scheme 10, carried out with higher catalyst loading and 
higher temperatures.36 
 
Rutjes and co-workers also utilised the RCM approach to produce a fluorinated piperidine 
47.37 Alkylating amine 45 with 1-chloro-2-fluoro-2-propene they could produce the RCM 
precursor 46 in 79% yield. The RCM proceeded smoothly with Grubbs 2nd generation 
catalyst to afford the fluoro-piperidine 47 in 99% yield (Scheme 12).  
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79% 46 47
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Scheme 12. Synthetic route to fluorinated piperidine 47 with ester substituent.37 
 
Rutjes and coworkers also managed to extend this methodology to synthesise a 7-
membered ring variant. Using Mitsunobu chemistry, they synthesised the RCM precursor 
49 in a 68% yield. With the vinyl fluoride in hand, treatment with Grubbs 2nd generation 
lead to rapid metathesis giving the 7-membered fluorinated piperidine 50 in a good 94% 
yield (Scheme 13).38  
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Scheme 13. Mitsunobu conditions were used to alkylate electron deficient sulfonyl amine 48 to 
form 49, followed by ring closure to produce heterocycle 50.38 
 
Hammond and co-workers also used a RCM approach,34 this time an ene-yne metathesis 
process to produce a number of difluorinated δ-lactams 54-56 in good yields (Scheme 
14).  
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69-70%51 R = H
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O
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Scheme 14. Treatment with Hoveyda-Grubbs catalyst 2nd generation afforded the lactams 54-56 
via an ene-yne metathesis reaction starting from the gem-difluoropropargyl amides 51-53.34 
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1.3.3: Pyrrole  
 
Pyrroles are historically one of the most important heterocyclic compounds, finding many 
uses in medicinal and pharmaceutical chemistry as key drug fragments.39 As a result, the 
synthesis of these molecules has been widely explored with much success;40 however the 
synthesis of fluorinated pyrroles, as with many fluorinated compounds, has lagged behind 
and routes are plagued with low yields and poor selectivity.  
 
1.3.3.1: Direct fluorination of pyrrole rings 
 
Direct fluorination of the pyrrole ring would be seen as the most atom-efficient route for 
yielding the target molecules. This has been explored by Fornarini and coworkers using 
elemental fluorine with N-methylpyrrole 57, however, rapid polymerisation led to a mixture 
of products being formed.41 Fornarini reported poor selectivity, forming the 2-fluoropyrrole 
58, 3-fluoropyrrole 59 as well as fluorination on the N-methyl group forming 60 (Scheme 
15).      
 
N N N NF
F
FF2-pyridine
CHCl3
- 60 oC
57 58 59 60  
Scheme 15. Direct fluorination of N-methylpyrrole with elemental fluorine in pyridine. Yields were 
not given for the mixture of products obtained 58-60.41 
 
Yamamoto and co-workers reported a more useful Lewis acid catalysed fluorination of 
pyrrole 61 yielding 2-fluoropyrrole 62 in a moderate 53% yield.42 Compared to many of the 
direct fluorination conditions, the reagents N-fluorobenzenesulfonimide (NFSI) and ZrCl4 
are reasonably easy to handle and convenient to use (Scheme 16).  
 
H
N
H
NF
NFSI, ZrCl4
CH2Cl2
53%61 62
12 h, rt
 
Scheme 16. Lewis acid catalysed fluorination of pyrrole 61 described by Yamamoto et al.42  
 
Lindel and coworkers utilised microwave irradiation to convert a number of substituted 
pyrroles 63-66 into the corresponding 5-fluoro-pyrroles 67-70.43 The conditions were mild, 
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using Selectfluor® as the fluorinating source, however the yields were moderate to poor 
with large amounts of starting material recovered in all cases (Scheme 17). The pyrroles 
generated were then utilised in the synthesis of a number of fluorinated analogues of the 
serotonergic receptor antagonist, hymenidin.43 
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H
NFO
R XX
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RCH3CN, MW
reflux, 5 min
Selectfluor®
32-45%63 X = H,  R = CCl3
64 X = Br, R = CCl3
65 X = H,  R = i-Bu
66 X = H,  R = NH2
67 X = H,  R = CCl3
68 X = Br, R = CCl3
69 X = H,  R = i-Bu
70 X = H,  R = NH2  
Scheme 17. Microwave irradiation of substituted pyrroles 63-66 with Selectfluor®, by Lindel and 
coworkers, produced the fluorinated pyrroles 67-70 in moderate yields.43  
 
Metalation and addition to an electrophillic fluorine source is also a common way to 
fluorinate heterocycles. It is usually not as efficient as direct fluorination as the 
corresponding halo-pyrrole often has to be produced first; however good selectivity for 
fluorination can usually be achieved. Starting with 3-bromopyrrole 71 it has been shown 
that it is possible to form the equivalent 3-fluoropyrrole 72 via two different metalation 
conditions (Scheme 18). Exchange of the bromine atom for a lithium atom, before addition 
of the lithiated pyrrole to electrophilic fluorine source NFSI, can be used to yield 3-
fluoropyrrole 72 in a moderate 50% yield.44 Alternatively, it is also possible to form a 
Grignard reagent which can be added to NFSI yielding the same fluoropyrrole 72 in a 
slightly lower 43% yield.45 
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2. NFSI, 25 oC, 24 h
1. i-PrMgCl·LiCl
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50% 43%
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Scheme 18. Metalation of the bromopyrrole 71 before treatment with NFSI to give the 
corresponding fluoropyrrole 72 in moderate yields.44,45  
 
1.3.3.2: Pyrrole synthesis via cyclisation of fluorinated precursors 
 
Aromatisation of 3,3-difluoro-1-pyrrolidine 75-76 via reaction with different sodium 
alkoxides was used by De Kimpe and coworkers to produce 3-fluoropyrroles 77-78 in 
variable yields.46 Fluorination of the pyrrolidines 73-74 was undertaken using Selectfluor® 
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and a catalytic amount of TFA to ensure enamide formation could allow a second 
fluorination (Scheme 19).   
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73 Ar = Ph 
74 Ar = 4-FC6H4
75 Ar = Ph 
76 Ar = 4-FC6H4
77 Ar = Ph 
78 Ar = 4-FC6H4  
Scheme 19. Fluorination followed by elimination allowed the conversion of pyrrolidine compounds 
73-74 to 3-fluoropyrroles 77-78 as reported by De Kimpe et al.46  
 
In a further report, De Kimpe et al. used gold catalysis to cyclise a range of fluorinated 
alkyne compounds 81a-d to form the corresponding 3-fluoropyrroles 82a-d in good 
yields.47 Lithiation of a difluorobromoalkyne 80 followed by reaction with various 
sulfonimines 79a-d formed the fluorinated cyclisation precursors 81a-d in variable yields 
(Scheme 20).  
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Scheme 20. Synthesis of 3-fluoropyrroles 82a-d through a gold catalysed cyclisation reaction 
reported by De Kimpe et al.47  
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2: Aims  
 
Over the past few years, there has been a developing interest in the synthesis of 
fluorinated nitrogen heterocycles and many successful routes have been proposed. 
However, most of the routes are either low yielding or require the use of starting materials 
that are not readily accessible. Therefore, there is a requirement for new routes that are 
efficient, short and generated from readily available starting materials.  
 
A key aim of the present work is to produce such a route and to synthesise an array of 
fluorinated nitrogen heterocycle analogues. One of our proposed routes involves the aza-
Achmatowicz rearrangement as the key step. This would produce a novel fluorinated 
pyridone 84 that could in turn be converted to fluorinated pyridine or piperidine analogues, 
83 and 85 (Figure 7).  
 
N
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NH
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F
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83 84 85  
Figure 7. Examples of targeted fluorinated nitrogen heterocycles, 83-85, to be accessed via an 
Achmatowicz rearrangement approach.   
 
Another route that will be investigated, utilises a ring-closing metathesis protocol with vinyl 
fluorine precursors to give the desired fluorinated heterocycles. It is hoped that the 
flexibility of this methodology will allow for a variety of different ring sizes and heterocycle 
classes, 86-89, to be accessed in a synthetically expedient manner (Figure 8). 
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Figure 8. Examples of targeted fluorinated nitrogen heterocycles 86-89 to be accessed via an 
RCM approach.   
 
Once an efficient and flexible route has been established, the next aim would be to utilise 
the methodology to produce some fluorinated biologically active compounds. A number of 
nitrogen heterocycles that are active in the inhibition of poly ADP ribose polymerase 
(PARP) enzymes are of interest in this respect.  
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3: Fluorinated nitrogen heterocycle synthesis via the aza-
Achmatowicz rearrangement 
 
3.1: Introduction 
 
Nitrogen heterocycles can be formed by an oxidation cascade initiated by an oxidative 
ring expansion of α-furylamides to form hemiaminals.48 The oxidative ring expansion in 
question is known commonly as the aza-Achmatowicz rearrangement.48  
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Scheme 21. The accepted mechanism for the aza-Achmatowicz rearrangement, R is an electron 
withdrawing group, for example a tosyl or a carbamate.49, 50 
 
The mechanism, synonymous to the classic Achmatowicz rearrangement,51 proceeds via 
a directed epoxidation followed by ring opening. Ring expansion occurs as the nitrogen 
atom is incorporated to yield a new heterocyclic structure 91 (Scheme 21).49,50    
 
There has been significant attention given to this transformation in the field of total 
synthesis as it allows rapid access to some interesting families of natural products. 
Cuifolini and co-workers utilised this protocol in the synthesis of the piperidine alkaloid, 
desoxoprosopinine B, 94 (Scheme 22).49 In 2006, Padwa and co-workers applied the aza-
Achmatowicz rearrangement to the synthesis of the Cassia and Prosopis alkaloid family, 
97-100 (Scheme 23).50  
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27 
Scheme 22. Cuifolini et al. published the synthesis of desoxoprosopinine B 94, the key step being 
an aza-Achmatowicz rearrangement using Br2 and MeOH.49 
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Scheme 23. Cassia and Prosopis alkaloid family, 97-100, were accessed by Padwa and co-
workers in 2006 through the rearrangement of furan 95 to hemiaminal 96 using mCPBA.50 
 
Perry and co-workers utilised the aza-Achmatowicz rearrangement in the synthesis of a 
range of pyridines 107-109 (Scheme 24).52 Oxidative rearrangement of furan precursors 
101-103 was followed by Lewis acid promoted aromatisation to produce 3-tosylpyridines 
107-109 in good yields over the two steps. The protecting group migrated from the 
nitrogen to the oxygen during the aromatisation procedure.  
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Scheme 24. Pyridine synthesis via aza-Achmatowicz rearrangement followed by Lewis acid 
promoted aromatisation in 36-91% yields the for 107-109 over the two steps.52 
 
Our aim was to utilise this process in the synthesis of fluorinated nitrogen heterocycles 
such as pyridines, lactams and piperidines (Figure 9). Initial optimisation would focus on 
the development of a non-fluorinated analogue to validate the route before incorporation 
of a fluorine atom.  
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Figure 9. Examples of targeted fluorinated nitrogen heterocycles, 83-85, to be accessed via an 
aza-Achmatowicz rearrangement approach.   
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3.2: Retrosynthetic analysis for the synthesis of fluorinated pyridines 
 
The retrosynthetic analysis proposed envisions the target pyridines 110 as originating 
from the aromatisation of pyridinones 111 (Scheme 25). Pyridinones 111 is the product of 
the aza-Achmatowicz rearrangement from precursors 112. Furfuryl amines 112 can be 
formed from the aldehyde 113, which is first converted to the imine followed by addition of 
a nucleophile to install various R groups. Aldehyde 114 will be produced from the 
fluorofuran 115, which in turn could be produced from the commercially available 3-
bromofuran 116 via lithium-halogen exchange.53 
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Scheme 25. Retrosynthetic analysis for the synthesis of fluorinated pyridine 110 the key step being 
an aza-Achmatowicz rearrangement. 
 
3.3: Optimisation of non-fluorinated route – building the rearrangement 
precursor  
 
Before adding a fluorine atom into the system, attempts were made to convert the furan 
starting material into the rearrangement precursor. This would be needed if the 
subsequent fluorinated route, starting from 3-bromofuran 116, was to be carried out. The 
formylation of furan and subsequent conversion to the imine 118 were carried out using 
conditions reported by Padwa et al (Scheme 26).54  
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Scheme 26. The production of sulfonamide 119 from furan in 3 steps.54,55 
 
With the formation of the imine in place, an array of different groups could be added in the 
form of Grignard reagents. This would provide the flexibility needed to prepare an array of 
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different pyridine analogues from a common intermediate. Following a procedure reported 
by Padwa and co-workers, ethyl magnesium bromide was added to imine 118 to produce 
amine 119, the rearrangement precursor (Scheme 26).54  
 
3.4: Optimisation of non-fluorinated route – rearrangement and 
aromatisation 
 
Initial testing and optimisation of the rearrangement and aromatisation methodologies 
were undertaken. Furfurylamine was used as a model system due to its commercial 
availability and ease of conversion into a precursor for the rearrangement (Scheme 27). 
Furfurylamine was converted to the sulfonamide 120 through a reaction with p-
toluenesulfonyl chloride and pyridine, in an unoptimised process, to give the sulfonamide 
120 in a moderate yield. 
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Scheme 27. Protection of furfurylamine with a tosyl group producing 120.56  
 
Having established a viable synthesis of the sulfonamide precursor, the aza-Achmatowicz 
rearrangement was attempted using m-CPBA as the oxidant.57 The rearrangement 
proceeded smoothly with complete conversion to product after 7 hours. The use of N-
bromosuccinamide (NBS) as a potential oxidant was also investigated. This accelerated 
the reaction, achieving complete conversion in less than 10 minutes without the need for 
anhydrous conditions (Scheme 28).52 The cyclised product 121 was not purified due to 
fears over its instability; however, the crude material was of sufficient purity to move 
forward with the synthesis.    
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Scheme 28. aza-Achmatowicz rearrangement of amine 120 to generate hemi-aminal 121 using 
NBS as the oxidant.52  
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Following a literature procedure, the aromatisation step was carried out using AlCl3 as a 
Lewis acid, however, only a low yield of 122 resulted (Scheme 29).52 In an attempt to 
increase the aromatisation yield, the Lewis acid was switched to BF3·OEt2 and the 
reaction re-attempted (Scheme 29). Under these conditions, a much improved 70% yield 
of pyridine 122 was achieved.  
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Scheme 29. Lewis acid promoted aromatisation of the pyridinone 121 to the analogous pyridine 
122.52  
 
3.5: Optimisation of fluorinated route starting from 3-bromofuran 
 
Following the successful production of a pyridine core and the development of a plausible 
synthetic route, investigations began into the fluorination of the furan and the conversion 
of the product into the rearrangement precursor. The initial plan was to use a lithium-
halogen exchange reaction on commercially available 3-bromofuran and introduce the 
fluorine using an electrophilic fluorine source (Scheme 30).53 This was attempted initially 
with n-butyllithium and subsequently t-butyllithium, however, no product was formed in 
either case. A complex mixture of products was formed in the reaction and the volatility of 
the desired compound lead difficulty in purification.  
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Scheme 30. Lithium-halogen exchange of 3-bromofuran 116 to yield the resulting fluorinated 
compound 115, however 115 could not be isolated.53 
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Formylation of 116 was attempted, in order to functionalise the ring prior to fluorination. 
Thus, a Vilsmeir-Haack reaction was carried out on 3-bromofuran 116, however, no 
product could be detected (Scheme 31).55 Although other formylation techniques could be 
attempted they usually require the use of incompatible reagents. Thus, concerns about 
the stability of the starting material under these conditions prevented us pursuing this 
approach.  
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Scheme 31. The Vilsmier-Haack formylation on furan to yield furaldehyde 117. However no 
product was attained from the brominated example 116.55 
 
At this stage, more promising developments with regards to other synthetic routes shifted 
our attention to different chemistry (vide infra) and no further work was carried out in this 
area.  
 
3.6: Conclusion and future work 
 
Investigations into the use of the aza-Achmatowicz rearrangement as a tool to produce 
fluorinated nitrogen heterocycles were conducted. A non-fluorinated pyridine 122 was 
generated in a quick, efficient manner from a furan starting material 120 (Scheme 32).  
However, when the incorporation of a fluorine atom was probed, the synthesis of the 
fluorinated furan starting material proved non-trivial. As a result, the aza-Achmatowicz 
rearrangement on a fluorinated furan precursor could not be carried out.  
 
O NHTs
120
NTs
O
OH
NBS
THF-H2O (9:1)
Na2CO3, NaOAc
0 oC, 0.1 h
121
Quantitative
N
OTsBF3
·OEt2
CH2Cl2
-78 oC, 2 h
122
70%
 
Scheme 32. Synthesis of pyridine 122 in two steps from furan 120.  
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Hammond and co-workers reported the synthesis of 3-fluorofuran compounds such as 
125 in good yields from difluoroalkene starting materials, 124 (Scheme 33).58 Utilising this 
chemistry to produce such starting 3-fluorofuran compounds, it may be possible to build 
the aza-Achmatowicz rearrangement precursor and produce fluorinated pyridines via this 
synthetic route.  
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Scheme 33. 3-Fluorofuran synthesis reported by Hammond.58 
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4: The synthesis of 6-membered nitrogen heterocycles using 
ring-closing metathesis 
 
4.1: Introduction 
 
Ring-closing metathesis (RCM) is a type of olefin metathesis in which two alkene 
moieties, bound by a linker, are reacted together to form an unsaturated ring.59 The 
process has been documented since 1980,60 however pioneering work by Grubbs and 
Schrock in the early 90’s brought it into mainstream organic chemistry with the 
development of stable metathesis pre-catalysts (Figure 10).59 A Nobel Prize for chemistry 
was awarded to both Schrock and Grubbs for their contributions to this field along with 
Chauvin for his integral mechanistic insight into this process.61  
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PCy3Cl
Cl Ru
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Cl
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CF3
CF3
CF3
CF3
126 127 128  
Figure 10. Structures of common metathesis precatalysts: Schrock A 126, Grubbs 1st generation 
127 and Grubbs 2nd generation 128 from left to right.62,63,64 
 
Following in situ catalyst activation, the mechanism involves a [2+2] cycloaddition 
between the catalyst and an alkene to form a cycloruthenabutane intermediate. This ring 
then collapses to give the metal carbene with elimination of ethene. The metal carbene 
can now undergo another [2+2] cycloaddition to the second tethered alkene and the same 
process leads to elimination of the ring-closed product and regeneration of the active 
catalyst (Figure 11).65  
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Figure 11. A simplified mechanism of the RCM reaction with activated metal catalyst.65 
 
In 1992, the first nitrogen heterocycles were synthesised through a ring-closing 
metathesis approach by Grubbs and co-workers.66 Using the molybdenum catalyst 
developed by Schrock 126 (Figure 10), they were able to produce an array of unsaturated 
nitrogen heterocycles, 132-134, ranging from 5- to 7-membered rings in good yields (73-
86%) (Scheme 34).  
 
NN
n n
73 - 86%
Schrock Cat. 126
benzene
rt
132 n = 1
133 n = 2
134 n = 3
129 n = 1
130 n = 2
131 n = 3  
Scheme 34. RCM reactions perfomed by Grubbs and co-workers yielding a number of saturated 
nitrogen heterocycles 132-134.66 
 
One of our initial ideas focused on utilising a ring-closing metathesis (RCM) approach to 
access a range of fluorinated nitrogen heterocycles. Previous work in this area by the 
groups of Haufe, Rutjes and Hammond, amongst others, has demonstrated the potential 
of RCM for the production of fluorinated heterocycles (Section 1.3.2).34-38 It is the aim of 
the present work to produce a route to a common α,β-unsaturated lactam intermediate 87 
which could be converted late-stage into a number of heterocycle classes 86 and 88. 
Initial attempts will focus on the synthesis of heterocycles featuring a 6-membered ring. 
Following this, attempts will be made to develop a more general procedure for the 
production of heterocycles containing different ring sizes, such as fluorinated pyrrole 89 
(Figure 12).  
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Figure 12. Examples of targeted fluorinated nitrogen heterocycles, 86-89, to be accessed via an 
RCM approach.   
 
4.2:  Retrosynthetic analysis for the synthesis of fluorinated nitrogen 
heterocycles 
 
The commercial availability of a range of fluorinated alkenes, such as 135 and 136, 
presented us with the opportunity to build fluorinated nitrogen heterocycles via an RCM 
process.  
 
   
F
OMe
O
136
F
OH
O
135  
Figure 13. Commercially available fluorinated alkene compounds. 
 
Retrosynthetically, we envisioned pyridone 137 as originating via an oxidative process 
from the unsaturated lactam 87 (Scheme 35). Ring-closing metathesis could be used to 
form the cyclic system from the diene 138. Diene 137 could be formed through the 
coupling between allyl amine 139 and fluorinated acid 135, with amine 139 being 
generated from a commercially available aldehyde. 
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Scheme 35. Retrosynthetic analysis of potential route to fluorinated pyridones, 137.  
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4.3: Production of nitrogen heterocycles using ring-closing metathesis 
methodology  
 
Initial testing and optimisation of the ring-closing metathesis methodology for the 
synthesis of nitrogen heterocycles was first undertaken without inclusion of the fluorine 
functionality.  
 
The first step in the forward synthesis was the generation of allyl amine 139 from 
benzaldehyde using aqueous ammonia and allylboronic acid pinacol ester (Scheme 36), 
under conditions reported by Kobayashi and co-workers.67 Initial attempts resulted in the 
formation of amine 139 in a 52% yield. The main side product was alcohol 141, which was 
formed by the reaction of the boronic ester with the starting material, in a reaction that 
competed with the desired process (Figure 14). However, alcohol 141 was easily removed 
via an acid-base extraction.67 The allylic amine 139 was coupled with acryloyl chloride to 
produce diene 140 in a moderate yield of 56%.68  
 
O NH2
HN
O
Cl
O
Et3N
CH2Cl2
139 140
BPin
25% aq. NH3
DBSA
52% 56%
 
Scheme 36. Aminoalkylation of benzaldehyde, followed by acryloyl chloride addition to produce 
140. DBSA stands for dodecyl benzenesulfonic acid.67, 68 
 
OH
141  
Figure 14. Alcohol 141. The main side product of the amino-alkylation reaction.67 
 
Ring-closing metathesis of diene 140 proceeded in high yield to give the bicyclic unit 142 
(Scheme 37). As with all metathesis reactions, control of the concentration was vital to 
ensure the desired process occurred instead of the competing dimerisation that could 
occur through cross metathesis.69 In an initial attempt, a concentration of diene in 
dichloromethane of 0.042 g mL-1 was used, however, only a 42% yield of 142 was 
isolated. The mixture was subsequently diluted to 0.01 g mL-1 and the desired RCM 
reaction occurred in a favourable 94% yield.    
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Scheme 37. The ring-closing metathesis on 140 to give dihydro-pyridinone 142.69  
 
The final step in the synthesis involved the oxidation of the dihydro-pyridinone 142 to the 
analogous pyridone 143. For this to be achieved, a hydride at the 6- position needed to be 
extracted, requiring the use of a strong oxidising agent. For this purpose, we chose to 
treat our recently obtained α,β-unsaturated lactam 142 with 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) in CH2Cl2 at room temperature.70 The reaction was not complete 
after 18 hours; however, a promising yield of around 30% was obtained. In order to 
increase the yield, the solvent was switched to toluene and the reaction heated to reflux. 
After stirring for 18 hours at reflux, an acceptable yield of 68% was achieved (Scheme 
38).  
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Scheme 38. The oxidation of ring-closed product 142 to the analogous pyridone 143.70 
 
4.4: Optimisation of one-pot diene synthesis 
 
The success of the aromatisation reaction (Section 4.3) meant that a short 4 step 
synthesis of pyridones from a commercially available aldehyde had been completed. 
However, the yield of the first step was unacceptable, thus before attempting to develop 
the synthesis of fluorinated analogues a significant improvement to the route had to be 
made. 
 
Veenstra and co-workers reported a one-pot procedure to synthesise a range of protected 
allylic amines, such as 144, using allyltrimethylsilane and BF3·OEt2 in CH2Cl2 or MeCN in 
good yields of up to 95% (Scheme 39).71 Hence, we proposed that if a similar coupling 
reaction could be carried out using acrylamide, the diene precursor 140 could be obtained 
in a single step (Scheme 40).  
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Scheme 39. Synthesis of benzyl carbamate 144 reported by Veenstra and co-workers.71  
 
In order to test this hypothesis, benzaldehyde, acrylamide and allyltrimethylsilane were 
stirred together in acetonitrile with Lewis acid BF3·OEt2 at room temperature (Scheme 40). 
The reaction was very slow and took four days to reach completion; however, the dialkene 
140 was isolated in an excellent yield of 66%. The success of this one pot procedure 
meant that the target pyridone synthesis could be reduced to three steps (Scheme 41).  
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Scheme 40. The one pot production of dialkene 140. 
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Scheme 41. The 3 step synthesis of pyridone 143.      
 
4.5: Scope of three component coupling reaction.  
 
The next stage was to determine the scope of the methodology and produce an array of 
substituted pyridones. Therefore, the one pot dialkene formation was performed on a 
range of different aldehydes and the results are displayed in Table 1.  
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Table 1. Unoptimised yields for the one-pot aminoalkylation with various different aldehydes 
0 - rt R
HN
O
R
O
SiMe3
H2N
O
+ +
BF3·OEt2
MeCNH
 
O
O
O
MeO
O2N
O
O
HN
O
HN
O
HN
O
MeO
HN
O
O2N
HN
O
140
147
145
146
148
Yield / %aTime / dAldehyde Product
4
4
4
6
6
66
45
19
10
46
Entry number
1
4
2
3
5
H
H
H
H
H
a Isolated Yield 
 
As can be seen in Table 1, the results produced were mixed. Low yields were obtained 
when the electronics of the aromatic ring were changed from benzaldehyde (Entry 1) 
which exhibited the highest yield. In the presence of an electron-donating substituent 
(Entry 2), a poor yield of 19% of 145 was obtained due to poor reactivity of the starting 
aldehyde. In the presence of an electron-withdrawing substituent (Entry 3) a yield of 10% 
of 146 was obtained. In the case of the electron withdrawing group, a 52% yield of the 
alcohol 149 was obtained (Figure 15), showing that the highly electrophilic nature of the 
aldehyde favoured addition of the allyltrimethylsilane to the aldehyde before the desired 
imine formation could take place. Aliphatic examples, 147 (Entry 4) and 148 (Entry 5), 
were generated in moderate yields of 45% and 46% yields respectively. 
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Figure 15. Alcohol 149. The main side product of the amino-alkylation reaction with p-
nitrobenzaldehyde. 
 
As the yields and time scale for the reaction were not satisfactory, further optimisation of 
this step was carried out. It was thought that the reason the reaction was so slow was due 
to the unreactive nature of acrylamide (Figure 16). The competition between the 
acrylamide and the allyltrimethylsilane to react with the aldehyde was severely lowering 
the reaction yields and dramatically reducing the routes scope.  
 
NH2
O
NH2
O
 
Figure 16. Resonance forms of acrylamide reducing the nucleophilicity of the nitrogen.  
 
Taking this into account, the reaction was modified in order to increase the likelihood of 
the imine formation. Under the new procedure, the aldehyde was stirred with 3 
equivalents of acrylamide and 1 equivalent of Lewis acid for 5 hours prior to subsequent 
addition of allyltrimethylsilane and a further equivalent of Lewis acid. This modification 
was first attempted on benzaldehyde and resulted in a dramatic increase in the yield to 
88%, in addition to a reduction in the reaction time to a total of 22 hours (Scheme 42).  
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Scheme 42. Optimised one pot production of dialkene 140.  
 
4.6: Extension of methodology for non-fluorinated nitrogen heterocycle 
synthesis 
 
Having developed an expedient methodology for heterocycle synthesis, a range of 
aldehydes were subjected to the reaction conditions and the results are displayed in Table 
2. 
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Table 2. Results of the optimised one pot production of dialkene analogues 140, 145-148 and 151-
155, using a range of aldehydes. 
HN
O
R
O
H2N
O
+
R
N
O
MeCN R
5 h, rt
BF3·OEt2
SiMe3
17 h, rt
BF3·OEt2
 
140
147
145
146
148
MeO
O2N
Product Yield / %a Product Yield / %a
N
O
O
88
66
83
34
86
91
20 41
0
0
HN
HN
HN
HN
HN
HN
HN
152
151 155
153
154
Entry no Entry no
1
4
2
3
5
6
7
8
9
10
O
O
O
O
O
N
HN
O
O
O
HN
O
HN
O
a Isolated Yield 
 
The results were promising for a variety of aldehydes (Table 2). The electron rich 4-
methoxybenzaldhyde was converted to amide 145 in an 83% yield (Entry 2), as compared 
with 19% under the previous conditions (Table 1, Entry 2). The electron poor 4-
nitrobenzene analogue 146 (Entry 3) was obtained in an improved yield of 34%, however 
insolubitiy issues with the intermediate imine prevented higher conversion to the desired 
product. Aliphatic examples 148 (Entry 6) and 152 (Entry 7) worked especially well with 
yields of 86 and 91% obtained respectively. A few of the desired products were not 
formed under the reaction conditions including furan 153 (Entry 9) and pyridine 154 (Entry 
10). This could be explained by the presence of heteroatoms in the ring systems, which 
could result in an interaction with the Lewis acid in the mixture. This is especially prevalent 
in the case of furfural (Entry 9) which in the presence of BF3·OEt2 has the potential to ring 
open. However, in contrast, a 41% yield of the oxazole 155 was obtained (Entry 8).   
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Following the successful dialkene formation, the ring-closing metathesis was performed 
on the range of analogues (Table 3). This was carried out as previously described 
(Section 4.3) using 10 mol% Grubbs 1st generation catalyst 127 in dichoromethane at 
reflux. 
 
Table 3. The products and yields of the ring closing metathesis reaction to generated α,β-
unsaturated lactams 142, 156-162. 
R
HN
O
R
HN
OGrubbs I cat. 127
 (10 mol %)
CH2Cl2
reflux, 18 h  
MeO
O2N
RCM product Yield / %a,b RCM product Yield / %a,b
N
O
94
94
99
99
90
84
68
0
HN
HN
HN
HN
HN
HN
HN
O
HN
O
O
O
O
O
O
O
142
158
156
157
162
159
160
161
Entry no
1
4
2
3
Entry no
6
7
8
5
 
  a Isolated Yield. b Concentration = 0.01 g ml-1. 
 
The RCM reaction proceeded efficiently with the majority of the analogues tested, 
producing the target dihydropyridones in good yields (Table 3). The analogues possessing 
electron donating and electron withdrawing groups, 156 and 157 respectively, (Entries 2 
and 3) were both obtained in an excellent 99% yield. Ring closure occurred selectively in 
the case of the unsaturated diene 151 to produce 161 in a good yield of 68% (Entry 7). 
The one analogue that was not obtained was the substituted oxazole 162 (Entry 8); it is 
possible that the presence of electron rich heteroatoms may have poisoned the catalyst 
before the reaction could proceed.72 
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The next step involved an oxidation with DDQ to yield the relevant pyridone. Using the 
procedure as previously described (Section 4.3) with DDQ in toluene at reflux, the 
oxidations were attempted on the RCM products (Table 4). 
 
 
Table 4. The oxidation of RCM products with DDQ to form pyridone compounds 143 and 163-168. 
R
HN
O
R
HN
O
PhMe
reflux, 18 h
1.5 eq. DDQ
 
MeO
O2N
RCM product Yield / %a RCM product Yield / %a
68
0
76
0
0
0
0
HN
HN
HN
HN
HN HN
O
HN
O
O
OO
O
O
143
165
163
166
167
168164
Entry no
1
4
2
7
Entry no
6
3
5
   a Isolated Yield 
 
Disappointingly, the previously successful oxidation of the phenyl analogue (Entry 1) could 
not be replicated with the vast majority of the other analogues. It was evident from the 
results that the electronics of the R group were integral to the success of the oxidation 
reaction. With the phenyl and aromatic electron donating substituents 143 and 163 the 
reaction proceeded in reasonable yields (Entries 1 and 2), however with an aromatic 
electron withdrawing substituent or aliphatic substituents, 164 and 165-167, the reaction 
did not proceed at all (Entries 3-7). It has been postulated by Linstead and co-workers that 
the mechanism of DDQ dehydrogenation proceeds initially via a hydride abstraction to 
leave a carbocation followed by a further adjacent proton removal to yield the saturated 
system (Scheme 43).73 This being the case, a possible reason for the failed oxidation of 
most analogues could be due to a lack of stabilisation of the carbocation in the transition 
state, meaning hydride abstraction was disfavoured. This would also explain the good 
yield observed in the presence of the compound 163, with the electron donating 
substituent, as in that instance the carbocation would be stabilised.  
44 
 
R
HN
O
H H H
O
O
CN
CNCl
Cl
HN
O
H H
R
O
OH
Cl
Cl CN
CN
HN
O
R
OH
OH
Cl
Cl CN
CN
170
169
171
172  
Scheme 43. Mechanism proposed by Linstead and co-workers for mechanism for DDQ 
dehydrogenation applied to the reaction carried out above.73 
 
4.7: Optimisation of conditions for the oxidation of α,β-unsaturated lactam 
142 
 
With the DDQ reaction only oxidising two analogues, more general conditions were 
required if aromatic heterocylces were to be accessed via this route. The conditions 
attempted could be split into to two categories: firstly oxidisation of the ring directly and 
the second ring modification followed by elimination (Table 5).   
 
Table 5. Reagents and conditions used to aromatise dihydropyridone 142 to pyridone 143 by direct 
oxidation.74-77 
HN
O
HN
O
 
Entry No. Reagents Conditions Yield / %a 
1 DDQ CH2Cl2, rt 30 
2 DDQ toluene, reflux 68 
3 CAN MeCN, reflux 0 
4 IBX DMSO, 45 to 80 °C 0 
5 Hg(OAc)2 H2O/EtOH 0 
6 DBU/CCl3Br CH2Cl2, rt 0 
                 a Isolated Yield. 
 
The direct oxidation of the ring was attempted with CAN (Entry 3),74 IBX (Entry 4),75 
Hg(OAc)2 (Entry 5),76 and DBU/CCl3Br (Entry 6),77 however there was no reaction with any 
of these oxidising agents (Table 5). 
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Table 6. Reagents and conditions used to aromatise dihydropyridone 142 to pyridone 143 via 173 
using a halogenation-elimination approach.78-79 
HN
O
HN
O
N
O
X
 
Entry No. Reagents Conditions Yield / %a 
1 tBuOK/NCSb THF, rt 0 
2 NBS/DBUc CH2Cl2, rt 0 
3 Br2/DBUc CH2Cl2, rt 0 
a Isolated Yield. b X = Cl. C X = Br. 
 
In the second category, halogenation of the amide followed by elimination was attempted 
under various conditions (Table 6). Chlorination was attempted with NCS, to form a N-Cl 
bond, before potassium tert-butoxide was added to eliminate the chlorine however no 
product was isolated (Entry 1).78 Bromination was also attempted with firstly NBS followed 
by bromine elimination with DBU but again only starting material was isolated (Entry 2).79 
Bromine was also used to followed by DBU, however, this time there was evidence of new 
product characteristic of over brominated material and not the desired product (Entry 3).   
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Scheme 44. Attempted allylic oxidation of dihydropyridone 142 using SeO2.80  
 
Finally, selenium dioxide was used as a stratergy to add an allylic alcohol, 174, that could 
be eliminated to yield the desired product, however no oxidation was observed (Scheme 
44).80  
 
4.8 Conclusions and future work 
 
A three step, two-pot route to dihydropyridones was established and a library of 
compounds synthesised (Scheme 45). Imine formation followed by allylation yielded the 
intermediate diene compounds 151-155 in an efficient one-pot process. Ring-closing 
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metathesis could then occur smoothly on addition of Grubbs 1st generation catalyst 127 
producing the dihydropyridones 156-162 in high yields.  
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Scheme 45. Rapid, protecting group free synthesis of dihydropyridones 156-162 starting from 
common aldehydes.  
 
General conditions for oxidation from the dihydropyridone to the pyridone and 
subsequently the pyridine have not been achieved so far. Donohoe and co-workers 
produced the pyridone 176 and pyridine 178 via elimination reactions using 1,8-
diazabicycloundec-7-ene (DBU); a similar approach in this work may lead to successful 
pyridine synthesis (Scheme 46).79  
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Scheme 46. Synthesis of pyridone 176 and pyridine 178 reported by Donohoe.79 
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5: Development of a route to fluorinated nitrogen heterocycles 
using a ring-closing metathesis protocol  
 
5.1 Introduction  
 
Novel synthetic routes to access fluorinated nitrogen heterocyclic are of keen interest to 
the scientific community. Compounds 87 and 179 are examples of nitrogen heterocycles 
that have been targeted in this thesis and it is our aim to synthesise such compounds via 
a ring-closing metathesis approach (Figure 17).  
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Figure 17. Examples of targeted fluorinated nitrogen heterocycles, 87 and 179, to be accessed via 
an RCM approach.   
 
Following the success of the two step synthesis of dihydropyridones (Section 4.6), our 
next aim was to introduce a fluorine atom into the system. The oxidation of the 
dihydropyridones 156-162 had not been achieved (Section 4.6), however reduction to the 
δ-lactam 180, shown previously by Marquez and co-workers, had been demonstrated in 
quantitative yields (Scheme 47).81 Therefore, a three step synthesis of fluorinated δ-
lactams was targeted, with fluorinated lactam 87 being a key intermediate.  
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Scheme 47. Work within the Marquez group has shown the dihydropyridone 142 can be reduced 
to the lactam 180.81 
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5.2 Retrosynthetic analysis 
 
A new retrosynthetic approach was devised starting from the fluorinated δ-lactam 179 
(Scheme 48). The δ-lactam 179 would be generated, as described, from the 
dihydropyridone 87. This in turn would be produced through the ring-closing metathesis 
reaction of the dialkene 138, with ring closure taking place between with the vinyl fluoride 
and allylic alkene. The RCM precursor was envisaged as originating from the 
commercially available aldehyde through a one-pot aminoalkylation as described 
previously, with 2-fluoroacrylamide 181 replacing the acrylamide.  
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Scheme 48. Retrosynthetic pathway for the synthesis of fluorinated δ-lactams.  
 
5.3: Use of 2-fluoroacrylamide for the synthesis of the fluorinated ring-
closing metathesis precursor 
 
In order to commence this route, 2-fluoroacrylamide 181 was synthesised in one step from 
commercially available 2-fluoroacrylic acid methyl ester, 136 using conditions reported by 
Nagata.82 The generation of the amide unit was accomplished in a good yield of 80% by 
stirring the ester 136 with aqueous ammonia (Scheme 49). 
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Scheme 49. Conversion of fluorinated ester 136 to the fluorinated amide 181.82 
 
2-Fluoroacrylamide 181 was then used in the one pot dialkene formation following the 
same conditions described previously (Section 4.4). However, after repeated attempts the 
reaction did not proceed as desired (Scheme 50). It was thought that the fluorine caused 
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the amide to become more electron deficient and was rendered less reactive towards the 
aldehyde.  
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Scheme 50. Attempted one pot dialkene formation attempted with 2-fluoroacrylamide 181 in place 
of acrylamide. 
 
5.4: Synthesis of the fluorinated ring-closing metathesis precursor and initial 
attempts at fluorinated ring-closing metathesis reaction. 
 
With the failure of the one-pot procedure, the synthetic route had to go via the amine 139. 
In the first instance, an amino-allylation reaction could be attempted to form the allylic 
amine 139, which could then be acylated to form the cyclisation precursor 182. The 
synthesis of amine 139 had been attempted previously (Section 4.3, Scheme 36), using 
aqueous ammonia and allyl boronic pinacol ester to produce the homo-allylic amine 139, 
however this only worked in low yields.67 To improve this step, a procedure reported by 
Kobayashi and co-workers was utilised.83 The authors used liquid ammonia to form an 
imine before treatment with allyl boronic pinacol ester to generate 139. Kobayashi 
reported good yields for this reaction in the range of 80 to 90% for a variety of aldehydes 
(Scheme 51).83 
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Scheme 51. An example aminoalkylation reported by Koybayashi and colleagues forming 139 in a 
84% yield.83 
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Following Kobayashi conditions, the amino-allylation reaction was carried out using 
benzaldehyde and the allylic amine 139 was formed.83 The product was purified using an 
acid-base work up and the next step was carried out on the crude material (Scheme 52).  
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Scheme 52. Two step procedure to form diene 182 in 85% from the benzaldehyde.83 
 
The addition of the vinyl fluorine to the system was our next goal. To do this an amide 
coupling reaction was performed with 2-fluoroacrylic acid 135 in the presence of HBTU. 
The coupling reaction proceeded efficiently with complete consumption of starting material 
in under an hour, producing the target dialkene 182 in an excellent yield of 85% from 
benzaldehyde (Scheme 52).  
 
The free acid 135, required to perform the amide coupling, was generated from the 
corresponding methyl ester 136. This hydrolysis was carried out to form the sodium salt, 
followed by acidification to yield the free acid 135 in a high yield of 87% (Scheme 53).84  
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Scheme 53. Conversion of ester 136 to acid 135 in 87% yield.84 
 
Following the successful production the dialkene 182, ring-closing metathesis was then 
attempted to generate the cyclic amide 183. Initially, the previously described conditions 
(Section 4.3, Scheme 37) were tested which utilised 10 mol% Grubbs 1st generation 
catalyst 127 at reflux in dichloromethane (Table 7, Entry 1). However, only cross 
metathesis products were identified and no cyclised product was isolated. The presence 
of the fluorine atom, as expected, caused the alkene to be more electron deficient thereby 
reducing its reactivity towards metathesis.85 The adjacent alkene, however, had no such 
problem and it seemed it was interacting with the catalyst and cross coupling before 
coordination with the electron deficient alkene could occur. In an attempt to circumvent 
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this, the reactions were performed at a higher dilution and the catalyst was switched to the 
more reactive Grubbs 2nd generation catalyst 128 (Table 7, Entries 2 and 3).85 Therefore, 
7.5 mol% Grubbs 2nd generation catalyst 128 was used but under these modified 
conditions the reaction still did not proceed as desired (Entry 2). There was still evidence 
of cross-metathesis and starting material. The reaction was attempted under microwave 
irradiation (Entry 3) but no product was obtained. A different catalyst, Zhan 1B 184 (Figure 
18), was also used but again no product was detected (Entry 4).86   
 
Table 7.  Results for the attempted RCM reactions of 182 to 183.85,86 
HN
F
O
HN
O
F
182 183  
Entry  Pre-catalyst Conditions Yield / % 
1 Grubbs 1st gen. 127 10 mol%, CH2Cl2, refluxa 0 
2 Grubbs 2nd gen. 128 7.5 mol%, toluene, 100 °Cb 0 
3 Grubbs 2nd gen. 128 7.5 mol%, toluene, MW, 100 °Cb 0 
4 Zhan 1B 184 7.5 mol%, toluene, 80 °Cb 0 
       a concentration = 0.01 g mL-1. b concentration = 0.0025 g mL-1 
 
 
Ru
Cl
Cl
NN MesMes
O SO2NMe2
184  
Figure 18. Zhan 1B catalyst, 184.86 
 
The observed failure of the metathesis reaction could be explained by the electron 
deficiency of the fluorinated olefin. However, this may not be the case as there are several 
examples of metathesis with vinyl fluorides in the literature.35-38 On the other hand, 
examination of the literature revealed that there were no examples of ring-closing 
metathesis using substrates containing an unprotected amide within the ring that was to 
be formed.35-38 It was proposed that the available alkene was coordinating to the 
ruthenium catalyst, but the second alkene was being held in position facing away from the 
reactive site preventing further metathesis. It was proposed that the RCM may work using 
a substrate in which the amide was protected. Amide protection could prevent the 
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unwanted interaction of the ruthenium centre with the amide,72 and could also alter the 
conformation of the molecule to potentially bring the two alkenes into closer proximity, 
facilitating the desired reaction via a possible Thorpe-Ingold type effect.87  
5.5: Protection of amide and ring-closing metathesis 
 
Although the installation and removal of a protecting group would result in the lengthening 
of the proposed four step synthesis, it would allow for more flexibility and could potentially 
lead to the synthesis of different final products which could also be of synthetic interest. It 
was proposed that the installation of a protecting group that could be removed by 
elimination, for example tosyl, would allow access of aromatic fluorinated rings 187 
(Scheme 54).79 Alternatively, to access the lactam 190, a benzyl group could be installed 
that could be potentially removed in the same step as the olefin under hydrogenative 
conditions (Scheme 54).   
 
N
O
F
N
F
O
HN
O
F
N
F
O
Ts
N
F
O
HN
F
O
H2 Pd/C
MeOH
DBUTs
185 186 187
188 189 190  
Scheme 54. Two strategies for using protecting groups to aid in the production of fluorinated 
heterocycles. The top scheme utilises the tosyl group where as the bottom uses a benzyl group.79   
 
The first attempt at tosyl protection of amide 185 was carried out with p-toluenesulfonyl 
chloride, triethylamine and DMAP (Table 8, Entry 1), however, this reaction was 
unsuccessful. It was proposed that the amide nitrogen was sufficiently electron deficient 
that it would not attack the tosyl chloride directly following deprotonation. More rigorous 
conditions were then applied, using stronger bases including sodium hydride and n-
butyllithium but only starting material was isolated in both cases (Entries 2 and 3).   
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Table 8. Conditions used for the protection of dialkene 182 with a tosyl group. 
HN
F
O
182
TsN
F
O
185  
Entry No. Base Conditions Yield / % 
1 Et3N/DMAP CH2Cl2, 0 °C to rt, 17 h 0 
2 NaH THF, 0 °C to rt, 2 h 0 
3 n-BuLi THF, -78 °C to rt, 1.5 h 0 
 
After failing to directly protect the amide 182, protection of the allylic amine 139 followed 
by acylation was attempted. The tosyl protection proceeded in a good yield of 86%, 
however, the amide coupling of the resulting sulfonylamide 191 proved challenging 
(Scheme 55). The amide coupling failed both when heated to reflux (Table 9, Entry 2) and 
under microwave conditions (Entry 3).  
 
NH2 NHTsTsCl
DMAP
CH2Cl2, rt
86%
Et3N
139 191  
Scheme 55. Tosyl protection of amine 139 to form sulfonamide 191.  
 
Table 9. Conditions attempted for amide coupling between fluorinated acid 135 with sulphonamide 
191 to give diene 185. 
N
F
O
TsNHTs OH
O
F
HBTU
CH2Cl2
191 185
135
DIPEA
 
Entry No. Conditions Yield / % 
1 rt, 17 h 0 
2 reflux, 17 h 0 
3 MW, 80 °C, 2 h 0 
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As previously described (Vide Supra), an alternative route using a benzyl protecting group 
was also proposed. This was attempted initially using the amine 139 with benzyl bromide, 
however, only product resulting from a double addition was obtained. A subsequent 
attempt using the same substrate utilised benzaldehyde to form the imine, followed by 
reduction with NaBH4 to produce the benzyl protected amine 192. This resulted in the 
isolation of 192 in 68% yield over the two steps (Scheme 56).88 
 
NH2
NH
1.
toluene 
Na2SO4
Ph
2. NaBH4, MeOH
0 oC, 1.5 h
68%
192139
O
reflux, 3h
H
 
Scheme 56. Two step synthesis of protected amine 192 in good yields of 68%.88 
 
Whilst carrying out the above procedure, it was realised that an alternative protocol could 
be used to form the product 192 in one step. Treating benzaldehyde with benzylamine 
followed by alkylation should give 192, thus removing the need to use liquid ammonia and 
the expensive allyl boronic pinacol ester.89 Using this modified approach, benzaldehyde 
was cleanly converted into protected amine 192 in 80% yield in a single pot procedure 
(Scheme 57).  
 
O
NH2
1.
toluene, reflux, 3 h
2. MgBr
Et2O, 0 
oC - rt, 17 h
80%
NH
192
H
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Scheme 57. One pot production of the benzyl protected amine 192 starting from benzaldehyde.88 
 
The protected amine 192 could now be used in the amide coupling reaction with 2-
fluoroacrylamide 135 (Table 10). The reaction was attempted at room temperature (Entry 
1), reflux (Entry 2) and in the microwave (Entry 3) with the best result coming from 
refluxing overnight in CH2Cl2 (Entry 2). These conditions allowed formation of the amide in 
a good yield of 84% (Table 25).  
55 
 
Table 10. Conditions explored for amide coupling reaction to form the dialkene 188  
NH
OH
F
O
HBTU
DIPEA
CH2Cl2
84%
N
F
O
192 188
135
 
Entry No. Conditions Yield / %a 
1 rt, 17 h 42 
2 reflux, 17 h 84 
3 MW, 80 °C, 2 h 71 
              a Isolated Yield 
 
The ring-closing metathesis reaction was then attempted using the protected RCM 
precursor 188. With the protecting group in place, the reaction proceeded efficiently and 
went to completion within an hour. Only 2.5 mol% of Grubbs 2nd generation catalyst 128 
was needed to produce the cyclic amide 189 in 98% yield (Scheme 58).35   
 
188 189
N
F
O
Grubbs II cat. 128 
(2.5 mol %)
toluene
98%
N
O
F
100 oC, 1 h
 
Scheme 58.  Ring closing metathesis reaction to yield the cyclic amide 189 in 98%.35 
 
A hydrogenation reaction was then carried out with the intention of reducing the alkene 
whilst removing the benzyl group simultaneously. Two different sources of H2 were tested, 
ammonium formate with Pd/C in MeOH were used at reflux in the first instance. Under 
these conditions, the olefin was hydrogenated effectively but removal of the benzyl group 
was unsuccessful. It was, therefore, decided to use hydrogen instead of the ammonium 
formate to remove the benzyl group. This was also unsuccessful, hydrogenating the olefin 
but leaving the benzyl group to produce the protected lactam 193 in 81% yield (Scheme 
59). Even when increasing the pressure of hydrogen, the benzyl group could not be 
removed.  
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Scheme 59. Hydrogenation reaction to remove the olefin and the benzyl group however only the 
olefin could be removed to form 193. 
 
5.6: Protection of amide with p-methoxybenzyl group and synthesis of 
fluorinated δ-lactam 
 
An alternative strategy for the removal of the benzyl group would be to employ a strong 
acid, however, this would restrict the scope of the methodology, precluding the use of 
substrates bearing acid labile groups. Therefore, it was decided to use a more easily 
removed protecting group. With this in mind we decided to use a p-methoxybenzyl group, 
which is similar in structure but could be more easily removed by hydrogenation or 
oxidation.91  
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Et2O, 0 
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135
 
Scheme 60. Four step synthesis of protected lactam 196 incorporating a p-methoxybenzyl group 
instead of a benzyl group. 
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The previous reaction sequence was carried out, this time with the installation of a p-
methoxybenzyl protecting group instead of a benzyl protecting group (Scheme 60). 
Following allylmagnesium bromide addition, the protected amine 194 was formed in a high 
yield of 95%. Amide coupling was then carried out with identical conditions to those used 
in the benzyl example this time giving a 60% yield of 195. The RCM reaction was then 
found to proceed in a quantitative yield to form the unsaturated lactam 196 (Scheme 60).  
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F
OMe
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196 197
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Scheme 61. Hydrogenation reaction to yield 197 in 99% yield.  
 
The resulting unsaturated lactam 196 was then subjected to hydrogenation conditions in 
an attempt to remove both the alkene and the p-methoxybenzyl protecting group. 
However, yet again only the alkene was hydrogenated producing the protected lactam 
197 in a 99% yield (Scheme 61).  
 
The p-methoxybenzyl protecting group can also be removed by oxidation, therefore, the 
oxidising agent ceric ammonium nitrate (CAN) was used with this aim.90 The deprotection 
went to completion in 7 hours and resulted in a yield of 94% of the deprotected 
unsaturated lactam 198.22 Hydrogenation was then undertaken, under the conditions used 
previously, to yield the fluorinated lactam 190 in 75% yield, isolated as a single 
diastereomer (Scheme 62). 
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Scheme 62. Removal of the p-methoxybenzyl group followed by hydrogenation to yield the 
fluorinated lactam 190 in 42% yield over five steps.90 
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The hydrogenation of the unsaturated lactam was found to occur selectively on the 
opposite face to the phenyl ring, resulting in the fluorine and the phenyl group residing in a 
cis geometry to one another. This was confirmed by the 1H NMR analysis and 
corroborated by crystal X-ray diffraction analysis (Figure 19).  
 
 
Figure 19. The crystal structure of lactam 190. The fluorine atom in yellow is shown to be on the 
same face as the phenyl ring. 
 
5.7: Extension of the methodology towards the synthesis of a family of 
fluorinated δ-lactams  
 
5.7.1: Extension of the methodology – secondary amine synthesis 
 
Having developed an efficient route to fluorinated lactams, attempts were made to extend 
the scope of the methodology, in order to incorporate a variety of functional groups on the 
lactam ring. Therefore, the amino-alkylation protocol was carried out on a range of 
aldehyde substrates, with good yields obtained in all cases (Table 11). The electronics of 
the aromatic substituent were varied and the effect on the yield investigated. In the 
presence of an electron donating substituent on the aryl ring (Entry 2) and electron 
withdrawing substituent (Entry 3), the desired products 199 and 200 were formed in good 
yields of 80% and 66% respectively. Further examples possessing aromatic substituents, 
1-naphthaldehyde and 4-bromobenzaldehyde were also subjected to the conditions 
producing amines 201 and 202 in excellent 99% and 97% yields (Entries 4 and 5). 
Isovaleraldehyde and cyclohexanecarboxaldehyde were converted to the corresponding 
amines 203 and 204 in 76% and 74% respectively showing that aliphatic aldehydes could 
be incorporated easily (Entries 6 and 7). Finally, a variety of products possessing 
heteroaromatic substituents, 205-207, were synthesised from the relevant aldehydes in 
good yields (Entries 8, 9 and 10).   
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Table 11. The production of amines 199-207 formed in a two step procedure from the 
corresponding aldehydes. 
R
O
NH2
MeO1.
toluene, reflux, 3h
2. MgBr
Et2O, 0 
oC - rt, 17 h R
NH
OMe
H
Na2SO4
 
Product Yield / %a Product Yield / %a
95
76
NH
NH
OMe
OMe
NH
OMe
NH
OMe
MeO
NH
OMe
F3C
NH
OMe
Br
NH
OMe
O
NH
OMe
Ts
N
NH
OMe
N
NH
OMe
80
66
97
99
73
85
83
74
Product Yield / %aEntry No. Entry No. Entry No.
1
2
3
4
5
6
7
8
9
10
194
199
200
201
202
203
204
205
207
206
a Isolated Yield  
5.7.2: Extension of the methodology – amide coupling reaction 
 
The previously described conditions for amide coupling (Section 5.6) were then applied to 
all the secondary amine analogues produced with varied results (Table 12). Compound 
209 (Entry 2), possessing a 4-methoxybenzene substituent on the nitrogen, was 
generated in a good yield of 66%. The reaction proved troublesome in the presence of 
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other aromatic substituents, with a 45%, 54% and 34% yield for the trifluorobenzene, p-
bromobenzene and naphthyl compounds 210-212 respectively (Entries 3, 4 and 5), a 
result of the lowered nucleophilic nature of their nitrogen atom. The compounds 
possessing aliphatic substituents (213 and 214) reacted efficiently, with yields greater 
than 70% obtained in both cases (Entries 6 and 7).  The furan- and pyrrole-containing 
substrates 215 and 216 gave moderate yields, with only 28% and 50% yields obtained 
(Entries 8 and 9); however, a good yield was recorded for the pyridine analogue 217 
(Entry 10).  
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Table 12. The amide coupling reaction of amines 199-207 with the fluorinated acid to produce the 
RCM precursors 208-217.   
R
NH
OMe
R
N
F
O
OMe
OH
F
O
HBTU
DIPEA
CH2Cl2
reflux, 17 h
135
 
Product Yield / %a Product Yield / %a
60
74
N
N
OMe
OMe
N
OMe
N
OMe
MeO
N
OMe
F3C
N
OMe
Br
N
OMe
O
N
OMe
Ts
N
N
OMe
N
N
OMe
66
45
54
34
68
50
28
70
Product Yield / %a
O
F
F
O
O
F
F
O
F
O
O
F
F
O
O
F
O
F
F
O
Entry No. Entry No.Entry No.
1
2
3
4
5
6
7
8
9
10
195
209
210
211
212
213
214
215
216
217
a Isolated Yield 
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5.7.3: Extension of the methodology – RCM reaction 
 
Having obtained sufficient amounts of the appropriate fluorinated diene compounds (209-
217), ring-closing metathesis reactions were attempted using previously described 
conditions (Section 5.6). The RCM reactions proceeded smoothly in nearly all cases 
(Table 13); quantitative yields were recorded for compounds bearing a 4-methoxybenzene 
substituent 218 (Entry 2), a trifluorobenzene substituent 219 (Entry 3) and a naphthyl 
substituent 221 (Entry 5). High yields were also obtained for the compounds 222-225, 
which gave us access to a range of fluorinated aliphatic and heterocyclic substituted α,β-
unsaturated lactams (Entries 6-9). In contrast, the 2-pyridyl substrate failed to undergo 
ring closure (Entry 10) and a quantitative yield of the starting material 217 was isolated. A 
possible explanation is that the nitrogen lone pair on the pyridine ring coordinated to the 
ruthenium centre, resulting in inhibition of the catalytic activity.72 
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Table 13. RCM of dienes 209-217 to produce the fluorinated α,β-unsaturated lactams 218-226. 
R
N
F
O
OMe
N
O
F
OMe
R
Grubbs II cat. 128
(2.5 mol %)
toluene
100 oC, 1h
 
Product Yield / %a,b Product Yield / %a,b
quant
85
N
N
OMe
OMe
N
OMe
N
OMe
MeO
N
OMe
F3C
N
OMe
Br
N
OMe
O
N
OMe
Ts
N
N
OMe
N
N
OMe
quant
quant
99
quant
0
77
64
89
Product Yield / %a,b
O
F
F
O
F
O
F
O
F
O
F
O
F
O
O
F
F
O
F
O
Entry No. Entry No. Entry No.
1
2
3
4
5
6
7
8
9
10
196
218
219
220
221
222
223
224
225
226
a Isolated Yield. b Concentration = 0.0025 g mL-1. 
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5.7.4: Extension of the methodology – p-methoxybenzyl deprotection 
 
The p-methoxybenzyl deprotection proved inconsistent when applied to a variety of 
analogues (Table 14); much lower yields were obtained for compounds with p-
methoxybenzene 227 and p-trifluoromethanebenzene substiuents 228 of 40% and 47% 
respectively (Entries 2 and 3) compared to the original phenyl substituted compound 197 
(Entry 1). The p-bromobenzene and naphthyl compounds 229 and 230 showed better 
conversions with 72% and 61% yields isolated respectively (Entries 4 and 5). The aliphatic 
analogues reacted efficiently under these conditions, with a 97% yield obtained for the 
isovaleryl lactam 231 (Entry 6) and a 79% yield achieved for the cyclohexyl lactam 232 
(Entry 7). The use of heterocyclic compounds 233 and 234 resulted in no product 
formation on treatment with CAN; we believe that these heterocyclic compounds were not 
compatible with the oxidative conditions used and a complex mixture of breakdown 
products was generated (Entries 8 and 9).91  
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Table 14. Removal of p-methoxybenzyl group to give α,β-unsaturated lactams 227-234.90 
N
O
F
OMe
R
HN
O
F
R
MeCN/H2O
CAN
7 h, rt
 
Product Yield / %a Product Yield / %a
94 97
HN
HN
HNHN
MeO
HN
F3C
HN
Br
HN
O
HN
Ts
N
HN
40
47
72
61
0
0
79
O
F
F
O
F
O
F
O
F
O
F
O
F
O
O
F
F
O
Entry No. Entry No.
1
2
3
4
5
6
7
8
9
198
227
228
229
230
231
232
233
234
 a Isolated Yield. 
 
5.7.5: Extension of the methodology – hydrogenation to yield fluorinated δ-lactams 
 
Hydrogenation of α,β-unsaturated lactams 227-234 to give the target fluorinated δ-lactams 
235-240 proceeded efficiently for the majority of substrates (Table 15). In all cases, the 
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hydrogenation occurred selectively on the opposite face to the bulky group producing the 
desired δ-lactam exclusively as the cis diastereomer (Entries 1-7). Quantitative yields 
were obtained for the p-trifluoromethylbenzyl (Entry 3), 2-naphthyl (Entry 5), isovaleryl 
(Entry 6) and cyclohexyl (Entry 7) analogues 236, 238-240. The presence of a bromine 
atom on the aromatic substituent was not tolerated under the reaction conditions and the 
desired product 237 was not formed, instead the bromine atom was lost and 190 was 
instead formed in a quantitative yield. This was due to hydrogenation of not only the olefin 
but also of the aromatic bromine atom.  
 
Table 15. Hydrogenation of α,β-unsaturated lactams 227-234 to form the fluorinated δ-lactams 
235-240. 
H2 Pd/C
MeOH
1 h, rt R
HN
O
F
R
HN
O
F
 
Product Yield / %a Product Yield / %a
98
HN
HN
HN
MeO
HN
F3C
HN
Br
HN
83
quant
0b
quant
quant
O
F
F
O
F
O
F
O
F
O
F
O
quantHN
F
O
Entry No.
1
2
3
Entry No.
5
6
4
7
190
235
236
237
238
239
240
         a Isolated yield. b  Quantitative yield of 190 isolated. 
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5.8: Attempts to reduce bromo-analogue 229 and Suzuki cross-coupling 
 
In order to achieve a selective reaction of 229, in the presence of a 4-bromobenzyl 
functional group (Table 15, Entry 4), different conditions were applied to attempt the 
selective alkene hydrogenation (Table 16). In the first instance, the solvent was changed 
to ethyl acetate as it had been reported previously that aromatic halides did not undergo 
reduction under such conditions; however, no reduction of either the alkene or the halide 
were observed (Entry 2).92 This was attributed to a lack of solubility of the starting material 
in the solvent. The catalyst was changed to the less reactive Wilkinson’s Catalyst, with 
benzene as the solvent, but no product was isolated under these conditions (Entry 3).93 
Reduction was attempted through generation of a diimide species from the reaction 
between dipotassium azodicarboxylate and acetic acid, however when the resulting 
diimide was introduced to our unsaturated compound 229, only starting material was 
recovered (Entry 4).94 In a final attempt, a conjugate reduction was attempted using 
Stryker’s reagent, however, no addition took place (Entry 5).95 
 
Table 16. Conditions attempted for the hydrogenation of the α,β unsaturated lactam 229 however 
no product could be isolated in all cases.92-15 
HN
O
F
HN
O
F
Br Br
X
229 237  
Entry No. Conditions Yield / % 
1 H2, Pd/C, MeOH 0 
2 H2, Pd/C, EtOAc 0 
3 
Wilkinson’s Catalyst, H2, 
C6H6 
0 
4 
Dipotassium 
azodicarboxylate, AcOH 
0 
5 Stryker reagent, THF 0 
                                             a Isolated yield. 
 
In the absence of suitable reduction conditions allowing the bromide to be retained as a 
molecular handle, a new strategy was devised whereby a cross-coupling reaction could 
be performed prior to reduction in order to exploit the bromide functionality. Hence, a 
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Suzuki coupling was carried out using phenyl boronic acid and [Pd(PPh3)4]  and resulted in 
the installation of a further phenyl ring in a quantitative yield.96 Owing to the well-
documented scope of palladium-catalysed cross-coupling reactions, a whole range of 
different groups could be installed, demonstrating the expedient nature of the 
methodology.97 Once the Suzuki coupling had taken place, the alkene was reduced to 
yield the lactam 242 in a quantitative yield and with complete diastereocontrol (Scheme 
63).   
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O
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90% quantitative229 241 242
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(20 mol%)
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Scheme 63. Suzuki cross-coupling followed by hydrogenation to generate δ-lactam 242.96 
 
5.9: Towards the synthesis of fluorinated goniothalamin analogues 
 
(R)-(+)-Goniothalamin 243 was first isolated from Cryptocarya caloneura in 1967 and 
since that time it has been shown to exhibit a wide range of biological activities.98 The 
most interesting of these properties was the cytotoxicity towards a number of human 
cancer cell lines including leukaemia, kidney, ovarian and prostate.99 The presence of a 
Michael acceptor in its structure is a key element in its activity and enzyme inhibition; 
therefore, we envisaged that the production of fluorinated analogues possessing a more 
reactive Michael acceptor could increase the biological activity.99  
 
Using the methodology described previously (Section 5.6), it was thought we could access 
the racemic fluorinated analogue 244 by a similar route but with Grignard addition taking 
place onto an aldehyde rather than onto an imine.   
 
O
O
O
O
F
243 244  
Figure 20. Anticancer compound (R)-(+)-goniothalamin 243 and target fluorinated analogue 244. 
 
In the first step, cinnamaldehyde was reacted with allylmagnesium bromide generating the 
desired alcohol 245 in 94% yield (Scheme 64).  
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OHO MgBr
THF, 0 °C, 1 h
94% 245
H
 
Scheme 64. The addition of a Grignard reagent to cinnamaldehyde to give alcohol 245 in a 94% 
yield.  
 
Having obtained sufficient quantities of alcohol 245, a coupling reaction between the 
alcohol 245 and fluorinated acid 135 was carried out using conditions developed for the 
equivalent amide coupling performed previously (Section 5.6). However, only a low yield 
of 33% of the resulting ester 246 was obtained (Scheme 65). This lower yield could be 
due to the reduced nucleophilicity of the alcohol compared to the secondary amine used 
previously as much unreactive starting material was recovered.    
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Scheme 65. Coupling of alcohol 245 to fluorinated acid 135 forming diene 246 in 33% yield.  
 
The fluorinated diene 246 was then subjected to the standard metathesis conditions, 
however, after heating for 72 h in the presence of 7.5 mol% catalyst 128 reaction occurred 
(Scheme 66). This was similar to the unprotected amine example (Section 5.4, Table 7) 
where the presence of coordinating heteroatoms and conformational issues were 
observed to be deleterious to the catalysis. Therefore, the diene was re-subjected to the 
metathesis conditions and an equivalent of Lewis acid, Ti(OiPr)4, was added to sequester 
the lone pairs on the oxygen atom and thus allowing catalysis to occur.100 Unfortunately, 
this was unsuccessful and no reaction occurred under the revised conditions.  
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O
O
F
O
F
O
244
Grubbs II cat. 128
(2.5 mol %)
toluene
100 oC, 1h
X
 
Scheme 66. Attempted RCM reaction to form fluorinated goniothalamin analogue 244 however 
only starting material was isolated.  
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5.10: Conclusion and future work 
 
A route to fluorinated α,β-unsaturated lactams was produced with the development of a 
four step protocol, starting from commercially available aldehydes. Imine formation and 
allylation gave the amines 199-207, followed by amide coupling with fluorinated acid 135 
to produce the RCM precursor compounds 208-217.  RCM reactions occurred rapidly, 
proceeding to completion in less than 1 hour on treatment of the substrate with Grubbs 2nd 
generation catalyst 128. A number of fluorinated α,β-unsaturated lactams 218-226 were 
produced in excellent yields using this method (Scheme 67).   
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R
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Scheme 67. Four step synthesis of fluorinated α,β-unsaturated lactams 218-226. 
 
The α,β-unsaturated lactams 218-226 could be converted in two steps into an array of 
novel fluorinated δ-lactams 227-234. Protecting group removal was carried out followed 
by a diastereoselective reduction to produce a number of novel fluorinated δ-lactams 235-
240 (Scheme 68).  
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Scheme 68. Synthesis of fluorinated δ-lactams 235-240. 
 
The present work has detailed the development of a specific synthesis of a fluorinated δ-
lactam as a single cis diastereomer (Section 5.6). It would be of greater synthetic utility to 
be able to generate both the trans and cis products selectively from the α,β-unsaturated 
lactam 87, thus conditions will be sought whereby the trans product can be generated. 
The cis product is generated as the hydrogenation occurs on the unhindered side of the 
molecule placing the fluorine and R group on the same face. There is the potential to 
attempt this reduction with a copper hydride reagent, such as a modified Stryker's 
reagent.101 Following addition of the hydride, an enol-type intermediate would be formed, 
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which on uptake of a hydrogen atom could give the trans relationship between the fluorine 
and R group.  
 
R
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O
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R
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R
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F
87245 246  
Scheme 69. Desired diastereoselective reduction to form trans-product 246. 
 
As stated above, the process as developed previously can produce a single diastereomer, 
however, it is not enantioselective. The stereochemistry of the C-N chiral centre could be 
installed early in the synthesis, ideally in a flexible manner allowing access to both the R 
and the S enantiomer. This enantioselective addition to the imine has been carried out 
previously by Yamamoto and co-workers using allyltributylstannane and chiral palladium 
complexes, such as 249, to generate the S enantiomer 248 in yields of up to 80% and 
enantiomeric excesses of up to 82% (Scheme 70).102 The conditions developed by 
Yamamoto and co-workers could be considered as a starting point for optimisation using 
our system.   
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Scheme 70. Enantioselective addition to imine 247 reported by Yamamoto and co-workers using 
chiral palladium complex 249 to generate the S enatiomer of 248 in a 62% yield and 81% ee.102  
 
Work on this project so far has resulted in the synthesis of some specific fluorinated ring 
systems, however, there is scope to extend this methodology to allow for the generality 
that is required in modern organic synthesis. We have successfully produced 6-membered 
lactams, therefore, it would be of interest to develop a synthesis of fluorinated 7- and 8-
72 
membered ring systems. Employing longer chains in the Grignard reagents would 
potentially give us access to such molecules (Scheme 71).  
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Scheme 71. Potential route to α,β-unsaturated ε-lactam 252.  
 
The ability to place fluorine atoms at multiple different positions on the ring is a further 
target for the development of this methodology. This would allow access to a variety of 
fluorinated lactams in addition to multi-fluorinated versions. A potentially fruitful approach 
would be to add a fluorinated allylsilane to the imine intermediate 247; this would position 
the fluorine on carbon 4 or 5 of the nitrogen heterocycle 255 depending on the allylsilane 
used (Scheme 72). A proposed synthesis of a suitable allylsilane for use in this reaction is 
shown in scheme 73. These steps were developed by Usuki and co-workers for the 
synthesis of an analogous compound.103  
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Scheme 72. Potential synthesis of fluorinated nitrogen heterocycle 255. The fluorine atom would 
be introduced via addition of fluorinated allyltrimethylsilane 253 to imine 247.  
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Scheme 73. Potential synthesis of the fluorinated allyltrimethylsilane 253 in two steps from 
fluorinated alcohol 256 using conditions reported by Usuki and co-workers.103 
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6: Synthesis of novel fluorinated pyrroles 
 
6.1: Introduction  
 
Following the success of the fluorinated 6-membered ring series (Section 5), work began 
on adapting the methodology to access 5-membered rings in the hope of generating a 
synthesis of novel fluorinated pyrroles. The target molecules are polysubstituted pyrroles 
with substituents in up to four sites on the pyrrole core (Figure 21). If successful this would 
generate a number of interesting compounds, and allow for the incorporation of the wide 
array of functionalities needed in medicinal chemistry.39,40   
 
N
F
R1
R3
R2
258  
Figure 21. Target Polyfunctionalised fluorinated pyrrole 258. A variety of different functionality at 
R1-3 will lead to an array of fluorinated pyrroles. 
 
6.2: Retrosynthetic analysis  
 
Following retrosynthetic analysis, it was envisaged that the target pyrrole 259 could be 
synthesised through the aromatisation of the α, β-unsaturated lactam 260 (Scheme 74). A 
similar ring-closing metathesis approach to previous work could be used to form the α, β-
unsaturated lactam 260 from diene 261. Diene 261 could be accessed from the amide 
coupling reaction between amine 262 and fluorinated acid 135. The allylic amine 262 
could be made by the same aminoalkylation protocol as in the 6-membered ring series but 
with the addition of vinyl Grignard reagent to the imine instead of the allyl Grignard used 
previously (Section 5.6).   
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Scheme 74. Retrosynthetic analysis for fluorinated pyrrole series.  
 
6.3: The development of an efficient route for the synthesis of fluorinated 
pyrroles 
 
Using the same conditions as previously detailed in the 6-membered ring series (Section 
5.6), benzaldehyde was reacted first with p-methoxybenzylamine to form the imine 247, 
before the addition of 1.5 equivalents of vinyl bromide and stirred for 17 hours to give the 
amine 263 (Table 17, Entry 1). Unfortunately, the yield obtained was less than 
satisfactory, with only 4% of the desired product being isolated. Vinylmagnesium bromide 
exhibits reduced nucleophilicity compared with allylmagnesium bromide; in order to 
counter the poor reactivity the reaction was repeated with more equivalents of the vinyl 
Grignard (Entry 2). The yield only improved to 9% which demonstrated that the addition 
reaction was much slower than expected. The reaction time was increased to 48 h, with a 
considerable jump in yield to 29% (Entry 3), and after stirring for 7 days a more 
acceptable 62% yield was recorded (Entry 4). In an attempt to increase the yield of the 
addition reaction, the mixture was heated to 55 °C and as a result a 55% yield could be 
attained after 72 hours (Entry 5).  
 
75 
Table 17. Formation of imine 247 and optimisation of Grignard addition to imine 247 to form amine 
263.  
O
NH
OMe
toluene, reflux, 3 h
NH2
MeO
N
OMe
quantitative
MgBr
247 263
H
H
Na2SO4
 
Entry 
No. 
Conditions for Grignard 
reaction 
Time Yield / %a 
1 1.5 eq, rt, Et2O 17 h 4% 
2 5 eq, rt, Et2O 17 h 9% 
3 5 eq, rt, Et2O 48 h 29% 
4 3 eq, rt, Et2O 168 h 62% 
5 3 eq, 55 °C, THF 72 h 55% 
           a Isolated Yield 
 
Whilst the Grignard addition resulted in the production of sufficient material to explore 
subsequent synthetic steps, the long reaction times, low yields and poor reproducibility 
meant these conditions were not acceptable for the synthesis of an array of analogues. In 
an attempt to identify a viable alternative, the addition of vinyl lithium was explored. 
Therefore, the imine substrate 247 was synthesised in a quantitative yield (Scheme 75).  
 
O
toluene, reflux, 3 h
NH2
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247
H
H
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Scheme 75. Synthesis of imine 247 from benzaldehyde in quantitative yield.  
 
The vinyllithium was generated in situ from the reaction between tert-butyllithium and vinyl 
bromide following a literature procedure,104 and a solution of imine 247 was added. After 
several attempts to affect the addition at varied temperatures, the highest yield recorded 
was a disappointing 24% (Scheme 76). A significant by-product in the reaction was p-
methoxybenzaldehyde (~30%), the formation of which suggested that the vinyllithium was 
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acting as a base and removing a benzylic proton.105 The resulting negative charge could 
be stabilised by delocalisation, before quenching and hydrolysis during the work up.  
 
HN
PMB
Br
1. tBuLi, diethyl ether
2. 247
24%
263  
Scheme 76. Formation of vinyllithium and subsequent addition to imine 247 to form the amine 263 
in 24% yield.104  
 
In order to counter this problem, the reaction was attempted using two substrates that did 
not possess benzylic protons (264 and 266). The first, formed using nonylamine, 
produced a moderate but improved 46% yield of the desired amine 265. However, the 
second imine, 266, formed using phenylamine, did not react and full recovery of starting 
material was observed (Scheme 77).   
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reflux, 3h
264 265
266 267
 tBuLi
 tBuLi
 
Scheme 77. Attempted formation of amine compounds 265 and 267, via imine formation and vinyl 
lithium addition.104  
 
The reaction was also attempted, under these conditions, with the more nucleophilic 2-
lithiumpropene and an improved yield of 74% was obtained in only 1 hour (Scheme 78). 
The amine 268 could now be used in the amide coupling step to generate the fluorinated 
diene 269. However, the reaction did not proceed and only unreacted starting material 
was isolated.  This was attributed to the increased steric hindrance present in the starting 
material due to the presence of the additional methyl group.  
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Scheme 78. Formation of amine 269 was achieved through addition of a vinyl lithium species to 
imine 247. Amide coupling conditions were then applied to generate 269, but no reaction 
occurred.104  
 
6.4: Ellman’s sulfinamide approach to give allylic amine 
 
As a dependable route that would allow for a flexible pyrrole synthesis remained elusive, it 
was decided that a more convenient approach would be to access the primary amine 270 
first before subsequent functionalisation.  
 
NH2
270  
Figure 22. Target primary amine 270. 
 
Ellman’s sulfinimide has been used widely in organic chemistry as an auxiliary to facilitate 
enantioselective additions for the formation of functionalised primary amines (Scheme 
79).106 It was our aim to utilise the electrophilic nature of the sulfinimide to facilitate a fast 
addition of the vinyl Gringard reagent. The resulting sulfinamide could then be readily 
deprotected to yield the desired primary amine 270 on reaction with acid. Therefore, 
benzaldehyde was reacted with tert-butylsulfinamide before addition of vinylmagnesium 
bromide was carried out to produce the sulfinamide 274. The resulting sulfinamide 274 
was stirred in acid before utilising an acid-base extraction to obtain the desired amine 270 
in a good yield of 77% (Scheme 80).  
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Scheme 79. Use of Ellmans sulfinimide to access primary amine 273 with high yield and 
diastereoselectivity.106 
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Scheme 80. Formation of primary amine 270 from benzaldehyde, via a sulfinamide intermediate 
274.106 
 
6.5: Protecting group free amide coupling and ring-closing metathesis  
 
The amine 270 was subjected to the amide coupling conditions yielding the fluorinated 
diene 275 in a good yield (Scheme 81). The RCM reaction could then be attempted, in 
order to determine whether this system could be ring-closed in the absence of a protecting 
group. Disappointingly, no product was obtained under these conditions (Scheme 81).   
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Scheme 81. Amide coupling reaction to form fluorinated amide 275. A RCM reaction with 
fluorinated amide 275 to form α,β-unsaturated lactam 276 was attempted, however no product was 
isolated.  
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6.6: Formation of a fluorinated 5-membered α,β-unsaturated lactam 
 
In previous examples where 6-membered rings were formed in the RCM step (Section 
5.5), the presence of a protecting group on the amide was required in order to allow the 
metathesis reactions to proceed. An identical approach was adopted here, using the 
previously successful p-methoxybenzyl protecting group in an attempt to replicate the 
earlier procedure.  
 
In order to achieve this, the amine 270 was initially reacted with p-methoxybenzaldehyde 
and the resulting imine was subsequently reduced to the secondary amine on addition of 
NaBH4 (Scheme 82). A good yield of 76% was recorded of the desired amine 263.  
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Scheme 82. Two step synthesis of secondary amine 263 from primary amine 270 in an 80% yield, 
via imine formation and reduction.  
 
The previously described amide coupling conditions were applied, as used in the six-
membered ring series (Section 5.6), however, only a moderate yield of 45% was achieved 
for 277 (Scheme 83). More forcing conditions were applied in an attempt to achieve a 
higher conversion to the product, resulting in an improved yield of 61% (Scheme 84). 
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Scheme 83. Amide coupling of amine 263 with fluorinated acid 135 (1.5 equivalents) to form diene 
277 in a 45% yield.  
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Scheme 84. Improved amide coupling of amine 263, with increased reaction time (72 h) and 
increased equivalents of fluorinated acid 135 (2), to form diene 277 in a 61% yield.  
 
The resulting diene compound 277 was subjected to ring-closing metathesis conditions, 
the reaction needed a catalyst loading of 7.5 mol% and reaction time of 20 h to go to 
completion. The α,β-unsaturated lactam 278 was isolated in a good yield of 83% (Scheme 
85).35 
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(7.5 mol %)
toluene
100 °C, 20 h
277 278  
Scheme 85. The formation of α,β-unsaturated lactam 278 in 83% yield from diene 277.35  
 
6.7: Protecting group removal and aromatisation 
 
Having produced sufficient amounts of the α,β-unsaturated lactam 278, an attempt to 
remove the p-methoxybenzyl group was made in order to obtain the unprotected lactam 
276. The protected lactam 278 was stirred with ceric ammonium nitrate (CAN) for 20 h 
however no product was detected (Scheme 86).90  
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Scheme 86. Attempted deprotection of p-methoxybenzyl group on α,β-unsaturated lactam 278 with 
CAN, however, no product was isolated.90  
 
As the deprotection was unsuccessful at the initial attempt (Scheme 86), aromatisation 
conditions were probed and the protecting group would be removed afterwards. There are 
a number of examples in the literature in which α,β-unsaturated lactams are converted to 
the corresponding pyrrole via treatment with a base and a electrophile.107 Bermajo and co-
workers used this stratergy to convert Boc protected α,β-unsaturated lactam 279 to the 
pyrrole 280 in a excellent 95% yield (Scheme 87).108  
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Scheme 87. Conversion of the α,β-unsaturated lactam 279 to the pyrrole 280 as reported by 
Bermejo and co-workers.108 
 
Taking inspiration from the literature precedent,108 conditions using triethylsilyl 
trifluoromethanesulfonate (TESOTf) and triethylamine were attempted however no 
reaction occurred (Table 18, Entry 1). This was also the case when the base was changed 
to DBU (Entry 2), and when the α,β-unsaturated lactam 278 was treated with DBU alone 
(Entry 3), a quantitative recovery of starting material was observed.  
 
82 
Table 18. Conditions attempted for conversion of α,β-unsaturated lactam 278 to a pyrrole ring 
system 281-282.108  
N
O
F
OMe
N
X
F
OMe
278 281 X = OTES282 X = OH  
Entry No. Conditionsa X Yield / %b 
1 TESOTf, Et3N, CH2Cl2, rt OTES 0 
2 TESOTf, DBU, CH2Cl2, rt OTES 0 
3 DBU, CH2Cl2, rt OH 0 
       a Reaction times = 24 h. b Isolated Yield. 
 
Looking at the problem from a different perspective, reducing the lactam could cause 
rearrangement into the aromatic ring system. There has been several examples in the 
literature of such reactions, De Kimpe and co-workers used this approach to synthesis a 
number of disubstituted pyrroles 284 (Scheme 88).109 Therefore, the lactam 278 was 
treated with an equivalent of DIBAL, in an attempt to reduce the amide to the hemiaminal 
and subsequent elimination could generate the pyrrole unit. This was successful and an 
encouraging 35% yield was isolated of the desired pyrrole 285 (Table 19, Entry 1). 
Increasing the number of equivalents of DIBAL to three allowed the pyrrole 285 to be 
generated in an excellent yield of 85% (Entry 2).   
 
N
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PhPh
283 284  
Scheme 88. Reduction of α,β-unsaturated lactam 283 followed by aromatisation to yield pyrrole 
284 as reported by De Kimpe.109 
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Table 19. Conditions attempted for conversion of 278 to a pyrrole ring system.  
N
O
F
OMe
N
X
F
OMe
278 285 X = H  
Entry No. Conditionsa X Yield / %b 
1 DIBAL (1 eq), CH2Cl2, -78 °C to rt H 35% 
1 DIBAL (3 eq), CH2Cl2, -78 °C to rt H 85% 
          a Reaction times = 17 h.  b Isolated Yield. 
 
In order to develop a more flexible methodology, attempts were made to extend the 
protocol to allow the incorporation of different nucleophiles (Table 20). This was first 
attempted with methyllithium, the α,β-unsaturated lactam was rapidly converted to the 
pyrrole 286 in an 86% yield after 1 hour (Entry 1). Alternative lithium reagents, n-
butyllithium and phenyllithium, could be used in the same way forming the substituted 
pyrroles 287 and 288 in yields of 78% and 93% respectively (Entries 2 and 4). Finally, the 
addition of the Grignard reagent allylmagnesium bromide resulted in the facile 
transformation of the starting material to 289 in a good yield of 75% (Entry 4).  
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Table 20. Nucleophilic addition of organometallic reagents to lactam 278 to form pyrrole 
compounds 286-289.   
N
O
F
OMe
N
R
F
OMe
R-M
diethyl ether
0 °C, 1 h
 
Product Yield / %a
N
F
OMe
N
F
OMe
N
F
OMe
N
F
OMe
86
78
93
75
3
4
Entry No.
1
2
R-M
MeLi
MgBr
PhLi
Product Yield / %aEntry No. R-M
286
287
288
289
nBuLi
 a Isolated Yield 
 
6.8: Attempts at protecting group removal 
 
In order to obtain the desired fluorinated pyrroles such as 290, conditions for the removal 
of the protecting group were required. This, however, proved challenging and an array of 
conditions were used without success (Table 21). Initial attempts employed the typical 
CAN reagent, however, this failed to yield any product (Entry 1).90 Another well-utilised 
reagent for PMB removal, DDQ, also failed to produce the desired product, returning 
starting material and a complex mixture of breakdown products (Entry 2).110 The pyrrole 
285 was treated with trifluoroacetic acid at reflux but still no product was detected (Entry 
3).111 A hydrogenation approach was employed, however, only starting material was 
recovered from the treatment of the pyrrole with Pd/C and H2 (Entry 4).112 Oxidising agent 
SnCl4 was used in conjunction with PhSH, however, no reaction occurred (Entry 5).113 
Conditions using oxone with KBr (Entry 6),114 Hg(OAc)2 (Entry 7),115 and KMnO4 (Entry 8 
and 9) were employed,116 however, no product was formed in any of these cases. Finally, 
a Birch reduction was attempted (Entry 10). This proved unsuccessful due to the presence 
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of several aromatic rings, resulting in the degradation of the starting material into a 
complex mixture of breakdown products.117 
 
Table 21. Conditions attempted for the removal of the p-methoxybenzyl group from 285 to give 
pyrrole 290.110-117  
N
F
OMe
HN
F
285 290  
Entry No. Conditions Yield / % 
1 CAN, MeCN/H2O, rt 0 
2 DDQ, CH2Cl2/H2O, rt 0 
3 TFA, CH2Cl2, reflux 0 
4 Pd/C, H2, MeOH, rt 0 
5 PhSH, SnCl4, CH2Cl2, -78 °C 0 
6 KBr, oxone, MeCN, rt 0 
7 Hg(OAc)2, H2O/EtOH, 80 °C 0 
8 KMnO4, acetone/H2O, rt 0 
9 KMnO4, acetone/H2O, 50 °C 0 
10 NH3, Li wire, THF,  -78 °C to rt 0 
 
6.9: Extension of methodology to generate an array of novel fluorinated 
heterocycles 
 
6.9.1: Extension of methodology – secondary amine synthesis  
 
Many of the pyrroles in medicinal chemistry have substituents on the nitrogen that link to 
another building block or functional group.118 Therefore, whilst working on deprotection 
conditions, the integration of different groups on the nitrogen was also explored to see 
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what different functionalities could be introduced. By changing the aldehyde that was 
condensed with the allylic amine 270, different groups could be installed at this position.  
 
In addition to the p-methoxybenzyl group already discussed, four other examples were 
chosen with varying properties to demonstrate the scope of the methodology (Table 22). 
Addition of a simple benzyl group was initially attempted, resulting in the formation of 
amine 291 in a 74% yield (Entry 1). Following this, a 4-bromobenzyl analogue was utilised 
as an electron withdrawing group as well as incorporating a synthetic handle for further 
chemistry (Entry 3). A 78% yield of the 4-bromobenzyl substituted amine 292 was 
recorded (Entry 3). Two further analogues including the aliphatic example 293 and 
heterocyclic methyl pyrrole 294 were also produced in good yields of 80% and 68% 
respectively (Entry 4 and 5). 
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Table 22. One-pot conversion of primary amine 270 into secondary amines 291-294.  
NH2
NH
R
1. R O
MeOH
reflux, 3 h
2. NaBH4
0 °C, 1.5 h  
Product Yield / %a Product Yield / %a
NH
NH
NH
NH
NH
74
76
78
80
68
N
Br
OMe
Entry No.
1
2
3
Entry No.
4
5
291
263
292
293
294
         a Isolated Yield  
 
6.9.2: Extension of methodology – amide coupling reaction 
 
The secondary amines 291-294 could now be subjected to the amide coupling conditions 
(Table 23). The aromatic examples: 295 (Entry 1), 296 (Entry 3) and 298 (Entry 5) all 
underwent efficient amide coupling reactions with 73%, 71% and 63% yields recorded 
respectively. The aliphatic analogue 297 also worked well with a good yield of 86% 
recorded (Entry 4).  
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Table 23. Amide coupling reactions between secondary amines 291-294 and fluorinated acid 135 
to form dienes 295-298.  
NH N
F
OR R135
HBTU,DIPEA
CH2Cl2
F
OH
O
72 h, reflux
 
Product Yield / %a Product Yield / %a
N
N
N
N
N
73
61
71
86
63
N
Br
OMe
F
O
F
O
F
O
F
O
O
F
Entry No.
1
2
3
Entry No.
4
5
295
277
296
297
298
  a Isolated Yield  
 
6.9.3: Extension of methodology – ring-closing metathesis 
 
Ring-closing metathesis of the fluorinated dienes obtained in the previous step 295-298 
yielded the α,β-unsaturated lactam series 299-302 in excellent yields in all cases (Table 
24).35 The benzyl 299 and 4-bromobenzyl examples 300 were isolated in excellent yields 
of 98% and 96% respectively (Entry 1 and 3). A 92% yield was achieved for the aliphatic 
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example 301 and the methyl pyrrole 302 was formed in a good yield of 81% (Entries 4 and 
5).  
 
Table 24. RCM reactions of 295-298 to form α, β-unsaturated lactams 299-302.35 
Grubbs II cat. 128
(7.5 mol%)
toluene
100 °C, 20 h
N
F
O
N
O
F
RR
 
Product Yield / %a,b Product Yield / %a,b
N
N
N
N
N
98
83
96
92
81
N
Br
OMe
O O
O
O
O
F F
F
F
F
Entry No.
4
5
Entry No.
1
2
3
299
278
300
301
302
 
         a Isolated Yield. b concentration = 0.005 g mL-1. 
6.9.4: Extension of methodology – addition-aromatisation reaction 
 
Having synthesised a range of compounds with the 5-membered ring structure in place, 
the final step was to carry out the addition-aromatisation reaction (Table 25). We decided 
to carry out methyllithium addition on all the analogues as it provided a quick, efficient 
process unlike the DIBAL reduction, which required excess reagent and 17 h stirring. High 
yields for all the analogues in question generated an array of fluorinated pyrroles 303-306 
(Table 25, Entries 1-5).  
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Table 25. Addition of methyllithium to lactams 299-302 to form the target pyrrole compounds 303-
306. 
diethyl ether
0 °C, 1 h
N
O
F
N
F
R R
MeLi
 
Product Yield / %a Product Yield / %a
N
N
N
N
N
86
86
83
84
75
N
Br
OMe
F F
F
F
F
Entry No.
1
2
3
Entry No.
4
5
303
286
304
305
306
       a isolated Yield 
 
6.10: Synthesis of fluorinated pyrroles with alternate groups at the 5-position  
 
At this point two different groups had been successfully altered around the fluorinated 
pyrrole ring producing some interesting novel compounds. In all examples presented thus 
far, the 5 position of the pyrrole ring has borne a phenyl substituent. In order to expand 
the methodology further and construct more complex products, the starting amine could 
be altered to incorporate alternative functional groups at this position. A range of different 
amines to be used as starting materials could be synthesised using the Ellman protocol 
(Section 6.4).106  
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6.10.1: Extension of methodology – synthesis of allyl amines 
 
In order to allow variation of the physical and electronic properties at the position in 
question, amines were formed from five different aldehydes (Table 26). The effect of the 
electronics of the benzene ring was initially probed using aldehydes bearing an electron 
donating group and an electron withdrawing substituent. The corresponding amines 307 
and 308 were generated in reasonable yields of 71% and 61% respectively (Entries 2 and 
3). Another aromatic example, 4-bromobenzene 309 was produced in a satisfactory yield 
of 75% (Entries 4). Finally, aliphatic analogues, cyclohexyl 310 and phenylpropyl 311, 
were formed in moderate 50% and 58% yields (Entry 5 and 6).  
 
Table 26. Three step synthesis of allyl amines 307-311.106 
R
O
2. Vinyl MgBr, diethyl ether
toluene, reflux, 3 h
1.tert-butylsulfinamide
R
NH2
3. HCl, MeOH, rt, 30 min
0 °C - rt, 17 h
H
 
Product Yield / %a Product Yield / %a
NH2
NH2
NH2
NH2
NH2
NH2
MeO
F3C
Br
81
71
61
75
50
58
Entry No.
1
2
3
Entry No.
4
5
6
270
307
308
309
310
311
       a Isolated Yield 
 
6.10.2: Extension of methodology – synthesis of secondary amines 
 
The allylic amines 307-311 could then be benzyl protected as described previously 
(Section 6.6). Good yields of 70-86% were established across the series to yield the 
fluorinated diene compounds 312-316 (Table 27).  
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Table 27. One-pot conversion of primary amines 307-311 into benzyl amines 312-316. 
R
NH2
R
NH
1.
2. NaBH4
O
Na2SO4, MeOH
reflux, 3 h
0 °C, 1.5 h
H
 
Product Yield / %a Product Yield / %a
NH
NH
NH
NH
NH
NH
MeO
F3C
Br
74
79
80
84
70
86
Entry No.
1
2
3
Entry No.
4
5
6
291
312
313
314
315
316
         a Isolated yield  
 
6.10.3: Extension of methodology – amide coupling reaction 
 
The fluorinated RCM precursor could then be generated through the amide coupling 
protocol (Table 28). Reasonable yields of 62-76% were recorded for the analogues 317, 
319-321 (Entries 1, 2 and 4-6). The only exception was the example 318 which, consistent 
with results obtained for the 6-membered ring series, was coupled in a lower 45% yield 
due to reduced electron density on the nucleophilic nitrogen (Entry 3).   
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Table 28. Amide coupling reactions between secondary amines 312-316 and fluorinated acid 135 
to form dienes 317-321. 
NH
R
N
F
O
R
135
HBTU,DIPEA
CH2Cl2
F
OH
O
72 h, reflux
 
Product Yield / %a Product Yield / %a
N
N
N
N
N
N
MeO
F3C
Br
73
62
45
62
76
75
O
F
O
F
O
F
O
F
O
F
O
F
Entry No.
1
2
3
Entry No.
4
5
6
295
317
318
319
320
321
      a Isolated Yield.  
 
6.10.4: Extension of methodology – ring-closing metathesis 
 
With sufficient quantities of the diene compounds 317-321 in hand, construction of the ring 
system through metathesis could now be carried out (Table 29). Elevated reaction times 
and catalyst loading are needed for several examples in this series. Namely, the 4-
trifluoromethanebenzene 318 and 4-bromobenzene 319 analogues with their electron 
withdrawing properties hindered the metathesis reactions due a lower electron density at 
their reactive alkene site (Entries 3 and 4). The diene compound 318 required the 
harshest conditions taking 4 days and 15 mol% catalyst loading to achieve an 88% yield 
of 323 (Entry 3). The 4-bromobenzene example 319 took 48 h and 10 mol% catalyst to go 
to completion and produce 324 in a good yield of 96% (Entry 4). The standard conditions 
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of 20 h and 7.5 mol% catalyst were applied to the other analogues 317, 320-321 yielding 
good results of between 78 and 98% of the α,β-unsaturated lactams 322, 325-326 
(Entries 1, 2, 5 and 6).  
 
Table 29. RCM reactions of 317-321 to form α, β-unsaturated lactams 322-326.  
R
N
F
O
R
N
O
F
Grubbs II cat. 128
toluene
100 °C
 
Product Yield / %a Product Yield / %a
N
N
N
N
N
N
MeO
F3C
Br
98b
78b
88c
96d
95b
96b
O O
O
OO
O
F F
F F
FF
Entry No.
1
2
3
Entry No.
4
5
6
299
322
323
324
325
326
 a Isolated Yield. b  7.5 mol% catalyst, 20 h, 0.005 g mL-1. c  15 mol% catalyst, 96 h, 0.005 g mL-1. d 10   
mol%, 48 h, 0.005 g mL-1. 
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6.10.5: Extension of methodology – addition-aromatisation reaction 
 
Finally, aromatisation of the α,β-unsaturated lactam compounds 322-326 by methyllithium 
addition was carried out. Facile conversion to the corresponding fluorinated pyrrole 327-
331 occurred in each case giving good yields of 73-92% (Table 30, Entries 1-6).  
 
Table 30. Addition of methyllithium to lactams 322-326 to form the target pyrrole compounds 327-
331. 
R
N
O
F
R
N
F
MeLi
diethyl ether
0 °C, 1 h
 
Product Yield / %a Product Yield / %a
N
N
N
N
N
N
MeO
F3C
Br
86
88
73
78
92
74
F F
F F
FF
Entry No.
1
2
3
Entry No.
4
5
6
303
327
328
329
330
331
         a Isolated Yield 
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6.11: Conclusion and future work 
 
A novel route for the synthesis of fluorinated polyfunctionalised pyrroles was investigated 
and optimised. Efficient conditions for the aromatisation of fluorinated α,β-unsaturated γ-
lactams into the relevant fluorinated pyrrole was established using nucelophilic 
organometallics. The methodology could then be extended to produce a library to 
polysubstituted fluorinated pyrroles bearing aromatic, aliphatic and heterocyclic 
functionality.  
 
R
NH
R
N
F
OR2
HBTU
DIPEA2. NaBH4
71-81% 60-86%
R2
1.
R
O
2. Vinyl MgBr, Et2O
50-81%
toluene
1. tert-butylsulfinamide
R
NH2
HCl
R2
3.
O
MeOH
HO
F
O
CH2Cl2
307-311
312-316 317-321
295-298291-294
135
H
H
 
Scheme 89. Synthesis of the fluorinated diene compounds 291-294 and 317-321, key 
intermediates in the synthesis of fluorinated pyrroles. 
 
The fluorinated dienes 295-298 and 317-321 could be synthesised in six steps from 
commercially available aldehydes (Scheme 89). RCM reactions proceeded in excellent 
yields to give the fluorinated γ-lactams 299-302 and 322-326. Treating the α,β-
unsaturated γ-lactams with various nucleophiles, to allow late-stage variation, resulted in 
the rapid formation of fluorinated polyfunctionalised pyrroles 303-306 and 327-331 in high 
yields (Scheme 90). 
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Grubbs II cat. 128
 
Scheme 90. Ring-closing metathesis followed by aromatisation to yield the target fluorinated 
pyrrole compounds 303-306 and 327-331.  
 
Repeated attempts were made to remove the p-methoxybenzyl protecting group to 
unmask the fluorinated pyrrole series (Section 6.8), however, all conditions used were 
unsuccessful. Different protecting groups, that can be removed easily but do not hinder 
other steps in the synthesis, need to be investigated in this case. One example that is of 
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interest in this regard is a 2-(trimethylsilyl)ethoxymethyl (SEM) group as it should be viable 
to install onto the primary amine (Scheme 91), be compatible with all the synthetic steps 
and be easily removed.119  
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FR1 N
F
R2
R2
R1
TBAFO
SiMe3
R1
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O
Si
R1
NH2
307-311 332 333 334  
Scheme 91. Potential synthesis of fluorinated pyrrole 334 using a SEM group as a protecting 
group. The SEM group could be removed easily using fluorine source, TBAF.119,120 
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7: Other routes investigated towards the synthesis of fluorinated 
nitrogen heterocycles  
 
Along with the successful routes to access fluorinated δ-lactams and pyrroles, the 
synthesis of nitrogen heterocycles with fluorine atoms present at different positions on the 
ring systems were investigated. The potential to develop synthetic pathways to novel 
fluorinated compounds for use in medicinal chemistry was the driving force behind this 
research.  
 
7.1: Use of difluoroalkene in fluorinated nitrogen heterocycle synthesis 
 
7.1.1: Introduction  
 
To access a number of nitrogen heterocycles with different sites of fluorination, some 
different fluorinated starting materials were evaluated. 3,3-difluoro-3-bromopropene was 
identified as a promising reagent as it has been shown, in the presence of indium, to 
undergo nucleophillic addition to aldehydes in water forming interesting fluorinated 
compounds such as 335 (Scheme 92).121  It was envisaged that addition of 3,3-difluoro-3-
bromopropene to a range of imines would provide the building blocks for a synthesis of 
fluorinated piperidenes and pyridines. 
 
O OH
F F
F F
Br
In
H2O
98% 335
60 °C, 17 h
 
Scheme 92. Nucleophilic addition of 3,3-difluoro-3-bromopropene to benzaldehyde to give alcohol 
335.121 
 
7.1.2: Retrosynthetic analysis 
 
The retrosynthetic analysis starts with the pyridine 336 that is formed from aromatisation 
of the amine 337, aided by loss of one of the fluorine atoms (Scheme 93). The ring would 
be formed in a RCM process from the diene 338. Compound 338 in turn is produced from 
the reaction between the imine 339 and 3,3-difluoro-3-bromopropene. 
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Scheme 93. The retrosynthetic analysis for the synthesis of fluorinated pyridine 336.  
 
7.1.3: Development of 3,3-Difluoro-3-bromopropene addition to an imine 
 
In order to begin the identified synthetic route, benzaldehyde was reacted with allylamine 
to form the imine 339. The imine 339 was then subjected to an indium slurry in water and 
the difluorobromopropene, however, no product was detected and only the alcohol 335 
was formed in an 85% yield (Scheme 94).121  
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Scheme 94. Formation of imine 340 from allyl amine and benzaldehyde followed by attempted 
indium assisted addition of 3,3-difluoro-3-bromopropene to imine 340. However only alcohol 335 
was isolated in 85% yield.121  
 
It was thought that performing the reaction in water lead to hydrolysis of the imine 340 
before the desired addition reaction could take place. To prevent this, the reaction was 
carried out in anhydrous DMF and THF, however, the alcohol 335 was the only product in 
both cases (Scheme 95).122  
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Scheme 95. Further attempts at indium assisted addition of 3,3-difluoro-3-bromopropene to imine 
340 in different solvents. Unfortunately, only alcohol 335 was isolated in 70% and 81% yields 
respectively.122  
 
Even under anhydrous conditions, it appeared that hydrolysis of the imine was faster than 
the desired addition. We decided to use a more reactive imine to enhance the addition 
reaction and reduce the efficacy of the competing hydrolysis. p-Toluenesulfonyl amine 
was reacted with benzaldehyde to give the imine 342, before treatment with the 
fluorinated alkene in THF (Scheme 96). However, this was similarly unsuccessful, 
providing 97% of the unwanted alcohol 335.   
 
O HN
F F
F F
Br
In
THF
N
toluene
NH2Ts
Ts Ts
3 h, reflux
quantitative
X
60 °C, 17 h
342 343
H
 
Scheme 96. Formation of imine 342 from the reaction between tosylamine and benzaldehyde. The 
imine 342 was then treated with indium and 3,3-difluoro-3-bromopropene however only alcohol 335 
was isolated in a 97% yield.122 
 
In an attempt to use the formation of the undesired alcohol 335 to our advantage, a 
Mistunobu reaction was attempted with the tosyl amine 344, Diisopropyl azodicarboxylate 
(DIAD) and PPh3 to form the sulfonamide 345. However only starting material was 
isolated from the reaction (Scheme 97).123  
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Scheme 97. The Mitsunobu reaction attempted on alcohol 335 to produce the sulfonamide 345 
however only starting material was isolated.123   
 
7.1.4: Conclusion and future work 
 
Preliminary work has been carried out on the use of 3,3-difluoro-3-bromopropene to 
generate a difluorodiene compound for use in the synthesis of fluorinated nitrogen 
heterocycles. To date, there has been no success with the addition of 
3,3-difluoro-3-bromopropene to any imine to generate the desired amine (Scheme 98). 
Future work in this area should involve screening alternative metals, such as zinc, and a 
range of imines in order to produce sufficient quantities of the desired amine 347. In 
related work, Qing and co-workers reported the addition of bromodifluoropropene to a 
hydrazone 348 using Zn in good yields, which are conditions that we would like to apply to 
our system in the near future (Scheme 99).124 
 
R
N
R
NHR
Br
R
F F
R
N
F
FF
M
346 347 336  
Scheme 98. A screening of metals and imines is required for the metal facilitated addition of 
bromodifluoropropene to imines 346 to find conditions for the generation of fluorinated amine 
compounds such as 247.  
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Scheme 99. Successful addition of 3,3-difluoro-3-bromopropene reported by Quing and co-
workers.124 
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7.2: Electrophilic fluorination through reaction with allylsilane.  
 
7.2.1: Introduction  
 
In 2003, Gouverneur and co-workers developed an electrophillic fluorination reaction in 
which an allyl silane attacks the electrophilic fluorine present in Selectfluor®.125 The 
authors developed a methodology that incorporated a cross metathesis between an 
unsaturated substrate and allyltrimethylsilane before fluorination with Selectfluor® to give 
the alkene product (Scheme 100).126 
 
Ph O
O
Ph O
O
SiMe3 Ph O
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Scheme 100. Cross metathesis and electrophilic fluorination protocol published by Gouverneur 
and co-workers.126 
 
It was our aim to extend this methodology to produce compounds such as 353-355 
selectively by building in allyltrialkylsilane functionality when preparing the ring (Figure 
23).   
 
TsN
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TsN
FR
N
FR
353 354 355  
Figure 23. Target fluorinated nitrogen heterocycles 353-355.  
 
7.2.2: Retrosynthetic analysis 
 
The fluorinated nitrogen heterocycle 356 could be synthesised from the relevant ring 
system with allyltrialkylsilane functionality in place such as 357 (Scheme 101). This in turn 
could be synthesised through a ring-closing metathesis procedure from the corresponding 
diene. The diene 358 could be produced from the allylic alcohol 359 and sulfonamide 360 
in a Mitsunobu reaction.  
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Scheme 101. Retrosynthetic analysis for the synthesis of fluorinated nitrogen heterocycles, such 
as 356, via electrophilic fluorination. 
 
7.2.3: Forward synthesis to generate ring system with allyltrimethylsilane in place 
 
In order to generate the desired silylated compound 359, allyl alcohol was first 
deprotonated and silylated with t-butlydimethylsilyl chloride (TBDMSCl). Addition of 
stronger base sec-butyllithium allowed deprotonation to occur alpha to the silylated 
alcohol, resulting in the subsequent migration of the silyl group from the oxygen to the 
carbon in a good yield over the three steps (Scheme 102).127 This process was driven by 
formation of a more stable anion on the oxygen, rather than the higher energy 
carbanion.128   
 
OH
SiOH
1. nBuLi, THF
-78 °C - rt, 0.5 h
TBDMSCl, rt, 17 h
3. sBuLi
 -50 °C, 2 h
60%
2.
359  
Scheme 102. One-pot silylation of allyl alcohol, firstly onto the alcohol before base mediated 
migration to form 359 in a 60% yield.127  
 
The sulfonamide coupling partner 191 had been previously synthesised in an 86% yield 
(Section 5.5, Scheme 57). With sufficient quantities of the alcohol 359 in place, a 
Mitsunobu reaction was attempted using diisopropyl azodicarboxylate and 
triphenylphosphine.123 Unfortunately, a less than satisfactory result was obtained for this 
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step, with the diene 358 produced in a 34% yield (Scheme 103). Further optimisation 
would be needed to make this a plausible step, although it did result in enough material to 
attempt the next reaction. 
 
NHTs
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359
191 358  
Scheme 103. Mitsunobu reaction between sulfonamide 190 and alcohol 359 to yield 34% of diene 
358.123 
 
Diene 358 was subjected to Grubbs 2nd generation catalyst 128 and stirred at reflux for 3 
hours (Scheme 104). However, even though a new product was formed seemingly very 
cleanly it was not the desired product 357 instead it was the desilylated compound 360 
(Figure 24).  
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358 357  
Scheme 104. Attempted RCM reaction on 358, however none of the desired product 357 was 
isolated. Desilylated product 360 was formed in 81% yield.  
 
TsN
360  
Figure 24. Desilylated product from the RCM reaction with diene 360.  
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7.2.4: Conclusions and future work 
 
A preliminary investigation into an electrophilic nitrogen ring fluorination was carried out, 
however, the synthesis of the fluorination precursor proved problematic (Scheme 105). 
The planned RCM reaction occurred with loss of the all important silane. 
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358 357  
Scheme 105. Attempted RCM reaction on 358, however none of the desired product 357 isolated.  
 
To investigate this further, alternative metathesis catalysts will be probed. Non-ruthenium 
based catalysts, such as Schrock’s catalyst 126, will be given particular attention, to see if 
the same process occurs (Scheme 106).62 If the heterocyclic can be synthesised with the 
silane intact, a fluorination reaction will be attempted to try attain the fluorinated 
heterocycle 356.  
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Scheme 106. Screening of metathesis catalysts and conditions is needed to allow the RCM 
reaction to form nitrogen heterocycle 356, prior to the fluorination step.  
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8:  Synthesis of poly(ADP-ribose) polymerase (PARP) inhibitors  
 
8.1: Introduction 
 
Once an efficient methodology was established for the synthesis of fluorinated nitrogen 
heterocycles, it was our aim to use the methodology to produce fluorinated analogues of 
biologically active compounds. This would demonstrate the significance of the 
methodology as well as produce some interesting medically relevant structures. 
Therefore, it was decided to use the methodology established to generate δ-lactams 
(Section 5) for the synthesis of a number of fluorinated PARP inhibitors. 
 
8.1.1 Poly(ADP-ribose) polymerase enzymes 
 
Poly(ADP-ribose) polymerase (PARP) enzymes make up a family of 18 members that, as 
the name suggests, catalyse the polymerisation of ADP-ribose units.129 This 
polymerisation is integral for the repair of double and single stranded DNA breaks, which 
in turn is essential for the healthy continuation of the cell cycle.129 DNA is damaged 
internally during cell replication and also externally by a variety of conditions such as UV 
radiation, radiotherapy and chemotherapy. Prevention of DNA repair leads to cell death.129 
 
In order to carry out this function, all PARP enzymes have an active site which is highly 
conserved throughout the family. This contains the PARP ‘signature motif’ which is 100% 
conserved within vertebrates.128 The active site facilitates the transfer of nicotinamide 
adenine dinucleotide (NAD+) to nuclear acceptor proteins; this occurs multiple times 
forming long, branched chains.130 Following this activity, the PARP enzyme leaves the site 
of the damage and specific DNA repair enzymes recognise the nuclear acceptor proteins 
and so can repair the damage.130 PARP-1, the most studied member of the family, can 
bind a wide variety of DNA structures including single and double strand breaks, 
crossovers, supercoils and cruciforms.129 
 
8.1.2 PARP in cancer treatment 
 
In recent years, there has been significant interest in inhibiting PARP enzymes as a 
treatment for cancer. Breast cancer, early onset (BRCA1 and BRCA2) genes are human 
tumour suppressor genes expressed in the breast and other tissue including the ovary, 
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pancreas and lung.131 The genes are important for the destruction of cells that cannot be 
repaired and the proteins coded by the genes are integral in the repair of double DNA 
strand breaks.131 Certain people have hereditary mutations in the BRCA gene increasing 
their risk of gene malfunction and tumour growth. Research has found an 80% risk of 
developing breast cancer and 55% risk of developing ovarian cancer in women with 
BRCA mutations.132  
 
The resulting tumours have a deficiency in BRCA genes which was a significant driving 
force behind the tumour growth.131 However, this also leads to an innate weakness that 
can be exploited for the treatment of these specific tumours. The BRCA deficient tumours 
have a reduced capacity to repair double strand DNA breaks.131 By inhibiting PARP 
enzymes, which is a key component of the cells protocol for fixing single strand breaks, 
the naturally occurring single strand breaks cannot be repaired efficiently. The single 
strand breaks are converted into double strand breaks during cell replication processes. 
This flooding of the cell DNA with double strand breaks, which BRCA deficient tumour 
cells cannot repair, is followed swiftly by cell death and tumour suppression.131   
 
This treatment demonstrates cancer cell selectivity in two ways: firstly, healthy cells have 
a better ability to repair double strand breaks and secondly, healthy cells do not replicate 
as rapidly as cancer cells, therefore are less heavily dependant on DNA repair processes. 
DNA is also damaged during other cancer treatment programs, including both 
radiotherapy and chemotherapy, in the hope of killing the cancerous cells and thus 
suppressing the tumour. This being the case, PARP inhibitors could also be used in 
conjunction with other treatments to prevent the repair of the damaged DNA increasing 
the likelihood of cell death.133  
 
8.1.3 Known PARP inhibitors 
 
In late 2014, the first PARP inhibitor, Olaparib 361 (AstraZeneca), was approved for 
treatment of germline BRCA mutated (gBRCAm) advanced ovarian cancer (Figure 25). It 
is an inhibitor of both the PARP-1 and PARP-2 enzymes with IC50 values of 0.005 μM and 
0.001 μM respectively and demonstrated a good oral exposure during pharmacokinetic 
studies.134 It has only been approved for mono-therapy initially, however, there are 
presently investigations into duel therapy with traditional platinum cancer drugs which are 
ongoing.133 
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Figure 25. FDA approved PARP inhibitor (AstraZeneca) Olaparib 361.134  
 
Veliparib 362, a PARP inhibitor produced by Abbott Laboratories, is currently in phase III 
clinical trials for both non-small cell lung cancer and breast cancer (Figure 26). With IC50 
values of 0.005 μM for PARP-1 and 0.003 μM for PARP-2, it is a potent inhibitor and 
excellent drug candidate.135 Similar to Olaparib 361, there are many ongoing tests into 
combinational therapy approaches towards the treatment of a whole range of cancers.135  
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Figure 26. PARP inhibitor (Abbot), Veliparib 362.135 
 
In 2010, Penning and co-workers reported an extended SAR of the veliparib 
benzimidazole scaffold, in which a benzene linker has been added between the eastern 
and western fragments (Table 31).136 The eastern fragment was altered to incorporate 
various nitrogen heterocycles and the resulting changes in the cellular EC50 was tracked. 
The selection shown in Table 31 demonstrates the nitrogen heterocycle could be altered 
without a significant effect on the activity, with 363-366 (Entries 1-4) having cellular EC50 
values ranging between 0.002 and 0.008 μM.136  
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Table 31. Enzyme binding and in vitro results for potential inhibitor compounds 363 to 366 reported 
by Penning and co-workers.136  
N
H
N
CONH2
Compound No. R
R
PARP-1 (Ki, uM) Cellular (EC50, uM)
363
364
364
365
N
H
HN
N
N
0.003
0.004
0.006
0.002
0.003
0.004
0.002
0.008
Entry No.
1
2
3
4
 
 
The crystal structure of PARP-1 with inhibitor 366 bound to the active site shows how the 
compounds interact with the enzyme (Figure 28).136 The benzimidazole fragment forms 
strong interactions, primarily through hydrogen bonding, between the amide substituent 
and the nearby glycine and serine residues. The amine present in the imidazole ring forms 
a hydrogen bond to glutamine 988 and there is a stabilising π-π interaction between the 
benzene ring and a tyrosine residue. This inhibitor boasts a fluorine atom on the 
unsaturated linker which also forms hydrogen bond interactions to the enzyme.136    
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Figure 27. PARP inhibitor reported by Penning and co-workers.136 
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Figure 28. Cocrystal structure of PARP-1 active site with compound 366 bound, Ki = 0.006 μM.136 
 
The eastern fragment, in comparison, has limited contact with the enzyme only forming 
hydrogen bond interactions through the available amine.136 Upon examination of the 
active site, there appears to be space in this region to allow for further functionalisation on 
a potential inhibitor.136 Development of next generation inhibitors could take advantage of 
this free space to increase the number of binding interactions and improve the 
pharmacokinetic properties (Figure 28). 
 
8.2 Aims  
 
Following the success of the fluorinated δ-lactam synthesis (Section 5), the opportunity 
arose to use the methodology to make some more specific targets with the aim of 
producing some biologically active compounds. The amides 366 and 367 are examples 
from a range of poly(ADP-ribose) polymerase 1 (PARP-1) inhibitors synthesised and 
tested by Penning et al (Figure 29).136 The eastern side of the molecule bares a certain 
resemblance to the δ-lactams produced above and it was envisaged that using the 
brominated analogue 229 (Figure 30) we could readily access the complete compound via 
cross-coupling chemistry, a novel approach to this family of compounds. 
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Figure 29. PARP inhibitors 366 and 367 reported by Penning and co-workers and potential 
fluorinated analogues 368 and 369.136  
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Figure 30. Para brominated α,β-unsaturated lactam 229. 
 
8.3: Results and Discussion  
 
To develop the appropriate methodology we first attempted production of compounds 
which did not possess the amide side chain present on the western fragment of 367. This 
would allow us to probe the cross coupling reaction with readily available starting 
materials, benzoxazole and benzimidazole. Therefore, the bromo α,β-unsaturated lactam 
220, was reacted with benzoxazole using a palladium-copper co-catalyst system in an 
attempt to activate a C-H bond on the benzoxazole and couple with the aromatic bromine 
(Table 32).137  
 
The reaction was first attempted with 1 mol% palladium catalyst at reflux in toluene, in 
accordance with conditions developed Huang for the coupling of bromobenzene and 
benzoxazole (Entry 1).137 However, under these preliminary conditions only starting 
material could be isolated. An increase to 10 mol% palladium catalyst under otherwise 
identical conditions resulted in a 24% yield of the desired coupled product (Entry 2). An 
increase of catalytic loading and time from 17 h to 48 h only improved the yield to 28% 
(Entry 3). Finally, the reaction was attempted in the microwave for 4 hours at 128 °C and 
to our delight an excellent 73% yield of 370 was produced (Entry 4). 
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Table 32. Conditions attempted for the C-H activation protocol to form benzoxazole product 370.137 
N
O
N
O
OMe
F
N
O
OMe
FBr
PPh3
K2CO3
O
N
220 370  
Entry 
No. 
Catalytic System Conditions Yield / %a 
1 
Cu(II)OAc2.H2O (20 mol%), 
[Pd(PPh3)4] (1 mol%) 
reflux, toluene, 17 h 0% 
2 
Cu(II)OAc2.H2O (20 mol%), 
[Pd(PPh3)4] (10 mol%) 
reflux, toluene, 17 h 24% 
3 
Cu(II)OAc2.H2O (50 mol%), 
[Pd(PPh3)4] (20 mol%) 
reflux, toluene, 48 h 28% 
4 
Cu(II)OAc2.H2O (20 mol%), 
[Pd(PPh3)4] (10 mol%) 
128 °C, MW, toluene, 
4 h 
73% 
       a Isolated Yield 
 
The reaction could then be attempted on the unprotected amide 229 forming 371 in a 70% 
yield (Scheme 107).  
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Scheme 107. C-H activation protocol to form benzoxazole product 371 in a 70% yield. 
 
With the cross-coupled product 371 in hand, further interconversions could be carried out 
to form different compounds for testing. Firstly, the olefin was hydrogenated to give the δ-
lactam 372 in a 99% yield. As in previous examples, this occurred on the opposite face to 
the bulky group producing a single diastereomer (Scheme 108).  
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Scheme 108. Reduction of α,β-unsaturated lactam 371 to δ-lactam 372 in a 99% yield. 
 
In order to access benzimidazole analogues, the amine present needed to be protected to 
allow for C-H activation. Therefore, benzimidazole was reacted with benzyl bromide under 
microwave irradiation in an unoptimised procedure to give the protected amine 373 in a 
poor 14% yield (Scheme 109).138 Despite this, sufficient quantities of the protected 
benzimidazole 373 were obtained to test the next step, however, further optimisation on 
this step is required in order to provide an expedient synthetic route.  
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Scheme 109. Benzyl protection of benzimidazole to form 373 in a 14% yield.138  
 
The cross-coupling reaction was carried out as previously described and proceeded in an 
excellent 96% yield (Scheme 110). This compound 374 can now be subjected to 
hydrogenation conditions to remove the protecting group and the alkene, giving us access 
to a key compound for testing. Reduction to the amine will also be carried out to produce 
a further analogue.  
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Scheme 110. Cross-coupling reaction between benzyl protected benzimidazole 373 and 229 to 
produce the compound 374 in a 96% yield.  
 
The compounds made will be tested in collaboration with Prof. A. Chalmers at the Cancer 
Research UK Beatson Institute, Glasgow. Further examples with the relevant amide side 
chain (Figure 31) are also under investigation and excellent binding properties to the 
PARP active site are expected.  
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Figure 31. Future PARP inhibitor targets 368 and 369 with primary amide side chain which is 
important in enzyme binding.    
 
8.4: Conclusion and future work 
 
An investigation into the synthesis of some potential fluorinated PARP inhibitors has been 
carried out and a C-H activation cross-coupling reaction has been utilised to produce the 
scaffold of the inhibitors. Several compounds have been synthesised and will be tested for 
biological activity in collaboration with Prof. A. Chalmers at the Cancer Research UK 
Beatson Institute (Figure 32).  
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Figure 32. Fluorinated lactam compounds 370-372 and 374 to be tested for inhibition of PARP 
enzymes 
 
Conditions for the reduction of the fluorinated lactams need to be sought to yield the 
desired fluorinated amines that mimic previous inhibitors.  
 
The synthesis of the benzimidazole analogues 375-376 needs to be completed before 
they can be submitted for testing. A hydrogenation reaction to remove the benzyl 
protecting group and the alkene will be carried out before the lactam will be reduced to the 
amine (Scheme 111).  
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Scheme 111. Reduction of alkene and protecting group removal to unmask potential PARP 
inhibitor 375 and lactam reduction to give amine 376.  
 
The literature PARP inhibitors, synthesised by Penning and co-workers, all exhibit amide 
functionality on the benzimidazole fragment.136 Our work so far has not incorporated this 
group which is key for good enzyme binding, therefore, the inclusion of this functionality is 
an important future aim. In this case, we need to synthesise the western fragment to 
include the amide group.  A three step synthesis has been envisaged to form the acid 379 
from commercially available 2-Amino-3-nitrobenzoic acid (Scheme 112).139  
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Scheme 112. Potential synthesis of acid 379 in three steps from commercially available 2-Amino-
3-nitrobenzoic acid.139  
 
The cross coupling reaction will be carried out with the acid 379 before conversion to the 
amide and protecting group removal to give the fluorinated PARP inhibitor 381 (Scheme 
113).  
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Scheme 113. The synthesis of the amide bearing PARP inhibitors will be completed with a cross-
coupling of acid 379 to produce the fluorinated lactam 380 followed by amide formation and 
protecting group removal to give 381.  
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9. Experimental  
 
All reactions were performed in oven-dried glassware under an inert argon atmosphere 
unless otherwise stated. Tetrahydrofuran (THF), diethyl ether, toluene and 
dichloromethane were purified through a Pure Solv 400-5MD solvent purification system 
(Innovative Technology, Inc). All reagents were used as received, unless otherwise 
stated. Solvents were evaporated under reduced pressure at 40°C using a Buchi 
Rotavapor unless otherwise stated. IR spectra were recorded as thin films on NaCl plates 
using a JASCO FT/IR410 Fourier Transform spectrometer. Only significant absorptions 
(νmax) are reported in wavenumbers (cm-1). Proton magnetic resonance spectra (1H 
NMR), fluorine magnetic resonance spectra (19F) and carbon magnetic resonance spectra 
(13C NMR) were respectively recorded at 400 MHz, 377 MHz and 100 MHz using a Bruker 
DPX Avance400 instrument. Proton magnetic resonance spectra (1H NMR), fluorine 
magnetic resonance spectra (19F) and carbon magnetic resonance spectra (13C NMR) 
were respectively recorded at 500 MHz, 470 MHz and 125 MHz using a Bruker DPX 
Avance500 instrument. Chemical shifts (δ) are reported in parts per million (ppm) and are 
referenced to the residual solvent peak. The order of citation in parentheses is (1) number 
of equivalent nuclei (by integration), (2) multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, quint = quintet, sext = sextet, sept = septet, m = multiplet, br = broad), (3) and 
coupling constant (J) quoted in Hertz to the nearest 0.1 Hz. High resolution mass spectra 
were recorded on a JEOL JMS-700 spectrometer by electrospray (EI) chemical ionisation 
(CI) mass spectrometery operating at a resolution of 15000 full widths at half height. Flash 
chromatography was performed using silica gel (Flurochem Silica Gel 60, 40-63 micron) 
as the stationary phase. TLC was performed on aluminium sheets pre-coated with silica 
(Merck Silica Gel 60 F254) unless otherwise stated. The plates were visualised by the 
quenching of UV fluorescence (λmax254nm) and/or by staining with either anisaldehyde, 
potassium permanganate, iodine or cerium ammonium molybdate followed by heating. 
 
General procedure A: Synthesis of PMB protected allylic amines, from aldehydes.  
 
Na2SO4 (1.00 g) was dried under vacuum in a round bottom flask for 10 min. Aldehyde (1 
eq) was then added, followed by toluene (15 mL) and 4-methoxybenzylamine (1.1 eq). 
The resulting reaction mixture was then heated to reflux for 3 h. The reaction was then 
cooled down to rt, and the solid residue filtered off.  
The solvent was removed in vacuo and the residue was redissolved in anhydrous diethyl 
ether (20 mL).  The solution was cooled down to 0 °C before allylmagnesium bromide (1.5 
eq, 1 M in THF) was added dropwise. The resulting mixture was allowed to warm up to rt 
and was stirred for 17 h. The reaction was quenched with water (20 mL) and extracted 
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with diethyl ether (3 × 20 mL).  The combined organic extracts were dried over sodium 
sulphate, and the solvent was removed in vacuo. The crude residue was purified by flash 
column chromatography to afford the corresponding allylic amine.    
 
General procedure B: Amide coupling of allylic amines 
 
2-Fluoroacrylic acid (1.5 eq) and HBTU (1.5 eq) were dry mixed and then dissolved in 
CH2Cl2 (20 mL). DIPEA (1.5 eq) was added followed by the corresponding amine (1 eq). 
The solution was heated to reflux and stirred for 17 h. The reaction was cooled down to rt 
and the solvent was then removed in vacuo. The crude material was purified by flash 
column chromatography. 
 
General procedure C: Ring-closing metathesis of fluorinated dialkene 
 
A solution of the dialkene (1 eq) in toluene (2.5 mg mL-1) was treated with Grubbs 2nd 
generation catalyst (2.5 mol%) and the resulting mixture was heated to 100 °C until 
completion (1-4 h). The reaction was cooled down to rt, the solvent was removed in vacuo 
and the crude material was purified by flash column chromatography. 
 
General procedure D: Removal of p-methoxybenzyl protecting group 
 
The cyclic amide (1 eq) was dissolved in a MeCN/H2O (8:2, 4 mL) mixture and ceric 
ammonium nitrate was added portion wise. The solution was stirred at rt for 7 h. The 
reaction was quenched with aq. sat. NaHCO3 (10 mL) and extracted with diethyl ether (3 × 
10 mL). The orgaincs were combined, dried (Na2SO4) and removed in vacuo. The crude 
material was purified flash column chromatography. 
 
General procedure E: Hydrogenation of α,β-unsaturated lactam 
 
A solution of dihydropyridone (1 eq) in MeOH (2 mL) was treated with palladium activated 
charcoal (10% by weight) and the suspension was stirred under a H2 atmosphere until 
completion (1-4 h). The resulting mixture was filtered through celite, dried (Na2SO4) and 
the solvent was removed in vacuo. The crude product was purified by flash column 
chromatography.  
 
General procedure F: Synthesis of allylic amines, from aldehydes 
 
Na2SO4 (1.00 g) was dried under vacuum in a round bottom flask for 10 min. Aldehyde (1 
eq) was then added, followed by toluene (10 mL) and tert-butylsulfinamide (1.1 eq). The 
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resulting reaction mixture was then heated to reflux for 4 h. The reaction was then cooled 
down to room temperature, and the solid residue filtered off.  
The solution was concentrated in vacuo and the residue was redissolved in anhydrous 
diethyl ether (10 mL).  The solution was placed under argon and cooled down to 0 °C. The 
solution was then treated dropwise with vinylmagnesium bromide (3 eq) and the resulting 
mixture was allowed to warm up to room temperature for 17 h. The reaction was 
quenched with H2O (20 mL) and extracted with diethyl ether (3 × 20 mL). The combined 
organic extracts were dried over sodium sulphate, and evaporated under reduced 
pressure. 
The crude residue was dissolved in MeOH (20 mL) before HCl (6M) was added dropwise 
until a pH of 1 was reached. The solution was stirred for 1 h following which the reaction 
was diluted with H2O (20 mL) and the mixture was extracted with diethyl ether (3 × 20 
mL). The aqueous phase was basified to a pH of 14 with 15% NaOH and then extracted 
with CH2Cl2 (3 × 20 mL). The resulting organics were dried (Na2SO4) and the solvent was 
removed in vacuo to give the corresponding allylic amine without need for further 
purification.  
 
General procedure G: Formation of secondary amines 
 
Na2SO4 (1 g) was dried under vacuum in a round bottom flask for 10 min. Amine (1 eq) 
was then added, followed by MeOH (6 mL) and aldehyde (1.05 eq). The resulting reaction 
mixture was then heated to reflux and stirred for 3 h. The reaction was then cooled down 
to 0 °C, the solution was treated with NaBH4 (1.5 eq) and the mixture was stirred for 1.5 h. 
Following this time, the reaction was quenched with H2O (20 mL) and extracted with 
diethyl ether (3 × 20 mL). The organics were combined and dried (Na2SO4) before the 
solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography to afford the corresponding secondary amine. 
 
General procedure H: amide coupling to form diene 
 
2-Fluoroacrylic acid (2 eq) and HBTU (2 eq) were dry mixed and then dissolved in CH2Cl2 
(10 mL). DIPEA (2 eq) was added followed by the corresponding amine (1 eq). The 
resulting solution was heated to reflux for 72 h. The reaction was cooled down to rt and 
the solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography. 
 
 
 
 
120 
General procedure I: Ring-closing metathesis of fluorinated dialkene 
 
A solution of the diene (1 eq) in toluene (5.0 mg mL-1) and was heated to 100 °C. Grubbs 
2nd generation catalyst was added in portions and the reaction was stirred until 
completion. The reaction was cooled down to rt, the solvent was removed in vacuo and 
the crude material was purified by flash column chromatography.  
 
General procedure J: Nucleophilic addition and aromatisation to form pyrrole 
system 
 
α,β-Unsaturated lactam (1 eq) was dissolved in diethyl ether (5 mL) and cooled to 0 °C. 
Methyllithium (1.1 eq) was added dropwise and the mixture was stirred for 1 h. The 
reaction was quenched with H2O (10 mL), extracted with diethyl ether (3 × 10 mL), dried 
(Na2SO4) and removed in vacuo. The crude residue was purified be flash column 
chromatography.  
 
2-Furaldehyde, 117.55 
 
O
CHO
 
 
POCl3 (3.50 mL, 38.0 mmol) was added dropwise, ensuring the temperature did not rise 
above 25 °C, to DMF (6.27 mL, 75.1 mmol) at 0 °C. To the resulting mixture was gradually 
added furan (2.60 mL, 38.0 mmol) ensuring the temperature did not rise above 25 °C.  
The mixture was stirred for a further 1 h at 0 °C before being allowed to warm to rt and 
was stirred for 17 h. Sat. K2CO3 (10 mL) was added slowly to neutralise the mixture before 
extracting the aqueous phase with diethyl ether (3 × 15 mL). The combined organics were 
washed with H2O (3 × 30 mL) and brine (2 × 30 mL) before being dried (Na2SO4) and 
removed in vacuo to yield the desired product 117 as a pale yellow oil (2.74 g, 28.5 mmol, 
74%). 
 
1H (CDCl3, 400 MHz) δ: 9.60 (1H, s, CHO), 7.69 (1H, d, JH = 1.6, 0.8 Hz, OCH), 7.25 (1H 
dd, JH = 3.6, 1.6 Hz, OC(CHO)CH), 6.60 (1H, dd, JH = 3.6, 1.6 Hz (OCHCH). 
13C (CDCl3, 125 MHz) δ: 177.9 (CHO), 153.0 (OC(CHO)CH), 148.1 (OCH), 121.0 
(OC(CHO)CH), 112.6 (OCHCH). 
The spectral data is in agreement with the literature values.55 
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N-Furan-2-ylmethylene-4-methyl-benzenesulfonamide, 118.54 
 
O NT
s
 
 
To a solution of 2-furaldehyde 117 (0.89 mL, 10.4 mmol) in toluene (10 mL) was added p-
toluenesulphonamide (1.8 g, 10.4 mmol) and p-toluenesulphonic acid (18 mg, 104 µmol). 
The mixture was heated to reflux for 17 h with the use of Dean-Stark apparatus. After this 
time, charcoal was added to the hot solution and it was further stirred for 1 h. The solids 
were filtered off, the solvent was removed in vacuo and the resulting material was 
recrystallised (benzene) to yield the desired product 118 as a brown solid (2.2 g, 8.83 
mmol, 84%). 
 
1H (CDCl3, 400 MHz) δ: 8.84 (1H, s, CHNTs), 7.89 (2H, d, JH = 8.4 Hz, Ar-H), 7.75 (1H, s, 
OCH), 7.37-7.12 (3H, m, Ar-CH and OC(CHNTs)CH), 6.67 (1H, dd, JH = 2.0, 1.6 Hz, 
OCHCH) 2.48 (3H, s, CH3). 
13C (CDCl3, 125 MHz) δ: 155.7 (CHN) 149.7 (CSO2) 144.6 (OC(CHNTs), 135.2 (CCH3) 
129.8  (2C, Ar-CH) 128.3 (OCH) 128.1 (2C, Ar-CH) 126.5 (OC(CHNTs)CH), 113.7 
(OCHCH), 21.7 (CH3).  
The spectral data is in agreement with the literature values.54 
 
N-(1-Furan-2-yl-propyl)-4-methyl-benzenesulfonamide, 119.54 
 
O NHT
s
 
 
The tosylated imine 118 (1.0 g, 4.01 mmol) was dissolved in THF (15 mL) and cooled to 0 
°C. Ethylmagnesium bromide (8.02 mmol, 2.7 mL of a 3 M solution in THF) was added to 
the solution and the reaction mixture was stirred for 5 min. The reaction was quenched 
with aq. NaHCO3 (30 mL) and extracted with diethyl ether (3 × 30 mL). The combined 
organics were dried (Na2SO4), filtered and removed in vacuo. The crude product was 
purified by flash column chromatography (10% diethyl ether in petroleum ether) to yield 
the desired product 119 as a white solid (0.42 g, 1.51 mmol, 38%). 
 
1H (CDCl3, 400 MHz) δ: 7.63 (2H, d, JH = 8.0 Hz, Ar-H), 7.21 (2H, d, JH = 8.0 Hz, Ar-H) 
7.16 (1H, d, JH = 1.2 Hz, OCH), 6.14 (1H, dd, JH = 3.2, 1.8 Hz, OCHCH), 5.92 (1H, d, JH = 
3.2 Hz, OC(CHNTs)CH), 4.81 (1H, d, JH = 8.8 Hz, NH), 4.34 (1H, quart, JH = 8.8 Hz, 
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CHNH), 2.40 (3H, s, Ar-CH3), 1.82 (2H, quint, JH = 7.2 Hz, CH2), 0.83 (3H, t, JH = 7.6 Hz, 
CH2CH3). 
13C (CDCl3, 125 MHz) δ: 152.7 (CSO2), 143.0 (OC(CHNTs), 141.8 (OCH) 137.7 (CCH3) 
129.4  (2C, Ar-CH) 127.0 (2C, Ar-CH), 109.9 (OCHCH), 106.9 (OC(CHNTs)CH), 53.2 
(CNHTs), 28.2 (CH2), 21.7 (Ar-CH3) 10.2 (CH3) 
The spectral data is in agreement with the literature values.54 
 
N-Furan-2-ylmethyl-4-methyl-benzenesulfonamide, 120.56 
 
O NHTs
 
 
Procedure A 
To a solution of furfuryl amine (0.90 mL, 10.3 mmol) in CH2Cl2 (32 mL), triethylamine (3.8 
mL, 26.0 mmol) was added and the reaction was stirred for 30 min. The mixture was then 
cooled to 0 °C before p-toluenesulfonyl chloride (2.98 g, 15 mmol) was added. The 
reaction was allowed to warm to rt before the mixture was stirred for 17 h. The solution 
was washed with sat. aq. NaHCO3 (20 mL) and brine (20 mL). Following this, the organic 
phase was dried (Na2SO4), filtered and the solvent was removed in vacuo. The crude 
product was recrystallised (diethyl ether) to yield the desired product 120 as a white solid 
(0.91 g, 3.62 mmol, 35%).  
 
Procedure B 
Pyridine (0.85 mL, 10.6 mmol) and p-toluenesulfonyl chloride (1.9 g, 10.5 mmol) were 
dissolved in THF (30 mL) at 0 °C. The solution was stirred for 15 min before furfurylamine 
(0.90 mL, 10.3 mmol) was added dropwise, not allowing the temperature to rise above 15 
°C. The reaction mixture was stirred for a further 2 h. aq. NaOH (1M, 30 mL) was added 
and the resulting mixture was stirred for 30 min before extraction with EtOAc (3 × 20 mL). 
The combined organics were washed with brine, dried (Na2SO4) and filtered through 
silica, eluting with EtOAc. The crude material was purified by flash column 
chromatography (20% diethyl ether in petroleum ether) to yield the desired product 120 as 
a white solid (1.0 g, 4.10 mmol, 40%).  
 
1H (CDCl3, 400 MHz) δ: 7.74 (2H, d, JH = 8.4 Hz, Ar-CH), 7.30 (2H, d, JH = 8.4 Hz, Ar-CH), 
7.25 (1H, d, JH = 2.4 Hz, OCH), 6.24 (1H, dd, JH = 3.2, 2.0 Hz, OCHCH), 6.10 (1H, d, JH = 
3.2 Hz, (OC(CH2N)CH), 4.72 (1H, br s, NH), 4.20 (2H, d, JH = 6.1 Hz, CCH2), 2.42 (3H, s, 
CH3).  
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13C (CDCl3, 125 MHz) δ: 149.1 (SO2C), 143.5 (OC(CH2N)CH), 142.3 (CHCHO), 136.0 
(CH3C), 129.4 (2C, Ar-CH), 127.8 (2C, Ar-CH), 109.9 (OCHCH), 108.6 (OC(CH2N)CH), 
39.8 (CH2), 21.0 (CH3). 
The spectral data is in agreement with the literature values.56 
 
6-Hydroxy-1-(toluene-4-sulfonyl)-1,6-dihydro-2H-pyridin-3-one, 121.57 
 
NTs
O
OH  
 
Procedure A 
Furfuryl tosylamine 120 (0.20 g, 0.79 mmol) was dried under vacuum for 1 h before the 
addition of CH2Cl2 (5 mL). The solution was cooled to 0 °C then treated with dropwise 
addition of m-CPBA (0.18 g, 1.1 mmol) not allowing the temperature to rise above 10 °C. 
After 20 min of stirring at the 0 °C, the reaction was allowed to warm to rt and stirring was 
continued for 7 h. The reaction mixture was washed with sat. aq. NaHCO3 (5 mL) and 
brine (5 mL), dried (Na2SO4) and the solvent was removed in vacuo. This gave the desired 
product 121 as a pale yellow oil (0.21 g, 0.79 mmol, quantitative yield). 
 
Procedure B 
To a solution of furfuryl tosylamine 120 (0.10 g, 0.39 mmol) in THF-H2O (8:2 mL) was 
added NaHCO3 (60 mg, 0.80 mmol), NaOAc (30 mg, 0.40 mmol) and NBS (0.08 g, 0.44 
mmol) in one portion at 0 °C. The reaction mixture was stirred until completion (0.1 h), 
before quenching with 30% aq. Na2S2O3 (10 mL). The aqueous phase was extracted with 
diethyl ether (3 × 20 mL) and the combined organics were washed with sat. NH4Cl (20 
mL) and brine (20 mL). The solution was dried (Na2SO4) and the solvent was removed in 
vacuo to leave the desired product 121 as a pale yellow oil (0.12 g, 0.39 mmol, 
quantitative yield), which was not purified further due to instability.  
 
1H (CDCl3, 400 MHz) δ: 7.63 (2H, d, JH = 8.0 Hz, Ar-CH), 7.21 (2H, d, JH = 8.0 Hz, Ar-CH), 
6.85 (1H, dd, JH = 10.4, 5.2 Hz, CHCHCO), 6.24 (1H, d, JH = 6.8 Hz, CHCHCO), 5.92 (1H, 
d, JH = 4.8 Hz, CHOH), 3.96 (1H, d, JH = 18 Hz, CHH), 3.93 (1H, d, JH = 18 Hz, CHH), 
2.32 (3H, s, CH3).  
The spectral data is in agreement with the literature values.57 
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3-(p-Toluenesulfonyloxy)pyridine, 122.52 
 
N
OTs
 
 
Procedure A 
To a stirred solution of pyridone 121 (80 mg, 0.30 mmol) in THF (5 mL) was added AlCl3 
(0.36 mL, 1M solution in THF, 0.36 mmol) at -78 °C. After 1 h, the reaction was quenched 
with Et3N (0.5 mL) and poured into H2O. The aqueous layer was extracted with CH2Cl2 (3 
× 10 mL) and combined organics were dried (Na2SO4), filtered and removed in vacuo. The 
crude product was purified by flash column chromatography (30% EtOAc in hexane) to 
yield the desired product 122 as a yellow solid (24 mg, 96 μmol, 32%).  
 
Procedure B  
To a stirred solution of pyridone 121 (0.15 g, 0.56 mmol) in CH2Cl2 (7 mL) was added 
BF3·OEt2 (90 µL, 0.70 mmol) at -78 °C. After 1 h, the reaction was quenched with Et3N 
(0.5 mL) and poured into H2O. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL) 
and combined organics were dried (Na2SO4), filtered and removed in vacuo. The crude 
product was purified by flash column chromatography (15% EtOAc in petroleum ether) to 
yield the desired product 122 as a yellow solid (70 mg, 0.28 mmol, 46%).  
 
1H (CDCl3, 400 MHz) δ: 8.52 (1H, d, JH = 3.6 Hz, NCHCOTs), 8.17 (1H, d, JH = 2.4 Hz, 
NCHCH), 7.72 (2H, d, JH = 8.4 Hz, Ar-CH), 7.49 (1H, dq, JH = 8.3, 1.2 Hz, CHCOTs), 7.36 
(2H, d, JH = 8.4 Hz, Ar-CH), 7.31 (1H, dd, JH = 8.3, 4.6 Hz, NCHCH), 2.46 (3H, s, CH3).  
13C (CDCl3, 125 MHz) δ: 148.9 (NCHCOTs), 146.6 (CSO2), 146.1 (COTs), 144.3 
(NCHCH), 131.6 (CH3C) 129.8 (CHCOTs), 129.7 (2C, Ar-CH), 127.8 (2C, Ar-CH), 123.8 
(NCHCH), 21.0 (CH3). 
The spectral data is in agreement with the literature values.52 
 
2-Fluoroacrylic Acid, 135.140 
 
OH
F
O
 
 
2-Fluoroacylic acid methyl ester 136 (0.87 mL, 9.61 mmol) was dissolved in EtOH/H2O 
(8.7:1.3, 10 mL). aq. NaOH (2M) was then added dropwise until pH 11 was reached, and 
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the resulting mixture was stirred for 30 min. After which, the solvent was removed in 
vacuo to yield the sodium salt as a white solid. Diethyl ether (20 mL) was added to the 
salt, followed by aq. HCl (6M) dropwise until the solid dissolved. The layers were then 
separated, and the aqueous layer was extracted with diethyl ether (10 mL). The organics 
were combined, dried (Na2SO4) and removed in vacuo to yield the desired product 135 as 
a white solid (0.74 g, 8.20 mmol, 87%). 
 
1H (CDCl3, 400 MHz) δ: 9.56 (1H, br s, OH), 5.85 (1H, dd, JF = 42.8, JH = 3.6 Hz, CHH), 
5.51 (1H, dd, JF = 12.4, JH = 3.2 Hz, CHH). 
19F (CDCl3, 377 MHz) δ: -118.3.  
13C (CDCl3, 125 MHz) δ:  165.4 (d, JF = 46.3, COOH), 151.3 (d, JF = 323.8 Hz, CF), 105.2 
(d, JF = 18.8, CH2). 
The spectral data is in agreement with the literature values.140 
 
1-Phenyl-but-3-enylamine, 139.141 
 
NH2
 
 
Procedure A 
Allylboronic acid pinacol ester (1.2 g, 10.8 mmol) and dodecyl benzenesulfonic acid (10 
mol%, 0.27 mL, 910 µmol) were added to 25-30% aqueous ammonia (10 mL) and the 
mixture was stirred for 30 min. After which, benzaldehyde (0.96 mL, 9.43 mmol) was 
added and the suspension was vigorously stirred for 4.5 h. The solution was then acidified 
to pH 1-2 and the organics extracted with CH2Cl2 (3 × 20 mL). The resulting aqueous 
phase was basified to pH 12-13 and the organics extracted with CH2Cl2 (3 × 20 mL). The 
organics were dried (Na2SO4), filtered and the solvent was removed in vacuo. This gave 
the desired product 139 as a colourless oil (0.72 g, 4.89 mmol, 52%).  
 
 
Procedure B 
Benzaldehyde (0.21 g, 1.96 mmol) was dissolved in MeOH (4 mL) and the resulting 
solution was cooled to -78 °C. NH3 (ca. 4 mL) was condensed into the solution, and the 
resulting reaction mixture was warmed to -10 °C and stirred until the excess ammonia had 
evaporated (3 h). Allyl boronic pinacol ester (0.76 mL, 3.93 mmol) was added and the 
reaction was stirred for 2 h. The reaction vessel was then allowed to warm up to rt and 
stirred for a further 1 h. aq. HCl (6 M) was added slowly to the solution until pH 1 and the 
mixture was extracted with diethyl ether (3 × 20 mL). The aqueous phase was collected, 
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and aq. NaOH (2 M) was added slowly until pH 14. The aqueous solution was extracted 
with CH2Cl2 (3 × 20 mL). The combined CH2Cl2 phases were then dried (Na2SO4), filtered 
and the solvent was removed in vacuo to yield the desired product 139 as a colourless oil 
(0.28 g, 1.90 mmol, 95%).  
 
1H (CDCl3, 400 MHz) δ: 7.20-7.35 (5H, m, Ar-H), 5.65-5.75 (1H, m, CH2CHCH2), 5.04-5.17 
(2H, m, CHCH2), 3.99 (1H, dd, JH = 8.0, 5.2 Hz, CHNH2) 2.29-2.45 (2H, m, CHCH2CH), 
1.54 (2H, br s, NH2). 
13C (CDCl3, 125 MHz) δ: 145.8 (ArC-CHN), 135.4 (CHCH2,) 128.4 (2C, Ar-CH), 127.9 (Ar-
CH), 126.4 (2C, Ar-CH), 117.7 (CHCH2), 55.4 (CHNH2), 44.2 (CHCH2CH).  
The spectral data is in agreement with the literature values.141 
 
N-(1-Phenyl-3-buten-1-yl)propenamide, 140.142 
 
HN
O
 
 
Procedure A  
To a solution of acryloyl chloride (0.29 mL, 4.63 mmol) in CH2Cl2 (5 mL) was added a 
solution of allyl amine 139 (0.68 g, 4.63 mmol) with Et3N (1.3 mL, 9.25 mmol) in CH2Cl2 (5 
mL). The resulting mixture was stirred at rt for 2 h. The reaction was quenched with sat. 
NH4Cl (10 mL) and the phases separated. The organic phase was dried (Na2SO4) and the 
solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography (20% EtOAc in petroleum ether) to yield the desired product 140 as a 
white solid (0.54 g, 2.59 mmol, 56%). 
 
Procedure B  
Benzaldehyde (0.50 g, 4.72 mmol), acrylamide (0.45 g, 7.08 mmol) and 
allyltrimethylsilane (1.1 mL, 7.08 mmol) were dissolved in MeCN (10 mL). The solution 
was cooled to 0 °C before BF3·OEt2 (1.1 mL, 8.90 mmol) was added. The reaction mixture 
as stirred for 30 min at 0 °C, then allowed to warm to rt and stirred for a further 96 h. The 
solution was poured into sat. aq. NaHCO3 (20 mL) and extracted with CH2Cl2 (3 × 20 mL). 
The combined organics were then dried (Na2SO4), filtered and removed in vacuo. The 
crude residue was purified by flash column chromatography (20% EtOAc in petroleum 
ether) to yield the desired product 140 as a white solid (0.62 g, 3.11 mmol, 66%). 
 
Procedure C 
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To a solution of benzaldehyde (0.20 g, 1.88 mmol) in MeCN (2 mL), acrylamide (0.38 g, 
5.66 mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.23 mL, 1.88 mmol) was added 
slowly and the reaction mixture was stirred for 15 min. The solution was allowed to warm 
to rt and then stirred for a further 5 h. Following this time, allyltrimethylsilane (0.59 mL, 
3.76 mmol) and BF3·OEt2 (0.23 mL, 1.88 mmol) were added and the resulting mixture was 
stirred for 17 h. The solution was poured into sat. aq. NaHCO3 (10 mL) and extracted with 
CH2Cl2 (3 × 20 mL). The organics were dried (Na2SO4), filtered and the solvent was 
removed in vacuo. The resulting residue was purified by flash column chromatography 
(20% EtOAc in petroleum ether) to yield the desired product 140 as a white solid (0.33 g, 
1.65 mmol, 88%). 
 
1H (CDCl3, 400 MHz) δ: 7.38-7.25 (5H, m, Ar-H), 6.31 (1H, dd, JH = 16.8, 2.0 Hz, 
COCHCHH), 6.13 (1H, dd, JH = 16.8, 10.0 Hz, COCHCH2), 5.88 (1H, m, NH), 5.78-5.60 
(2H, m, COCHCHH and CH2CHCH2), 5.22-5.10 (3H, m, CH2CHCH2 and CHNH), 2.64 (2H, 
t, JH = 6.8 Hz, CHCH2CH).  
13C (CDCl3, 125 MHz) δ: 164.7 (CO), 141.4 (ArC-CHN), 133.9 (CHCH2), 130.8 (COCH) 
128.6 (2C, Ar-C), 127 4 (Ar-C), 126.7 (COCHCH2) 126.5 (2C, Ar-C), 118.3 (CHCH2), 52.1 
(CHNH), 40.4 (CHCH2CH).  
The spectral data is in agreement with the literature values.142 
 
6-Phenyl-5,6-dihydro-1H-pyridin-2-one, 142.143 
 
HN
O
 
 
To a solution of dialkene 140 (0.10 g, 0.50 mmol) in CH2Cl2 (5.5 mL) was added Grubbs I 
catalyst (10 mol%, 40 mg, 50 µmol) and the reaction was stirred at reflux for 17 h. The 
solvent was removed in vacuo and the crude residue was purified by flash column 
chromatography (10 - 30% EtOAc in petroleum ether) to yield the desired product 142 as 
a grey solid (80 mg, 0.45 mmol, 90 %).  
 
1H (CDCl3, 400 MHz) δ: 7.39-7.42 (5H, m, Ar-H), 6.68 (1H, ddd, JH = 10.0, 5.6, 3.2 Hz, 
COCHCH), 6.06 (1H, d, JH = 10.0 Hz, COCH), 5.57 (1H, br s, NH) 4.77 (1H, dd, JH = 10.8, 
5.6 Hz, CHNH), 2.55 (2H, m, CHCH2CH).  
13C (CDCl3, 125 MHz) δ: 166.5 (CO), 141.1 (ArC-CHN), 140.2 (COCHCH2), 129.0 (2C, Ar-
C), 128.4 (Ar-C) 126.4 (2C, Ar-C), 124.6 (COCH), 55.9 (CHNH), 33.13 (CHCH2CH). 
The spectral data is in agreement with the literature values.143 
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 6-Phenyl-1H-pyridin-2-one, 143.144 
 
HN
O
 
 
To a solution of amide 142 (30 mg, 0.19 mmol) in toluene (5 mL) was added 2,3-dichloro-
5,6-dicyano-1,4-benzoquinone (70 mg, 0.29 mmol) and the reaction was stirred at reflux 
for 17 h. The solvent was removed in vacuo and the crude residue purified by flash 
column chromatography (10 - 30% EtOAc in petroleum ether) to yield the desired product 
143 as a white solid (20 mg, 0.13 mmol, 68%).  
 
1H (CDCl3, 400 MHz) δ: 7.72 (1H, dd, JH = 8.0, 1.6 Hz, COCHCH), 7.54-7.47 (5H, m, Ar-
H), 6.56 (1H, d, JH = 9.2 Hz, COCH), 6.51 (2H, d, JH = 7.2 Hz, NHCCH).  
13C (CDCl3, 125 MHz) δ: 164.7 (CO), 146.7 (CNH), 141.4 (COCHCH2), 133.5 (ArC-CHN), 
130.1 (2C, Ar-C), 129.3 (Ar-C) 126.5 (2C, Ar-C), 118.8 (COCH), 104.7 (NHCCH). 
The spectral data is in agreement with the literature values.144 
 
N-[1-(4-Methoxyphenyl)-3-buten-1-yl]-propenamide, 145.68 
 
HN
O
MeO  
 
To a solution of 4-methoxybenzaldehyde (0.17 mL, 1.46 mmol) in MeCN (2 mL), 
acrylamide (0.31 g, 4.38 mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.17 mL, 1.46 
mmol) was added slowly and the reaction mixture was stirred for 15 min. The solution was 
allowed to warm to rt and then stirred for a further 6 h. Following this time, 
allyltrimethylsilane (0.46 mL, 2.92 mmol) and BF3·OEt2 (0.17 mL, 1.46 mmol) were added 
and the resulting mixture was stirred for 17 h. The solution was poured into sat. aq. 
NaHCO3 (10 mL) and extracted with CH2Cl2 (3 × 20 mL). The organics were dried 
(Na2SO4), filtered and the solvent was removed in vacuo. The crude residue was purified 
by flash column chromatography (20% EtOAc in petroleum ether) to yield the desired 
product 145 as a white solid (0.27 g, 1.17 mmol, 83%). 
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1H (CDCl3, 400 MHz) δ: 7.27 (2H, d, JH = 8.4 Hz, Ar-H), 6.81 (2H, d, JH = 8.4 Hz, Ar-H), 
6.27 (1H, dd, JH = 16.8, 1.6 Hz, COCHCHH), 6.11 (1H, dd, JH = 17.2, 10.4 Hz, 
COCHCH2), 5.77-5.71 (1H, m, CH2CHCH2), 5.91 (1H, d, JH = 7.6 Hz, NH), 5.64 (1H, dd, 
JH = 10.4, 1.6 Hz, COCHCHH), 5.15-5.10 (3H, m, CH2CHCH2 and CHNH), 3.80 (3H, s, 
OCH3), 2.64-2.60 (2H, m, CHCH2CH). 
13C (CDCl3, 125 MHz) δ: 164.7 (CO), 158.9 (COMe), 134.1 (CHCH2), 133.6 (ArC-CHN), 
130.9 (COCH) 127.7 (2C, Ar-C), 126.7 (COCHCH2) 118.1 (CHCH2), 114.0 (2C, Ar-C), 
55.3 (OCH3), 52.0 (CHNH), 40.3 (CHCH2CH). 
The spectral data is in agreement with the literature values.68 
 
N-[1-(4-Nitro-phenyl)-but-3-enyl]-propenamide, 146. 
 
HN
O
O2N  
 
To a solution of 4-nitrobenzaldehyde (0.20 g, 1.3 mmol) in MeCN (2 mL), acrylamide (0.28 
g, 4.0 mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.16 mL, 1.3 mmol) was added 
slowly and the reaction mixture was stirred for 15 min. The solution was allowed to warm 
to rt and then stirred for a further 6 h. Allyltrimethylsilane (0.41 mL, 2.64 mmol) and 
BF3·OEt2 (0.40 mL, 3.4 mmol) were added and the resulting mixture was stirred for 17 h. 
The solution was poured into sat. aq. NaHCO3 (10 mL) and extracted with CH2Cl2 (3 × 20 
mL). The organics were dried (Na2SO4), filtered and the solvent was removed in vacuo. 
The crude residue was purified by flash column chromatography (20% EtOAc in 
petroleum ether) to yield the desired product 146 as a white solid (0.11 g, 0.44 mmol, 
34%). 
 
1H (CDCl3, 400 MHz) δ: 8.11 (2H, d, JH = 8.5 Hz, Ar-H), 7.38 (2H, d, JH = 8.5 Hz, Ar-H) 
6.38 (1H, dd, JH = 16.5, 1.0 Hz, COCHCHH), 6.14 (1H, d, JH = 7.0 Hz, NH), 6.08 (1H, dd, 
JH = 16.5, 10.0 Hz, COCHCH2), 5.63-5.53 (2H, m, COCHCHH and CH2CHCH2), 5.13-5.07 
(3H, m, CH2CHCH2 and CHNH), 2.53-2.50 (2H, m, CHCH2CH). 
13C (CDCl3, 125 MHz) δ: 165.0 (CO), 149.1 (CNO2), 147.2 (ArC-CHN), 132.7 (CHCH2), 
130.1 (COCH), 127.6 (COCHCH2), 127.3 (2C, Ar-C), 123.9 (2C, Ar-C), 119.5 (CHCH2), 
52.3 (CHNH), 40.2 (CHCH2CH). 
m/z [EI (+ve)] 246.2 [M]+, HRMS found [M]+ 246.1003, C13H14N2O3 requires 246.1004.  
IR (thin film) vmax = 3290, 3090, 2920, 1680, 1610, 1525, 1510 cm-1.  
m.p. 84-86 ˚C. 
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N-(1-Phenethyl-but-3-enyl)-propenamide, 147. 
 
HN
O
 
 
To a solution of 3-phenylpropionaldehyde (0.20 mL, 1.49 mmol) in MeCN (2 mL), 
acrylamide (0.32 g, 4.47 mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.18 mL, 1.49 
mmol) was added slowly and the reaction mixture was stirred for 15 min. The solution was 
allowed to warm to rt and then stirred for a further 6 h. Allyltrimethylsilane (0.47 mL, 2.98 
mmol) and BF3·OEt2 (0.18 mL, 1.78 mmol) were added and the resulting mixture was 
stirred for 17 h. The solution was poured into sat. aq. NaHCO3 (10 mL) and extracted with 
CH2Cl2 (3 × 20 mL). The organics were dried (Na2SO4), filtered and the solvent was 
removed in vacuo. The crude residue was purified by flash column chromatography (10% 
EtOAc in petroleum ether) to yield the desired product 147 as a white solid (0.22 g, 1.00 
mmol, 66%). 
 
1H (CDCl3, 400 MHz) δ: 7.32-7.19 (5H, m, Ar-H), 6.31 (1H, dd, JH = 17.2, 1.2 Hz, 
COCHCHH), 6.08 (1H, dd, JH = 17.2, 10.4 Hz, COCHCH2), 5.85-5.75 (1H, m, 
CH2CHCH2), 5.66 (1H, dd, JH = 10.4, 1.6 Hz, COCHCHH), 5.53 (1H, d, JH = 8.4, NH), 
5.13-5.09 (2H, m, CH2CHCH2), 4.17-4.15 (1H, m, CHNH), 2.70 (2H, t, JH = 8.4 Hz, 
PhCH2) 2.35-2.31 (2H, m, CHCH2CH), 1.86-1.83 (2H, m, PhCH2CH2). 
13C (CDCl3, 125 MHz) δ: 164.7 (CO), 141.7 (ArC-CH2), 134.0 (CHCH2), 131.0 (COCH), 
128.5 (2C, Ar-C), 128.4 (2C, Ar-C), 126.4 (COCHCH2) 125.9 (Ar-C), 118.2 (CHCH2), 48.6 
(CHNH), 39.2 (Ph-CH2), 36.2 (CHCH2CH), 32.4 (PhCH2CH2).  
m/z [EI (+ve)] 229.2 [M]+, HRMS found [M]+ 229.1465, C15H19NO requires 229.1467.  
IR (thin film) vmax = 3250, 3100, 2920, 1640, 1605, 1550 cm-1.  
m.p. 85-87 ˚C. 
 
N-(1-Isobutyl-but-3-enyl)-propenamide, 148.145 
 
HN
O
 
 
131 
To a solution of isovaleraldehyde (0.25 mL, 2.33 mmol) in MeCN (2 mL), acrylamide (0.49 
g, 6.99 mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.28 mL, 2.33 mmol) was 
added slowly and the reaction mixture was stirred for 15 min. The solution was allowed to 
warm to rt and then stirred for a further 6 h. Allyltrimethylsilane (0.72 mL, 4.66 mmol) and 
BF3·OEt2 (0.28 mL, 2.33 mmol) were added and the resulting mixture was stirred for 17 h. 
The solution was poured into sat. aq. NaHCO3 (10 mL) and extracted with CH2Cl2 (3 × 20 
mL). The organics were dried (Na2SO4), filtered and the solvent was removed in vacuo. 
The crude residue was purified by flash column chromatography (20% EtOAc in 
petroleum ether) to yield the desired product 148 as a white solid (0.36 g, 2.00 mmol, 
86%). 
 
1H (CDCl3, 400 MHz) δ: 6.29 (1H, dd, JH = 17.2, 1.6 Hz, COCHCHH), 6.06 (1H, dd, JH = 
17.2, 10.4 Hz, COCHCH2), 5.85-5.74 (1H, m, CH2CHCH2), 5.63 (1H, dd, JH = 10.4, 1.6 
Hz, COCHCHH), 6.15-6.13 (1H, m, NH), 5.08-5.06 (2H, m, CH2CHCH2), 4.19-4.17 (1H, 
m, CHNH), 2.31-2.28 (2H, m, CHCH2CH), 1.66-1.64 (1H, m, CH(CH3)2CH2), 1.35-1.32 
(2H, m, CH(CH3)2CH2), 0.98 (3H, d, JH = 6.6 Hz, CH3), 0.96 (3H, d, JH = 6.6 Hz, CH3). 
13C (CDCl3, 125 MHz) δ: 165.0 (CO), 134.3 (CHCH2), 131.1 (COCH), 127.6 (COCHCH2), 
117.8 (CHCH2), 46.8 (CHNH), 43.7 (CHCH2CH), 39.7 (CH(CH3)2CH2), 24.9 
(CH(CH3)2CH2) 23.1 (CH3CHCH3), 23.1 (CH3CHCH3).  
The spectral data is in agreement with the literature values.145 
 
(E)-N-(1-Phenylhexa-1,5-dien-3-yl)acrylamide, 151.99 
 
HN
O
 
 
To a solution of cinnamaldehyde (0.20 mL, 1.5 mmol) in MeCN (2 mL), acrylamide (0.32 
g, 4.5 mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.18 mL, 1.5 mmol) was added 
slowly and the reaction mixture was stirred for 15 min. The solution was allowed to warm 
to rt and then stirred for a further 6 h. Allyltrimethylsilane (0.48 mL, 3.0 mmol) and 
BF3·OEt2 (0.37 mL, 3.0 mmol) were added and the resulting mixture was stirred for 17 h. 
The solution was poured into sat. aq. NaHCO3 (10 mL) and extracted with CH2Cl2 (3 × 20 
mL). The organics were dried (Na2SO4), filtered and the solvent was removed in vacuo. 
The crude residue was purified by flash column chromatography (15% EtOAc in 
petroleum ether) to yield the desired product 151 as a white solid (70 mg, 0.16 mmol, 
20%). 
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1H (CDCl3, 400 MHz) δ: 7.27-7.11 (5H, m, Ar-H), 6.45 (1H, dd, JH = 16.8, 1.6 Hz, 
COCHCHH), 6.24 (1H, dd, JH =10.8, 1.6 Hz, PhCHCH), 6.12 (1H, dd, JH =16.8, 6.5 Hz, 
COCHCH2), 6.03 (1H, d, JH = 10.8 Hz, PhCH), 5.75-5.70 (2H, m, CH2CHCH2 and NH), 
5.59 (1H, dd, JH = 6.5, 1.6 Hz, COCHCHH), 5.14-5.08 (2H, m, CH2CHCH2), 4.76-4.74 (1H, 
m, CHNH), 2.41-2.37 (2H, m, CHCH2CH). 
13C (CDCl3, 125 MHz) δ: 164.8 (CO), 136.6 (ArC-CH2), 133.7 (CHCH2), 130.9 (2C, PhCH 
and COCH), 128.9 (Ar-C), 128.6 (2C, Ar-CH), 127.7 (PhCHCH) 126.7 (COCHCH2), 126.4 
(2C, Ar-CH), 118.6 (CHCH2), 50.0 (CHNH), 39.4 (Ph-CH2). 
The spectral data is in agreement with the literature values.99  
 
N-(1-Allyl-decyl)-propenamide, 152. 
 
HN
O
 
 
 
To a solution of decanal (0.24 mL, 1.28 mmol) in MeCN (2 mL), acrylamide (0.27 g, 3.84 
mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.15 mL, 1.30 mmol) was added slowly 
and the reaction mixture was stirred for 15 min. The solution was allowed to warm to rt 
and then stirred for a further 6 h. Following this time, allyltrimethylsilane (0.40 mL, 2.56 
mmol) and BF3·OEt2 (0.15 mL, 1.28 mmol) were added and the resulting mixture was 
stirred for 17 h. The solution was poured into sat. aq. NaHCO3 (10 mL) and extracted with 
CH2Cl2 (3 × 20 mL). The organics were dried (Na2SO4), filtered and the solvent was 
removed in vacuo. The resulting residue was purified by flash column chromatography 
(5% EtOAc in petroleum ether) to yield the desired product 152 as a white solid (0.29 g, 
1.19 mmol, 91%). 
 
1H (CDCl3, 400 MHz) δ: 6.18 (1H, dd, JH = 16.8, 1.6 Hz, COCHCHH), 5.98 (1H, dd, JH = 
16.8, 10.4 Hz, COCHCH2), 5.75-5.64 (1H, m, CH2CHCH2), 5.54 (1H, dd, JH = 10.4, 1.6 
Hz, COCHCHH), 5.26 (1H, d, JH = 8.8 Hz, NH), 5.01-4.96 (2H, m, CH2CHCH2), 4.02-4.01 
(1H, m, CHNH), 2.23-2.20 (2H, m, CHCH2CH), 1.34-1.31 (2H, m, CH2(CH2)7), 1.19-1.08 
(14H, m, CH2(CH2)7CH3), 0.84-0.80 (3H, m, CH2(CH2)8CH3). 
13C (CDCl3, 100 MHz) δ: 165.0 (CO), 134.3 (CHCH2), 131.1 (COCH), 126.1 (COCHCH2), 
117.9 (CHCH2), 48.7 (CHNH), 39.1 (CHCH2CH), 34.4 (CH2), 31.9 (CH2), 29.5 (CH2), 29.5 
(CH2), 29.3 (CH2), 25.9 (CH2), 25.5 (CH2), 22.7 (CH2), 14.1 (CH3).  
m/z [EI (+ve)] 251.2 [M]+, HRMS found [M]+ 251.2244, C16H29NO requires 251.2249.  
IR (thin film) vmax = 3267, 2924, 2854, 1654, 1548, 1263, 1099 cm-1. 
m.p. 56-58 ˚C. 
133 
 
 
 
N-[1-(2-Methyl-oxazol-4-yl)-but-3-enyl]-propenamide, 153. 
 
N
O
HN
O
 
 
To a solution of 2-methyl-oxazole-4-carbaldehyde (0.20 g, 1.8 mmol) in MeCN (2 mL), 
acrylamide (0.38 g, 5.4 mmol) was added. After cooling to 0 °C, BF3·OEt2 (0.22 mL, 1.8 
mmol) was added slowly and the reaction mixture was stirred for 15 min. The solution was 
allowed to warm to rt and then stirred for a further 6 h. Following this time, 
allyltrimethylsilane (0.57 mL, 3.6 mmol) and BF3·OEt2 (0.22 mL, 1.8 mmol) were added 
and the resulting mixture was stirred for 17 h. The solution was poured into sat. aq. 
NaHCO3 (10 mL) and extracted with CH2Cl2 (3 × 20 mL). The organics were dried 
(Na2SO4), filtered and the solvent was removed in vacuo. The crude residue was purified 
by flash column chromatography (20% EtOAc in petroleum ether) to yield the desired 
product 153 as a yellow oil (0.16 g, 0.76 mmol, 42%). 
 
1H (CDCl3, 400 MHz) δ: 7.36 (1H, s, CHCO), 6.23 (1H, dd, JH = 17.2, 1.6 Hz, COCHCHH), 
6.15 (1H, m, NH), 6.01 (1H, dd, JH = 17.2, 10.0 Hz, COCHCH2), 5.70-5.60 (1H, m, 
CH2CHCH2), 5.57 (1H, dd, JH = 10.0, 1.6 Hz, COCHCHH) 5.08-5.00 (3H, m, CH2CHCH2 
and CHNH ), 2.54-2.52 (2H, m, CHCH2CH), 3.37 (3H, s, CH3). 
13C (CDCl3, 100 MHz) δ: 164.9 (CO), 161.9 (NC(CH3)O), 139.8 (CHC(CH)N), 134.6 
(CHCH2), 133.7 (Ar-CH), 130.7 (COCH), 126.7 (COCHCH2), 118.2 (CHCH2), 45.2 
(CHNH), 38.6 (CHCH2CH),14.0 (CH3).  
m/z [ESI (+ve)] 229.1 [M+Na]+, HRMS found [M+Na]+ 229.0943, C11H14N2O2Na requires 
229.0947.  
IR (thin film) vmax = 3267, 1656, 1539, 1408, 1244, 1099 cm-1. 
 
5,6-Dihydro-6-(4-methoxyphenyl)pyridin-2(1H)-one, 156.68 
 
HN
O
MeO  
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To a solution of dialkene 145 (0.10 g, 0.43 mmol) in CH2Cl2 (5.5 mL) was added Grubbs I 
catalyst (10 mol%, 40 mg, 40 µmol) and the reaction was stirred at reflux for 17 h. The 
mixture was removed in vacuo and the crude material was purified by flash column 
chromatography (10 - 30% EtOAc in petroleum ether) to yield the desired product 156 as 
a grey solid (90 mg, 0.43 mmol, quantitative).  
 
1H (CDCl3, 400 MHz) δ: 7.31 (2H, d, JH = 8.8 Hz, Ar-H), 6.93 (2H, d, JH = 8.8 Hz, Ar-H), 
6.67 (1H, ddd, JH = 10.0, 5.2, 3.6 Hz, COCHCH), 6.03 (1H, d, JH = 10.0 Hz, COCH), 5.50 
(1H, br s, NH), 4.70 (1H, dd, JH = 10.0, 6.4 Hz, CHNH), 3.84 (3H, s, OCH3), 2.52 (2H, m, 
CHCH2CH).  
13C (CDCl3, 125 MHz) δ: 166.5 (CO), 159.6 (Ar-COCH3), 140.3 (COCHCH), 133.1 (ArC-
CHN), 127.7 (2C, Ar-C), 124.6 (COCH), 114.3 (2C, Ar-C), 55.4 (CHNH), 55.3 (OCH3), 
33.2 (CHCH2CH). 
The spectral data is in agreement with the literature values.68 
 
5,6-Dihydro-6-(4-nitrophenyl)pyridin-2(1H)-one, 157.146 
 
HN
O
O2N  
 
To a solution of dialkene 146 (0.10 g, 0.40 mmol) in CH2Cl2 (5.5 mL) was added Grubbs I 
catalyst (10 mol%, 30 mg, 40 µmol) and the reaction was stirred at reflux for 17 h. The 
mixture was removed in vacuo and the crude material was purified by flash column 
chromatography (15 - 40% EtOAc in petroleum ether) to yield the desired product 157 as 
a grey solid (90 mg, 0.40 mmol, quantitative).  
 
1H (CDCl3, 400 MHz) δ: 8.17 (2H, d, JH = 8.8 Hz, Ar-H), 7.48 (2H, d, JH = 8.8 Hz, Ar-H), 
6.55 (1H, m, COCHCH), 6.15 (1H, br s, NH),  5.96 (1H, d, JH = 8.0 Hz, COCH), 4.82 (1H, 
dd, JH = 8.0, 4.8 Hz, CHNH), 2.63 (1H, m, CHCHHCH), 2.43 (1H, m, CHCHHCH). 
13C (CDCl3, 125 MHz) δ: 166.3 (CO), 148.4 (Ar-CNO2), 147.9 (ArC-CHN), 139.5 
(COCHCH), 127.3 (2C, Ar-CH), 124.8 (COCH), 124.3 (2C, Ar–CH), 55.0 (CHNH), 32.6 
(CHCH2CH). 
The spectral data is in agreement with the literature values.146 
 
 
135 
5,6-Dihydro-6-(phenylpropionyl)pyridin-2(1H)-one, 158.   
 
HN
O
 
 
To a solution of dialkene 147 (0.10 g, 0.44 mmol) in CH2Cl2 (5.5 mL) was added Grubbs I 
catalyst (10 mol%, 40 mg, 40 µmol) and the reaction was stirred at reflux for 17 h. The 
mixture was removed in vacuo and the crude material was purified by flash column 
chromatography (15 - 30% EtOAc in petroleum ether) to yield the desired product 158 as 
a grey solid (80 mg, 0.41 mmol, 94%).  
 
1H (CDCl3, 400 MHz) δ: 7.34-7.20 (5H, m, Ar-H), 6.24-6.21 (1H, m, COCHCH), 5.93 (1H, 
dd, JH = 9.6, 1.2 Hz, COCH), 5.84 (1H, br s, NH), 3.63-3.62 (1H, m, CHNH), 2.74-2.70 
(2H, m, PhCH2), 2.44-2.41 (1H, m, CHCHHCH), 2.26-2.24 (1H, m, CHCHHCH), 1.91-1.89 
(2H, m, PhCH2CH2). 
13C (CDCl3, 125 MHz) δ: 166.1 (CO), 140.6 (ArC-CH2), 140.1 (COCHCH), 128.6 (2C, Ar-
CH), 128.2 (Ar-CH), 126.3 (2C, Ar-CH), 124.6 (COCH), 50.5 (CHNH), 37.1 (CH2), 31.6 
(CH2), 29.9 (CH2). 
m/z [EI (+ve)] 201.2 [M]+, HRMS found [M]+ 201.1153, C13H15NO requires 201.1154.  
IR (thin film) vmax = 3059, 2922, 2868, 1676, 1608, 1415, 1325 cm-1. 
m.p. 116-118 ˚C. 
 
5,6-Dihydro-6-(isobutyl)pyridin-2(1H)-one, 159.145   
 
HN
O
 
 
To a solution of dialkene 148 (0.12 g, 0.67 mmol) in CH2Cl2 (9.1 mL) was added Grubbs I 
catalyst (10 mol%, 60 mg, 70 µmol) and the reaction was stirred at reflux for 17 h. The 
mixture was removed in vacuo and the crude material purified by flash column 
chromatography (15 - 20% EtOAc in petroleum ether) to yield the desired product 159 as 
a grey solid (90 mg, 0.56 mmol, 84%).  
 
1H (CDCl3, 400 MHz) δ: 6.62 (1H, m, COCHCH), 5.92 (1H, d, JH = 8.8 Hz, COCH), 5.61 
(1H, br s, NH), 3.70-3.69 (1H, m, CHNH), 2.38-2.36 (1H, m, CHCHHCH), 2.16-2.14 (1H, 
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m, CHCHHCH), 1.71 (1H, quint, JH = 6.8 Hz, CH(CH3)2CH2), 1.45-1.43 (2H, m, 
CH(CH3)2CH2), 0.96 (3H, d, JH = 6.6 Hz, CH3), 0.94 (3H, d, JH = 6.6 Hz, CH3). 
13C (CDCl3, 125 MHz) δ: 165.0 (CO), 140.5 (COCHCH), 124.8 (COCH), 49.1 (CHNH), 
44.8 (CHCH2CH), 30.5 (CH(CH3)2CH2), 24.3 (CH3CHCH3), 22.7 (CH3CHCH3), 22.2 
(CH(CH3)2CH2). 
The spectral data is in agreement with the literature values.145 
 
5,6-Dihydro-6-(decanyl)pyridin-2(1H)-one, 160. 
 
HN
O
 
 
To a solution of dialkene 152 (0.10 g, 0.40 mmol) in CH2Cl2 (5.5 mL) was added Grubbs I 
catalyst (10 mol%, 30 mg, 40 µmol) and the reaction was stirred at reflux for 17 h. The 
mixture was removed in vacuo and the crude material was purified by flash column 
chromatography (15 - 20% EtOAc in petroleum ether) to yield the desired product 160 as 
a grey solid (80 mg, 0.35 mmol, 90%).  
 
1H (CDCl3, 400 MHz) δ: 6.53 (1H, m, COCHCH), 5.83 (1H, dd, JH = 8.0, 0.8 Hz, COCH), 
5.54 (1H, br s, NH), 3.50 (1H, sept, JH = 4.8 Hz, CHNH), 2.33-2.30 (1H, m, CHCHHCH), 
2.08-2.06 (1H, m, CHCHHCH), 1.44-1.41 (2H, m, CH2(CH2)8CH3), 1.23-1.18 (14H, m, 
CH2(CH2)7CH3), 0.81 (3H, t, JH = 5.6 Hz, CH(CH2)8CH3). 
13C (CDCl3, 125 MHz) δ: 166.5 (CO), 140.7 (COCHCH), 124.5 (COCH), 51.1 (CHNH), 
35.5 (CH2), 31.9 (CH2), 30.0 (CH2), 29.5 (CH2), 29.4 (CH2), 29.3 (CH2), 25.3 (CH2), 25.2 
(CH2), 22.7 (CH2), 14.1 (CH3). 
m/z [EI (+ve)] 223.3 [M]+, HRMS found [M]+ 223.1933, C14H25NO requires 223.1936.  
IR (thin film) vmax = 2924, 2852, 2360, 1678, 1610, 1419, 1309 cm-1. 
m.p. 38-40 ˚C. 
 
 (E)-6-Styryl-5,6-dihydropyridin-2(1H)-one, 161.99 
 
HN
O
 
 
To a solution of dialkene 151 (80 mg, 0.35 mmol) in CH2Cl2 (5.5 mL) was added Grubbs I 
catalyst (10 mol%, 30 mg, 40 µmol) and the reaction was stirred at reflux for 17 h. The 
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mixture was removed in vacuo and the crude material was purified by flash column 
chromatography (15 - 30% EtOAc in petroleum ether) to yield the desired product 161 as 
a grey solid (50 mg, 0.24 mmol, 68%).  
 
1H (CDCl3, 400 MHz) δ: 7.39-7.29 (5H, m, Ar-H), 6.69-6.59 (2H, m, COCHCH and PhCH), 
6.22 (1 H, dd, JH = 15.6, 7.6 Hz, PhCHCH), 5.99 (1H, d, JH = 8.4 Hz, COCH), 5.68 (1H, br 
s, NH), 4.34-4.32 (1H, m, CHNH), 2.57-2.55 (1H, m, CHCHHCH), 2.42-2.39 (1H, m, 
CHCHHCH). 
13C (CDCl3, 100 MHz) δ: 165.9 (CO), 139.8 (COCHCH), 135.9 (ArC-CH2), 134.3 (PhCH), 
128.8 (2C, Ar-CH), 128.5 (Ar-CH), 128.2 (PhCHCH), 126.6 (2C, Ar-CH), 124.7 (COCH), 
53.7 (CHNH), 30.6 (CH2). 
The spectral data is in agreement with the literature values.99 
 
6-(4-Methoxyphenyl)-1H-pyridin-2-one, 163. 
 
HN
O
MeO  
 
To a solution of amide 156 (60 mg, 0.30 mmol) in toluene (6 mL) was added 2, 3-dichloro-
5,6-dicyano-1,4-benzoquinone (0.10 g, 0.45 mmol) and the reaction was stirred at reflux 
for 17 h. The solvent was removed in vacuo and the crude residue was purified by flash 
column chromatography (0 - 40% EtOAc in petroleum ether) to yield the desired product 
163 as a white solid (50 mg, 0.23 mmol, 76%). 
 
1H (CDCl3, 400 MHz) δ: 10.9 (1H, br s, NH), 7.63-7.34 (3H, m, Ar-H and COCHCH), 6.94 
(2H, br s, Ar-H), 6.44 (1H, br s, COCH), 6.30 (1H, br s, PhCCH), 3.80 (3H, br s, OCH3).  
13C (CDCl3, 125 MHz) δ: 161.2 (2C, CO and Ar-COCH3), 128.14 (2C, Ar-CH), 126.0 (2C, 
ArC-CHN and COCHCH), 114.7 (4C, COCH, NHCCH and Ar-CH), 104.5 (NHCCH), 55.4 
(OCH3),  
m/z [EI (+ve)] 201.1 [M]+, HRMS found [M]+ 201.0788, C12H11O2N requires 201.0790.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
IR (thin film) vmax = 2924, 1643, 1608, 1253 cm-1.  
m.p. 203-205 ˚C. 
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2-Fluoro-acrylamide, 181.82 
 
F
NH2
O
 
 
Methyl ester 136 (0.89 mL, 9.61 mmol) was dissolved in a solution of 28-30% NH4OH (10 
mL) and the mixture stirred at rt until completion (20 h). The solvent was removed in 
vacuo and the resulting material azeotroped with CHCl3 (3 × 2 mL) to leave 181 as a white 
solid (0.70 g, 7.86 mmol, 80%). 
 
1H (CDCl3, 400 MHz) δ: 6.15 (2H, br s, NH2), 5.73 (1H, dd, JF = 47.2, JH = 3.6 Hz, CHH), 
5.20 (1H, dd, JF = 14.8, JH = 3.6 Hz, CHH). 
19F (D2O, 400 MHz) δ: -118.5.  
13C (D2O, 125 MHz) δ: 164.4 (d, JF = 33.8 Hz, CO), 155.0 (d, JF = 262.5 Hz, CF), 100.5 (d, 
JF = 15.0, CH2). 
The spectral data is in agreement with the literature values.82 
 
2-Fluoro-N-(1-phenyl-but-3-enyl)-propenamide, 182. 
 
HN
F
O
 
 
A solution of 2-fluoroacylic acid 135 (0.41 g, 4.50 mmol) in CH2Cl2 (25 mL) was treated 
with HBTU (2.6 g, 6.82 mmol) and was then cooled down to 0 °C. DIPEA (1.2 mL, 6.96 
mmol) and amine 139 (0.80 g, 5.43 mmol) were sequentially added, and the reaction was 
stirred for 1 h. The solvent was removed in vacuo, and the crude residue was purified by 
flash column chromatography (0 - 5% EtOAc in petroleum ether) to yield the desired 
product 182 as a white solid (0.89 g, 4.06 mmol, 89%).  
 
1H (CDCl3, 400 MHz) δ: 7.40-7.29 (5H, m, Ar-H), 6.57 (1H, br s, NH), 5.70 (2H, m, 
CFCHH and CH2CHCH2), 5.19-5.12 (4H, m, CFCHH, CH2CHCH2 and CHNH),   2.65 (2H, t, 
JH = 6.8 Hz, CHCH2CH).  
19F (CDCl3, 400 MHz) δ: -121.3.  
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13C (CDCl3, 125 MHz) δ: 158.8 (d, JF = 30.0 Hz, CO), 156.2 (d, JF = 268.8 Hz, COCF) 
140.8 (Ar-CCHN), 133.4 (CHCH2), 128.8 (2C, Ar-CH), 127.7 (Ar-CH), 126.5 (2C, Ar-CH), 
118.3 (CHCH2), 99.1 (d, JF = 15.0 Hz, COCFCH2), 52.6 (CHNH), 40.3 (CHCH2CH).  
m/z [CI (+ve)] 220.3 [M+H]+, HRMS found [M+H]+ 220.1135, C13H15FNO requires 
220.1138.  
IR (thin film) vmax = 3338, 1651, 1529, 1190 cm-1. 
m.p. 63-65 ˚C. 
 
N-Benzyl-2-fluoro-N-(1-phenyl-but-3-enyl)-propenamide. 188. 
 
N
O
F
 
 
2-Fluoroacrylic acid 135 (56 mg, 0.63 mmol) and HBTU (0.23 g, 0.63 mmol) were 
dissolved in CH2Cl2 (5 mL). DIPEA (0.11 mL, 0.63 mmol) was added followed by amine 
192 (0.10 g, 0.42 mmol). The resulting solution was heated to reflux and stirred for 17 h. 
After which, the solvent removed in vacuo and the crude residue was purified by flash 
column chromatography (0 - 2.5% diethyl ether in petroleum ether) to yield the desired 
product 188 (0.11 g, 0.38 mmol, 85%) as a colourless oil. 
 
1H (CDCl3, 400 MHz) δ: 7.37-7.05 (10H, m, Ar-H), 5.75-5.68 (1H, m, CH2CHCH2), 5.32 
(1H, br. s, CFCHH), 5.28 (1H, br s, CFCHH), 5.11-5.04 (3H, m, CHCH2 and PhCHH), 4.54 
(1H, d, JH = 16.0 Hz, PhCHH), 4.24 (1H, br. s, CHN), 2.75 (2H, br. s, CHCH2CH). 
19F (CDCl3, 400 MHz) δ: -102, -116.7.  
13C (CDCl3, 125 MHz) δ: 163.4 (d, JF = 27.5 Hz, CO), 159.2 (d, JF = 271.3, CF), 138.2 (Ar-
C-CHN), 137.7 (Ar-CCH2), 134.4 (CHCH2,) 128.6 (2C, Ar-CH), 128.2 (2C, Ar-CH) 128.1 
(2C, Ar-CH), 127.7 (2C, Ar-CH), 127.3 (Ar-CH), 127.2 (Ar-CH), 117.5 (CHCH2), 99.4 (d, JF 
= 15.0 Hz, CFCH2), 61.3 (CHNH2), 35.7 (CHCH2CH), 28.6 (PhCH2). 
m/z [EI (+ve)] 309.1 [M]+, HRMS found [M]+ 309.1526, C20H20FNO requires 309.1529.  
IR (thin film) vmax = 3063, 1637, 1419, 1190, 1151 cm-1. 
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1-Benzyl-3-fluoro-6-phenyl-5,6-dihydro-1H-pyridin-2-one, 189. 
 
N
O
F
 
 
Dialkene 188 (0.13 g, 0.44 mmol) was dissolved in toluene (52 mL). Grubbs 2nd 
generation catalyst (9.3 mg, 11 μmol, 2.5 mol%) was added and the resulting mixture was 
heated to 100 °C for 1 h The solvent was removed and the crude residue was purified by 
flash column chromatography (0 - 10% EtOAc in petroleum ether) to yield the desired 
product 189 as a colourless oil (0.12 g, 0.43 mmol, 98%). 
 
1H (CDCl3, 400 MHz) δ: 7.37–7.05 (10H, m, Ar-H), 5.68 (1H, m, CFCH), 5.51 (1H, d, JH = 
14.8 Hz, PhCHH), 4.47 (1H, dd, JH = 7.6, 2.4 Hz, CHN), 3.49 (1H, d, JH = 14.8 Hz, 
PhCHH), 2.89 (1H, m, CHCHHCH), 2.40 (1H, m, CHCHHCH). 
19F (CDCl3, 400 MHz) δ: -126.5. 
13C (CDCl3, 125 MHz) δ: 159.9 (d, JF = 30.0 Hz, CO), 149.4 (d, JF = 252.5 Hz, COCF) 
139.4 (Ar-C-CHN), 137.0 (Ar-CCH2), 129.0 (2C, Ar-CH), 128.9 (Ar-CH), 128.7 (Ar-CH), 
128.2 (Ar-CH), 128.1 (Ar-CH), 128.0 (Ar-CH), 127.7 (Ar-CH), 126.4 (Ar–CH), 125.3 (Ar-
CH), 109.6 (d, JF = 13.8 Hz, COCFCH), 57.4 (CHN), 47.9 (PhCH2), 29.4 (d, JF = 6.3 Hz, 
CHCH2CH).  
m/z [EI (+ve)] 281.2 [M]+, HRMS found [M]+ 281.1214, C18H16FNO requires 281.1216.  
IR (thin film) vmax = 3066, 1653, 1452, 1219 cm-1. 
 
4-Methyl-N-(1-phenylbut-3-en-1-yl)methylbenzenesulfonamide, 191.147 
 
NHTs
 
 
Amine 139 (0.10 g, 0.68 mmol) was dissolved in CH2Cl2 (5 mL). Et3N (0.14 mL, 1.0 mmol) 
and DMAP (8.3 mg, 68 μmol) were added and the mixture was cooled to 0 °C. Tosyl 
chloride (0.19 g, 1.0 mmol) was added and the resulting solution was allowed to warm to 
rt and stirred for 17 h. The reaction mixture was diluted with CH2Cl2, washed with aq. 
NaHCO3 (15 mL) and brine (15 mL). The organic phase was dried (Na2SO4), filtered and 
the solvent was removed in vacuo. The crude residue was purified by flash column 
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chromatography (0 - 5% EtOAc in petroleum ether) to yield the desired product 191 as a 
white solid (0.13 g, 0.42 mmol, 86%). 
 
1H (CDCl3, 400 MHz) δ: 7.56 (2H, d, JH = 6.4 Hz, Ar-H), 7.24-7.02 (7H, m, Ar-H), 5.58-5.47 
(1H, m, CH2CHCH2), 5.11-5.06 (2H, m, CHCH2), 4.81 (1H, d, JH = 6.4 Hz, NH), 4.39 (1H, 
q, JH = 6.4 Hz, CHNH) 2.48 (2H, m, CHCH2CH), 2.39 (3H, s, CH3). 
13C (CDCl3, 125 MHz) δ: 143.1 (Ar-C-CHN), 140.3 (Ar-CSO2), 137.5 (Ar-CCH3), 133.1 
(CHCH2,) 129.3 (2C, Ar-CH), 128.4 (2C, Ar-CH) 127.4 (2C, Ar-CH), 127.2 (2C, Ar-CH), 
126.6 (Ar-C), 119.3 (CHCH2), 57.1 (CHNH2), 41.9 (CHCH2CH), 21.4 (CH3). 
NMR data matches literature vales.147 
 
N-Benzyl-1-phenylbut-3-en-1-amine, 192, 148 
 
NH
 
 
Procedure A 
Amine 139 (0.10 g, 0.68 mmol) and benzaldehyde (0.076 mL, 0.74 mmol) were added 
along with toluene (5 mL). The resulting mixture was heated to reflux and stirred for 3 h. 
The solution was filtered and the solvent was removed. The residue was redissovled in 
MeOH (5 mL), cooled to 0 °C and NaBH4 (28 mg, 0.74 mmol) was added portionwise over 
30 min. The reaction was stirred at 0 °C for 2 h followed by quenching with H2O (10 mL). 
The aqueous phase was extracted with CH2Cl2 (2 × 15 mL) and the organic were 
combined, dried (Na2SO4), filtered and removed in vacuo. The crude residue was purified 
by flash column chromatography (0 - 2.5% EtOAc in petroleum ether) to yield the desired 
product 192 as a pale yellow oil (0.11 g, 0.46 mmol, 68%).  
 
Procedure B 
Benzaldehyde (0.95 mL, 9.43 mmol) was added along with toluene (15 mL). Benzamine 
(1.1 mL, 10.3 mmol) was added and the solution was heated to reflux for 3 h. After which, 
the mixture was filtered and the solvent was removed. The residue was redissolved in 
diethyl ether (20 mL) and cooled to 0 °C. Allyl magnesium bromide (1M in diethyl ether, 
14.1 mmol, 14 mL) was added dropwise and the reaction was stirred at 0 °C for a further 1 
h before being warmed to rt and stirred for 17 h. The reaction was quenched (H2O, 10 mL) 
and extracted with diethyl ether (3 × 30 mL). The combined organics were dried (Na2SO4), 
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filtered and removed in vacuo. The crude product was purified by flash column 
chromatography (0 - 2.5% EtOAc in petroleum ether) to yield the desired product 192 as a 
pale yellow oil (1.8 g, 7.54 mmol, 80%). 
 
1H (CDCl3, 400 MHz) δ: 7.41-7.28 (10H, m, Ar-H), 5.82-5.72 (1H, m, CH2CHCH2), 5.17-
5.10 (2H, m, CHCH2), 3.78 (2H, m, CHNH2 and PhCHH), 3.58 (1H, d, JH = 13.2 Hz, 
PhCHH), 2.43 (2H, m, CHCH2CH), 1.79 (1H, br s, NH). 
13C (CDCl3, 125 MHz) δ: 143.9 (Ar-C-CHN), 140.7 (Ar-CCH2), 135.5 (CHCH2), 128.4 (2C, 
Ar-CH), 128.4 (2C, Ar-CH) 128.1 (2C, Ar-CH), 127.3 (2C, Ar-CH), 127.1 (Ar-CH), 126.8 
(Ar-C), 117.5 (CHCH2), 61.7 (CHNH2), 51.5 (CHCH2CH), 43.2 (PhCH2). 
NMR data matches literature vales.148 
 
1-Benzyl-3-fluoro-6-phenyl-piperidin-2-one, 193. 
 
N
O
F
 
 
Procedure A 
Fluoro-lactam 189 (42 mg, 0.14 mmol) was dissolved in MeOH (3 mL). Palladium on 
activated carbon (5.0 mg, 10% by weight) and ammonium formate (75 mg, 1.4 mmol) 
were added and the mixture was heated to reflux and stirred for 6 h. After this time, the 
suspension was filtered through celite and the filtrate was removed in vacuo. The crude 
residue was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) 
to yield the desired product 193 as a white solid (23 mg, 82.0 μmol, 58%). 
 
Procedure B  
Palladium on activated carbon (11 mg, 10% by weight) was added to a solution of fluoro-
lactam 189 (0.11 g, 0.38 mmol) in MeOH (5 mL) and the reaction was stirred under an 
atmosphere of H2 for 6 h. After this time, the suspension was filtered through celite, the 
filtrate was removed in vacuo. The crude residue was purified by flash column 
chromatography (0 - 10% EtOAc in petroleum ether) to yield the desired product 193 as a 
white solid (87 mg, 0.31 mmol, 81%). 
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1H (CDCl3, 400 MHz) δ: 7.35-7.03 (10H, m, Ar-H), 5.51 (1H, d, JH = 14.8 Hz, PhCHH), 
4.94 (1H, dt, JF = 47.2 Hz, JH = 7.2 Hz, CFH), 4.37 (1H, m, CHN), 3.33 (1H, dd, JH = 14.8, 
1.6 Hz, PhCHH), 2.00-1.88 (4H, m, CHCH2CH2 and CFHCH2). 
19F (CDCl3, 400 MHz) δ: -185.1. 
13C (CDCl3, 125 MHz) δ: 160.2 (d, JF = 30.0 Hz, CO), 140.0 (Ar-C-CHN), 136.5 (Ar-CCH2), 
129.0 (2C, Ar-CH), 128.7 (2C, Ar-CH), 128.4 (2C, Ar-CH), 128.0 (2C, Ar-CH), 127.7 (Ar-
CH), 126.7 (Ar-CH), 86.4 (d, JF = 222.5 Hz, COCF), 59.5 (CHN), 47.7 (PhCH2), 27.6 (d, JF 
= 10.0 Hz, CH2CH2), 23.8 (d, JF = 25.0 Hz, CH2CH2). 
m/z [EI (+ve)] 283.0 [M]+, HRMS found [M]+ 283.1373, C18H18FNO requires 283.1372.  
IR (thin film) vmax = 2956, 1660, 1446, 1354, 1076 cm-1. 
m.p. 104-106 ˚C. 
 
4'-Methoxy-N-(1-phenyl-3-butenyl)benzylamine, 194.149 
 
NH
OMe
 
 
Following General Procedure A, benzaldehyde (0.95 mL, 9.43 mmol) reacted with 4-
methoxybenzylamine (1.4 mL, 10.4 mmol) and allylmagnesium bromide (14 mL 1.0 M in 
THF, 14.3 mmol). The crude residue was purified by flash column chromatography (0 - 
2.5% EtOAc in petroleum ether) to yield the desired product 194 (2.4 g, 8.96 mmol, 95% 
yield) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.39-7.37 (4H, m, Ar-H), 7.30-7.28 (1H, m, Ar-H), 7.20 (2H, d, JH 
= 8.6 Hz, Ar-H), 6.88 (2H, d, JH = 8.6 Hz, Ar-H), 5.75-5.70 (1H, m, CH2CHCH2), 5.70-5.10 
(2H, m, CHCH2), 3.83 (3H, s, CH3), 3.71 (1H, dd, JH = 7.8, 5.9 Hz, CHN), 3.64 (1H, d, JH = 
13.2 Hz, ArCHH), 3.49 (1H, d, JH = 13.2 Hz, ArCHH), 2.44-2.41 (2H, m, CHCH2CH), 1.73 
(1H, br s, NH).  
13C (CDCl3, 125 MHz) δ: 158.5 (COMe), 143.9 (Ar-CCH2), 135.5 (CHCH2) 132.8 (Ar-
CCH), 129.3 (2C, Ar-CH), 128.4 (2C, Ar-CH), 127.3 (2C, Ar-CH), 127.0 (Ar-CH), 117.5 
(CHCH2), 113.7 (2C, Ar-CH), 61.5 (OCH3), 55.3 (CHNH), 50.8 (CH2NH), 43.1 
(CHCH2CH). 
The spectral data is in agreement with the literature values.149 
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2'-Fluoro-N-(4''-methoxybenzyl)-N-(1-phenyl-3-butenyl)acrylamide, 195. 
 
N
OMe
F
O
 
 
Amine 194 (0.50 g, 1.87 mmol) was coupled with 2-fluoroacrylic acid (0.25 g, 2.81 mmol) 
using HBTU (1.1 g, 2.81 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 5% diethyl ether in petroleum ether) to yield 
the desired product 195 (0.38 g, 1.11 mmol, 60% yield) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.36-7.32 (5H, m, Ar-H), 6.97 (2H, d, JH = 8.6 Hz, Ar-H), 6.76 (2H, 
d, JH = 8.6 Hz, Ar-H), 5.75-5.66 (1H, m, CH2CHCH2), 5.35 (1H, br s, CFCHH), 5.26 (1H, br 
s, CFCHH), 5.08-4.99 (3H, m, ArCHH and CHCH2), 4.47 (1H, d, JH = 15.7 Hz, ArCHH), 
4.16 (1H, br s, ArCHN), 3.78 (3H, s, CH3), 2.74 (2H, br s, CHCH2CH). 
19F (CDCl3, 470 MHz) δ: -102.4, -114.2.   
13C (CDCl3, 125 MHz) δ: 163.3 (d, JF = 30.0 Hz, CO), 158.7 (Ar-COMe), 158.2 (d, JF = 
271.3, CF), 138.1 (Ar-CCHN), 134.3 (CHCH2), 134.1 (2C, CHCH2 and Ar-CCH2), 129.2 
(2C, Ar-CH), 128.6 (2C, Ar-CH) 128.1 (2C, Ar-CH), 118.1 (CHCH2), 113.6 (2C, Ar-CH,), 
99.4 (d, JF = 16.3 Hz, CFCH2), 55.2 (CH3), 35.7 (PhCH2), 33.5 (CHN), 28.6 (CHCH2CH). 
m/z [EI (+ve)] 339.2 [M]+, HRMS found [M]+ 339.1639, C21H22FNO2 requires 339.1635.  
IR (thin film) vmax = 2937, 1637, 1512, 1417, 1246, 1176, 1033 cm-1. 
 
3-Fluoro-1-(4'-methoxybenzyl)-6-phenyl-5, 6-dihydro-1H-pyridin-2-one, 196. 
 
N
OMe
F
O
 
 
Dialkene 195 (0.11 g, 0.32 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) 
to yield the desired product 196 (0.10 g, 0.32 mmol, quantitative yield) as a colourless oil.    
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1H (CDCl3, 400 MHz) δ: 7.40-7.34 (3H, m, Ar-H), 7.19 (2H, d, JH = 7.2 Hz, Ar-H), 7.15 (2H, 
d, JH = 8.6 Hz, Ar-H), 6.86 (2H, d, JH = 8.6 Hz, Ar-H), 5.77 (1H, m, CFCH), 5.54 (1H, d, JH 
= 14.8 Hz, ArCHH), 4.57 (1H, dd, JH = 7.7, 2.6 Hz, ArCHN), 3.83 (3H, s, OCH3), 3.51 (1H, 
d, JH = 14.8 Hz, ArCHH), 2.99-2.93 (1H, m, CHCHHCH), 2.50-2.44 (1H, m, CHCHHCH). 
19F (CDCl3, 470 MHz) δ: -126.8. 
13C (CDCl3, 125 MHz) δ: 159.8 (d, JF = 30.0 Hz, CO), 159.2 (COMe), 149.4 (d, JF = 251.2 
Hz, CF), 139.4 (Ar-CCHN), 129.6 (2C, Ar-CH), 129.0 (Ar-CH), 128.9 (2C, Ar-CH), 128.0 
(Ar-C), 126.4 (2C, Ar-CH), 114.1 (2C, Ar-CH), 109.5 (CFCH, d, JF = 14.6 Hz), 57.0 (CHN), 
55.3 (OCH3), 47.2 (NCH2), 29.4 (CHCH2CH, d, JF = 6.0 Hz).  
m/z [EI (+ve)] 311.2 [M]+. HRMS found [M]+ 311.1318, C19H18FNO2 requires 311.1322.  
IR (thin film) vmax = 2933, 2837, 1651, 1512, 1247, 1176, 1031 cm-1. 
 
3-Fluoro-6-phenyl-5,6-dihydro-1H-pyridin-2-one, 198. 
 
HN
F
O
 
 
α,β-Unsaturated lactam 196 (96 mg, 0.31 mmol), was subjected to General Procedure D 
and treated with ceric ammonium nitrate (0.45 g, 2.7 eq, 0.86 mmol). The crude residue 
was purified by flash column chromatography (0 - 30% EtOAc in petroleum ether) to yield 
the desired product 198 (55 mg, 0.29 mmol, 94%) as a white solid.  
 
1H (CDCl3, 400 MHz) δ: 7.45-7.37 (5H, m, Ar-H), 6.09 (1H, ddd, JF = 11.1 Hz, JH = 5.9, 3.3 
Hz, CFCH), 5.62 (1H, br s, NH), 4.82 (1H, dd, JH = 11.6, 5.8 Hz, CHNH), 2.75-2.60 (2H, 
m, CHCH2CH).  
19F (CDCl3, 470 MHz) δ: -129.9. 
13C (CDCl3, 125 MHz) δ: 161.2 (d, JF = 32.8 Hz, CO), 149.1 (d, JF = 253.2 Hz, CF), 139.9 
(Ar-CCH), 129.2 (2C, Ar-CH), 128.8 (Ar-CH), 126.4 (2C, Ar-CH), 113.5 (d, JF = 13.8 Hz, 
CFCH), 56.1 (CHN), 31.2 (d, JF= 5.0 Hz, CHCH2CH).  
m/z [EI (+ve)] 191.1 [M]+, HRMS found [M]+ 191.0748, C11H10FNO requires 191.0746.  
IR (thin film) vmax = 2356, 1705, 1670, 1248 cm-1. 
m.p. 109-111 ˚C. 
 
146 
3-Fluoro-6-phenyl-piperidin-2-one, 190. 
 
HN
F
O
 
 
Dihydropyridone 198 (43 mg, 0.22 mmol) was subjected to General Procedure E. The 
crude residue was purified by flash column chromatography (0 - 30% EtOAc in petroleum 
ether) to yield the product 190 (32 mg, 0.17 mmol, 75%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.45-7.32 (5H, m, Ar-H), 5.93 (1H, br s, NH), 4.95 (1H, dt, JF = 
46.27 Hz, JH = 5.28 Hz, CHF), 4.61-4.60 (1H, m, CHNH), 2.28-2.24 (1H, m, CHH), 2.17-
2.03 (3H, m, CHH and CH2).  
19F (CDCl3, 470 MHz) δ: -180.3. 
13C (CDCl3, 125 MHz) δ: 167.5 (d, JF = 20.1 Hz, CO), 141.4 (Ar-CCH), 129.0 (2C, Ar-CH), 
128.4 (Ar-CH), 126 1 (2C, Ar-CH), 85.7 (d, JF = 175.1 Hz, CF), 57.3 (CHCN), 27.3 (d, JF = 
3.8 Hz, CHCH2), 26.2 (d, JF = 20.2 Hz, CFCH2). 
m/z [EI (+ve)] 193.1 [M]+. HRMS found [M]+ 193.0904, C11H12FNO requires 193.0903.  
IR (thin film) vmax = 3194, 2066, 2958, 1666, 1329 cm-1. 
m.p. 149-151 ˚C. 
 
4'-Methoxy-N-[1-(4''-methoxyphenyl)-3-butenyl]benzylamine, 199.149 
 
NH
OMe
MeO  
 
Following General Procedure A, 4-methoxybenzaldehyde (0.84 mL, 7.34 mmol) reacted 
with 4-methoxybenzylamine (1.1 mL, 8.03 mmol) and allylmagnesium bromide (11 mL 1.0 
M in THF, 11.0 mmol). The crude residue was purified by flash column chromatography (0 
- 5% diethyl ether in petroleum ether) to yield the desired product 199 (1.7 g, 5.62 mmol, 
77% yield) as a pale yellow oil. 
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1H (CDCl3, 400 MHz) δ: 7.29 (2H, d, JH = 8.8 Hz, Ar-H), 7.18 (2H, d, JH = 8.6 Hz, Ar-H), 
6.92 (2H, d, JH = 8.8 Hz, Ar-H), 6.87 (2H, d, JH = 8.6 Hz, Ar-H), 5.75-5.70 (1H, m, 
CH2CHCH2), 5.12-5.04 (2H, m, CHCH2), 3.85 (3H, s, OCH3) 3.82 (3H, s, OCH3), 3.68-3.60 
(2H, m, ArCHH and NHCH), 3.47 (1H, d, JH = 12.9 Hz, ArCHH), 2.44-2.39 (2H, m, 
CHCH2CH) 
13C (CDCl3, 125 MHz) δ: 158.6 (COMe), 158.5 (COMe), 135.9 (Ar-CCH2), 135.6 (CHCH2) 
132.8 (Ar-CCH), 129.3 (2C, Ar-CH), 128.3 (2C, Ar-CH), 117.4 (CHCH2), 113.7 (2C, Ar-
CH), 113.6 (2C, Ar-CH), 60.81 (CHNH), 55.3 (OCH3), 55.2 (OCH3), 50.7 (CH2NH), 43.2 
(CHCH2CH). 
The spectral data is in agreement with the literature values.149 
 
 
4'-Methoxy-N-[1-(4''-trifluoromethanephenyl)-3-butenyl]benzylamine, 200. 
 
NH
OMe
F3C  
 
Following General Procedure A, 4-(trifluoromethyl)benzaldehyde (0.78 mL, 5.74 mmol) 
reacted with 4-methoxybenzylamine (0.83 mL, 6.32 mmol) and allylmagnesium bromide 
(8.6 mL 1.0 M in THF, 8.61 mmol). The crude residue was purified by flash column 
chromatography (0 - 5% diethyl ether in petroleum ether) to yield the desired product 200 
(1.3 g, 3.79 mmol, 66% yield) as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.62 (2H, d, JH = 8.2 Hz, Ar-H), 7.51 (2H, d, JH = 8.2 Hz, Ar-H), 
7.18 (2H, d, JH = 8.8 Hz, Ar-H), 6.88 (2H, d, JH = 8.8 Hz, Ar-H), 5.75-5.65 (1H, m, 
CH2CHCH2), 5.12-5.08 (2H, m, CHCH2), 3.83 (3H, s, OCH3), 3.77 (1H, dd, JH = 7.6, 5.6 
Hz, CHN), 3.64 (1H, d, JH = 13.2 Hz, ArCHH), 3.45 (1H, d, JH = 13.2 Hz, ArCHH), 2.45-
2.34 (2H, m, CHCH2CH).  
19F (CDCl3, 400 MHz) δ: -62.3.  
13C (CDCl3, 125 MHz) δ: 158.7 (Ar-COMe), 148.2 (Ar-CCF3),  134.8 (CHCH2,), 132.4 
(CF3), 129.8 (2C, Ar-CH), 127.7 (2C, Ar-CH), 125.7 (Ar-CCN), 125.4 (2C, Ar-CH), 125.3 
(Ar-CCH2), 118.2 (CHCH2) 113.8 (2C, Ar-CH), 61.2 (CHN), 55.3 (OCH3), 44.2 (CH2), 33.6 
(CH2).  
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m/z [CI (+ve)] 336.1 [M+H]+. HRMS found [M+H]+ 336.1572, C19H21F3NO requires 
336.1575.  
IR (thin film) vmax = 2935, 1612, 1512, 1323, 1246, 1120, 1066 cm-1. 
 
4'-Methoxy-N-[1-(4''-bromophenyl)-3-butenyl]benzylamine, 201. 
 
NH
OMe
Br  
 
Following General Procedure A, 4-bromobenzaldehyde (1.0 g, 5.40 mmol) reacted with 4-
methoxybenzylamine (0.74 mL, 5.40 mmol) and allylmagnesium bromide (8.1 mL 1.0 M in 
THF, 8.11 mmol). The crude residue was purified by flash column chromatography (0 - 
5% diethyl ether in petroleum ether) to yield the desired product 201 (1.8 g, 5.25 mmol, 
97% yield) as a pale yellow oil.    
 
1H (CDCl3, 500 MHz) δ: 7.48 (2H, d, JH = 8.4 Hz, Ar-H), 7.27 (2H, d, JH = 8.4 Hz, Ar-H), 
7.15 (2H, d, JH = 9.1 Hz, Ar-H), 6.87 (2H, d, JH = 9.1 Hz, Ar-H), 5.72-5.63 (1H, m, 
CH2CHCH2), 5.10-5.05 (2H, m, CH2CHCH2), 3.82 (3H, s, OCH3), 3.66 (1H, dd, JH = 7.8, 
6.3 Hz, CHNH), 3.61 (1H, d, JH = 13.1 Hz, ArCCHH), 3.46 (1H, d, JH = 13.1 Hz, ArCCHH), 
2.40-2.35 (2H, m, CHCH2CH).  
13C (CDCl3, 125 MHz) δ: 158.7 (Ar-COMe), 142.8 (Ar-CBr), 134.9 (CHCH2), 132.2 (Ar-C), 
131.4 (2C, Ar-CH), 129.2 (2C, Ar-CH), 129.1 (2C, Ar-CH), 120.7 (Ar-C), 117.9 (CHCH2), 
113.8 (2C, Ar-CH), 60.9 (OCH3), 55.3 (CHN), 50.8 (ArCCH2), 43.1 (CHCH2CH).  
m/z [CI (+ve)] 345.8 M+, HRMS found [M+H]+ 346.0804, C18H21BrNO requires 346.0807.  
IR (thin film) vmax = 2945, 2835, 1511, 1245, 1035, 1009 cm-1. 
 
4'-Methoxy-N-[1-(naphthalen-1''-yl)-3-butenyl]benzylamine, 202. 
 
NH
OMe
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Following General Procedure A, 1-napthaldehyde (0.86 mL, 6.40 mmol) reacted with 4-
methoxybenzylamine (0.84 mL, 7.04 mmol) and allylmagnesium bromide (9.6 mL 1.0 M in 
THF, 9.60 mmol). The crude residue was purified by flash column chromatography (0 - 
10% diethyl ether in petroleum ether) to yield the desired produce 202 (2.0 g, 6.38 mmol, 
99% yield) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 8.10 (1H, appt d, JH = 7.41 Hz, Ar-H), 7.81-7.79 (1H, m, Ar-H), 
7.72-7.67 (2H, m, Ar-H), 7.44-7.38 (3H, m, Ar-H), 7.09 (2H, d, JH = 8.6 Hz, Ar-H), 6.76 
(2H, d, JH = 8.6 Hz, Ar-H), 5.75-5.67 (1H, m, CH2CHCH2), 5.05-4.97 (2H, m, CH2CHCH2), 
3.71 (3H, s, OCH3), 3.60 (1H, d, JH = 13.0 Hz, ArCCHH), 3.44 (1H, d, JH = 13.0 Hz, 
ArCCHH), 2.59-2.54 (1H, m, CHCHHCH), 2.41-2.35 (1H, m, CHCHHCH). 
13C (CDCl3, 125 MHz) δ: 158.6 (Ar-COMe), 139.2 (Ar-CCHN), 138.9 (CHCH2), 135.6 (Ar-
CH), 134.1 (Ar-C), 132.8 (Ar-C), 131.6 (Ar-C), 129.4 (2C, Ar-CH), 129.0 (Ar-CH), 127.3 
(Ar-CH), 125.7 (Ar-CH), 125.3 (Ar-CH), 123.9 (Ar-CH), 123.1 (Ar-CH), 117.6 (CHCH2), 
113.7 (2C, Ar-CH), 56.9 (CHN), 56.3 (OCH3), 51.1 (ArCCH2), 42.1 (CHCH2CH). 
m/z [CI (+ve)] 318.2 [M+H]+, HRMS found [M+H]+ 318.1862, C22H24NO requires 318.1858.  
IR (thin film) vmax = 2960, 1511, 1246, 1035 cm-1. 
 
4'-Methoxy-N-(1-isobutyl-3-butenyl)benzylamine, 203. 
 
NH
OMe
 
 
Following General Procedure A, isovaleraldehyde (1.25 mL, 11.6 mmol) reacted with 4-
methoxybenzylamine (1.67 mL, 12.7 mmol) and allylmagnesium bromide (17.4 mL 1.0 M 
in THF, 17.4 mmol). The crude residue was purified by flash column chromatography (0 - 
5% diethyl ether in petroleum ether) to yield the desired product 203 (2.06 g, 8.34 mmol, 
76% yield) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.26 (2H, d, JH = 8.8 Hz, Ar-H), 6.86 (2H, d, JH = 8.8 Hz, Ar-H), 
5.82-5.70 (1H, m, CH2CHCH2), 5.14-5.00 (2H, m, CHCH2), 3.81 (3H, s, OCH3), 3.73 (1H, 
quint, JH = 6.4 Hz, CHNH), 2.70-2.65 (2H, m, CH2), 2.25-2.03 (2H, m, CHCH2CH), 1.62 
(1H, appt sept, JH = 6.8 Hz, CH(CH3)2CH2), 1.46-1.23 (2H, m, CH(CH3)2CH2), 0.88 (3H, d, 
JH = 6.6 Hz, CH3), 0.85 (3H, d, JH = 6.6 Hz, CH3). 
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13C (CDCl3, 100 MHz) δ: 158.5 (Ar-COMe), 135.8 (CHCH2,), 133.0 (Ar-CCH2), 129.4 (2C, 
Ar-CH), 118.8 (CHCH2), 113.7 (2C, Ar-CH), 55.3 (OCH3), 54.0 (CHN), 50.5 (ArCH2), 41.2 
(CH2), 38.6 (CH(CH3)2CH2) 24.7 (CH(CH3)2CH2), 22.5 (CH(CH3)2CH2) .  
m/z [CI (+ve)] 248.2 [M+H]+, HRMS found [M+H]+ 248.2018, C16H26NO requires 248.2014.  
IR (thin film) vmax = 2953, 2906, 1612, 1512, 1464, 1246 cm-1. 
 
4'-Methoxy-N-(1-cyclohexyl-3-butenyl)benzylamine, 204. 
 
NH
OMe
 
 
Following General Procedure A, cyclohexanecarboxaldehyde (1.08 mL, 8.87 mmol) 
reacted with 4-methoxybenzylamine (1.16 mL, 9.76 mmol) and allylmagnesium bromide 
(13.3 mL 1.0 M in THF, 13.3 mmol). The crude residue was purified by flash column 
chromatography (0 - 2.5% diethyl ether in petroleum ether) to yield the desired product 
204 (1.81 g, 6.56 mmol, 74% yield) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.26 (2H, d, JH = 8.6 Hz, Ar-H), 6.87 (2H, d, JH = 8.6 Hz, Ar-H), 
5.85-5.75 (1H, m, CH2CHCH2), 5.11-5.06 (2H, m, CHCH2), 3.83 (3H, s, OCH3), 3.71 (2H, 
s, ArCH2), 2.42-2.38 (1H, m, CHNH), 2.32-2.26 (1H, m, CHCHHCH), 2.16-2.09 (1H, m, 
CHCHHCH), 1.81-1.70 (4H, m, CHCH2CH2), 1.47-1.43 (1H, m, CHCHCH2), 1.31-1.18 
(4H, m, CH2CH2CH2), 1.10-1.00 (2H, m, CH2). 
13C (CDCl3, 125 MHz) δ: 158.5 (Ar-COMe), 136.8 (CHCH2), 133.3 (Ar-CCH2), 129.3 (2C, 
Ar-CH), 116.7 (CHCH2), 113.7 (2C, Ar-CH), 61.1 (OCH3), 55.3 (CHN), 51.3 (ArCH2), 40.6 
(CHCHN), 35.3 (CHCH2CH), 29.7 (CH2), 28.9 (CH2), 26.8 (CH2), 26.7 (CH2), 26.7 (CH2).  
m/z [CI (+ve)] 274.2 [M+H]+, HRMS found [M+H]+ 274.2171, C18H28NO requires 274.2168.  
IR (thin film) vmax = 2924, 1511, 1246, 1037 cm-1. 
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4'-Methoxy-N-[1-(furan-2''-yl)-3-butenyl]benzylamine, 205. 
 
O
NH
OMe
 
 
Following General Procedure A, 2-furaldehyde (0.86 mL, 10.4 mmol) reacted with 4-
methoxybenzylamine (1.3 mL, 11.4 mmol) and allylmagnesium bromide (16 mL, 1.0 M in 
THF, 15.6 mmol). The crude residue was purified by flash column chromatography (0 - 
5% diethyl ether in petroleum ether) to yield the desired product 205 (2.2 g, 8.59 mmol, 
83% yield) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.42 (1H, dd, JH = 1.8, 0.8 Hz, Ar-H), 7.23 (2H, d, JH = 8.7 Hz, Ar-
H), 6.88 (2H, d, JH = 8.7 Hz, Ar-H), 6.36 (1H, dd, JH = 3.7, 1.8 Hz, Ar-H), 6.21 (1H, d, JH = 
3.7 Hz, Ar-H), 5.79-5.62 (1H, m, CH2CHCH2), 5.14-5.06 (2H, m, CH2CHCH2), 3.83 (3H, s, 
OCH3), 3.79 (1H, t, JH = 6.8 Hz, CHNH), 3.72 (1H, d, JH = 13.0 Hz, ArCCHH), 3.56 (1H, d, 
JH = 13.0 Hz, ArCCHH), 2.58-2.53 (2H, m, CHCH2CH). 
13C (CDCl3, 125 MHz) δ: 158.6 (Ar-COMe), 156.3 (Ar-C(O)CH), 141.6 (Ar-CH), 134.9 
(CHCH2), 132.4 (Ar-C), 129.4 (2C, Ar-CH), 117.5 (CHCH2), 113.8 (2C, Ar-CH), 109.9 (Ar-
CH), 106.6 (Ar-CH),  55.3 (OCH3), 54.7 (CHN), 50.5 (ArCCH2), 39.3 (CHCH2CH). 
m/z [CI (+ve)] 258.2 [M+H]+, HRMS found [M+H]+ 258.1492, C16H20NO2 requires 
258.1494.  
IR (thin film) vmax = 2930, 2850, 1511, 1441, 1246, 1035 cm-1. 
 
4'-Methoxy-N-[1-(1''-(toluene-4'''-sulfonyl)-1H-pyrrol-2''-yl)-3-butenyl]benzylamine, 
206. 
 
Ts
N
NH
OMe
 
 
Following General Procedure A, 1-(toluene-4’-sulfonyl)-1H-pyrrol-2-carboxaldehyde (1.0 
g, 4.02 mmol) reacted with 4-methoxybenzylamine (0.53 mL, 4.42 mmol) and 
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allylmagnesium bromide (6.0 mL 1.0 M in THF, 6.03 mmol). The crude residue was 
purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) to yield the 
desired product 206 (1.4 g, 3.42 mmol, 85% yield) as a brown oil.    
 
1H (CDCl3, 500 MHz) δ: 7.62 (2H, d, JH = 8.3 Hz, Ar-H), 7.36 (1H, dd, JH = 3.2, 1.7 Hz, Ar-
H), 7.25 (2H, d, JH = 8.3 Hz, Ar-H), 7.15 (2H, d, JH = 8.6 Hz, Ar-H), 6.84 (2H, d, JH = 8.6 
Hz, Ar-H), 6.35-6.33 (1H, m, Ar-H), 6.30 (1H, t, JH = 3.3 Hz, Ar-H), 5.73-5.63 (1H, m, 
CH2CHCH2), 5.05-4.98 (2H, m, CH2CHCH2), 4.22 (1H, dd, JH = 7.3, 5.1 Hz, CHNH), 3.84 
(3H, s, OCH3), 3.43 (1H, d, JH = 12.6 Hz, ArCCHH), 3.25 (1H, d, JH = 12.6 Hz, ArCCHH), 
2.47-2.30 (2H, m, CHCH2CH), 2.41 (3H, s, CH3). 
13C (CDCl3, 125 MHz) δ: 158.5 (Ar-COMe), 144.8 (Ar-CSO2), 137.9 (Ar-C), 136.8 (Ar-C), 
135.0 (CHCH2), 132.5 (Ar-C), 129.9 (Ar-CH), 129.1 (2C, Ar-CH), 126.7 (2C, Ar-CH), 122.9 
(2C, Ar-CH), 117.4 (CHCH2), 113.7 (2C, Ar-CH), 112.6 (Ar-CH), 111.5 (Ar-CH), 55.3 
(OCH3), 54.0 (CHN), 50.6 (ArCCH2), 40.7 (CHCH2CH), 21.6 (CH3).  
m/z [ESI] 433.1 [M+Na]+, HRMS found [M+Na]+ 433.1539, C23H26N2O3SNa requires 
433.1556.  
IR (thin film) vmax = 2975, 1512, 1247, 1172 cm-1. 
 
4'-Methoxy-N-[1-(pyridin-2''-yl)-3-butenyl]benzylamine, 207. 
 
N
NH
OMe
 
 
Following General Procedure A, pyridine-2-carboxaldehyde (0.89 mL, 9.30 mmol) reacted 
with 4-methoxybenzylamine (1.2 mL, 10.2 mmol) and allylmagnesium bromide (14 mL 1.0 
M in THF, 14.0 mmol). The crude residue was purified by flash column chromatography (0 
- 25% diethyl ether in petroleum ether) to yield the desired product 207 (1.8 g, 6.78 mmol, 
73% yield) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 8.51 (1H, dq, JH = 4.8, 0.9 Hz, Ar-H), 7.58 (1H, td, JH = 7.7, 1.8 
Hz, Ar-H), 7.30 (1H, d, JH = 7.7 Hz, Ar-H), 7.12 (2H, d, JH = 8.6 Hz, Ar-H), 7.08 (1H, ddd, 
JH = 7.7, 4.8, 0.9 Hz, Ar-H), 6.76 (2H, d, JH = 8.6 Hz, Ar-H), 5.70-5.60 (1H, m, 
CH2CHCH2), 4.99-4.92 (2H, m, CH2CHCH2), 3.75 (1H, dd, JH = 7.8, 5.9 Hz, CHNH), 3.71 
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(3H, s, OCH3), 3.54 (1H, d, JH = 12.9 Hz, ArCCHH), 3.43 (1H, d, JH = 12.9 Hz, ArCCHH), 
2.50-2.43 (1H, m, CHCHHCH), 2.39-2.32 (1H, m, CHCHHCH). 
13C (CDCl3, 125 MHz) δ: 163.3 (Ar-C(N)CH), 158.5 (Ar-COMe), 149.4 (Ar-CH), 136.3 (Ar-
CH), 135.3 (CHCH2), 132.6 (Ar-C), 129.3 (2C, Ar-CH), 121.9 (2C, Ar-CH), 117.5 (CHCH2), 
113.7 (2C, Ar-CH), 62.9 (CHN), 55.3 (OCH3), 51.0 (ArCCH2), 41.6 (CHCH2CH). 
m/z [CI (+ve)] 269.1 [M+H]+, HRMS found [M+H]+ 269.1653, C17H21N2O requires 
269.1654.  
IR (thin film) vmax = 2836, 1512, 1247, 905 cm-1. 
 
2'-Fluoro-N-(4''-methoxybenzyl)-N-[1-(4'''-methoxyphenyl)-3-butenyl]acrylamide, 209. 
 
N
OMe
MeO
F
O
 
 
Amine 199 (0.55 g, 1.85 mmol) was coupled with 2-fluoroacrylic acid (0.25 g, 2.77 mmol) 
using HBTU (1.1 g, 2.77 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 5% diethyl ether in petroleum ether) to yield 
the desired product 209 (0.44 g, 1.19 mmol, 66%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.27 (2H, d, JH = 8.6 Hz, Ar-H), 6.98 (2H, d, JH = 8.6 Hz, Ar-H), 
6.89 (2H, d, JH = 8.4 Hz, Ar-H), 6.77 (2H, d, JH = 8.4 Hz, Ar-H), 5.73-5.64 (1H, m, 
CH2CHCH2), 5.35 (1H, br s, CFCHH), 5.23 (1H, br s, CFCHH), 5.07-4.92 (3H, m, ArCHH 
and CHCH2), 4.46 (1H, d, JH = 15.5 Hz, ArCHH), 4.14 (1H, br s, ArCHN), 3.83 (3H, s, 
OCH3), 3.78 (3H, s, OCH3), 2.69 (2H, br s, CHCH2CH). 
19F (CDCl3, 470 MHz) δ: -102.1, -104.2.  
13C (CDCl3, 125 MHz) δ: 163.2 (d, JF = 30.0 Hz, CO), 159.4 (Ar-COMe), 159.3 (Ar-COMe), 
158.7  (ArC), 158.5 (d, JF = 271.3, CF), 134.2 (CHCH2), 134.1 (Ar-CCH2), 129.8 (2C, Ar-
CH), 129.2 (2C, Ar-CH), 118.0 (CHCH2), 113.9 (2C, Ar-CH), 113.6 (2C, Ar-CH), 99.3 (d, 
JF = 15.0 Hz, CFCH2), 77.3 (CHN), 65.9 (PhCH2), 55.3 (CH3), 55.2 (CH3), 33.5 
(CHCH2CH). 
m/z [EI (+ve)] 369.2 [M]+, HRMS found [M]+ 369.1743, C22H24FNO3 requires 369.1740.  
IR (thin film) vmax = 2933, 2837, 1635, 1512, 1246, 1178, 1033 cm-1. 
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2'-Fluoro-N-(4''-methoxybenzyl)-N-[1-(4'''-trifluoromethanephenyl)-3-
butenyl]acrylamide, 210. 
 
N
OMe
F3C
F
O
 
 
Amine 200 (0.64 g, 1.8 mmol) was coupled with 2-fluoroacrylic acid (0.25 g, 2.7 mmol) 
using HBTU (1.1 g, 2.7 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 5% diethyl ether in petroleum ether) to yield 
the desired product 210 (0.33 g, 0.80 mmol, 45%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.57 (2H, d, JH = 8.0 Hz, Ar-H), 7.44 (2H, d, JH = 8.0 Hz, Ar-H), 
6.98 (2H, d, JH = 8.4 Hz, Ar-H), 6.76 (2H, d, JH = 8.4 Hz, Ar-H), 5.76–5.66 (1H, m, 
CH2CHCH2), 5.41 (1H, d, JH = 3.2 Hz, CFCHH), 5.29 (1H, d, JH = 3.2 Hz, CFCHH), 5.14-
5.09 (3H, m, CHCH2 and PhCHH), 4.43 (1H, d, JH = 15.6 Hz, PhCHH), 4.34 (1H, br. s, 
CHN), 3.80 (3H, s, OCH3), 2.79 (2H, br. s, CHCH2CH). 
19F (CDCl3, 400 MHz) δ: -62.3, -102.9.   
13C (CDCl3, 125 MHz) δ: 163.4 (d, JF = 29.8 Hz, CO), 159.0 (Ar-COMe), 158.0 (d, JF = 
273.0 Hz, CF), 142.5 (Ar-CCF3), 139.0 (CF3), 137.8 (CHCH2), 133.9 (Ar-CCHN), 129.9 
(Ar-CCH2), 129.2 (2C, Ar-CH), 128.8 (2C, Ar-CH), 125.3 (2C, Ar-CH), 118.5 (CHCH2), 
113.7 (2C, Ar-CH), 99.8 (d, JF = 12.5 Hz, CFCH2), 66.7 (PhCH2), 59.8 (CHN), 55.2 (CH3), 
35.4 (CHCH2CH). 
m/z [EI (+ve)] 407.1 [M]+, HRMS found [M]+ 407.1504, C22H21F4NO2 requires 407.1508.  
IR (thin film) vmax = 2939, 1639, 1514, 1415, 1325, 1246, 1120, 1068 cm-1.  
 
2'-Fluoro-N-(4''-methoxybenzyl)-N-[1-(4'''-bromophenyl)-3-butenyl]acrylamide, 211. 
 
N
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F
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Amine 201 (0.50 g, 1.4 mmol) was coupled with 2-fluoroacrylic acid (0.19 g, 2.2 mmol) 
using HBTU (0.82 g, 2.2 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 5% diethyl ether in petroleum ether) to yield 
the desired product 211 (0.24 g, 0.58 mmol, 41%) as a colourless oil. 
 
1H (CDCl3, 400 MHz) δ: 7.47 (2H, d, JH = 8.1 Hz, Ar-H), 7.21 (2H, d, JH = 8.1 Hz, Ar-H), 
6.99 (2H, d, JH = 8.6 Hz, Ar-H), 6.79 (2H, d, JH = 8.6 Hz, Ar-H), 5.74-5.63 (1H, m, 
CH2CHCH2), 5.40-5.25 (2H, m, CFCH2), 5.19-5.05 (3H, m, CHCH2 and ArCHH), 4.44 (1H, 
d, JH = 16.0 Hz, ArCHH), 4.25 (1H, m, CHN), 3.81 (3H, s, OCH3), 2.74-2.69 (2H, m, CH2). 
19F (CDCl3, 470 MHz) δ: -102.3, -104.2. 
13C (CDCl3, 125 MHz) δ: 163.3 (d, JF = 29.4 Hz, CO), 158.9 (Ar-COMe), 157.9 (d, JF = 
273.3 Hz, CF), 137.3 (Ar-CBr), 133.9 (CHCH2), 131.6 (2C, Ar-CH), 130.3 (2C, Ar-CH), 
129.1 (2C, Ar-CH), 129.0 (Ar-C), 122.0 (Ar-C),  118.3 (CHCH2), 113.7 (2C, Ar-CH), 99.7 
(d, JF = 15.6 Hz, CFCH), 59.4 (CHN), 55.3 (OCH3), 35.6 (ArCH2), 23.9 (CH2). 
m/z [EI (+ve)] 417.0 [M]+, HRMS found [M]+ 417.0739, C21H21BrFNO2 requires 417.0740.  
IR (thin film) vmax = 2940, 1639, 1513, 1247, 1176 cm-1. 
 
2'-Fluoro-N-(4''-methoxybenzyl)-N-[1-(naphthalen-1'''-yl)-3-butenyl]acrylamide, 212. 
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Amine 202 (0.50 g, 1.6 mmol) was coupled with 2-fluoroacrylic acid (0.21 g, 2.4 mmol) 
using HBTU (0.89 g, 2.4 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 5% diethyl ether in petroleum ether) to yield 
the desired product 212 (0.21 g, 0.53 mmol, 34%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 8.07 (1H, d, JH = 8.4 Hz, Ar-H), 7.87 (1H, br d, JH = 8.4 Hz, Ar-H), 
7.82 (1H, t, JH = 4.6 Hz, Ar-H), 7.59-7.51 (2H, m, Ar-H), 7.44 (2H, d, JH = 5.0 Hz, Ar-H), 
6.76 (2H, d, JH = 8.3 Hz, Ar-H), 6.63 (2H, d, JH = 8.3 Hz, Ar-H), 6.57 (1H, br s, CHN), 5.87-
5-76 (1H, m, CH2CHCH2), 5.32 (1H, br d, JF = 47.8 Hz, CFCHH), 5.15-5.05 (3H, m, 
CFCHH and CHCH2), 4.40 (1H, br d, JH = 16.2 Hz, ArCHH), 3.91 (1H, dd, JH = 16.2, 1.7 
Hz, ArCHH), 3.76 (3H, s, OCH3), 2.77 (2H, appt t, JH = 6.7 Hz, CHCH2CH). 
19F (CDCl3, 376 MHz) δ: -103.7, -103.8. 
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13C (CDCl3, 100 MHz) δ: 162.9 (d, JF = 30.4 Hz, CO), 158.7 (Ar-COMe), 158.2 (d, JF = 
263.3 Hz, CF), 147.5 (Ar-C), 141.9 (Ar-C), 134.7 (CHCH2), 134.0 (Ar-C), 132.6 (Ar-C), 
129.3 (Ar-CH), 128.9 (Ar-CH), 128.6 (2C, Ar-CH), 126.9 (Ar-CH), 126.5 (Ar-CH), 126.0 
(Ar-CH), 124.6 (Ar-CH), 123.4 (Ar-CH), 117.7 (CHCH2), 113.4 (2C, Ar-CH), 99.9 (d, JF = 
15.8 Hz, CFCH2), 61.2 (CHN), 55.2 (OCH3), 48.2 (Ar-CCH2), 35.6 (CH2). 
m/z [EI (+ve)] 389.2 [M]+. HRMS found [M]+ 389.1794, C25H24FNO2 requires 389.1791.  
IR (thin film) vmax = 2970, 1632, 1513, 1246, 1176 cm-1. 
 
2'-Fluoro-N-(4''-methoxybenzyl)-N-(1-isobutyl-3-butenyl)acrylamide, 213. 
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Amine 203 (0.27 g, 1.1 mmol) was coupled with 2-fluoroacrylic acid (0.15 g, 1.7 mmol) 
using HBTU (0.63 g, 1.7 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 213 (0.26 g, 0.81 mmol, 74%) as a colourless oil.    
 
1H (CDCl3, 400 MHz) δ: 7.27 (2H, d, JH = 8.0 Hz, Ar-H), 6.85 (2H, d, JH = 8.0 Hz, Ar-H), 
5.73-5.62 (1H, m, CH2CHCH2), 5.26 (1H, br s, CFCHH), 5.15 (1H, br s, CFCHH), 5.13-
5.02 (2H, m, CHCH2), 4.54-4.39 (2H, m, ArCH2), 4.19-4.01 (1H, m, CHN), 3.81 (3H, s, 
OCH3), 2.33-2.19 (2H, m, CHCH2CH), 1.52-1.16 (3H, m, CH2 and CH), 0.85 (3H, d, JH = 
6.4 Hz, CH3), 0.74 (3H, d, JH = 6.0 Hz, CH3). 
19F (CDCl3, 376 MHz) δ: -102.4, -103.6. 
13C (CDCl3, 125 MHz) δ: 163.9 (CO), 158.7 (Ar-COMe), 158.3 (d, JF = 270.0, CF), 135.4 
(Ar-CCHN), 134.3 (CHCH2), 130.3 (Ar-CCH2), 129.2 (2C, Ar-CH), 118.0 (CHCH2), 113.9 
(2C, Ar-CH), 98.5 (CFCH2), 57.7 (CHN), 55.3 (CH3), 44.1 (PhCH2), 42.0 (CHCH2CH), 38.9 
(CH2), 24.6 (CH), 22.7 (CH3). 
m/z [CI (+ve)] 320.2 [M+H]+, HRMS found [M+H]+ 320.2025, C19H27FNO2 requires 
320.2026.  
IR (thin film) vmax = 2958, 1637, 1514, 1246 cm-1 
 
2'-Fluoro-N-(4''-methoxybenzyl)-N-(1-cyclohexyl-3-butenyl)acrylamide, 214. 
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Amine 204 (0.48 g, 1.74 mmol) was coupled with 2-fluoroacrylic acid (0.24 g, 2.62 mmol) 
using HBTU (1.0 g, 2.62 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 214 (0.44 g, 1.27 mmol, 70%) as a colourless oil. 
 
1H (CDCl3, 400 MHz) δ: 7.32 (2H, d, JH = 8.6 Hz, Ar-H), 6.84 (2H, d, JH = 8.6 Hz, Ar-H), 
5.63-5.56 (1H, m, CH2CHCH2), 5.27-4.91 (4H, m, CFCH2 and CHCH2), 4.44 (2H, s, 
ArCH2), 3.81 (3H, s, OCH3), 3.69 (1H, br t, JH = 9.3 Hz, CHN), 2.51-2.44 (1H, m, 
CHCHHCH), 2.33-2.25 (1H, m, CHCHHCH), 1.85-1.51 (5H, m, CH2 and CH), 1.20-1.05 
(2H, m, CH2),  0.97-0.81 (4H, m, CH2). 
19F (CDCl3, 470 MHz) δ: -102.7. 
13C (CDCl3, 125 MHz) δ: 164.7 (d, JF = 30.0 Hz, CO), 158.7 (Ar-COMe), 158.2 (d, JF = 
270.0 Hz, CF), 134.6 (CHCH2), 130.1 (ArC-C), 129.8 (2C, Ar-CH), 117.7 (CHCH2), 113.7 
(2C, Ar-CH), 98.5 (d, JF = 15.0 Hz, CFCH2), 64.7 (CHN), 55.3 (OCH3), 44.8 (Ar-CCH2), 
40.9 (CH), 35.1 (CH2), 30.5 (CH2), 30.4 (CH2), 26.2 (CH2) , 26.1 (CH2), 26.0 (CH2).  
m/z [CI (+ve)] 346.3 [M+H]+, HRMS found [M+H]+ 346.2176, C21H29FNO2 requires 
346.2182.  
IR (thin film) vmax = 2924, 2852, 1635, 1513, 1442, 1246 cm-1. 
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2'-Fluoro-N-(4''-methoxybenzyl)-N-[1-(furan-2'''-yl)-3-butenyl]acrylamide, 215. 
 
O
N
OMe
F
O
 
 
Amine 205 (0.50 g, 1.9 mmol) was coupled with 2-fluoroacrylic acid (0.26 g, 2.9 mmol) 
using HBTU (1.10 g, 2.9 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 10% diethyl ether in petroleum ether) to yield 
the desired product 215 (0.18 g, 0.54 mmol, 28%) as a yellow oil.  
 
1H (CDCl3, 400 MHz) δ: 7.36 (1H, br  s, Ar-H), 7.00 (2H, d, JH = 8.6 Hz, Ar-H), 6.77 (2H, d, 
JH = 8.6 Hz, Ar-H), 6.35-6.25 (2H, m, Ar-H), 5.72-5.64 (1H, m, CH2CHCH2), 5.38-5.24 (2H, 
m, CFCH2), 5.10-5.05 (3H, m, CHCH2 and ArCHH), 4.55 (1H, d, JH = 15.7 Hz, ArCHH), 
4.27 (1H, m, CHN), 3.80 (3H, s, OCH3), 2.65-2.58 (2H, m, CH2). 
19F (CDCl3, 470 MHz) δ: -103.5, -105.3. 
13C (CDCl3, 125 MHz) δ: 163.2 (d, JF = 29.4 Hz, CO), 158.6 (Ar-COMe), 157.6 (d, JF = 
267.8 Hz, CF), 151.9 (Ar-C(O)CH), 142.4 (Ar-C), 133.1 (CHCH2), 129.2 (2C, Ar-C), 118.6 
(CHCH2), 114.2 (Ar-CH), 113.6 (2C, Ar-CH), 110.4 (Ar-CH), 109.3 (Ar-CH), 99.4 (CFCH2), 
57.7 (CHN), 55.2 (OCH3), 44.4 (ArCH2), 23.8 (CH2). 
m/z [EI (+ve)] 329.2 [M]+, HRMS found [M]+ 329.1427, C19H20FNO3 requires 329.1428. 
IR (thin film) vmax = 2956, 1699, 1513, 1246, 1117 cm-1. 
 
2'-Fluoro-N-(4''-methoxybenzyl)-N-[1-(1'''-(toluene-4''''-sulfonyl)-1H-pyrrol-2'''-yl)-3-
butenyl]acrylamide, 216. 
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Amine 206 (0.66 g, 1.6 mmol) was coupled with 2-fluoroacrylic acid (0.22 g, 2.4 mmol) 
using HBTU (0.92 g, 2.4 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 15% EtOAc in petroleum ether) to yield the 
desired product 216 (0.39 g, 0.81 mmol, 50%) as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.72 (2H, br s, Ar-H), 7.39 (1H, br s, Ar-H), 7.31 (2H, d, JH = 8.3 
Hz, Ar-H), 7.00 (2H, d, JH = 8.6 Hz, Ar-H), 6.81 (2H, d, JH = 8.6 Hz, Ar-H), 6.26-6.12 (2H, 
m, Ar-H), 5.75-5-65 (1H, m, CHN), 5.50-5.08 (3H, m, CH2CHCH2 and CFCH2), 4.81-4.53 
(3H, m, CHCH2 and ArCHH), 4.09 (1H, d, JH = 6.0 Hz, ArCHH), 3.81 (3H, s, OCH3), 2.49-
2.41 (5H, m, CH3 and CH2). 
19F (CDCl3, 470 MHz) δ: -103.9. 
13C (CDCl3, 125 MHz) δ: 162.4 (d, JF = 29.4 Hz, CO), 159.3 (Ar-COMe), 157.9 (d, JF = 
276.8 Hz, CF), 145.2 (Ar-CSO2), 143.4 (Ar-C), 137.0 (Ar-C), 135.9 (Ar-C), 133.8 (CHCH2), 
130.0 (2C, Ar-CH), 129.7 (2C, Ar-CH), 129.3 (Ar-CH), 127.2 (2C, Ar-CH), 117.8 (Ar-CH), 
117.4 (CHCH2), 114.0 (Ar-CH), 113.5 (2C, Ar-CH), 98.9 (CFCH2), 60.4 (CH2), 55.2 
(OCH3), 51.8 (CH), 46.7 (CH2), 21.6 (CH3). 
m/z [EI (+ve)] 482.1 [M]+, HRMS found [M]+ 482.1676, C26H27FN2O2S requires 482.1676.  
IR (thin film) vmax = 2975, 1652, 1511, 1247 cm-1. 
 
2'-Fluoro-N-(4''-methoxybenzyl)-N-[1-(pyridin-2'''-yl)-3-butenyl]acrylamide, 217. 
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Amine 207 (0.50 g, 1.86 mmol) was coupled with 2-fluoroacrylic acid (0.25 g, 2.79 mmol) 
using HBTU (1.1 g, 2.79 mmol) following General Procedure B. The crude residue was 
purified by flash column chromatography (0 - 25% diethyl ether in petroleum ether) to yield 
the desired product 217 (0.42 g, 1.24 mmol, 67%) as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 8.55 (1H, s, Ar-H), 7.63 (1H, dt, JH = 7.7, 1.8 Hz, Ar-H), 7.37 (1H, 
br s, Ar-H), 7.19 (1H, br s, Ar-H), 6.93 (2H, d, JH = 8.6 Hz, Ar-H), 6.70 (2H, d, JH = 8.6 Hz, 
Ar-H), 5.76-5.65 (1H, m, CH2CHCH2), 5.47-5.02 (5H, m, CFCH2, CHCH2 and CHN), 4.59 
(2H, s, ArCH2), 3.76 (3H, s, OCH3), 3.04-2.95 (1H, m, CHCHHCH), 2.89-2.80 (1H, m, 
CHCHHCH).  
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19F (CDCl3, 376 MHz) δ: -102.5, -105.1. 
13C (CDCl3, 125 MHz) δ: 163.5 (d, JF = 29.4 Hz, CO), 158.5 (Ar-COMe), 158.0 (d, JF = 
271.5 Hz, CF), 157.6 (Ar-C), 149.0 (Ar-CH), 136.5 (Ar-CH), 134.4 (CHCH2), 129.7 (2C, Ar-
CH), 128.7 (Ar-C), 124.1 (Ar-CH), 122.9 (Ar-CH), 118.3 (CHCH2), 113.5 (2C, Ar-CH), 99.5 
(d, JF = 16.5 Hz, CFCH2), 62.5 (CH2), 59.5 (CH), 55.1 (CH3), 35.0 (CH2).  
m/z [CI (+ve)] 341.1 [M+H]+, HRMS found [M+H]+ 341.1669, C20H22FN2O2 requires 
341.1665.  
IR (thin film) vmax = 1638, 1513, 1415, 1207, 1176 cm-1. 
 
3-Fluoro-1-(4'-methoxybenzyl)-6-(4''-methoxyphenyl)-5,6-dihydro-1H-pyridin-2-one, 
218. 
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Dialkene 209 (0.22 g, 0.58 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) 
to yield the desired product 218 (0.19 g, 0.58 mmol, quantitative yield) as a colourless oil.    
 
1H (CDCl3, 400 MHz) δ: 7.05 (2H, d, JH = 8.8 Hz, Ar-H), 7.00 (2H, d, JH = 8.8 Hz, Ar-H), 
6.80 (2H, d, JH = 8.8 Hz, Ar-H), 6.77 (2H, d, JH = 8.8 Hz, Ar-H), 5.70-5.66 (1H, m, CFCH), 
5.65 (1H, d, JH = 14.8 Hz, PhCHH), 4.41 (1H, dd, JH = 7.6, 3.2 Hz, CHN), 3.84 (3H, s, 
OCH3), 3.74 (3H, s, OCH3), 3.39 (1H, d, JH = 14.8 Hz, PhCHH), 2.84-2.79 (1H, m, 
CHCHHCH), 2.37-2.32 (1H, m, CHCHHCH). 
19F (CDCl3, 470 MHz) δ: -126.7.  
13C (CDCl3, 125 MHz) δ: 159.7 (d, JF = 30.0 Hz. CO), 159.4 (COMe), 159.2 (COMe), 
149.4 (d, JF = 252.5 Hz, CF), 131.2 (ArC-CN), 129.6 (2C, Ar-CH), 129.0 (ArC-CH2), 127.6 
(2C, Ar-CH), 114.2 (2C, Ar-CH), 114.1 (2C, Ar-CH), 109.6 (CFCH, d, JF = 13.8 Hz), 56.6 
(CHN), 55.4 (OCH3), 55.3 (OCH3), 47.1 (NCH2), 29.6 (CHCH2CH, d, JF = 5.0 Hz).  
m/z [EI (+ve)] 341.1 [M]+. HRMS found [M]+ 341.1420, C20H20FNO3 requires 341.1427.  
IR (thin film) vmax = 2951, 2837, 1651, 1512, 1462, 1247, 1178, 1033 cm-1. 
 
3-Fluoro-1-(4'-methoxybenzyl)-6-(4''-trifluoromethanephenyl)-5,6-dihydro-1H-
pyridin-2-one, 219.  
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Dialkene 210 (0.20 g, 0.49 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) 
to yield the desired product 219 (0.18 g, 0.49 mmol, quantitative yield) as a colourless oil.    
 
1H (CDCl3, 400 MHz) δ: 7.64 (2H, d, JH = 8.0 Hz, Ar-H), 7.30 (2H, d, JH = 8.4 Hz, Ar-H), 
7.14 (2H, d, JH = 8.6 Hz, Ar-H), 6.85 (2H, d, JH = 8.6 Hz, Ar-H), 5.78-5.75 (1H, m, CFCH), 
5.52 (1H, d, JH = 14.8 Hz, PhCHH), 4.62 (1H, dd, JH = 7.6, 2.0 Hz, CHN), 3.82 (3H, s, 
OCH3), 3.53 (1H, d, JH = 14.8 Hz, PhCHH), 3.05-2.98 (1H, m, CHCHHCH), 2.48-2.43 (1H, 
m, CHCHHCH). 
19F (CDCl3, 400 MHz) δ: -62.3, -126.1. 
13C (CDCl3, 125 MHz) δ: 159.6 (d, JF = 30.0 Hz. CO), 159.4 (COMe), 149.4 (d, JF = 253.8 
Hz, CF), 143.5 (Ar-CCF3), 130.6 (CF3), 130.3 (Ar-CCHN), 129.6 (2C, Ar-CH), 128.5 (ArC-
CH2), 126.8 (2C, Ar-CH), 124.9 (2C, Ar-CH), 114.2 (2C, Ar-CH), 109.3 (CFCH, d, JF = 
15.0 Hz), 56.7 (CHN), 55.3 (OCH3), 47.5 (NCH2), 29.2 (d, JF = 6.3 Hz, CHCH2CH).  
m/z [EI (+ve)] 379.0 [M]+, HRMS found [M]+ 379.1198, C20H17F4NO2 requires 379.1195.  
IR (thin film) vmax = 2970, 1737, 1654, 1512, 1413, 1327, 1249, 1112, 1068 cm-1. 
 
3-Fluoro-1-(4'-methoxybenzyl)-6-(4''-bromophenyl)-5,6-dihydro-1H-pyridin-2-one, 
220. 
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Dialkene 211 (0.17 g, 0.41 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 15% EtOAc in petroleum ether) 
to yield the desired product 220 (0.15 g, 0.39 mmol, 96%) as a colourless oil.  
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1H (CDCl3, 400 MHz) δ: 7.51 (2H, d, JH = 8.5 Hz, Ar-H), 7.14 (2H, d, JH = 8.6 Hz, Ar-H), 
7.05 (2H, d, JH = 8.5 Hz, Ar-H), 6.87 (2H, d, JH = 8.6 Hz, Ar-H), 5.79-5.74 (1H, m, CFCH), 
5.50 (1H, d, JH = 14.6 Hz, ArCHH), 4.52 (1H, dd, JH = 7.6, 2.4 Hz, CHNH), 3.83 (3H, s, 
OCH3), 3.51 (1H, d, JH = 14.6 Hz, ArCHH), 3.00-3.91 (1H, m, CHCHHCH), 2.46-2.38 (1H, 
m, CHCHHCH). 
19F (CDCl3, 377 MHz) δ: -126.3. 
13C (CDCl3, 100 MHz) δ: 159.6 (d, JF = 31.0 Hz. CO), 159.3 (COMe), 149.3 (d, JF = 253.0 
Hz, CF), 138.5 (Ar-CBr), 132.1 (2C, Ar-CH), 129.6 (2C, Ar-CH), 128.6 (Ar-CCH2), 128.1 
(2C, Ar-CH), 122.0 (Ar-CCH), 114.2 (2C, Ar-CH), 109.4 (d, JF = 15.0 Hz, CFCH), 56.6 
(CHN), 55.3 (OCH3), 47.3 (NCH2), 29.3 (d, JF = 6.0 Hz, CHCH2CH). 
m/z [CI (+ve)] 391.7 [M+H]+, HRMS found [M+H]+ 390.0489, C19H18BrFNO2 requires 
390.0505.  
IR (thin film) vmax = 2950, 1653, 1512, 1247, 1217 cm-1. 
 
3-Fluoro-1-(4'-methoxybenzyl)-6-(naphthalen-1''-yl)-5,6-dihydro-1H-pyridin-2-one, 
221. 
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Dialkene 212 (0.14 g, 0.36 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 15% EtOAc in petroleum ether) 
to yield the desired product 221 (0.13 g, 0.36 mmol, quantitative yield) as a colourless oil.   
 
1H (CDCl3, 400 MHz) δ: 7.97-7.94 (1H, m, Ar-H), 7.88 (1H, d, JH = 8.2 Hz, Ar-H), 7.78-7.75 
(1H, m, Ar-H), 7.56-7.53 (2H, m, Ar-H), 7.49 (1H, br t, JH = 7.7 Hz, Ar-H), 7.34 (1H, d, JH = 
7.2 Hz, Ar-H), 7.15 (2H, d, JH = 8.5 Hz, Ar-H), 6.86 (2H, d, JH = 8.5 Hz, Ar-H), 5.74-7.69 
(1H, m, CFCH), 5.61 (1H, d, JH = 14.8 Hz, ArCHH), 5.39 (1H, br d, JH = 8.3 Hz, CHNH), 
3.82 (3H, s, OCH3), 3.47 (1H, d, JH = 14.8 Hz, ArCHH), 3.12-3.04 (1H, m, CHCHHCH), 
2.70-2.62 (1H, m, CHCHHCH). 
19F (CDCl3, 400 MHz) δ: -127.5. 
13C (CDCl3, 125 MHz) δ: 160.5 (d, JF = 31.2 Hz. CO), 159.2 (COMe), 149.1 (d, JF = 255.0 
Hz, CF), 134.4 (Ar-C), 133.5 (Ar-C), 130.2 (Ar-C), 129.7 (Ar-CH), 129.5 (2C, Ar-CH), 
163 
129.1 (Ar-C), 128.8 (Ar-C), 126.7 (Ar-CH), 125.8 (Ar-CH), 125.3 (Ar-CH), 123.9 (Ar-CH), 
121.9 (Ar-CH), 114.1 (2C, Ar-CH), 109.9 (d, JF = 14.7 Hz, CFCH), 55.3 (OCH3), 53.7 
(CHN), 47.3 (NCH2), 27.8 (d, JF = 5.5 Hz, CHCH2CH). 
m/z [EI (+ve)] 361.2 [M]+. HRMS found [M]+ 361.1480, C23H20FNO2 requires 361.1478.  
IR (thin film) vmax = 2932, 1652, 1511, 1244, 1200 cm-1. 
 
3-Fluoro-1-(4'-methoxybenzyl)-6-isobutyl-5,6-dihydro-1H-pyridin-2-one, 222. 
 
N
OMe
F
O
 
 
Dialkene 213 (0.23 g, 0.71 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) 
to yield the desired product 222 (0.17 g, 0.60 mmol, 85%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.14 (2H, d, JH = 8.8 Hz, Ar-H), 6.79 (2H, d, JH = 8.8 Hz, Ar-H), 
5.77-5.71 (1H, m, CFCH), 5.27 (1H, d, JH = 14.8 Hz, ArCHH), 3.73 (3H, s, OCH3), 3.66 
(1H, d, JH = 14.8 Hz, ArCHH), 3.31-3.26 (1H, m, CHN), 2.48-2.44 (1H, m, CHCHHCH), 
2.14-2.07 (1H, m, CHCHHCH), 1.72-1.65 (1H, m, CH), 1.43-1.39 (1H, m, CHH), 1.27-1.17 
(1H, m, CHH), 0.85 (3H, d, JH = 6.8 Hz, CH3), 0.76 (3H, d, JH = 6.8 Hz, CH3). 
19F (CDCl3, 400 MHz) δ: -127.6. 
13C (CDCl3, 125 MHz) δ: 159.2 (COMe), 158.7 (d, JF = 31.3 Hz. CO), 149.6 (d, JF = 252.5 
Hz, CF), 129.5 (ArC-CH2), 129.4 (2C, Ar-CH), 114.1 (2C, Ar-CH), 109.3 (d, JF = 13.8 Hz, 
CFCH), 55.3 (OCH3), 52.0 (CHN), 46.9 (NCH2), 39.6 (CH2), 25.1 (CH), 24.6 (d, JF = 5.0 
Hz, CHCH2CH), 23.6 (CH3), 21.5 (CH3). 
m/z [EI (+ve)] 291.2 [M]+. HRMS found [M]+ 291.1629, C17H22FNO2 requires 291.1635.  
IR (thin film) vmax = 2955, 1651, 1512, 1249, 1201 cm-1. 
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3-Fluoro-1-(4'-methoxybenzyl)-6-cyclohexane-5,6-dihydro-1H-pyridin-2-one, 223. 
 
N
OMe
F
O
 
 
Dialkene 214 (0.35 g, 1.1 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) 
to yield the desired product 223 (0.30 g, 0.94 mmol, 89%) as a colourless oil. 
 
1H (CDCl3, 400 MHz) δ: 7.23 (2H, d, JH = 8.8 Hz, Ar-H), 6.87 (2H, d, JH = 8.8 Hz, Ar-H), 
5.83-5.79 (1H, m, CFCH), 5.49 (1H, d, JH = 14.9 Hz, PhCHH), 3.83 (3H, s, OCH3), 3.79 
(1H, d, JH = 14.9 Hz, PhCHH), 3.18 (1H, br t, JH = 6.8 Hz, CHN), 2.54-2.45 (1H, m, 
CHCHHCH), 2.36-2.28 (1H, m, CHCHHCH), 1.86-1.63 (6H, m, CH2), 1.29-1.07 (4H, m, 
CH2), 1.00-0.94 (1H, m, CH).  
19F (CDCl3, 400 MHz) δ: -128.2. 
13C (CDCl3, 125 MHz) δ: 159.2 (COMe), 159.0 (d, JF = 31.1 Hz. CO), 149.5 (d, JF = 253.2 
Hz, CF), 129.7 (Ar-CCH2), 129.3 (2C, Ar-CH), 114.1 (2C, Ar-CH), 110.6 (d, JF = 14.2 Hz, 
CFCH), 59.0 (CHN), 55.3 (OCH3), 48.7 (NCH2), 40.8 (CH), 30.3 (CH2), 30.2 (CH2), 26.4 
(CH2), 26.3 (CH2), 26.2 (CH2), 22.8 (d, JF = 5.5 Hz, CHCH2CH). 
m/z [CI (+ve)] 318.2 [M+H]+, HRMS found [M+H]+ 318.1871, C19H25FNO2 requires 
318.1869.  
IR (thin film) vmax = 2925, 2850, 1645, 1511, 1247, 1198 cm-1. 
 
3-Fluoro-1-(4'-methoxybenzyl)-6-(furan-2''-yl)-5,6-dihydro-1H-pyridin-2-one, 224. 
 
O
N
OMe
F
O
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Dialkene 216 (0.37 g, 1.1 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) 
to yield the desired product 224 (0.21 g, 0.69 mmol, 62%) as a colourless oil. 
 
1H (CDCl3, 400 MHz) δ: 7.40 (1H, dd, JH = 1.7, 0.6 Hz, Ar-H), 7.22 (2H, d, JH = 8.6 Hz, Ar-
H), 6.90 (2H, d, JH = 8.6 Hz, Ar-H), 6.36 (1H, dd, JH = 3.2, 1.7 Hz, Ar-H), 6.19 (1H, br d, JH 
= 3.2 Hz, Ar-H), 5.91-5.86 (1H, m, CFCH), 5.48 (1H, d, JH = 14.8 Hz, ArCHH), 4.59 (1H, 
dd, JH = 7.0, 2.5 Hz, CHNH), 3.84 (3H, s, OCH3), 3.75 (1H, d, JH = 14.8 Hz, ArCHH), 2.84-
2.75 (1H, m, CHCHHCH), 2.67-2.59 (1H, m, CHCHHCH). 
19F (CDCl3, 470 MHz) δ: -126.3.  
13C (CDCl3, 125 MHz) δ: 159.4 (d, JF = 30.0 Hz, CO), 152.2 (COMe), 149.1 (d, JF = 252.5 
Hz, CF), 142.5 (Ar-CH), 131.0 (Ar-C), 129.6 (2C, Ar-CH), 128.9 (Ar-C), 114.1 (2C, Ar-CH), 
110.3 (Ar-CH), 110.1 (d, JF = 16.5 Hz, CFCH), 107.5 (Ar-CH), 55.3 (OCH3), 51.6 (CHN), 
47.4 (NCH2), 26.2 (d, JF = 5.9 Hz, CHCH2CH). 
m/z [EI (+ve)] 301.2 [M]+. HRMS found [M]+ 301.1111, C17H16FNO3 requires 301.1114.  
IR (thin film) vmax = 2957, 2364, 1654, 1513, 1415, 1248, 1117 cm-1.  
 
3-Fluoro-1-(4'-methoxybenzyl)-6-(1''-(toluene-4'''-sulfonyl)-1H-pyrrol-2''-yl)-5,6-
dihydro-1H-pyridin-2-one, 225. 
 
Ts
N
N
OMe
F
O
 
 
Dialkene 216 (0.23 g, 0.47 mmol) was subjected to General Procedure C. The crude 
residue was purified by flash column chromatography (0 - 30% EtOAc in petroleum ether) 
to yield the desired product 225 (0.16 g, 0.36 mmol, 77%) as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.50 (2H, d, JH = 8.5 Hz, Ar-H), 7.37 (1H, dd, JH = 1.7, 1.5 Hz, Ar-
H), 7.30 (2H, d, JH = 8.5 Hz, Ar-H), 6.89 (2H, d, JH = 8.6 Hz, Ar-H), 6.83 (2H, d, JH = 8.6 
Hz, Ar-H), 6.28 (1H, t, JH = 3.3 Hz, Ar-H), 6.16-6.15 (1H, m, Ar-H), 5.76-5.72 (1H, m, 
CFCH), 5.30 (1H, d, JH = 15.0 Hz, ArCHH), 4.95 (1H, d, JH = 7.2 Hz, CHNH), 3.85 (3H, s, 
OCH3), 3.12 (1H, d, JH = 15.0 Hz, ArCHH), 2.94-2.87 (1H, m, CHCHHCH), 2.71-2.65 (1H, 
m, CHCHHCH), 2.47 (3H, s, CH3).  
19F (CDCl3, 400 MHz) δ: -127.9. 
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13C (CDCl3, 125 MHz) δ: 159.6 (d, JF = 30.0 Hz. CO), 159.1 (COMe), 148.8 (d, JF = 252.5 
Hz, CF), 145.4 (Ar-CSO2), 136.1 (Ar-C(N)CH), 132.5 (Ar-CCH2), 130.3 (2C, Ar-CH), 128.9 
(2C, Ar-CH), 128.8 (ArC), 126.4 (2C, Ar-CH), 124.8 (Ar-CH), 114.8 (Ar-CH), 114.0 (2C, 
Ar-CH), 112.0 (Ar-CH), 109.8 (d, JF = 15.0 Hz, CFCH), 55.3 (OCH3), 51.9 (CHN), 47.4 
(NCH2), 27.0 (d, JF = 6.3 Hz, CHCH2CH), 21.7 (CH3).  
m/z [ESI (+ve)] 477.1 [M+Na]+, HRMS found [M+Na]+ 477.1259, C24H23FN2O4SNa 
requires 477.1255. 
IR (thin film) vmax = 2955, 1630, 1515, 1447, 1276, 1205 cm-1. 
 
3-Fluoro-6-(4'-methoxyphenyl)-5,6-dihydro-1H-pyridin-2-one, 227. 
 
HN
F
O
MeO  
 
α,β-Unsaturated lactam 218 (0.14 g, 0.42 mmol) was subjected to General Procedure D 
and treated with ceric ammonium nitrate (1.30 g, 5.5 eq, 2.3 mmol). The crude residue 
was purified by flash column chromatography (0 - 25% EtOAc in petroleum ether) to yield 
the desired product 227 (37 mg, 0.17 mmol, 40%) as a yellow solid.  
 
1H (CDCl3, 400 MHz) δ: 7.21 (2H, d, JH = 8.6 Hz, Ar-H), 6.84 (2H, d, JH = 8.6 Hz, Ar-H), 
6.01-5.97 (1H, m, CFCH), 5.57 (1H, br s, NH), 4.67 (1H, dd, JH = 12.1, 5.6 Hz, CHNH), 
3.81 (3H, s, OCH3), 2.60-2.46 (2H, m, CHCH2CH).  
19F (CDCl3, 470 MHz) δ: -130.0. 
13C (CDCl3, 125 MHz) δ: 161.1 (d, JF = 31.3 Hz, CO), 159.8 (Ar-COMe), 149.8 (d, JF = 
253.8 Hz, CF), 131.9 (Ar-CCH), 127.6 (2C, Ar-CH), 114.4 (2C, Ar-CH), 113.6 (d, JF = 13.8 
Hz, CFCH), 55.6 (CHNH), 55.4 (OCH3), 31.2 (d, JF= 5.3 Hz, CHCH2CH). 
m/z [CI (+ve)] 222.1 [M+H]+, HRMS found [M+H]+ 222.0929, C12H13FNO2 requires 
222.09230. 
IR (thin film) vmax = 1695, 1630, 1250 cm-1. 
m.p. 133-135 ˚C. 
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3-Fluoro-6-(4'-trifluoromethanephenyl)-5,6-dihydro-1H-pyridin-2-one, 228. 
 
HN
F
O
F3C  
 
α,β-Unsaturated lactam 219 (0.16 g, 0.42 mmol) was subjected to General Procedure D 
and treated with ceric ammonium nitrate (1.1 g, 4.9 eq, 2.0 mmol). The crude residue was 
purified by flash column chromatography (0 - 20% EtOAc in petroleum ether) to yield the 
desired product 228 (50 mg, 0.20 mmol, 47%) as a white solid.  
 
1H (CDCl3, 500 MHz) δ: 7.60 (2H, d, JH = 8.2 Hz, Ar-H), 7.43 (2H, d, JH = 8.2 Hz, Ar-H), 
5.99 (1H, ddd, JF = 11.8 Hz, JH = 5.5, 3.6 Hz, CFCH), 5.93 (1H, br s, NH), 4.80 (1H, dd, JH 
= 10.5, 6.1 Hz, CHNH), 2.67-2.53 (2H, m, CHCH2CH). 
19F (CDCl3, 470 MHz) δ: -62.4, -129.1. 
13C (CDCl3, 125 MHz) δ: 161.1 (d, JF = 31.3 Hz, CO), 149.6 (d, JF = 253.8 Hz, CF), 144.0 
(Ar-CCF3), 131.1 (CF3), 130.9 (Ar-CCH), 126.8 (2C, Ar-CH), 126.1 (2C, Ar-CH), 113.2 (d, 
JF = 13.8 Hz, CHCF), 55.4 (CHNH), 30.9 (d, JF = 5.0 Hz, CH2).  
m/z [EI (+ve)] 259.1 [M]+, HRMS found [M]+ 259.0623, C12H9F4NO requires 259.0620.  
IR (thin film) vmax = 1720, 1705, 1680, 1305, 1180 cm-1. 
m.p. 104-105 ˚C. 
 
3-Fluoro-6-(4'-bromophenyl)-5,6-dihydro-1H-pyridin-2-one, 229. 
 
HN
Br
F
O
 
 
α,β-Unsaturated lactam 220 (0.19 g, 0.47 mmol) was subjected to General Procedure D 
and treated with ceric ammonium nitrate (0.98 g, 3.8 eq, 1.8 mmol). The crude residue 
was purified by flash column chromatography (0 - 20% EtOAc in petroleum ether) to yield 
the desired product 229 (92 mg, 0.34 mmol, 72%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.56 (2H, d, JH = 8.1 Hz, Ar-H), 7.27 (2H, d, JH = 8.1 Hz, Ar-H), 
6.09 (1H, dt, JF = 10.9 Hz, JH = 4.7 Hz, CFCH), 5.58 (1H, br s, NH), 4.79 (1H, t, JH = 8.5 
Hz, CHNH), 2.67-2.62 (2H, m, CHCH2CH). 
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19F (CDCl3, 470 MHz) δ: -129.6. 
13C (CDCl3, 125 MHz) δ: 161.0 (d, JF = 31.2 Hz, CO), 149.6 (d, JF = 253.2 Hz, CF), 138.9 
(Ar-CBr), 132.3 (2C, Ar-CH), 128.0 (2C, Ar-CH), 122.7 (Ar-CCH), 113.3 (d, JF = 13.8 Hz, 
CHCF), 55.5 (CHNH), 31.0 (d, JF = 5.0 Hz, CH2). 
m/z [CI (+ve)] 269.8 [M+H]+, HRMS found [M+H]+ 269.9945, C11H10BrFNO requires 
269.9930. 
IR (thin film) vmax = 1705, 1685, 1205, 1010 cm-1. 
m.p. 199-200 ˚C. 
 
3-Fluoro-6-(naphthalen-1'-yl)-5,6-dihydro-1H-pyridin-2-one, 230. 
 
HN
F
O
 
 
α,β-Unsaturated lactam 221 (0.11 g, 0.30 mmol) was subjected to General Procedure D 
and treated with ceric ammonium nitrate (0.97 g, 5.9 eq, 1.8 mmol). The crude residue 
was purified by flash column chromatography (0 - 15% EtOAc in petroleum ether) to yield 
the desired product 230 (37 mg, 0.15 mmol, 51%) as a yellow solid. 
 
1H (CDCl3, 400 MHz) δ: 7.96 (1H, d, JH = 8.1 Hz, Ar-H), 7.85 (1H, br d, JH = 8.1 Hz, Ar-H), 
7.79 (1H, d, JH = 8.1 Hz, Ar-H), 7.55-7.41 (4H, m, Ar-H), 6.04 (1H, dt, JF = 11.0 Hz, JH = 
4.6 Hz, CFCH), 5.74 (1H, br s, NH), 5.56 (1H, t, JH = 8.5 Hz, CHNH), 2.81-2.76 (2H, m, 
CHCH2CH).  
19F (CDCl3, 470 MHz) δ: -129.6. 
13C (CDCl3, 125 MHz) δ: 161.4 (d, JF = 33.0 Hz, CO), 149.6 (d, JF = 252.5 Hz, CF), 135.3 
(Ar-C), 134.1 (Ar-C), 130.0 (Ar-C), 129.4 (Ar-CH), 129.2 (Ar-CH), 126.9 (Ar-CH), 126.2 
(Ar-CH), 125.5 (Ar-CH), 123.9 (Ar-CH), 121.1 (Ar-CH), 113.7 (d, JF = 12.5 Hz, CHCF), 
52.3 (CHNH), 29.7 (d, JF = 5.0 Hz, CH2).  
m/z [EI (+ve)] 241.1 [M]+, HRMS found [M]+ 241.0902, C15H12FNO requires 241.0903.  
IR (thin film) vmax = 1715, 1797, 1320, 1180 cm-1. 
m.p. 135-137 ˚C. 
 
3-Fluoro-6-isobutyl-5,6-dihydro-1H-pyridin-2-one, 231. 
 
HN
F
O
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α,β-Unsaturated lactam 222 (0.13 g, 0.44 mmol) was subjected to General Procedure D 
and treated with ceric ammonium nitrate (0.91 g, 3.8 eq, 1.7 mmol). The crude residue 
was purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) to yield 
the desired product 231 (70 mg, 0.41 mmol, 92%) as a white solid.  
 
1H (CDCl3, 500 MHz) δ: 6.07 (1H, ddd, JF = 11.1 Hz, JH = 5.9, 3.3 Hz, CFCH), 5.59 (1H, br 
s, NH), 3.76-3.72 (1H, m, CHNH), 2.49-2.40 (1H, m, CHCHHCH), 2.34-2.25 (1H, m, 
CHCHHCH), 1.74-1.63 (1H, m, CH), 1.59-1.51 (1H, m, CHH), 1.45-1.36 (1H, m, CHH), 
0.97 (3H, d, JH = 6.6 Hz, CH3), 0.96 (3H, d, JH = 6.6 Hz, CH3). 
19F (CDCl3, 470 MHz) δ: -130.1. 
13C (CDCl3, 100 MHz) δ: 161.2 (d, JF = 28.0 Hz, CO), 149.7 (d, JF = 253.0 Hz, CF), 113.7 
(d, JF = 13.0 Hz, CHCF), 49.3 (CHNH), 44.0 (CH2), 28.3 (d, JF = 5.0 Hz, CH2), 24.4 (CH), 
22.6 (CH3), 22.3 (CH3). 
m/z [CI (+ve)] 172.1 [M+H]+, HRMS found [M+H]+ 172.1144, C9H15FNO requires 
172.1138.  
IR (thin film) vmax = 3219, 2934, 2906, 1696, 1669, 1264, 1206 cm-1. 
m.p. 61-63 ˚C. 
 
3-Fluoro-6-cyclohexane-5,6-dihydro-1H-pyridin-2-one, 232. 
 
HN
F
O
 
 
α,β-Unsaturated lactam 223 (0.22 g, 0.70 mmol) was subjected to General Procedure D 
and treated with ceric ammonium nitrate (1.4 g, 3.3 eq, 2.5 mmol). The crude residue was 
purified by flash column chromatography (0 - 10% EtOAc in petroleum ether) to yield the 
desired product 232 (0.11 g, 0.55 mmol, 79%) as a white solid.  
 
1H (CDCl3, 400 MHz) δ: 5.98 (1H, dt, JF = 11.4 Hz, JH = 4.3 Hz, CFCH), 5.54 (1H, br s, 
NH), 3.35 (1H, br q, JH = 7.7 Hz, CHNH), 2.32-2.29 (2H, m, CHCH2CH), 1.74-1.61 (5H, m, 
CH2 and CHH), 1.43-1.32 (1H, m, CH), 1.19-0.97 (3H, m, CH2 and CHH), 0.95-0.92 (2H, 
m, CH2).  
19F (CDCl3, 470 MHz) δ: -130.5. 
13C (CDCl3, 125 MHz) δ: 161.3 (d, JF = 31.3 Hz, CO), 149.6 (d, JF = 252.5 Hz, CF), 114.0 
(d, JF = 13.8 Hz, CHCF), 56.0 (CHNH), 41.4 (CH), 28.8 (CH2), 28.7 (CH2), 26.1 (CH2), 
25.9 (d, JF = 5.0 Hz, CH2), 24.9 (CH2), 24.8 (CH2). 
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m/z [CI (+ve)] 198.1 [M+H]+, HRMS found [M+H]+ 198.1295, C11H17FNO requires 
198.1294.  
IR (thin film) vmax = 2927, 2855, 1691, 1652, 1208, 1199 cm-1. 
m.p. 108-110 ˚C. 
 
3-Fluoro-6-(4'-methoxyphenyl)-piperidin-2-one, 235. 
 
HN
F
O
MeO  
 
Dihydropyridone 227 (24 mg, 0.11 mmol) was subjected to General Procedure E. The 
crude residue was purified by flash column chromatography (0 - 50% EtOAc in petroleum 
ether) to yield the desired product 235 (14 mg, 60 µmol, 58%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.25 (2H, d, JH = 8.6 Hz, Ar-H), 6.94 (2H, d, JH = 8.6 Hz, Ar-H), 
5.83 (1H, s, NH), 4.94 (1H, dt, JF = 47.1 Hz, JH = 4.6 Hz, CHF), 4.56-4.51 (1H, m, CHNH), 
3.84 (3H, s, OCH3), 2.34-2.24 (1H, m, CHH), 2.13-1.96 (3H, m, CHH and CH2). 
19F (CDCl3, 470 MHz) δ: -184.8. 
13C (CDCl3, 125 MHz) δ: 167.2 (d, JF = 22 Hz, CO), 159.6 (Ar-COMe), 133.4 (Ar-CCH), 
127.3 (2C, Ar-CH), 114.4 (2C, Ar-CH), 85.7 (d, JF = 176 Hz, CF), 57.0 (CHCN), 55.4 
(OCH3), 27.4 (d, JF = 4.6 Hz, CHCH2), 26.4 (d, JF = 21 Hz, CFCH2). 
m/z [EI (+ve)] 223.1 [M]+. HRMS found [M]+ 223.0999, C12H14FNO2 requires 223.1009. 
IR (thin film) vmax = 2930, 1695, 1510, 1230 cm-1. 
m.p. 159-161 ˚C. 
 
3-Fluoro-6-(4'-trifluoromethanephenyl)-piperidin-2-one, 236. 
 
HN
F
O
F3C  
 
Dihydropyridone 228 (29 mg, 0.11 mmol) was subjected to General Procedure E. The 
crude residue was purified by flash column chromatography (0 - 40% EtOAc in petroleum 
ether) to yield the desired product 236 (29 mg, 0.11 mmol, quantitative yield) as a white 
solid. 
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1H (CDCl3, 400 MHz) δ: 7.60 (2H, d, JH = 8.2 Hz, Ar-H), 7.38 (2H, d, JH = 8.2 Hz, Ar-H), 
5.93 (1H, s, NH), 4.86 (1H, dt, JF = 47.1 Hz, JH = 5.0 Hz, CHF), 4.59 (1H, br t, JH = 5.7 Hz, 
CHNH), 2.22-2.12 (1H, m, CHH), 2.11-1.89 (3H, m, CHH and CH2). 
19F (CDCl3, 470 MHz) δ: -62.4, -185.0. 
13C (CDCl3, 125 MHz) δ: 167.4 (d, JF = 22.3 Hz, CO), 145.4 (Ar-CCF3), 137.4 (CF3), 130.6 
(Ar-CCH), 126.6 (2C, Ar-CH), 126.1 (2C, Ar-CH), 85.5 (d, JF = 176 Hz, CF), 57.0 (CHCN), 
27.2 (d, JF = 4.2 Hz, CHCH2), 26.1 (d, JF = 21 Hz, CFCH2). 
m/z [EI (+ve)] 261.1 [M]+. HRMS found [M]+ 261.0773, C12H11F4NO requires 261.0777.  
IR (thin film) vmax = 3005, 2970, 1675, 1430 cm-1. 
m.p. 122-124 ˚C. 
 
3-Fluoro-6-(naphthalen-1'-yl)-piperidin-2-one, 238. 
 
HN
F
O
 
 
Dihydropyridone 230 (38 mg, 0.15 mmol) was subjected to General Procedure E. The 
crude residue was purified by flash column chromatography (0 - 40% EtOAc in petroleum 
ether) to yield the desired product 238 (29 mg, 0.12 mmol, 81%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.99-7.93 (2H, m, Ar-H), 7.87 (1H, d, JH = 8.0 Hz, Ar-H), 7.62-7.51 
(4H, m, Ar-H), 6.02 (1H, s, NH), 5.48-5.46 (1H, m, CHNH), 5.02 (1H, dt, JF = 46.9 Hz, JH = 
5.7 Hz, CHF), 2.43-2.33 (1H, m, CHH), 2.28-2.23 (3H, m, CHH and CH2).  
19F (CDCl3, 377 MHz) δ: -186.1. 
13C (CDCl3, 100MHz) δ: 168.3 (d, JF = 19.9 Hz, CO), 136.6 (Ar-C), 134.0 (Ar-C), 129.8 
(Ar-C), 129.4 (Ar-CH), 128.9 (Ar-CH), 126.8 (Ar-CH), 126.0 (Ar-CH), 125.4 (Ar-CH), 123.7 
(Ar-CH), 121.9 (Ar-CH), 85.8 (d, JF = 177.0 Hz, CF), 53.3 (CHCN), 25.9 (d, JF = 6.0 Hz, 
CHCH2), 25.7 (d, JF = 20.0 Hz, CFCH2). 
m/z [CI (+ve)] 244.0 [M+H]+, HRMS found [M+H]+ 244.1137, C15H15FNO requires 
244.1138. 
IR (thin film) vmax = 3240, 2900, 1650, 1110 cm-1. 
m.p. 144-147 ˚C. 
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3-Fluoro-6-isobutyl-piperidin-2-one, 239. 
 
HN
F
O
 
 
Dihydropyridone 231 (39 mg, 0.23 mmol) was subjected to General Procedure E. The 
crude residue was purified by flash column chromatography (0 - 20% EtOAc in petroleum 
ether) to yield the desired product 239 (40 mg, 0.23 mmol, quantitative yield) as a white 
solid. 
 
1H (CDCl3, 400 MHz) δ: 6.00 (1H, s, NH), 4.80 (1H, dt, JF = 48.6 Hz, JH = 4.5 Hz, CHF), 
3.40-3.37 (1H, m, CHNH), 2.16-2.13 (1H, m, CHH), 1.96-1.89 (1H, m, CHH), 1.81-1.77 
(1H, m, CH), 1.64-1.58 (2H, m, CH2), 1.40-1.31 (2H, m, CH2), 0.87 (3H, d, JH = 6.6 Hz, 
CH3), 0.85 (3H, d, JH = 6.6 Hz, CH3). 
19F (CDCl3, 470 MHz) δ: -185.0. 
13C (CDCl3, 125 MHz) δ: 167.4 (d, JF = 20.2 Hz, CO), 86.3 (d, JF = 173.8 Hz, CF), 50.8 
(CHCN), 45.6 (CH2), 26.5 (d, JF = 21.3 Hz, CFCH2), 24.3 (CH), 24.0 (d, JF = 3.8 Hz, 
CHCH2), 22.6 (CH3), 22.3 (CH3). 
m/z [CI (+ve)] 174.1 [M+H]+, HRMS found [M+H]+ 174.1300, C9H17FNO requires 
174.1294. 
IR (thin film) vmax = 2950, 2935, 1630 cm-1. 
m.p. 78-81 ˚C. 
 
3-Fluoro-6-cyclohexane-piperidin-2-one, 240. 
 
HN
F
O
 
 
Dihydropyridone 232 (80 mg, 0.40 mmol) was subjected to General Procedure E. The 
crude residue was purified by flash column chromatography (0 - 20% EtOAc in petroleum 
ether) to yield the desired product 240 (81 mg, 0.40 mmol, quantitative yield) as a white 
solid. 
 
1H (CDCl3, 500 MHz) δ: 5.93 (1H, s, NH), 4.74 (1H, dt, JF = 47.2 Hz, JH = 4.4 Hz, CHF), 
3.13-3.09 (1H, m, CHNH), 2.21-2.13 (1H, m, CHH), 1.90-1.79 (1H, m, CHH), 1.74-1.62 
173 
(7H, m, CH2 and CH), 1.35-1.30 (1H, m, CHH), 1.22-1.14 (2H, m, CH2), 1.11-1.03 (1H, m, 
CHH), 0.99-0.89 (2H, m, CH2). 
19F (CDCl3, 470 MHz) δ: -184.6. 
13C (CDCl3, 125 MHz) δ: 167.4 (d, JF = 19.9 Hz, CO), 86.0 (d, JF = 173.7 Hz, CF), 57.8 
(CHCN), 42.6 (CH), 28.6 (CH2), 28.4 (CH2), 26.9 (d, JF = 21.3 Hz, CFCH2), 26.2 (CH2), 
26.0 (CH2), 25.9 (CH2), 20.2 (d, JF = 3.4 Hz, CHCH2).  
m/z [EI (+ve)] 199.1 [M]+. HRMS found [M]+ 199.1376, C11H18FNO requires 199.1372.  
IR (thin film) vmax = 2926, 2870, 1664, 1410 cm-1. 
m.p. 148-159 ˚C. 
 
3-Fluoro-6-(4'-phenylphenyl)-5,6-dihydro-1H-pyridin-2-one, 241. 
 
HN
Ph
F
O
 
 
Dihydropyridone 220 (98 mg, 0.36 mmol) was dissolved in toluene/H2O (6:1, 14 mL). 
K2CO3 (0.11 g, 0.79 mmol), PhB(OH)2 (88 mg, 0.72 mmol) and Pd(PPh3)4 (84 mg, 20 
mol%) were then sequentially added and the resulting solution was heated at 90 °C for 16 
h. The reaction was cooled down to rt and was filtered through celite and the celite was 
washed with EtOAc (30 mL).  The organic layer was washed with H2O (1 × 10 mL) and 
brine (1 × 10 mL) and dried (Na2SO4). The solvent was removed in vacuo. The crude 
residue was purified by flash column chromatography (0 - 20% EtOAc in petroleum ether) 
to yield the desired product 241 (87 mg, 0.33 mmol, 90%) as a white soild.  
 
1H NMR (CDCl3, 400 MHz) δ: 7.58 (2H, d, JH = 8.0 Hz, Ar-H), 7.52 (2H, d, JH = 8.0 Hz, Ar-
H), 7.40-7.31 (5H, m, Ar-H), 6.02 (1H, ddd, JF = 11.0, JH = 5.8, 3.3 Hz, CFCH), 5.59 (1H, 
s, NH), 4.77 (1H, dd, JH = 11.3, 6.0 Hz, CHNH), 2.70-2.55 (2H, m, CHCH2CH). 
19F (CDCl3, 377 MHz) δ: -129.8. 
13C (CDCl3, 100 MHz) δ: 161.0 (d, JF = 31.1 Hz, CO), 149.9 (d, JF = 253.6 Hz, CF), 141.8 
(Ar-C), 140.2 (Ar-C), 138.9 (Ar-CCH), 128.9 (2C, Ar-CH), 127.8 (2C, Ar-CH), 127.7 (Ar-
CH), 127.1 (2C, Ar-CH), 126.8 (2C, Ar-CH), 113.5 (d, JF = 14.0 Hz, CHCF), 55.8 (CHNH), 
31.1 (d, JF = 5.7 Hz, CH2). 
m/z [EI (+ve)] 267.1 [M]+, HRMS found [M]+ 267.1058, C17H14FNO requires 267.1059. 
IR (thin film) vmax = 2358, 1693, 1658, 1258, 1198 cm-1. 
m.p. 199-201 ˚C. 
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3-Fluoro-6-(4'-phenylphenyl)-piperidin-2-one, 242. 
 
HN
Ph
F
O
 
 
Dihydropyridone 241 (34 mg, 0.13 mmol) was subjected to General Procedure E. The 
crude residue was purified by flash column chromatography (0 - 40% EtOAc in petroleum 
ether) to yield the desired product 242 (34 mg, 0.13 mmol, quantitative) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.64 (2H, d, JH = 7.5 Hz, Ar-H), 7.61 (2H, d, JH = 7.5 Hz, Ar-H), 
7.50-7.38 (5H, m, Ar-H), 5.91 (1H, s, NH), 4.97 (1H, dt, JF = 43.7 Hz, JH = 4.5 Hz, CHF), 
4.67-4.63 (1H, m, CHNH), 2.36-2.27 (1H, m, CHH), 2.20-2.04 (3H, m, CHH and CH2).  
19F (CDCl3, 377 MHz) δ: -185.1. 
13C (CDCl3, 100MHz) δ: 167.5 (d, JF = 19.8 Hz, CO), 141.4 (Ar-C), 140.3 (Ar-C), 140.2 
(Ar-C), 128.9 (2C, Ar-CH), 127.7 (2C, Ar-CH), 127.6 (Ar-CH), 127.1 (2C, Ar-CH), 126.6 
(2C, Ar-CH), 85.7 (d, JF = 176.0 Hz, CF), 57.2 (CHCN), 27.3 (d, JF = 4.0 Hz, CHCH2), 26.3 
(d, JF = 21.0 Hz, CFCH2). 
m/z [EI (+ve)] 269.0 [M]+, HRMS found [M]+ 269.1214, C17H16FNO requires 269.1216. 
IR (thin film) vmax = 3239, 2949, 2356, 1676, 1486 cm-1. 
m.p. 171-173 ˚C. 
 
 
(1E)-1-Phenylhexa-1,5-diene-3-ol, 245.150 
 
OH
 
 
Cinnamaldehyde (0.47 mL, 3.78 mmol) was dissolved in THF (15 mL) and cooled to 0 °C. 
Allylmagnesium bromide (4.2 mL, 4.16 mmol, 1M in diethyl ether) was added dropwise 
before the reaction mixture was stirred for 1 h at rt. Following this time, H2O (15 mL) was 
added slowly at 0 °C and the mixture was extracted with CH2Cl2 (3 × 10 mL). The organics 
were combined, dried (Na2SO4) and the solvent was removed in vacuo. The crude residue 
was purified by flash column chromatography (0 - 5% EtOAc in petroleum ether) to yield 
the desired product 245 (0.62 g, 3.56 mmol, 94%) as a yellow oil.  
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1H (CDCl3, 400 MHz) δ: 7.43-7.25 (5H, m, Ar-H), 6.44 (1H, d, JH = 15.9 Hz, PhCHCH), 
6.27 (1H, dd, JH = 15.9, 6.3 Hz, PhCHCH), 5.96-5.81 (1H, m, CHCH2), 5.25-5.16 (2H, m, 
CHCH2), 4.42-4.36 (1H, appt s, CHOH), 2.51-2.34 (2H, m, CHCH2CH), 1.86 (2H, d, JH = 
3.6 Hz, CHOH). 
13C (CDCl3, 125 MHz) δ: 136.7 (ArC), 134.1 (CH), 131.5 (CH), 130.4 (CH), 128.6 (2C, 
ArC-H), 127.7 (ArC-H), 126.5 (2C, ArC-H), 118.6 (CH2), 71.7 (CHOH), 42.0 (CH2). 
The spectral data is in agreement with the literature values.150 
 
(1E)-1-Phenylhexa-1,5-dien-3-yl-2-fluoroprop-2’-enoate, 246. 
 
O
O
F
 
 
2-Fluoroacrylic acid 135 (0.19 g, 2.2 mmol) and HBTU (0.82 g, 2.15 mmol) were dissolved 
in CH2Cl2 (10 mL). DIPEA (0.37 mL, 2.2 mmol) was added followed by alcohol 245 (0.25 
g, 1.4 mmol). The resulting solution was heated to reflux and stirred for 17 h. After which, 
the solvent was removed in vacuo and crude residue was purified by flash column 
chromatography (0 - 2.5% diethyl ether in petroleum ether) the desired product 246 (0.12 
g, 0.47 mmol, 33%) as a yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.45-7.26 (5H, m, Ar-H), 6.71 (1H, d, JH = 15.9 Hz, PhCHCH), 
6.21 (1H, dd, JH =15.9, 7.4 Hz, PhCHCH), 5.91-5.80 (1H, m, CHCH2), 5.72 (1H, dd, JF = 
43.6 Hz, JH = 3.2 Hz, CFCHH), 5.63 (1H, q, JH = 6.4 Hz, CHO),  5.37 (1H, dd, JF = 13.0 
Hz, JH = 3.2 Hz, CFCHH), 5.23-5.14 (2H, m, CHCH2), 4.42-2.68-2.54 (2H, m, CHCH2CH). 
19F (CDCl3, 377 MHz) δ: -116.8 (d, JH = 13.2 Hz), -116.9 (d, JH = 13.2 Hz). 
13C (CDCl3, 125 MHz) δ: 159.7 (d, JF = 36.4 Hz, CO), 153.5 (d, JF = 262.7 Hz, CF), 136.0 
(ArC), 133.4 (CH), 132.5 (CH), 128.6 (2C, ArC-H), 128.4 (ArC-H), 126.7 (2C, ArC-H), 
125.9 (CH), 118.7 (CH2), 102.71 (d, JF = 15.3 Hz, CFCH2), 75.8 (CHO), 39.0 (CH2). 
m/z [EI (+ve)] 246.2 [M]+, HRMS found [M]+ 246.1058, C15H15FO2 requires 246.1056.  
IR (thin film) vmax = 2924, 1736, 1654, 1313, 1165 cm-1. 
 
[(4-Methoxyphenyl)methyl](phenylmethylidene)amine, 247.148 
 
176 
N
OMe
 
 
Na2SO4 (1.0 g) was dried under vacuum in a round bottom flask for 10 min. Benzaldehyde 
(0.95 g, 9.43 mmol) was then added, followed by toluene (15 mL) and 4-
methoxybenzylamine (1.4 mL, 10.3 mmol). The resulting reaction mixture was then 
heated to reflux and stirred for 3 h. The reaction was cooled down to rt, the solid residue 
filtered off and the solvent was removed in vacuo to yield the crude product 247 (2.1 g, 
9.43 mmol, quantitative) as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 8.40 (1H, s, CHN), 7.87-7.76 (2H, m, Ar-H), 7.49-7.38 (3H, m, Ar-
H), 7.32-7.25 (2H, m, Ar-H), 6.91 (2H, d, JH = 8.6 Hz, Ar-H), 4.80 (2H, CH2N), 3.83 (3H, s, 
OCH3).  
13C (CDCl3, 125 MHz) δ: 161.7 (CN), 158.7 (ArC), 136.2 (ArC), 131.4 (ArC), 130.8 (ArC-
H), 129.3 (2C, ArC-H), 128.6 (2C, ArC-H), 128.3 (2C, ArC-H), 114.0 (2C, ArC-H), 64.5 
(CH2), 55.3 (OCH3). 
The spectral data is in agreement with the literature values.148 
 
N-(4’-Methoxyphenylmethyl)-1-phenyl-2-propenylamine, 263.151 
 
NH
OMe
 
 
Procedure 1 
Benzaldehyde (0.95 mL, 9.43 mmol) and p-methoxybenzylamine (1.4 mL, 10.3 mmol) 
were added to a suspension of Na2SO4 (1.0 g) in toluene (15 mL) and the resulting 
mixture was heated to reflux for 3 h. The solution was filtered and the solvent was 
removed in vacuo. The residue was redissovled in diethyl ether (20 mL) and 
vinylmagnesium bromide (28 mL, 28.2 mmol, 1M in diethyl ether) was added dropwise. 
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After the completed addition, the reaction heated to 50 °C for 72 h before quenching with 
H2O (10 mL). The aqueous phase was extracted with diethyl ether (3 × 15 mL) and the 
organic were combined, dried (Na2SO4), filtered and removed in vacuo. The crude residue 
was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
the desired product 263 as a pale yellow oil (1.3 g, 5.10 mmol, 54%).  
 
Procedure 2 
Following General Procedure G, amine 270 (0.11 g, 0.82 mmol) was reacted with p-
methoxybenzaldehyde (0.11 mL, 0.86 mmol) and NaBH4 (50 mg, 1.2 mmol). The crude 
residue was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum 
ether) to yield the desired product 263 (0.16 g, 0.63 mmol, 76%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.41-7.24 (7H, m, Ar-H), 6.88 (2H, d, JH = 8.4 Hz, Ar-H), 5.97 (1H, 
ddd, JH = 17.2, 10.4, 7.2 Hz, CHCH2), 5.25 (1H, appt dt, JH = 17.2, 1.2 Hz, CHCHH), 5.14 
(1H, ddd, JH = 10.4, 1.6, 0.8 Hz, CHCHH), 4.24 (1H, d, JH = 7.2 Hz, CHNH), 3.83 (3H, s, 
CH3), 3.71 (1H, d, JH = 13.6 Hz, CHHNH), 3.61 (1H, d, JH = 13.6 Hz, CHHNH), 1.60 (1H, 
s, NH). 
13C (CDCl3, 125 MHz) δ: 158.6 (ArC-OMe), 142.8 (ArC-CH2), 141.00 (CHCH2), 132.5 
(ArC-CH), 129.4 (2C, ArC-H), 128.6 (2C, ArC-H), 127.4 (2C, ArC-H), 127.2 (ArC-H), 115.2 
(CHCH2), 113.8 (2C, ArC-H), 65.0 (CHNH2), 55.3 (CH3), 50.7 (CH2). 
The spectral data is in agreement with the literature values.151 
 
 
Nonyl(phenylmethylidene)amine, 264.152 
 
N
 
 
Na2SO4 (1.0 g) was dried under vacuum in a round bottom flask for 10 min. Benzaldehyde 
(0.96 g, 9.43 mmol) was then added, followed by toluene (15 mL) and nonylamine (1.9 
mL, 10.4 mmol). The resulting reaction mixture was then heated to reflux and stirred for 3 
h. The reaction was cooled down to rt, the solid residue filtered off and the solvent was 
removed in vacuo to yield the desired product 264 (2.2 g, 9.43 mmol, quantitative) as a 
pale yellow oil. 
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1H (CDCl3, 400 MHz) δ: 8.30 (1H, s, CHN), 7.77-7.72 (2H, m, Ar-H), 7.45-7.39 (3H, m, Ar-
H), 3.63 (2H, td, JH = 7.1, 1.2 Hz, NCH2), 1.78-1.65 (2H, m, CH2), 1.44-1.32 (12H, m, 
CH2), 0.93-0.84 (3H, m, CH3). 
13C (CDCl3, 125 MHz) δ: 160.7 (CN), 136.4 (ArC-C), 130.5 (ArC-H), 128.6 (2C, ArC-H), 
128.0 (2C, ArC-H), 61.4 (CH2N), 31.9 (CH2), 31.0 (CH2), 29.6 (CH2), 29.5 (CH2), 29.3 
(CH2), 27.3 (CH2), 22.7 (CH2), 14.1 (CH3). 
The spectral data is in agreement with the literature values.152 
 
Nonyl(1-phenylprop-2-en-1-yl)amine, 265. 
 
HN
 
 
3-Bromopropene (3.2 mL, 3.23 mmol, 1 M in THF) was dissolved in THF (5 mL) and 
cooled to -78 °C. tert-Butyl lithium (3.8 mL, 6.45 mmol, 1.7 M in hexanes) was added 
slowly and the solution was stirred for 2 h at 0 °C. Imine 264 (0.50 g, 2.15 mmol) in THF 
(4 mL) was added the mixture was stirred for 30 min. After which, the reaction was 
allowed to warm to rt and stirred for 1 h before being quenched slowly with 1M HCl (5 mL) 
at 0 °C. The aqueous phase was extracted with diethyl ether (3 × 10 mL) which was 
subsequently dried (Na2SO4) and removed in vacuo at rt. The crude residue was purified 
by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to yield the 
desired product 265 (0.26 g, 1.00 mmol, 46%) as a pale yellow oil.  
 
1H (CDCl3, 400 MHz) δ: 7.32-7.27 (4H, m, Ar-H), 7.23-7.17 (1H, m, Ar-H), 5.90 (1H, ddd, 
JH = 17.2, 10.2, 7.2 Hz, CHCH2), 5.17 (1H, dt, J = 13.6, 1.2 Hz, CHCHH), 5.06 (1H, ddd, 
JH = 10.2, 1.5, 0.9 Hz, CHCHH), 4.14 (1H, d, JH = 7.2 Hz, CHN), 2.65-2.41 (2H, m, NCH2), 
1.52-1.39 (3H, m, CH2 and NH), 1.28-1.15 (12H, m, CH2), 0.88-0.72 (3H, m, CH3). 
13C (CDCl3, 125 MHz) δ: 143.1 (ArC), 141.2 (CHCH2), 128.5 (2C, ArC-H), 127.2 (2C, ArC-
H), 127.1 (ArC-H), 114.9 (CHCH2), 66.3 (CH), 47.7 (CH2N), 31.9 (CH2), 30.2 (CH2), 29.6 
(CH2), 29.3 (2C, CH2), 27.4 (CH2), 22.7 (CH2), 14.1 (CH3).  
m/z [ESI (+ve)] 260.2 [M+H]+, HRMS found [M+H]+ 260.2343, C18H30N requires 260.2346.  
IR (thin film) vmax = 2955, 2924, 2854, 1454, 1116 cm-1. 
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N-(Phenylmethylidene)aniline, 266.153 
 
N
 
 
Na2SO4 (1.00 g) was dried under vacuum in a round bottom flask for 10 min. 
Benzaldehyde (0.95 g, 9.43 mmol) was then added, followed by toluene (15 mL) and 
aniline (1.9 mL, 10.3 mmol). The resulting reaction mixture was then heated to reflux and 
stirred for 3 h. The reaction was cooled down to rt, the solid residue filtered off and the 
solvent was removed in vacuo to yield the crude product 266 (1.7 g, 9.43 mmol, 
quantitative) as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 8.50 (1H, s, CHN), 7.97-7.91 (2H, m, Ar-H), 7.55-7.49 (3H, m, Ar-
H), 7.47-7.40 (2H, m, Ar-H), 7.28-7.22 (3H, m, Ar-H). 
13C (CDCl3, 125 MHz) δ: 160.5 (CN), 152.1 (ArC-N), 136.3 (ArC-C), 131.5 (ArC-H), 129.3 
(2C, ArC-H), 128.9 (2C, ArC-H), 128.8 (2C, ArC-H), 126.0 (ArC-H), 121.0 (2C, ArC-H). 
The spectral data is in agreement with the literature values.153 
 
[(4’-Methoxyphenyl)methyl]-(2-methyl-1-phenylprop-2-en-1-yl)amine, 268. 
 
NH
OMe
 
 
2-Bromopropene (0.11 mL, 1.2 mmol) was dissolved in diethyl ether (5 mL) and cooled to 
-78 °C. tert-Butyl lithium (1.1 mL, 2.1 mmol, 1.9 M in hexanes) was added slowly and the 
resulting solution was stirred for 2 h. Imine 247 (0.25 g, 1.0 mmol) in diethyl ether (13 mL) 
was added the mixture was stirred for 20 min. After which, the reaction was allowed to 
warm to rt and stirred for 1 h before being quenched slowly with H2O (10 mL) at 0 °C. The 
aqueous phase was extracted with diethyl ether (3 × 10 mL) which was subsequently 
dried (Na2SO4) and removed in vacuo. The crude residue was purified by flash column 
chromatography (0 - 2.5% diethyl ether in petroleum ether) to yield the desired product 
268 (0.20 g, 0.75 mmol, 74%) as a pale yellow oil.  
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1H (CDCl3, 400 MHz) δ: 7.33-7.28 (2H, m, Ar-H), 7.29-7.21 (2H, m, Ar-H), 7.18-7.12 (3H, 
m, Ar-H), 6.79 (2H, d, JH = 8.6 Hz, Ar-H), 5.12-5.09 (1H, m, CCHH), 4.84-4.81 (1H, m, 
CCHH), 4.11 (1H, s, CHN), 3.73 (3H, s, OCH3), 3.59 (1H, d, JH = 13.0 Hz, CHHN), 3.54 
(1H, d, JH = 13.0 Hz, CHHN),1.62 (3H, s, CH3), 1.59 (1H, br s, NH). 
13C (CDCl3, 125 MHz) δ: 158.6 (Ar-C), 146.7 (C-CH3), 142.3 (Ar-C), 132.8 (Ar-C), 129.3 
(2C, ArC-H), 128.3 (2C, ArC-H), 127.4 (2C, ArC-H), 127.0 (ArC-H), 113.8 (2C, ArC-H), 
111.3 (CCH2), 67.7 (CHN), 55.3 (OCH3), 51.0 (CH2), 18.8 (CH3).  
m/z [ESI (+ve)] 268.2 [M+H]+, HRMS found [M+H]+ 268.1679, C18H22NO requires 
268.1696.  
IR (thin film) vmax = 2935, 2833, 1610, 1510, 1450, 1244, 1172, 1033 cm-1. 
 
1-Phenyl-2-propenylamine, 270.154 
 
NH2
 
 
Following General Procedure F, benzaldehyde (0.95 mL, 9.42 mmol) reacted with tert-
butylsulfinamide (1.3 g, 10.6 mmol) and vinylmagnesium bromide (29 mL 1.0 M in THF, 
28.5 mmol). Following acid-base work up the desired product 270 was yielded as a 
colourless oil (1.1 g, 7.96 mmol, 85%). 
 
1H (CDCl3, 400 MHz) δ: 7.38-7.36 (4H, m, Ar-H), 7.29–7.28 (1H, m, Ar-H), 6.05 (1H, ddd, 
JH = 17.1, 10.0, 6.1 Hz, CHCH2), 5.27 (1H, dt, JH = 17.1, 1.6 Hz, CHCHH), 5.14 (1H, dt, JH 
= 10.0, 1.6 Hz, CHCHH), 4.56 (1H, dt, JH = 6.1, 1.3 Hz, CHNH2), 1.59 (2H, br s, NH2). 
13C (CDCl3, 125 MHz) δ: 144.5 (ArC-CH), 142.3 (CHCH2), 128.7 (2C, ArC-H), 127.1 (ArC-
H), 126.6 (2C, ArC-H), 113.6 (CHCH2), 58.4 (CHNH2).  
The spectral data is in agreement with the literature values.154 
 
2-Fluoro-N-(1’-phenylprop-2’-en-1’-yl)prop-2-enamide, 275. 
 
HN
F
O
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A solution of 2-fluoroacylic acid 135 (0.17 g, 1.85 mmol) in CH2Cl2 (10 mL) was treated 
with HBTU (0.95 g, 2.52 mmol). DIPEA (0.44 mL, 2.52 mmol) and amine 270 (0.22 g, 1.68 
mmol) were sequentially added, and the reaction was stirred at rt for 1 h. The precipitate 
was filtered off and the solvent was removed in vacuo. The crude residue was purified by 
flash column chromatography (0 - 5% diethyl ether in petroleum ether) to yield the desired 
product 275 as a white solid (0.25 g, 1.22 mmol, 72%).  
 
1H (CDCl3, 400 MHz) δ: 7.43-7.37 (2H, m, Ar-H), 7.36-7.31 (3H, m, Ar-H), 6.55 (1H, br s, 
NH), 6.07 (1H, ddd, JH = 17.1, 10.4, 5.4 Hz, CHCH2), 5.75 (1H, dd, JF = 47.6 Hz, JH = 3.2 
Hz, CFCHH), 5.74-5.70 (1H, m, CHN),  5.35-5.26 (2H, m, CHCH2), 5.17 (1H, dd, JF = 15.3 
Hz, JH = 3.2 Hz, CFCHH). 
19F (CDCl3, 377 MHz) δ: -121.2, -121.3. 
13C (CDCl3, 100 MHz) δ: 158.6 (d, JF = 31.0 Hz, CO), 156.2 (d, JF = 270.0 Hz, CF), 139.7 
(ArC), 136.5 (CHCH2), 128.9 (2C, ArC-H), 128.0 (2C, ArC-H), 127.3 (ArC-H), 116.5 
(CHCH2), 99.3 (d, JF = 14.8 Hz, CFCH2), 55.1 (CHN). 
IR (thin film) vmax = 3331, 1651, 1523, 1311, 1182 cm-1. 
m/z [EI (+ve)] 205.2 [M]+, HRMS found [M]+ 205.0901, C12H12FNO requires 205.0903.  
m.p. 71-73 ˚C. 
 
2-Fluoro-N-[(4’’-methoxyphenyl)methyl]-N-[1’-phenylprop-2’-en-1’-yl]-prop-2-
enamide, 277.  
 
N
O
F
OMe
 
 
Amine 263 (0.12 g, 0.47 mmol) was coupled with 2-fluoroacrylic acid (90 mg, 0.95 mmol) 
using HBTU (0.35 g, 0.95 mmol) and DIPEA (0.16 mL, 0.95 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 2.5% 
diethyl ether in petroleum ether) to yield the desired product 277 (90 mg, 0.29 mmol, 61%) 
as a pale yellow oil. 
 
1H (CDCl3, 500 MHz) δ: 7.27-7.19 (5H, m, Ar-H), 6.92 (2H, d, JH = 8.2 Hz, Ar-H), 6.69 (2H, 
JH = 8.2 Hz, Ar-H), 6.03 (1H, ddd, JH = 17.0, 10.0, 7.2 Hz, CHCH2), 5.72 (1H, d, JH = 7.2 
Hz, CHNH), 5.27-5.17 (3H, m, CFCH2 and CHCHH), 5.01 (1H, dd, JH = 17.0, 2.5 Hz, 
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CHCHH), 4.50 (1H, d, JH = 16.0 Hz, CHHN), 4.27 (1H, d, JH = 16.0 Hz, CHHN), 3.71 (3H, 
s, CH3). 
19F (CDCl3, 470 MHz) δ: -103.0, -105.5. 
13C (CDCl3, 125 MHz) δ: 163.2 (d, JF = 27.3 Hz, CO), 158.7 (ArC-OMe), 157.9 (d, JF = 
272.4 Hz, CF), 138.2 (ArC), 134.6 (CHCH2), 129.4 (ArC), 128.8 (2C, ArC-H), 128.6 (2C, 
ArC-H), 128.0 (2C, ArC-H), 127.9 (ArC-H), 119.2 (CHCH2), 113.7 (2C, ArC-H), 99.4 
(CFCH2), 63.3 (CHN), 55.2 (CH3), 40.1 (PhCH2). 
m/z [ESI (+ve)] 348.1 [M+Na]+, HRMS found [M+Na]+ 348.1356, C20H20FNO2Na requires 
348.1359.  
IR (thin film) vmax = 2956, 1639, 1612, 1512, 1413, 1246, 1176 cm-1. 
 
3-Fluoro-1-[(4’-methoxyphenyl)methyl]-5-phenyl-2,5-dihydro-1H-pyrrol-2-one, 278. 
 
N
O
F
OMe
 
 
Dialkene 277 (0.27 g, 0.84 mmol) was treated with 7.5 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 15% EtOAc in petroleum ether) to yield the desired product 
278 (0.21 g, 0.71 mmol, 83%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.50-7.33 (3H, m, Ar-H), 7.20-7.09 (2H, m, Ar-H), 7.06 (2H, JH = 
8.6 Hz, Ar-H), 6.85 (2H, d, JH = 8.6 Hz, Ar-H), 6.26 (1H, d, JH = 1.6 Hz, CHCF), 5.12 (1H, 
d, JH = 14.8 Hz, CHHN), 4.78 (1H, dd, JF = 6.0 Hz, JH = 2.4 Hz, CHN), 3.82 (3H, m, CH3), 
3.58 (1H, JH = 14.8 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -138.5. 
13C (CDCl3, 125 MHz) δ: 163.0 (d, JF = 31.2 Hz, CO), 159.2 (ArC-OMe), 152.3 (d, JF = 
279.6 Hz, CF), 133.9 (d, JF = 2.1 Hz, ArC), 129.8 (2C, ArC-H), 129.3 (2C, ArC-H), 129.2 
(ArC-H), 128.6 (ArC), 127.6 (2C, ArC-H), 118.4 (d, JF = 4.4 Hz, CHCF), 114.2 (2C, ArC-
H), 59.1 (d, JF = 5.7 Hz, CHN), 55.3 (CH3), 43.5 (ArCH2). 
m/z [EI (+ve)] 297.2 [M]+, HRMS found [M]+ 297.1164, C18H16FNO2 requires 297.1165.  
IR (thin film) vmax = 2355, 1710, 1666, 1514, 1247 cm-1. 
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4-Fluoro-1-[(4’-methoxyphenyl)methyl]-2-phenyl-1H-pyrrole, 285. 
 
N F
OMe
 
 
α,β-Unsaturated lactam 278 (40 mg, 0.13 mmol) was dissolved in CH2Cl2 (4 mL) and 
cooled to -78 °C. DIBAL (0.41 mL, 0.41 mmol, 1 M in hexanes) was added dropwise and 
the mixture was stirred for 16 h. Following this time, the reaction was quenched with H2O 
(10 mL), extracted with diethyl ether (3 × 10 mL), dried (Na2SO4) and removed in vacuo. 
The crude residue was purified by flash column chromatography (0 - 2.5% diethyl ether in 
petroleum ether) to yield the desired product 285 (30 mg, 0.11 mmol, 85%) as a yellow oil.  
 
1H (CDCl3, 400 MHz) δ: 7.40-7.32 (5H, m, Ar-H), 6.98 (2H, d, JH = 8.7 Hz, Ar-H), 6.86 (2H, 
d, JH = 8.7 Hz, Ar-H), 6.46 (1H, dd, JF = 3.2 Hz, JH = 2.0 Hz, CHN), 6.04 (1H, d, JF = 2.4 
Hz, CHCF), 4.99 (2H, s, CH2), 3.82 (3H, s, CH3).  
19F (CDCl3, 470 MHz) δ: -165.4. 
13C (CDCl3, 125 MHz) δ: 159.0 (ArC-OMe), 152.0 (d, JF = 239.1 Hz, CF), 132.5 (d, JF = 
1.6 Hz, ArC), 131.8 (d, JF = 6.4 Hz, Ar-CN), 130.2 (ArC-CH2), 129.0 (2C, ArC-H), 128.5 
(2C, ArC-H), 127.9 (2C, ArC-H), 127.5 (ArC-H), 114.1 (2C, ArC-H), 105.5 (d, JF = 27.3 Hz, 
CHN), 97.1 (d, JF = 16.4 Hz, CHCF), 55.3 (OCH3), 50.2 (ArCH2). 
m/z [EI (+ve)] 281.1 [M]+, HRMS found [M]+ 281.1215, C18H16FNO requires 281.1216.  
IR (thin film) vmax = 2956, 2837, 1701, 1612, 1512, 1247, 1176 cm-1. 
 
3-Fluoro-1-[(4’-methoxyphenyl)methyl]-2-methyl-5-phenyl-1H-pyrrole, 286. 
 
N F
OMe
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α,β-Unsaturated lactam 278 (36 mg, 0.12 mmol) was reacted with methyl lithium (83 μL, 
0.13 mmol, 1.6 M in diethyl ether) following General Procedure J. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 286 (30 mg, 0.10 mmol, 86%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.35-7.13 (5H, m, Ar-H), 6.78-6.76 (4H, m, Ar-H), 5.96 (1H, s, 
CHCF), 4.93 (2H, s, CH2), 3.72 (3H, s, OCH3), 1.98 (3H, d, JF = 1.6 Hz, CH3).  
19F (CDCl3, 470 MHz) δ: -169.4. 
13C (CDCl3, 125 MHz) δ: 158.7 (ArC-OMe), 149.2 (d, JF = 235.6 Hz, CF), 132.9 (ArC), 
130.6 (ArC-CH2), 130.1 (d, JF = 6.9 Hz, Ar-CN), 128.8 (2C, ArC-H), 128.5 (2C, ArC-H), 
127.1 (ArC-H), 126.7 (2C, ArC-H), 114.2 (2C, ArC-H), 112.5 (d, JF = 24.3 Hz, CCH3), 96.4 
(d, JF = 16.4 Hz, CHCF), 55.3 (OCH3), 47.2 (ArCH2), 8.2 (CH3).  
m/z [EI (+ve)] 295.2 [M]+, HRMS found [M]+ 295.1373 C19H18FNO requires 295.1372.  
IR (thin film) vmax = 2928, 2359, 1614, 1599, 1512, 1352, 1249, 1174 cm-1. 
m.p. 73-75 ˚C. 
 
2-Butyl-3-fluoro-1-[(4’-methoxyphenyl)methyl]-5-phenyl-1H-pyrrole, 287. 
 
N F
OMe
 
 
α,β-Unsaturated lactam 278 (38 mg, 0.13 mmol) was dissolved in diethyl ether (5 mL) and 
cooled to 0 °C. n-Butyllithium (54 μL, 0.13 mmol, 2.5 M in hexanes) was added dropwise 
and the mixture was stirred for 1 h. Following this time, the reaction was quenched with 
H2O (10 mL), extracted with diethyl ether (3 × 10 mL), dried (Na2SO4) and removed in 
vacuo. The crude residue was purified by flash column chromatography (0 - 2.5% diethyl 
ether in petroleum ether) to yield the desired product 287 (34 mg, 0.10 mmol, 78%) as a 
white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.22-7.14 (5H, m, Ar-H), 6.75-6.73 (4H, m, Ar-H), 5.95 (1H, s, 
CHCF), 4.94 (2H, s, CH2), 3.71 (3H, s, OCH3), 2.37 (2H, t, JH = 7.6 Hz, CH2), 1.43-1.34 
(2H, m, CH2), 1.25-1.18 (2H, m, CH2), 0.78 (3H, t, JH = 7.3 Hz, CH3). 
19F (CDCl3, 470 MHz) δ: -168.0. 
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13C (CDCl3, 125 MHz) δ: 158.7 (ArC-OMe), 149.5 (d, JF = 236.1 Hz, CF), 133.0 (ArC), 
131.0 (ArC-CH2),130.0 (d, JF = 7.0 Hz, Ar-CN), 128.9 (2C, ArC-H), 128.4 (2C, ArC-H), 
127.1 (ArC-H), 126.7 (2C, ArC-H), 117.0 (d, JF = 23.5 Hz, CCH3), 114.1 (2C, ArC-H), 96.7 
(d, JF = 16.6 Hz, CHCF), 55.3 (OCH3), 47.1 (CH2N), 31.3 (d, JF = 2.0 Hz, CH2), 23.1 (d, JF 
= 2.6 Hz, CH2), 22.4 (CH2), 13.8 (CH3).  
m/z [EI (+ve)] 337.2 [M]+, HRMS found [M]+ 337.1840, C22H24FNO requires 337.1842.  
IR (thin film) vmax = 2956, 2929, 2858, 1612, 1595, 1512, 1464, 1249 cm-1. 
m.p. 32-34 ˚C. 
 
3-Fluoro-1-[(4’-methoxyphenyl)methyl]-2,5-diphenyl-1H-pyrrole, 288. 
 
N F
OMe
Ph
 
 
α,β-Unsaturated lactam 278 (45 mg, 0.15 mmol) was dissolved in diethyl ether (5 mL) and 
cooled to 0 °C. Phenyl lithium (87 μL, 0.16 mmol, 1.9 M in di-n-butyl ether) was added 
dropwise and the mixture was stirred for 1 h. Following this time, the reaction was 
quenched with H2O (10 mL), extracted with diethyl ether (3 × 10 mL), dried (Na2SO4) and 
removed in vacuo. The crude residue was purified by flash column chromatography (0 - 
2.5% diethyl ether in petroleum ether) to yield the desired product 288 (50 mg, 0.14 mmol, 
93%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.39-7.36 (7H, m, Ar-H), 7.35-7.37 (3H, m, Ar-H), 6.66 (2H, d, JH 
= 8.8 Hz, Ar-H), 6.55 (2H, d, JH = 8.8 Hz, Ar-H), 6.17 (1H, br s, CHCF), 5.10 (2H, s, CH2), 
3.74 (3H, s, CH3).  
19F (CDCl3, 470 MHz) δ: -165.3. 
13C (CDCl3, 125 MHz) δ: 158.5 (ArC-OMe), 149.6 (d, JF = 242.5 Hz, CF), 133.0 (d, JF = 
7.1 Hz, Ar-CN), 132.9 (d, JF = 1.8 Hz, ArC), 130.8 (ArC-CH2), 129.9 (d, JF = 3.3 Hz, ArC), 
129.5 (2C, ArC-H), 129.1 (2C, ArC-H), 128.5 (2C, ArC-H), 128.5 (2C, ArC-H), 127.5 (ArC-
H), 127.3 (2C, ArC-H), 127.2 (ArC-H), 119.1 (d, JF = 21.0 Hz, CCH3), 113.7 (2C, ArC-H), 
98.4 (d, JF = 16.6 Hz, CHCF), 55.2 (OCH3), 48.3 (ArCH2).  
m/z [EI (+ve)] 357.0 [M]+, HRMS found [M]+ 357.1531, C24H20FNO requires 357.1529.  
IR (thin film) vmax = 3063, 2955, 2835, 1610, 1512, 1492, 1435, 1247, 1176 cm-1. 
m.p. 84-86 ˚C. 
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3-Fluoro-1-[(4’’-methoxyphenyl)methyl]-5-phenyl-2-(prop-2’-en-1’-yl)-1H-pyrrole, 
289. 
 
N
F
OMe
 
 
α,β-Unsaturated lactam 278 (41 mg, 0.14 mmol) was dissolved in diethyl ether (5 mL) and 
cooled to 0 °C. Allylmagnesium bromide (0.21 mL, 0.21 mmol, 1 M in diethyl ether) was 
added dropwise and the mixture was stirred for 1.5 h. Following this time, the reaction was 
quenched with H2O (10 mL), extracted with diethyl ether (3 × 10 mL), dried (Na2SO4) and 
removed in vacuo. The crude residue was purified by flash column chromatography (0 - 
2.5% diethyl ether in petroleum ether) to yield the desired product 289 (34 mg, 0.11 mmol, 
75%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.30-7.12 (5H, m, Ar-H), 6.76-6.74 (4H, m, Ar-H), 5.98 (1H, s, 
CHCF), 5.76 (1H, ddt, JH = 16.1, 10.1, 6.0 Hz, CHCH2),  5.00-4.84 (4H, m, CH2N and 
CHCH2), 3.71 (3H, s, OCH3), 3.12 (2H, dd, JH = 5.9, 0.8 Hz, CH2). 
19F (CDCl3, 470 MHz) δ: -168.0. 
13C (CDCl3, 125 MHz) δ: 158.7 (ArC-OMe), 149.5 (d, JF = 237.3 Hz, CF), 135.3 (CHCH2), 
132.8 (ArC), 130.8 (ArC-CH2), 130.7 (Ar-CN), 128.9 (2C, ArC-H), 128.5 (2C, ArC-H), 
127.2 (ArC-H), 126.7 (2C, ArC-H), 115.4 (CHCH2), 114.2 (2C, ArC-H), 113.9 (d, JF = 23.5 
Hz, CCH3), 96.6 (d, JF = 16.3 Hz, CHCF), 55.3 (OCH3), 47.1 (PhCH2), 27.5 (d, JF = 2.1 Hz, 
CH2).  
m/z [EI (+ve)] 321.1 [M]+, HRMS found [M]+ 321.1526, C21H20FNO requires 321.1529.  
IR (thin film) vmax = 2931, 1612, 1595, 1512, 1354, 1247, 1174 cm-1. 
m.p. 30-32 ˚C. 
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N-(1-Phenyl-2-propenyl)benzylamine, 291.155 
 
NH
 
 
Following General Procedure G, amine 270 (0.40 g, 3.01 mmol) was reacted with 
benzaldehyde (0.32 mL, 3.16 mmol) and NaBH4 (0.17 g, 4.51 mmol). The crude residue 
was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 291 (0.50 g, 2.25 mmol, 74%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.41-7.34 (7H, m, Ar-H), 7.31–7.26 (3H, m, Ar-H), 5.98 (1H, ddd, 
JH = 17.2, 10.2, 7.2 Hz, CHCH2), 5.25 (1H, dt, JH = 17.2, 1.2 Hz, CHCHH), 5.15 (1H, dt, JH 
= 10.2, 1.2 Hz, CHCHH), 4.26 (1H, d, JH = 7.2 Hz, CHNH), 3.78 (1H, d, JH = 13.2 Hz, 
CHHNH), 3.74 (1H, d, JH = 13.2 Hz, CHHNH), 1.62 (1H, s, NH). 
13C (CDCl3, 125 MHz) δ: 142.8 (ArC-CH), 141.0 (CHCH2), 140.5 (ArC-CH2), 128.6 (2C, 
ArC-H), 128.4 (2C, ArC-H), 128.2 (2C, ArC-H), 127.4 (2C, ArC-H), 127.2 (ArC-H), 126.9 
(ArC-H), 115.2 (CHCH2), 65.1 (CHNH2), 51.3 (CH2). 
The spectral data is in agreement with the literature values.155 
 
N-(4’-Bromophenylmethyl)-1-phenyl-2-propenylamine, 292. 
 
NH
Br
 
 
Following General Procedure G, amine 270 (0.26 g, 1.95 mmol) was reacted with 4-
bromobenzaldehyde (0.40 g, 2.05 mmol) and NaBH4 (0.11 g, 2.93 mmol). The crude 
residue was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum 
ether) to yield the desired product 292 (0.46 g, 1.53 mmol, 78%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.46 (2H, d, JH = 8.4 Hz, Ar-H), 7.40-7.27 (5H, m, Ar-H), 7.23 (2H, 
d, JH = 8.4 Hz, Ar-H), 5.96 (1H, ddd, JH = 17.2, 10.4, 7.2 Hz, CHCH2), 5.25 (1H, appt dt, JH 
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= 17.2, 1.2 Hz, CHCHH), 5.16 (1H, ddd, JH = 10.4, 1.6, 1.2 Hz, CHCHH), 4.22 (1H, d, JH = 
6.8 Hz, CHNH), 3.73 (1H, d, JH = 13.6 Hz, CHHNH), 3.68 (1H, d, JH = 13.6 Hz, CHHNH), 
1.63 (1H, s, NH). 
13C (CDCl3, 125 MHz) δ: 142.6 (ArC-Br), 140.8 (CHCH2), 139.5 (ArC-CH2), 131.4 (2C, 
ArC-H), 129.9 (2C, ArC-H), 128.6 (2C, ArC-H), 127.3 (2C, ArC-H), 127.3 (ArC-H), 120.6 
(ArC-CH), 115.3 (CHCH2), 65.0 (CHNH2), 50.6 (CH2).  
m/z [EI (+ve)] 302.1 [M]+, HRMS found [M]+ 301.0469, C16H16BrN requires 301.0466.  
IR (thin film) vmax = 3026, 2831, 1487, 1452, 1099, 1070 cm-1. 
 
N-(Cyclohexylmethyl)-1-phenyl-2-propenylamine, 293. 
 
NH
 
 
Following General Procedure G, amine 270 (0.27 g, 2.03 mmol) was reacted with 
cyclohexanecarboxaldehyde (0.27 mL, 2.13 mmol) and NaBH4 (0.11 g, 3.04 mmol). The 
crude residue was purified by flash column chromatography (0 - 2.5% diethyl ether in 
petroleum ether) to yield the desired product 293 (0.37 g, 1.61 mmol, 80% yield) as a pale 
yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.27-7.15 (5H, m, Ar-H), 5.84 (1H, ddd, JH = 14.0, 8.4, 6.0 Hz, 
CHCH2), 5.12 (1H, appt d, JH = 13.6 Hz, CHCHH), 5.00 (1H, appt d, JH = 8.0 Hz, 
CHCHH), 4.05 (1H, d, JH = 6.0 Hz, CHNH), 2.35 (1H, dd, JH = 9.2, 5.2 Hz, CHHNH), 2.25 
(1H, dd, JH = 9.2, 5.2 Hz, CHHNH), 1.69-1.55 (5H, m, CH2 and NH), 1.42-1.33 (1H, m, 
CH), 1.15-1.01 (3H, m, CHH and CH2), 0.87-0.76 (3H, m, CHH and CH2). 
13C (CDCl3, 125 MHz) δ: 143.3 (ArC-CH), 141.5 (CHCH2), 128.5 (2C, ArC-H), 127.4 (2C, 
ArC-H), 127.0 (ArC-H), 114.7 (CHCH2), 66.3 (CHNH2), 54.4 (NHCH2), 38.2 (CHCH), 31.5 
(CH2), 31.4 (CH2), 26.7 (CH2), 26.1 (CH2), 26.0 (CH2).  
m/z [EI (+ve)] 229.2 [M]+, HRMS found [M]+ 229.1827, C16H23N requires 229.1830.  
IR (thin film) vmax = 2920, 2850, 1448, 1269, 1118 cm-1. 
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N-[(1’-methyl-1H-pyrrol-2’-yl)methyl]-1-phenyl-2-propenylamine, 294. 
 
NH
N
 
 
Following General Procedure G, amine 270 (0.14 g, 1.1 mmol) was reacted with 1-
methylpyrrole-2-carboxaldehyde (0.12 mL, 1.1 mmol) and NaBH4 (60 mg, 1.6 mmol). The 
crude residue was purified by flash column chromatography (0-2.5% diethyl ether in 
petroleum ether) to yield the desired product 294 (0.16 g, 0.71 mmol, 68%) as a pale 
yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.42-7.35 (4H, m, Ar-H), 7.31-7.26 (1H, m, Ar-H), 6.01 (1H, dd, JH 
= 2.4, 2.0 Hz, Ar-H), 6.01 (1H, m, Ar-H), 6.00 (1H, dd, JH = 3.6, 2.0 Hz, Ar-H), 5.95 (1H, 
ddd, JH = 17.2, 10.4, 7.2 Hz, CHCH2), 5.27 (1H, dt, JH = 17.2, 1.2 Hz, CHCHH), 5.15 (1H, 
ddd, JH = 10.4, 1.6, 1.2 Hz, CHCHH), 4.27 (1H, d, JH = 7.1 Hz, CHNH), 3.72 (1H, d, JH = 
13.6 Hz, CHHNH), 3.65 (3H, s, CH3), 3.62 (1H, d, JH = 13.6 Hz, CHHNH), 1.43 (1H, s, 
NH). 
13C (CDCl3, 125 MHz) δ: 142.9 (ArC-CH), 141.0 (CHCH2), 131.20 (ArC-CH2), 128.5 (2C, 
ArC-H), 127.3 (2C, ArC-H), 127.2 (ArC-H), 122.3 (ArC-H), 115.1 (CHCH2), 107.8 (ArC-H), 
106.4 (ArC-H), 65.4 (CHNH2), 43.2 (NHCH2), 33.8 (CH3). 
m/z [EI (+ve)] 226.2 [M]+, HRMS found [M]+ 226.1469, C15H18N2 requires 226.1470.  
IR (thin film) vmax = 2935, 2818, 1492, 1452, 1300, 1087 cm-1. 
 
N-Benzyl-2-fluoro-N-(1’-phenylprop-2’-en-1’-yl)-prop-2-enamide, 295.  
 
N
O
F
 
 
Amine 291 (0.30 g, 1.4 mmol) was coupled with 2-fluoroacrylic acid (0.24 g, 2.7 mmol) 
using HBTU (1.0 g, 2.7 mmol) and DIPEA (0.46 mL, 2.7 mmol) following General 
Procedure H. The crude product was purified by flash column chromatography (0 - 2.5% 
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diethyl ether in petroleum ether) to yield the desired product 295 (0.29 g, 0.98 mmol, 73%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.26-7.10 (8H, m, Ar-H), 7.01–6.98 (2H, m, Ar-H), 6.02 (1H, ddd, 
JH = 17.2, 10.4, 7.2 Hz, CHCH2), 5.77 (1H, d, JH = 7.2 Hz, CHN), 5.30-5.18 (3H, m, 
CFCH2 and CHCHH), 4.26 (1H, dd, JH = 17.2 Hz, 2.8 Hz, CHCHH), 4.57 (1H, d, JH = 16.1 
Hz, CHHN), 4.35 (1H, d, JH = 16.1 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -103.1, -105.5. 
13C (CDCl3, 125 MHz) δ: 163.3 (d, JF = 29.6 Hz, CO), 157.8 (d, JF = 273.3 Hz, CF), 138.1 
(ArC), 137.4 (ArC), 134.6 (CHCH2), 128.6 (2C, ArC-H), 128.3 (2C, ArC-H), 128.0 (2C, 
ArC-H), 127.9 (ArC-H), 127.3 (2C, ArC-H), 126.9 (ArC-H), 119.3 (CHCH2), 99.6 (CFCH2), 
63.5 (CHN), 48.9 (PhCH2). 
m/z [EI (+ve)] 294.9 [M]+, HRMS found [M]+ 295.1375, C19H18FNO requires 295.1372.  
IR (thin film) vmax = 3030, 2251, 1635, 1450, 1417, 1153 cm-1. 
 
2-Fluoro-N-[(4’’-bromophenyl)methyl]-N-[1’-phenylprop-2’-en-1’-yl]-prop-2-enamide, 
296.  
 
N
O
F
Br
 
 
Amine 292 (0.28 g, 0.94 mmol) was coupled with 2-fluoroacrylic acid (0.17 g, 1.9 mmol) 
using HBTU (0.71 g, 1.9 mmol) and DIPEA (0.32 mL, 1.9 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 2.5% 
diethyl ether in petroleum ether) to yield the desired product 296 (0.25 g, 0.67 mmol, 71%) 
as a pale yellow oil. 
 
1H (CDCl3, 500 MHz) δ: 7.26-7.17 (7H, m, Ar-H), 6.82 (2H, d, JH = 7.3 Hz, Ar-H), 5.99 (1H, 
ddd, JH = 16.8, 10.0, 7.0 Hz, CHCH2), 5.80 (1H, appt s, CHN), 5.31-5.21 (3H, m, CFCH2 
and CHCHH), 5.05 (1H, appt d, JH = 16.8 Hz, CHCHH), 4.44 (1H, d, JH = 15.8 Hz, CHHN), 
4.32 (1H, d, JH = 15.8 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -103.2, -106.4. 
13C (CDCl3, 125 MHz) δ: 163.2 (d, JF = 33.0 Hz, CO), 157.7 (d, JF = 275.0 Hz, CF), 137.8 
(ArC-Br), 136.5 (ArC), 134.4 (CHCH2), 131.3 (2C, ArC-H), 129.1 (2C, ArC-H), 128.7 (2C, 
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ArC-H), 128.1 (ArC-H), 128.0 (2C, ArC-H), 120.9 (ArC), 119.4 (CHCH2), 99.8 (CFCH2), 
63.4 (CHN), 53.6 (PhCH2). 
m/z [ESI (+ve)] 396.0 [M+Na]+, HRMS found [M+Na]+ 396.0351, C19H17BrFNONa requires 
396.0370.   
IR (thin film) vmax = 3030, 1641, 1489, 1404, 1209, 1072, 1010 cm-1. 
 
2-Fluoro-N-[cyclohexylmethyl]-N-[1’-phenylprop-2’-en-1’-yl]-prop-2-enamide, 297.  
 
N
O
F
 
 
Amine 293 (0.27 g, 1.17 mmol) was coupled with 2-fluoroacrylic acid (0.21 g, 2.34 mmol) 
using HBTU (0.89 g, 2.34 mmol) and DIPEA (0.40 mL, 2.34 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 2.5% 
diethyl ether in petroleum ether) to yield the desired product 297 (0.30 g, 1.01 mmol, 86%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.39-7.28 (5H, m, Ar-H), 6.23 (1H, br s, CHCH2), 5.74 (1H, br s, 
CHN), 5.44-5.21 (3H, m, CFCH2 and CHCHH), 5.12 (1H, dd, JH = 17.2 Hz, 3.5 Hz, 
CHCHH), 3.16 (2H, br s, CH2N), 1.66-1.58 (4H, m, CH2), 1.48-1.39 (1H, m, CH), 1.35-1.25 
(1H, m, CHH), 1.06-0.98 (3H, m, CHH and CH2), 0.90-0.74 (2H, m, CH2). 
19F (CDCl3, 470 MHz) δ: -102.3, -104.2. 
13C (CDCl3, 125 MHz) δ: 163.7 (CO), 158.2 (d, JF = 272.0 Hz, CF), 138.6 (ArC), 135.0 
(CHCH2), 128.6 (3C, ArC-H), 127.9 (2C, ArC-H), 118.9 (CHCH2), 98.8 (CFCH2), 63.6 
(CHN), 40.9 (PhCH2), 36.9 (CH), 31.1 (CH2), 30.8 (CH2), 26.3 (CH2), 25.9 (2C, CH2). 
m/z [ESI (+ve)] 324.2 [M+Na]+, HRMS found [M+Na]+ 324.1740, C19H24FNONa requires 
324.1735.   
IR (thin film) vmax = 2924, 2850, 1639, 1448, 1415, 1313, 1203, 1130 cm-1. 
 
 
 
 
 
 
192 
2-Fluoro-N-[(1’’-methyl-1H-pyrrol-2’’-yl)methyl]-N-[1’-phenylprop-2’-en-1’-yl]-prop-2-
enamide, 298.  
 
N
O
F
N
 
 
Amine 294 (0.11 g, 0.48 mmol) was coupled with 2-fluoroacrylic acid (90 mg, 0.97 mmol) 
using HBTU (0.38 g, 0.97 mmol) and DIPEA (0.17 mL, 0.97 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 2.5% 
diethyl ether in petroleum ether) to yield the desired product 298 (90 mg, 0.30 mmol, 63%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.30-7.15 (5H, m, Ar-H), 6.45 (1H, appt t, JH = 2.4 Hz, Ar-H), 5.91 
(1H, dd, JH = 3.2, 2.8 Hz, Ar-H), 5.79 (1H, m, CHCH2), 5.70 (1H, br s, Ar-H), 5.63 (1H, d, 
JH = 7.8 Hz, CHN), 5.25-5.09 (3H, m, CFCH2 and CHCHH), 5.03 (1H, dd, JF = 17.2 Hz, JH 
= 3.6 Hz, CHCHH), 4.69 (1H, d, JH = 15.6 Hz, CHHN), 4.17 (1H, br s, CHHN), 3.37 (3H, s, 
CH3).  
19F (CDCl3, 470 MHz) δ: -103.2. 
13C (CDCl3, 125 MHz) δ: 163.0 (d, JF = 30.3 Hz, CO), 157.8 (d, JF = 271.8 Hz, CF), 138.1 
(ArC), 134.4 (CHCH2), 128.6 (2C, ArC-H), 127.8 (ArC-H), 127.7 (2C, ArC-H), 127.4 (ArC), 
122.7 (ArC-H), 119.5 (CHCH2), 110.0 (ArC-H), 107.0 (ArC-H), 99.0 (d, JF = 15.3 Hz, 
CFCH2), 63.1 (CHN), 40.1 (PhCH2), 38.9 (CH3).  
m/z [EI (+ve)] 298.2 [M]+, HRMS found [M]+ 298.1478, C18H19FN2O requires 298.1481.  
IR (thin film) vmax = 2362, 1643, 1494, 1415, 1303, 1195 cm-1. 
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1-Benzyl-3-fluoro-5-phenyl-2,5-dihydro-1H-pyrrol-2-one, 299. 
 
N
O
F
 
 
Dialkene 295 (0.11 g, 0.36 mmol) was treated with 7.5 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 10% EtOAc in petroleum ether) to yield the desired product 
299 (0.10 g, 0.35 mmol, 98%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.35-7.29 (3H, m, Ar-H), 7.26-7.20 (3H, m, Ar-H), 7.05-7.01 (4H, 
m, Ar-H), 6.19 (1H, d, JH = 1.9 Hz, CHCF), 5.08 (1H, d, JH = 15.0 Hz, CHHN), 4.70 (1H, 
dd, JF = 5.8 Hz, JH = 2.3 Hz, CHN), 3.53 (1H, d, JH = 15.0 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -138.6. 
13C (CDCl3, 125 MHz) δ: 163.0 (d, JF = 31.3 Hz, CO), 152.4 (d, JF = 279.5 Hz, CF), 136.5 
(ArC), 133.8 (ArC), 129.3 (2C, ArC-H), 129.2 (ArC-H), 128.8 (2C, ArC-H), 128.4 (2C, ArC-
H), 127.8 (ArC-H), 127.6 (2C, ArC-H), 118.5 (d, JF = 4.4 Hz, CHCF), 59.3 (d, JF = 5.7 Hz, 
CHN), 44.1 (PhCH2). 
m/z [ESI (+ve)] 290.1 [M+Na]+, HRMS found [M+Na]+ 290.0943, C17H14FNONa requires 
290.0940.   
IR (thin film) vmax = 3063, 1710, 1666, 1456, 1220, 1186 cm-1. 
 
3-Fluoro-1-[(4’-bromophenyl)methyl]-5-phenyl-2,5-dihydro-1H-pyrrol-2-one, 300. 
 
N
O
F
Br
 
 
Dialkene 296 (0.12 g, 0.31 mmol) was treated with 7.5 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
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column chromatography (0 - 5% EtOAc in petroleum ether) to yield the desired product 
300 (0.10 g, 0.29 mmol, 96%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.36 (2H, d, JH = 8.3 Hz, Ar-H), 7.34-7.28 (3H, m, Ar-H), 7.03-7.00 
(2H, m, Ar-H), 6.91 (2H, d, JH = 8.3 Hz, Ar-H), 6.21 (1H, d, JH = 2.0 Hz, CHCF), 4.98 (1H, 
JH = 15.0 Hz, CHHN), 4.69 (1H, dd, JF = 5.8 Hz, JH = 2.2 Hz, CHN), 3.54 (1H, JH = 15.0 
Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -138.5. 
13C (CDCl3, 125 MHz) δ: 163.0 (d, JF = 31.3 Hz, CO), 152.3 (d, JF = 279.8 Hz, CF), 135.5 
(ArC), 133.6 (d, JF = 2.2 Hz, ArC), 132.0 (2C, ArC-H), 130.1 (2C, ArC-H), 129.4 (2C, ArC-
H), 129.3 (ArC-H), 127.5 (2C, ArC-H), 121.9 (ArC), 118.6 (d, JF = 4.4 Hz, CHCF), 59.4 (d, 
JF = 5.6 Hz, CHN), 43.6 (ArCH2). 
m/z [EI (+ve)] 344.9 [M]+, HRMS found [M]+ 345.0167, C17H13BrFNO requires 345.0165.  
IR (thin film) vmax = 2960, 1708, 1666, 1489, 1404, 1220, 1012 cm-1. 
 
3-Fluoro-1-(cyclohexylmethyl)-5-phenyl-2,5-dihydro-1H-pyrrol-2-one, 301. 
 
N
O
F
 
 
Dialkene 297 (0.15 g, 0.50 mmol) was treated with 7.5 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 7.5% EtOAc in petroleum ether) to yield the desired product 
301 (0.13 g, 0.46 mmol, 92%) as a pale yellow oil.    
 
1H (CDCl3, 500 MHz) δ: 7.37-7.22 (3H, m, Ar-H), 7.09-7.07 (2H, m, Ar-H), 6.20 (1H, d, JH 
= 1.5 Hz, CHCF), 4.90 (1H, dd, JF = 5.5 Hz, JH = 2.0 Hz, CHN), 3.48 (1H, dd, JH = 14.0, 
8.7 Hz, CHHN), 2.46 (1H, dd, JH = 14.0, 6.0 Hz, CHHN), 1.63-1.58 (2H, m, CH2), 1.40-
1.43 (3H, m, CH2 and CH), 1.09-1.04 (3H, m, CH2 and CHH), 0.87-0.79 (3H, m, CH2 and 
CHH).  
19F (CDCl3, 470 MHz) δ: -138.4. 
13C (CDCl3, 125 MHz) δ: 163.3 (d, JF = 31.0 Hz, CO), 152.6 (d, JF = 279.3 Hz, CF), 134.2 
(ArC), 129.3 (2C, ArC-H), 129.1 (ArC-H), 127.4 (2C, ArC-H), 117.9 (d, JF = 4.4 Hz, 
CHCF), 60.7 (d, JF = 5.9 Hz, CHN), 46.6 (CyCH2), 37.0 (CH), 30.9 (CH2), 30.4 (CH2), 26.3 
(CH2), 25.7 (CH2), 25.6 (CH2). 
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m/z [EI (+ve)] 273.2 [M]+, HRMS found [M]+ 273.1528, C17H20FNO requires 273.1529.  
IR (thin film) vmax = 2922, 2852, 1703, 1666, 1448, 1220, 1116 cm-1. 
 
3-Fluoro-1-[(1’-methyl-1H-pyrrol-2’-yl)methyl]-5-phenyl-2,5-dihydro-1H-pyrrol-2-one, 
302. 
 
N
O
F
N
 
 
Dialkene 298 (80 mg, 0.27 mmol) was treated with 7.5 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 5% EtOAc in petroleum ether) to yield the desired product 
302 (60 mg, 0.22 mmol, 81%) as a pale yellow solid.    
 
1H (CDCl3, 400 MHz) δ: 7.45-7.27 (3H, m, Ar-H), 7.09-7.06 (2H, m, Ar-H), 6.51 (1H, appt t, 
JH = 2.4 Hz, Ar-H), 6.18 (1H, d, JH = 2.0 Hz, CHCF), 5.95 (1H, dd, JH = 3.6, 2.8 Hz, Ar-H), 
5.78 (1H, dd, JH = 3.6, 2.0 Hz, Ar-H), 4.99 (1H, d, JH = 15.5 Hz, CHHN), 4.74 (1H, dd, JF = 
5.9 Hz, JH = 2.3 Hz, CHN), 3.60 (1H, d, JH = 15.5 Hz, CHHN), 3.48 (3H, s, CH3).  
19F (CDCl3, 470 MHz) δ: -138.7. 
13C (CDCl3, 125 MHz) δ: 162.4 (d, JF = 31.3 Hz, CO), 151.9 (d, JF = 279.8 Hz, CF), 133.7 
(ArC), 129.3 (2C, ArC-H), 129.1 (ArC-H), 127.6 (2C, ArC-H), 126.8 (ArC), 123.3 (ArC-H), 
118.8 (d, JF = 4.2 Hz, CHCF), 110.3 (ArC-H), 106.9 (ArC-H), 58.9 (d, JF = 5.5 Hz, CHN), 
35.4 (CH2), 34.1 (CH3).  
m/z [EI (+ve)] 270.1 [M]+, HRMS found [M]+ 270.1170, C16H15FN2O requires 270.1168.  
IR (thin film) vmax = 2960, 2359, 1716, 1666, 1417, 1217 cm-1. 
m.p. 92-94 ˚C. 
 
1-Benzyl-3-fluoro-2-methyl-5-phenyl-1H-pyrrole, 303. 
 
N F
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α,β-Unsaturated lactam 299 (33 mg, 0.13 mmol) was reacted with methyl lithium (98 μL, 
0.14 mmol, 1.4 M in diethyl ether) following General Procedure J. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 303 (29 mg, 0.11 mmol, 86%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.30-7.09 (8H, m, Ar-H), 6.87-6.84 (2H, m, Ar-H), 5.98 (1H, s, 
CHCF), 4.99 (2H, s, CH2), 1.97 (3H, d, JF = 1.6 Hz, CH3).  
19F (CDCl3, 470 MHz) δ: -169.3. 
13C (CDCl3, 125 MHz) δ: 149.2 (d, JF = 235.6 Hz, CF), 138.6 (ArC-CH2), 132.8 (ArC), 
130.2 (d, JF = 3.3 Hz, Ph-CN), 128.8 (2C, ArC-H), 128.8 (2C, ArC-H), 128.5 (2C, ArC-H), 
127.2 (ArC-H), 127.1 (ArC-H), 125.6 (2C, ArC-H), 112.6 (d, JF = 24.4 Hz, CCH3), 96.5 (d, 
JF = 16.5 Hz, CHCF), 47.8 (PhCH2), 8.2 (CH3).  
m/z [EI (+ve)] 265.1 [M]+, HRMS found [M]+ 265.1269, C18H16FN requires 265.1267.  
IR (thin film) vmax = 2924, 1662, 1599, 1452, 1352, 1118 cm-1. 
m.p. 44-46 ˚C. 
 
1-[(4’-Bromophenyl)methyl]-3-fluoro-2-methyl-5-phenyl-1H-pyrrole, 304. 
 
N F
Br
 
 
α,β-Unsaturated lactam 300 (38 mg, 0.11 mmol) was reacted with methyl lithium (74 μL, 
0.12 mmol, 1.6 M in diethyl ether) following general procedure J. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 304 (31 mg, 90 µmol, 83%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.36 (2H, d, JH = 8.6 Hz, Ar-H), 7.27-7.14 (5H, m, Ar-H), 6.72 (2H, 
d, JH = 8.6 Hz, Ar-H), 5.98 (1H, s, CHCF), 4.93 (2H, s, CH2), 1.97 (3H, d, JF = 1.6 Hz, 
CH3).  
19F (CDCl3, 470 MHz) δ: -168.8. 
13C (CDCl3, 125 MHz) δ: 149.3 (d, JF = 236.2 Hz, CF), 137.7 (ArC-CH2), 132.6 (ArC), 
131.9 (2C, ArC-H), 130.2 (d, JF = 6.8 Hz, Ar-CN), 128.8 (2C, ArC-H), 128.6 (2C, ArC-H), 
127.3 (2C, ArC-H), 127.3 (ArC-H), 121.0 (ArC), 112.4 (d, JF = 24.4 Hz, CCH3), 96.8 (d, JF 
= 16.5 Hz, CHCF), 47.2 (ArCH2), 8.1 (d, JF = 2.1 Hz, CH3).  
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m/z [EI (+ve)] 343.1 [M]+, HRMS found [M]+ 343.0367, C18H15BrFN requires 343.0372.  
IR (thin film) vmax = 2924, 1680, 1599, 1489, 1363, 1072, 1010 cm-1. 
m.p. 98-100 ˚C. 
 
1-(Cyclohexylmethyl)-3-fluoro-2-methyl-5-phenyl-1H-pyrrole, 305. 
 
N F
 
 
α,β-Unsaturated lactam 301 (36 mg, 0.13 mmol) was reacted with methyl lithium (91 μL, 
0.15 mmol, 1.6 M in diethyl ether) following general procedure J. The crude material was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 305 (29 mg, 0.11 mmol, 84%) as a white solid. 
 
1H (CDCl3, 500 MHz) δ: 7.31-7.28 (2H, m, Ar-H), 7.25-7.20 (3H, m, Ar-H), 5.81 (1H, s, 
CHCF), 3.66 (2H, d, JH = 7.0 Hz, CH2N), 2.17 (3H, d, JF = 1.6 Hz, CH3), 1.50-1.45 (3H, m, 
CH2 and CH), 1.28-1.23 (3H, m, CH2 and CHH), 0.98-0.88 (3H, m, CH2 and CHH), 0.56-
0.49 (2H, m, CH2). 
19F (CDCl3, 470 MHz) δ: -170.1. 
13C (CDCl3, 125 MHz) δ: 149.1 (d, JF = 235.0 Hz, CF), 133.9 (ArC), 130.0 (d, JF = 7.2 Hz, 
Ar-CN), 128.3 (2C, ArC-H), 128.3 (2C, ArC-H), 126.8 (ArC-H), 112.2 (d, JF = 23.8 Hz, 
CCH3), 96.3 (d, JF = 16.3 Hz, CHCF), 50.2 (CH2N), 39.2 (CH), 30.4 (2C, CH2), 26.2 (CH2), 
25.7 (2C, CH2), 8.5 (d, JF = 1.9 Hz, CH3). 
m/z [EI (+ve)] 271.1 [M]+, HRMS found [M]+ 271.1733, C18H22FN requires 271.1736.  
IR (thin film) vmax = 2926, 2852, 1597, 1450, 1348, 1112 cm-1. 
m.p. 73-75 ˚C. 
 
3-Fluoro-2-methyl-1-[(1’-methyl-1H-pyrrole-2’-yl)methyl]-5-phenyl-1H-pyrrole, 306. 
 
N F
N
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α,β-Unsaturated lactam 302 (31 mg, 0.12 mmol) was reacted with methyl lithium (79 μL, 
0.13 mmol, 1.6 M in diethyl ether) following general procedure J. The crude redidue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 306 (23 mg, 90 µmol, 75%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.28-7.23 (2H, m, Ar-H), 7.23-7.19 (3H, m, Ar-H), 6.46 (1H, appt t, 
JH = 2.5 Hz, Ar-H), 5.95 (1H, appt t, JH = 3.5 Hz, Ar-H), 5.92 (1H, s, CHCF), 5.70-5.69 (1H, 
m, Ar-H), 4.88 (2H, s, CH2N), 3.26 (3H, s, NCH3), 2.03 (3H, d, JF = 1.6 Hz, CH3). 
19F (CDCl3, 470 MHz) δ: -169.5. 
13C (CDCl3, 125 MHz) δ: 149.2 (d, JF = 235.4 Hz, CF), 133.0 (ArC), 129.9 (d, JF = 6.9 Hz, 
Ph-CN), 128.8 (3C, ArC-H and ArC), 128.5 (2C, ArC-H), 127.1 (ArC-H), 122.3 (ArC-H), 
112.9 (d, JF = 24.6 Hz, CCH3), 107.9 (ArC-H), 107.1 (ArC-H), 96.4 (d, JF = 16.5 Hz, 
CHCF), 41.6 (ArCH2), 33.7 (NCH3), 8.2 (CCH3).  
m/z [EI (+ve)] 268.1 [M]+, HRMS found [M]+ 268.1380, C17H17FN2 requires 268.1376.  
IR (thin film) vmax = 2922, 1705, 1599, 1469, 1361, 1301, 1089 cm-1. 
m.p. 69-71 ˚C. 
 
1-(4’-Methoxyphenyl)prop-2-en-1-amine, 307.156 
 
NH2
MeO  
 
Following General Procedure F, 4-methoxybenzaldehyde (0.42 mL, 3.67 mmol) reacted 
with tert-butylsulfinamide (0.48 g, 3.97 mmol) and vinylmagnesium bromide (11 mL, 1.0 M 
in THF, 10.8 mmol). Following acid-base work up the desired product 307 was yielded as 
a colourless oil (0.42 g, 2.60 mmol, 71%). 
 
1H (CDCl3, 400 MHz) δ: 7.30 (2H, d, JH = 8.4 Hz, Ar-H), 6.91 (2H, d, JH = 8.4 Hz, Ar-H), 
6.03 (1H, ddd, JH = 17.2, 10.2, 6.1 Hz, CHCH2), 5.24 (1H, dt, JH = 17.2, 1.6 Hz, CHCHH), 
5.12 (1H, dt, JH = 10.2, 1.6 Hz, CHCHH), 4.51 (1H, d, JH = 6.0 Hz, CHNH2), 3.83 (3H, s, 
CH3), 1.55 (2H, s, NH2). 
13C (CDCl3, 125 MHz) δ: 158.7 (ArC-OMe), 142.6 (CHCH2), 136.7 (ArC-CH), 127.7 (2C, 
ArC-H), 114.0 (2C, ArC-H), 113.4 (CHCH2), 57.8 (CHNH2), 55.3 (CH3). 
The spectral data is in agreement with the literature values.156 
 
1-(4’-(Trifluoromethyl)phenyl)prop-2-en-1-amine, 308.157 
 
199 
NH2
F3C  
 
Following General Procedure F, 4-(trifluoromethane)benzaldehyde (0.39 mL, 2.87 mmol) 
reacted with tert-butylsulfinamide (0.38 g, 3.16 mmol) and vinylmagnesium bromide (8.6 
mL, 1.0 M in THF, 8.61 mmol). Following acid-base work up the desired product 308 was 
yielded as a colourless oil (0.35 g, 1.75 mmol, 61%). 
 
1H (CDCl3, 400 MHz) δ: 7.53 (2H, d, JH = 8.0 Hz, Ar-H), 7.42 (2H, d, JH = 8.0 Hz, Ar-H), 
5.91 (1H, ddd, JH = 17.2, 10.4, 6.4 Hz, CHCH2), 5.19 (1H, dt, JH = 17.2, 1.2 Hz, CHCHH), 
5.08 (1H, dt, JH = 10.4, 1.2 Hz, CHCHH), 4.52 (1H, d, JH = 6.4 Hz, CHNH2), 1.51 (2H, s, 
NH2). 
19F (CDCl3, 470 MHz) δ: -62.4. 
13C (CDCl3, 125 MHz) δ: 148.3 (ArC-CF3), 141.5 (CHCH2), 129.4 (q, JF = 32.3 Hz, CF3), 
127.1 (2C, ArC-H), 125.5 (2C, ArC-H), 122.8 (ArC-CH), 114.6 (CHCH2), 58.1 (CHNH2).  
The spectral data is in agreement with the literature values.157 
 
1-(4’-Bromophenyl)-2-propenylamine, 309.156 
 
NH2
Br  
 
Following General Procedure F, 4-bromobenzaldehyde (0.50 g, 2.70 mmol) reacted with 
tert-butylsulfinamide (0.35 g, 2.97 mmol) and vinylmagnesium bromide (8.1 mL, 1.0 M in 
THF, 8.11 mmol). Following acid-base work up the desired product 309 was yielded as a 
colourless oil (0.43 g, 2.04 mmol, 75%). 
 
1H (CDCl3, 400 MHz) δ: 7.46 (2H, d, JH = 8.4 Hz, Ar-H), 7.25 (2H, d, JH = 8.4 Hz, Ar-H), 
5.99 (1H, ddd, JH = 16.8, 10.0, 6.2 Hz, CHCH2), 5.24 (1H, dt, JH = 16.8, 1.2 Hz, CHCHH), 
5.14 (1H, dt, JH = 10.0, 1.2 Hz, CHCHH), 4.51 (1H, d, JH = 6.2 Hz, CHNH2), 1.54 (2H, s, 
NH2). 
13C (CDCl3, 125 MHz) δ: 153.4 (ArC-Br), 141.8 (CHCH2), 131.6 (2C, ArC-H), 128.5 (2C, 
ArC-H), 120.9 (ArC-CH), 114.2 (CHCH2), 57.9 (CHNH2).  
The spectral data is in agreement with the literature values.156 
 
1-Cyclohexylprop-2-en-1-amine, 310.156 
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NH2
 
 
Following General Procedure F, cyclohexanecarboxaldehyde (0.53 mL, 4.44 mmol) 
reacted with tert-butylsulfinamide (0.59 g, 4.88 mmol) and vinylmagnesium bromide (13 
mL, 1.0 M in THF, 13.3 mmol). Following acid-base work up the desired product 310 was 
yielded as a colourless oil (0.31 g, 2.22 mmol, 50%). 
 
1H (CDCl3, 400 MHz) δ: 5.72 (1H, ddd, JH = 17.3, 10.3, 7.2 Hz, CHCH2), 5.04-4.95 (2H, m, 
CHCH2), 2.98 (1H, dd, JH = 7.2, 6.4 Hz, CHNH2), 1.72-1.57 (6H, m, CH2 and NH2), 1.25-
1.00 (5H, m, CH and CH2), 0.95-0.85 (2H, m, CH2). 
13C (CDCl3, 125 MHz) δ: 142.1 (CHCH2), 114.0 (CHCH2), 59.6 (CHNH2), 43.7 (CHCH), 
29.3 (CH2), 29.0 (CH2), 26.6 (CH2), 26.4 (CH2), 26.3 (CH2).  
The spectral data is in agreement with the literature values.156 
 
5-Phenylpent-1-en-3-amine. 311.156 
 
NH2
 
 
Following General Procedure F, 3-phenylpropionaldehyde (0.46 mL, 3.73 mmol, 95%) 
reacted with tert-butylsulfinamide (0.49 g, 4.10 mmol) and vinylmagnesium bromide (11 
mL, 1.0 M in THF, 11.1 mmol). Following acid-base work up the desired product 311 was 
yielded as a colourless oil (0.33 g, 2.05 mmol, 58%). 
 
1H (CDCl3, 400 MHz) δ: 7.23-7.18 (2H, m, Ar-H), 7.13–7.09 (3H, m, Ar-H), 5.75 (1H, ddd, 
JH = 17.2, 10.4, 6.8 Hz, CHCH2), 5.04 (1H, dt, JH = 17.2, 1.6 Hz, CHCHH), 4.98 (1H, dt, JH 
= 10.4, 1.6 Hz, CHCHH), 3.27-3.22 (1H,  m, CHNH2), 2.62-2.58 (2H, m, CH2), 1.71-1.65 
(2H, m, CH2), 1.14 (2H, s, NH2).  
13C (CDCl3, 125 MHz) δ: 143.3 (CHCH2), 142.1 (ArC-CH2), 128.4 (2C, ArC-H), 128.3 (2C, 
ArC-H), 125.8 (ArC-H), 113.7 (CHCH2), 54.1 (CHNH2), 39.2 (CH2), 32.4 (CH2). 
The spectral data is in agreement with the literature values.156 
 
 
 
 
201 
N-[1-(4’-Methoxyphenyl)-2-propenyl]benzylamine, 312.151 
 
NH
MeO  
 
Following General Procedure G, amine 307 (0.30 g, 1.84 mmol) was reacted with 
benzaldehyde (0.19 mL, 1.93 mmol) and NaBH4 (0.11 g, 2.76 mmol). The crude residue 
was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 312 (0.36 g, 1.42 mmol, 79%) as a pale yellow oil.  
 
 1H (CDCl3, 400 MHz) δ: 7.29-7.17 (7H, m, Ar-H), 6.80 (2H, d, JH = 8.8 Hz, Ar-H), 5.86 
(1H, ddd, JH = 17.2, 10.2, 7.2 Hz, CHCH2), 5.13 (1H, dt, JH = 17.2, 1.2 Hz, CHCHH), 5.03 
(1H, dt, JH = 10.2, 1.2 Hz, CHCHH), 4.09 (1H, d, JH = 7.2 Hz, CHNH), 3.72 (3H, s, CH3), 
3.66 (1H, d, JH = 13.6 Hz, CHHNH), 3.62 (1H, d, JH = 13.6 Hz, CHHNH), 1.64 (1H, s, NH). 
13C (CDCl3, 125 MHz) δ: 158.8 (ArC-OMe), 141.2 (CHCH2), 140.5 (ArC-CH2), 134.9 (ArC-
CH), 128.4 (2C, ArC-H), 128.2 (2C, ArC-H), 127.0 (ArC-H), 126.9 (2C, ArC-H), 114.8 
(CHCH2), 113.9 (2C, ArC-H), 64.4 (CHNH2), 55.3 (CH3), 51.3 (CH2). 
The spectral data is in agreement with the literature values.151 
 
N-[1-(4’-(Trifluoromethyl)phenyl)-2-propenyl]benzylamine, 313.158 
 
NH
F3C  
 
Following General Procedure G, amine 308 (0.26 g, 1.31 mmol) was reacted with 
benzaldehyde (0.14 mL, 1.38 mmol) and NaBH4 (70 mg, 1.96 mmol). The crude residue 
was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 313 (0.30 g, 1.03 mmol, 80%) as a pale yellow oil.   
 
1H (CDCl3, 400 MHz) δ: 7.53 (2H, d, JH = 8.4 Hz, Ar-H), 7.44 (2H, d, JH = 8.4 Hz, Ar-H), 
7.28-7.16 (5H, m, Ar-H), 5.83 (1H, ddd, JH = 17.2, 10.4, 7.2 Hz, CHCH2), 5.09 (1H, dt, JH = 
202 
17.2, 1.2 Hz, CHCHH), 5.08 (1H, dt, JH = 10.4, 1.2 Hz, CHCHH), 4.22 (1H, d, JH = 7.2 Hz, 
CHNH), 3.67 (1H, d, JH = 13.6 Hz, CHHNH), 3.61 (1H, d, JH = 13.6 Hz, CHHNH), 1.56 
(1H, s, NH). 
19F (CDCl3, 470 MHz) δ: -62.4. 
13C (CDCl3, 125 MHz) δ: 146.9 (ArC-CF3), 140.2 (CHCH2), 140.0 (ArC-CH2), 129.6 (q, JF = 
32.3 Hz, CF3), 128.5 (2C, ArC-H), 128.1 (2C, ArC-H), 127.7 (2C, ArC-H), 127.1 (ArC-H), 
125.5 (2C, ArC-H), 122.9 (ArC-CH), 116.0 (CHCH2), 64.8 (CHNH2), 51.3 (CH2).  
The spectral data is in agreement with the literature values.158 
 
N-[1-(4’-Bromophenyl)-2-propenyl]benzylamine, 314.159 
 
NH
Br
 
 
Following General Procedure G, amine 309 (0.30 g, 1.41 mmol) was reacted with 
benzaldehyde (0.15 mL, 1.49 mmol) and NaBH4 (80 mg, 2.12 mmol). The crude residue 
was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 314 (0.36 g, 1.20 mmol, 84%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.49 (2H, d, JH = 8.0 Hz, Ar-H), 7.38-7.26 (7H, m, Ar-H), 5.92 (1H, 
ddd, JH = 17.2, 10.4, 7.2 Hz, CHCH2), 5.24 (1H, dt, JH = 17.2, 1.2 Hz, CHCHH), 5.16 (1H, 
dt, JH = 10.4, 1.2 Hz, CHCHH), 4.23 (1H, d, JH = 7.2 Hz, CHNH), 3.76 (1H, d, JH = 13.2 
Hz, CHHNH), 3.71 (1H, d, JH = 13.2 Hz, CHHNH), 1.62 (1H, s, NH). 
13C (CDCl3, 125 MHz) δ: 141.9 (ArC-Br), 140.5 (CHCH2), 140.2 (ArC-CH2), 131.6 (2C, 
ArC-H), 129.1 (2C, ArC-H), 128.5 (2C, ArC-H), 128.1 (2C, ArC-H), 127.0 (ArC-H), 121.0 
(ArC-CH), 115.6 (CHCH2), 64.5 (CHNH2), 51.3 (CH2).  
The spectral data is in agreement with the literature values.159 
 
N-[1-Cyclohexyl-2-propenyl]benzylamine, 315. 
 
NH
 
203 
 
Following General Procedure G, amine 310 (0.22 g, 1.50 mmol) was reacted with 
benzaldehyde (0.17 g, 1.65 mmol) and NaBH4 (90 mg, 2.36 mmol). The crude residue 
was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 315 (0.24 g, 1.05 mmol, 70%) as a pale yellow oil. 
  
1H (CDCl3, 400 MHz) δ: 7.32-7.15 (5H, m, Ar-H), 5.54 (1H, ddd, JH = 14.0, 8.0, 7.2 Hz, 
CHCH2), 5.11-5.09 (1H, m, CHCHH), 4.99-4.96 (1H, m, CHCHH), 3.76 (1H, d, JH = 10.8 
Hz, CHHNH), 3.52 (1H, d, JH = 10.8 Hz, CHHNH), 2.69 (1H, dd, JH = 7.2, 5.2 Hz, CHNH), 
1.73-1.55 (5H, m, CH2 and NH), 1.31-1.25 (2H, m, CH2), 1.12-1.00 (3H, m, CH and CH2), 
0.95-0.85 (2H, m, CH2). 
13C (CDCl3, 125 MHz) δ: 140.9 (ArC-CH2), 139.6 (CHCH2), 128.3 (2C, ArC-H), 128.2 (2C, 
ArC-H), 126.7 (ArC-H), 116.7 (CHCH2), 66.3 (CHNH2), 51.3 (Ar-CH2), 42.3 (CHCH), 30.0 
(CH2), 29.2 (CH2), 26.7 (CH2), 26.4 (CH2), 26.3 (CH2).  
m/z [EI (+ve)] 229.3 [M]+, HRMS found [M]+ 229.1832, C16H23N requires 229.1830.  
IR (thin film) vmax = 2922, 2850, 1450, 1028 cm-1. 
 
N-[5-Phenylpent-1-3-yl]benzylamine, 316.160 
 
NH
 
 
Following General Procedure G, amine 311 (0.24 g, 1.53 mmol) was reacted with 
benzaldehyde (0.16 mL, 1.60 mmol) and NaBH4 (90 mg, 2.28 mmol). The crude residue 
was purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 316 (0.33 g, 1.31 mmol, 86%) as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.30-7.23 (4H, m, Ar-H), 7.21-7.07 (6H, m, Ar-H), 5.61 (1H, ddd, 
JH = 17.2, 10.0, 8.4 Hz, CHCH2), 5.15-5.05 (2H, m, CHCH2), 3.75 (1H, d, JH = 13.2 Hz, 
CHHNH), 3.56 (1H, d, JH = 13.2 Hz, CHHNH), 3.03-2.97 (1H,  m, CHNH), 2.64-2.52 (2H, 
m, CH2), 1.81-1.63 (2H, m, CH2). 
13C (CDCl3, 125 MHz) δ: 142.2 (ArC-CH2), 141.0 (CHCH2), 140.6 (ArC-CH2), 128.4 (2C, 
ArC-H), 128.4 (2C, ArC-H), 128.3 (2C, ArC-H), 128.2 (2C, ArC-H), 127.0 (ArC-H), 126.9 
(ArC-H), 116.6 (CHCH2), 60.8 (CHNH2), 51.2 (Ar-CH2), 37.3 (CH2), 32.2 (CH2). 
The spectral data is in agreement with the literature values.160 
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N-Benzyl-2-fluoro-N-[1’-(4’’-methoxyphenyl)prop-2’-en-1’-yl]-prop-2-enamide, 317.  
 
N
O
F
MeO  
 
Amine 312 (0.20 g, 0.79 mmol) was coupled with 2-fluoroacrylic acid (0.14 g, 1.6 mmol) 
using HBTU (0.60 g, 1.6 mmol) and DIPEA (0.28 mL, 1.6 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 5% 
diethyl ether in petroleum ether) to yield the desired product 317 (0.16 g, 0.49 mmol, 62%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.29-7.16 (5H, m, Ar-H), 7.09–7.07 (2H, m, Ar-H), 6.85 (2H, JH = 
8.8 Hz, Ar-H), 6.09 (1H, ddd, JH = 16.8, 10.4, 7.2 Hz, CHCH2), 5.84 (1H, d, JH = 7.2 Hz, 
CHN), 5.41-5.22 (3H, m, CFCH2 and CHCHH), 5.11 (1H, dd, JH = 16.8 Hz, 2.4 Hz, 
CHCHH), 4.61 (1H, d, JH = 16.0 Hz, CHHN), 4.45 (1H, d, JH = 16.0 Hz, CHHN), 3.81 (3H, 
s, CH3). 
19F (CDCl3, 470 MHz) δ: -102.9, -105.5. 
13C (CDCl3, 125 MHz) δ: 163.3 (d, JF = 31.0 Hz, CO), 159.2 (ArC-OMe), 157.9 (d, JF = 
272.0 Hz, CF), 137.5 (ArC), 134.9 (CHCH2), 130.0 (ArC), 129.4 (2C, ArC-H), 128.2 (2C, 
ArC-H), 127.3 (2C, ArC-H), 127.0 (ArC-H), 118.8 (CHCH2), 114.0 (2C, ArC-H), 99.3 
(CFCH2), 62.9 (CHN), 55.3 (CH3), 48.4 (PhCH2). 
m/z [EI (+ve)] 325.1 [M]+, HRMS found [M]+ 325.1476, C20H20FNO2 requires 325.1478.  
IR (thin film) vmax = 2252, 1633, 1421, 1249, 1178 cm-1. 
 
N-Benzyl-2-fluoro-N-[1’-(4’’-trifluoromethanephenyl)prop-2’-en-1’-yl]-prop-2-
enamide, 318.  
 
N
O
F
F3C  
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Amine 313 (0.22 g, 0.76 mmol) was coupled with 2-fluoroacrylic acid (0.15 g, 1.7 mmol) 
using HBTU (0.65 g, 1.7 mmol) and DIPEA (0.28 mL, 1.7 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 2.5% 
diethyl ether in petroleum ether) to yield the desired product 318 (0.13 g, 0.34 mmol, 45%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.47 (2H, JH = 8.2 Hz, Ar-H), 7.28 (2H, JH = 8.2 Hz, Ar-H), 7.23-
7.11 (3H, m, Ar-H), 7.08–7.00 (2H, m, Ar-H), 6.12-6.00 (1H, m, CHCH2), 5.64 (1H, appt s, 
CHN), 5.34-5.19 (3H, m, CFCH2 and CHCHH), 5.05 (1H, dd, JH = 13.6 Hz, 2.4 Hz, 
CHCHH), 4.58 (1H, d, JH = 16.0 Hz, CHHN), 4.43 (1H, d, JH = 16.0 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -62.6, -103.3, -105.7. 
13C (CDCl3, 125 MHz) δ: 163.1 (d, JF = 30.4 Hz, CO), 157.6 (d, JF = 272.6 Hz, CF), 142.3 
(ArC-CF3), 140.2 (CF3), 140.1 (ArC), 136.9 (ArC), 133.7 (CHCH2), 128.5 (2C, ArC-H), 
128.1 (ArC-H), 128.1 (2C, ArC-H), 127.4 (2C, ArC-H), 125.5 (2C, ArC-H),  120.3 (CHCH2), 
100.3 (CFCH2), 63.1 (CHN), 51.3 (PhCH2). 
m/z [EI (+ve)] 363.1 [M]+, HRMS found [M]+ 363.1245, C20H17F4NO requires 363.1246.  
IR (thin film) vmax = 3020, 1639, 1417, 1325, 1166, 1126, 1068 cm-1. 
 
N-Benzyl-2-fluoro-N-[1’-(4’’-bromophenyl)prop-2’-en-1’-yl]-prop-2-enamide, 319.  
 
N
O
F
Br  
 
Amine 314 (0.24 g, 0.78 mmol) was coupled with 2-fluoroacrylic acid (0.14 g, 1.6 mmol) 
using HBTU (0.60 g, 1.6 mmol) and DIPEA (0.28 mL, 1.6 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 5% 
diethyl ether in petroleum ether) to yield the desired product 319 (0.18 g, 0.48 mmol, 62%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.44 (2H, JH = 8.5 Hz, Ar-H), 7.29-7.23 (3H, m, Ar-H), 7.16–7.11 
(4H, m, Ar-H), 6.10 (1H, ddd, JH = 17.2, 10.4, 7.2 Hz, CHCH2), 5.72 (1H, d, JH = 7.2 Hz, 
CHN), 5.42-5.26 (3H, m, CFCH2 and CHCHH), 5.13 (1H, dd, JH = 17.2 Hz, 3.4 Hz, 
CHCHH), 4.64 (1H, d, JH = 16.2 Hz, CHHN), 4.47 (1H, d, JH = 16.2 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -103.2, -105.8. 
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13C (CDCl3, 125 MHz) δ: 163.2 (d, JF = 30.3 Hz, CO), 157.7 (d, JF = 272.5 Hz, CF), 140.5 
(ArC-Br), 137.2 (ArC), 137.1 (ArC), 134.0 (CHCH2), 131.7 (2C, ArC-H), 129.6 (3C, ArC-H), 
128.4 (2C, ArC-H), 127.3 (2C, ArC-H), 119.8 (CHCH2), 100.0 (CFCH2), 62.9 (CHN), 51.2 
(PhCH2). 
m/z [EI (+ve)] 373.2 [M]+, HRMS found [M]+ 373.0478, C19H17BrFNO requires 373.0478.  
IR (thin film) vmax = 3030, 1639, 1487, 1415, 1209, 1074, 1010 cm-1. 
 
N-Benzyl-2-fluoro-N-[1’-cyclohexylprop-2’-en-1’-yl]-prop-2-enamide, 320.  
 
N
O
F
 
 
Amine 315 (0.18 g, 0.78 mmol) was coupled with 2-fluoroacrylic acid (0.14 g, 1.6 mmol) 
using HBTU (0.59 g, 1.6 mmol) and DIPEA (0.26 mL, 1.6 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 2.5% 
diethyl ether in petroleum ether) to yield the desired product 320 (0.18 g, 0.59 mmol, 76%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.39-7.23 (5H, m, Ar-H), 6.00-5.68 (1H, m, CHCH2), 5.34-4.94 
(3H, m, CFCH2 and CHCHH), 4.82-4.58 (1H, m, CHCHH), 4.55-4.30 (1H, m, CHHN), 
4.14-3.80 (1H, m, CHHN), 2.04-1.51 (6H, m, CH2 and CH), 1.38-1.03 (3H, m, CHH and 
CH2), 0.97-0.68 (3H, m, CHH and CH2). 
19F (CDCl3, 470 MHz) δ: -102.5, -104.6. 
13C (CDCl3, 125 MHz) δ: 163.2 (d, JF = 33.7 Hz, CO), 158.0 (d, JF = 274.5 Hz, CF), 137.7 
(ArC), 135.2 (CHCH2), 128.3 (2C, ArC-H), 127.3 (2C, ArC-H), 126.9 (ArC-H), 119.3 
(CHCH2), 98.9 (CFCH2), 67.2 (CHN), 51.5 (PhCH2), 39.3 (CH), 30.7 (CH2), 29.9 (CH2), 
26.2 (CH2), 26.0 (CH2), 25.9 (CH2). 
m/z [ESI (+ve)] 373.2 [M+Na]+, HRMS found [M+Na]+ 373.1719, C19H24FNONa requires 
373.1719.  
IR (thin film) vmax = 2928, 2852, 1637, 1446, 1417, 1192 cm-1. 
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N-Benzyl-2-fluoro-N-[5’-phenylpent-1’-en-3’-yl]-prop-2-enamide, 321.  
 
N
O
F
 
 
Amine 316 (0.24 g, 0.96 mmol) was coupled with 2-fluoroacrylic acid (0.17 g, 1.9 mmol) 
using HBTU (0.73 g, 1.9 mmol) and DIPEA (0.33 mL, 1.9 mmol) following General 
Procedure H. The crude residue was purified by flash column chromatography (0 - 2.5% 
diethyl ether in petroleum ether) to yield the desired product 321 (0.23 g, 0.71 mmol, 75%) 
as a pale yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.34-7.20 (8H, m, Ar-H), 7.12–6.88 (2H, m, Ar-H), 6.02-5.84 (1H, 
m, CHCH2), 5.34-5.14 (3H, m, CFCH2 and CHN) 5.09 (1H, dd, JH = 17.1 Hz, 3.5 Hz, 
CHCHH), 4.81-4.31 (3H, m, CHCHH and CH2N), 2.59-2.44 (2H, m, CH2), 2.07-1.93 (2H, 
m, CH2). 
19F (CDCl3, 470 MHz) δ: -103.1, -104.7. 
13C (CDCl3, 125 MHz) δ: 163.6 (d, JF = 32.8 Hz, CO), 158.0 (d, JF = 270.9 Hz, CF), 141.1 
(ArC), 137.8 (ArC), 136.2 (CHCH2), 128.5 (2C, ArC-H), 128.4 (2C, ArC-H), 128.3 (2C, 
ArC-H), 127.8 (ArC-H), 127.4 (ArC-H), 126.1 (2C, ArC-H), 118.2 (CHCH2), 99.1 (CFCH2), 
60.4 (CHN), 40.9 (PhCH2), 32.8 (CH2), 32.6 (CH2). 
m/z [EI (+ve)] 323.2 [M]+, HRMS found [M]+ 323.1683, C21H22FNO requires 323.1685. 
IR (thin film) vmax = 2931, 1635, 1417, 1359, 1178, 1153 cm-1. 
 
1-Benzyl-3-fluoro-5-(4’-methoxyphenyl)-2,5-dihydro-1H-pyrrol-2-one, 322. 
 
N
O
F
MeO  
 
Dialkene 317 (0.10 g, 0.31 mmol) was treated with 7.5 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 10% EtOAc in petroleum ether) to yield the desired product 
322 (70 mg, 0.22 mmol, 71%) as a white solid.    
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1H (CDCl3, 400 MHz) δ: 7.35-7.29 (3H, m, Ar-H), 7.14-7.13 (2H, m, Ar-H), 7.03 (2H, d, JH 
= 8.7 Hz, Ar-H), 6.93 (2H, d, JH = 8.7 Hz, Ar-H), 6.25 (1H, d, JH = 1.6 Hz, CHCF), 5.15 
(1H, d, JH = 15.0 Hz, CHHN), 4.75 (1H, dd, JF = 5.8 Hz, JH = 2.1 Hz, CHN), 3.85 (3H, s, 
CH3), 3.61 (1H, d, JH = 15.0 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -138.7. 
13C (CDCl3, 125 MHz) δ: 162.9 (d, JF = 31.3 Hz, CO), 160.3 (ArC-OMe), 152.3 (d, JF = 
279.3 Hz, CF), 136.7 (ArC), 128.9 (2C, ArC-H), 128.8 (2C, ArC-H), 128.4 (2C, ArC-H), 
127.8 (ArC-H), 125.4 (d, JF = 2.1 Hz, ArC), 118.5 (d, JF = 4.0 Hz, CHCF), 114.6 (2C, ArC-
H), 58.7 (d, JF = 5.8 Hz, CHN), 55.4 (CH3), 43.9 (PhCH2). 
m/z [EI (+ve)] 297.1 [M]+, HRMS found [M]+ 297.1169, C18H16FNO2 requires 297.1165.  
IR (thin film) vmax = 2933, 1707, 1666, 1512, 1247, 1174, 1030 cm-1. 
m.p.  101-103 ˚C. 
 
1-Benzyl-3-fluoro-5-[(4’-trifluoromethyl)phenyl]-2,5-dihydro-1H-pyrrol-2-one, 323. 
 
N
O
F
F3C  
 
Dialkene 318 (80 mg, 0.22 mmol) was treated with 15 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 15% EtOAc in petroleum ether) to yield the desired product 
323 (70 mg, 0.20 mmol, 88%) as a pale yellow oil.   
 
1H (CDCl3, 400 MHz) δ: 7.58 (2H, d, JH = 8.1 Hz, Ar-H), 7.26-7.21 (3H, m, Ar-H), 7.16 (2H, 
d, JH = 8.1 Hz, Ar-H), 7.03-7.01 (2H, m, Ar-H), 6.19 (1H, d, JH = 1.2 Hz, CHCF), 5.09 (1H, 
d, JH = 15.0 Hz, CHHN), 4.77 (1H, dd, JF = 4.8 Hz, JH = 2.0 Hz, CHN), 3.57 (1H, d, JH = 
15.0 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -62.9, -137.2. 
13C (CDCl3, 125 MHz) δ: 162.9 (d, JF = 31.2 Hz, CO), 152.7 (d, JF = 280.9 Hz, CF), 138.1 
(CF3), 136.1 (ArC), 131.7 (ArC), 131.4 (ArC), 129.0 (2C, ArC-H), 128.4 (2C, ArC-H), 128.1 
(ArC-H), 128.0 (2C, ArC-H), 126.3 (2C, q, JF = 3.7 Hz, ArC-H), 118.0 (d, JF = 5.0 Hz, 
CHCF), 58.7 (d, JF = 5.7 Hz, CHN), 44.4 (PhCH2). 
m/z [EI (+ve)] 335.0 [M]+, HRMS found [M]+ 335.0932, C18H13F4NO requires 335.0933.  
IR (thin film) vmax = 2362, 2332, 1718, 1670, 1421, 1325, 1166, 1126, 1066 cm-1. 
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1-Benzyl-3-fluoro-5-(4’-bromophenyl)-2,5-dihydro-1H-pyrrol-2-one, 324. 
 
N
O
F
Br  
 
Dialkene 319 (99 mg, 0.26 mmol) was treated with 10 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 10% EtOAc in petroleum ether) to yield the desired product 
324 (87 mg, 0.25 mmol, 96%) as a pale yellow oil.    
 
1H (CDCl3, 400 MHz) δ: 7.54 (2H, d, JH = 8.4 Hz, Ar-H), 7.36-7.30 (3H, m, Ar-H), 7.13-7.10 
(2H, m, Ar-H), 7.00 (2H, d, JH = 8.4 Hz, Ar-H), 6.26 (1H, d, JH = 1.6 Hz, CHCF), 5.17 (1H, 
d, JH = 15.0 Hz, CHHN), 4.76 (1H, dd, JF = 5.8 Hz, JH = 2.2 Hz, CHN), 3.62 (1H, d, JH = 
15.0 Hz, CHHN). 
19F (CDCl3, 470 MHz) δ: -137.7. 
13C (CDCl3, 125 MHz) δ: 162.9 (d, JF = 31.2 Hz, CO), 152.5 (d, JF = 280.5 Hz, CF), 136.3 
(ArC), 132.9 (d, JF = 2.2 Hz, ArC), 132.5 (2C, ArC-H), 129.2 (2C, ArC-H), 128.9 (2C, ArC-
H), 128.4 (2C, ArC-H), 128.0 (ArC-H), 123.2 (ArC), 118.1 (d, JF = 4.7 Hz, CHCF), 58.6 (d, 
JF = 5.7 Hz, CHN), 44.2 (PhCH2). 
m/z [EI (+ve)] 345.1 [M]+, HRMS found [M]+ 345.0165, C17H13BrFNO requires 345.0165.  
IR (thin film) vmax = 3030, 1708, 1666, 1489, 1408, 1220, 1078, 1010 cm-1. 
 
1-Benzyl-3-fluoro-5-cyclohexyl-2,5-dihydro-1H-pyrrol-2-one, 325. 
 
N
O
F
 
 
Dialkene 320 (0.10 g, 0.34 mmol) was treated with 7.5 mol% Grubbs 2nd generation 
catalyst as described in General Procedure I. The crude residue was purified by flash 
column chromatography (0 - 5% EtOAc in petroleum ether) to yield the desired product 
325 (88 mg, 0.32 mmol, 95%) as a white solid.    
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1H (CDCl3, 400 MHz) δ: 7.28-7.16 (5H, m, Ar-H), 6.12 (1H, d, JH = 2.1 Hz, CHCF), 5.03 
(1H, d, JH = 15.2 Hz, CHHN), 4.01 (1H, d, JH = 15.2 Hz, CHHN), 3.73-3.70 (1H, m, CHN), 
1.83-1.69 (2H, m, CH2), 1.66-1.54 (3H, m, CH2 and CH), 1.31-1.18 (2H, m, CH2), 1.05-
0.97 (3H, m, CH2 and CHH), 0.87-0.77 (1H, m, CHH). 
19F (CDCl3, 470 MHz) δ: -136.9. 
13C (CDCl3, 125 MHz) δ: 163.4 (d, JF = 31.5 Hz, CO), 152.8 (d, JF = 277.4 Hz, CF), 136.7 
(ArC), 128.3 (2C, ArC-H), 128.0 (2C, ArC-H), 127.7 (ArC-H), 115.6 (d, JF = 4.2 Hz, 
CHCF), 60.1 (d, JF = 4.4 Hz, CHN), 44.2 (PhCH2), 37.8 (CH), 30.1 (CH2), 36.5 (CH2), 26.3 
(CH2), 25.7 (CH2), 25.5 (CH2). 
m/z [EI (+ve)] 273.2 [M]+, HRMS found [M]+ 273.1527, C17H20FNO requires 273.1529.  
IR (thin film) vmax = 2928, 2854, 1703, 1666, 1450, 1421, 1240, 1145 cm-1. 
m.p. 53-55 ˚C. 
 
1-Benzyl-3-fluoro-5-(2’-phenylethyl)-2,5-dihydro-1H-pyrrol-2-one, 326. 
 
N
O
F
 
 
Dialkene 321 (0.12 g, 0.38 mmol) was treated with 5 mol% Grubbs 2nd generation catalyst 
as described in General Procedure I. The crude residue was purified by flash column 
chromatography (0 - 10% EtOAc in petroleum ether) to yield the desired product 326 (0.11 
g, 0.36 mmol, 96%) as a white solid.    
 
1H (CDCl3, 400 MHz) δ: 7.26-7.11 (8H, m, Ar-H), 6.97-6.96 (2H, m, Ar-H), 6.17 (1H, d, JH 
= 1.6 Hz, CHCF), 5.00 (1H, d, JH = 15.2 Hz, CHHN), 4.06 (1H, d, JH = 15.2 Hz, CHHN), 
3.88-3.85 (1H, m, CHN),  2.49-2.31 (2H, m, CH2), 2.11-2.04 (1H, m, CHH), 1.86-1.75 (1H, 
m, CHH). 
19F (CDCl3, 470 MHz) δ: -137.0. 
13C (CDCl3, 125 MHz) δ: 163.1 (d, JF = 31.3 Hz, CO), 152.7 (d, JF = 278.2 Hz, CF), 140.4 
(ArC), 136.5 (ArC), 128.9 (2C, ArC-H), 128.7 (2C, ArC-H), 128.2 (2C, ArC-H), 128.1 (2C, 
ArC-H), 127.9 (ArC-H), 126.4 (ArC-H), 117.2 (d, JF = 4.2 Hz, CHCF), 55.0 (d, JF = 5.0 Hz, 
CHN), 44.3 (PhCH2), 31.7 (d, JF = 2.0 Hz, CH2CH), 30.0 (CH2).  
m/z [EI (+ve)] 295.2 [M]+, HRMS found [M]+ 295.1373, C19H18FNO requires 295.1372.  
IR (thin film) vmax = 2935, 2364, 1707, 1666, 1454, 1226 cm-1. 
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m.p. 62-65 ˚C. 
 
1-Benzyl-3-fluoro-5-(4’-methoxyphenyl)- 2-methyl-1H-pyrrole, 327. 
 
N
F
MeO  
 
α,β-Unsaturated lactam 322 (32 mg, 0.11 mmol) was reacted with methyl lithium (83 μL, 
1.16 mmol, 1.4 M in diethyl ether) following general procedure J. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 327 (28 mg, 90 µmol, 88%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.25-7.16 (3H, m, Ar-H), 7.10 (2H, d, JH = 8.9 Hz, Ar-H), 6.86-6.84 
(2H, m, Ar-H), 6.76 (2H, d, JH = 8.9 Hz, Ar-H), 5.91 (1H, s, CHCF), 4.95 (2H, s, CH2), 3.71 
(3H, s, OCH3), 1.97 (3H, d, JF = 1.6 Hz, CH3).  
19F (CDCl3, 470 MHz) δ: -169.6. 
13C (CDCl3, 125 MHz) δ: 158.9 (ArC-OMe), 149.1 (d, JF = 235.4 Hz, CF), 138.7 (ArC-CH2), 
130.2 (2C, ArC-H), 129.9 (d, JF = 3.3 Hz, Ar-CN), 128.8 (2C, ArC-H), 127.1 (ArC-H), 125.6 
(2C, ArC-H), 125.4 (d, JF = 1.6 Hz, ArC), 113.9 (2C, ArC-H), 111.8 (d, JF = 24.4 Hz, 
CCH3), 96.0 (d, JF = 16.4 Hz, CHCF), 55.3 (OCH3), 47.6 (PhCH2), 8.1 (d, JF = 2.0 Hz, 
CH3).  
m/z [EI (+ve)] 295.2 [M]+, HRMS found [M]+ 295.1373, C19H18FNO requires 295.1372.  
IR (thin film) vmax = 2929, 1653, 1603, 1454, 1249, 1176 cm-1. 
m.p. 74-76 ˚C. 
 
1-Benzyl-3-fluoro-2-methyl-5-[(4’-trifluoromethyl)phenyl]-1H-pyrrole, 328. 
 
N
F
F3C  
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α,β-Unsaturated lactam 323 (22 mg, 60 µmol) was reacted with methyl lithium (51 μL, 70 
µmol, 1.4 M in diethyl ether) following general procedure J. The crude residue was purified 
by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to yield the 
desired product 328 (16 mg, 50 µmol, 73%) as a yellow solid. 
 
1H (CDCl3, 400 MHz) δ: 7.46 (2H, d, JH = 8.7 Hz, Ar-H), 7.32-7.17 (5H, m, Ar-H), 6.87-6.85 
(2H, m, Ar-H), 6.05 (1H, s, CHCF), 5.01 (2H, s, CH2), 2.00 (3H, d, JF = 1.6 Hz, CH3).  
19F (CDCl3, 470 MHz) δ: -62.5, -168.5. 
13C (CDCl3, 125 MHz) δ: 149.3 (d, JF = 236.4 Hz, CF), 138.1 (ArC-CH2), 136.3 (CF3), 
129.0 (ArC), 128.9 (2C, ArC-H), 128.6 (d, JF = 7.2 Hz, Ar-CN), 128.5 (2C, ArC-H), 127.4 
(2C, ArC-H), 126.0 (d, JF = 3.8 Hz, ArC), 125.5 (ArC-H), 125.4 (2C, ArC-H), 114.1 (d, JF = 
24.4 Hz, CCH3), 96.7 (d, JF = 16.5 Hz, CHCF), 47.9 (PhCH2), 8.2 (d, JF = 2.0 Hz, CH3).  
m/z [EI (+ve)] 333.2 [M]+, HRMS found [M]+ 333.1139, C19H15F4N requires 333.1141.  
IR (thin film) vmax = 2926, 1606, 1325, 1166, 1124 cm-1. 
m.p. 75-77 ˚C. 
 
1-Benzyl-5-(4’-bromophenyl)-3-fluoro-2-methyl-1H-pyrrole, 329. 
 
N
F
Br  
 
α,β-Unsaturated lactam 324 (43 mg, 0.13 mmol) was reacted with methyl lithium (98 μL, 
0.14 mmol, 1.4 M in diethyl ether) following general procedure J. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 329 (34 mg, 0.10 mmol, 78%) as a brown solid. 
 
1H (CDCl3, 400 MHz) δ: 7.37 (2H, d, JH = 8.6 Hz, Ar-H), 7.29-7.16 (3H, m, Ar-H), 7.04 (2H, 
d, JH = 8.6 Hz, Ar-H), 6.85-6.83 (2H, m, Ar-H), 5.97 (1H, s, CHCF), 4.96 (2H, s, CH2), 1.98 
(3H, d, JF = 1.6 Hz, CH3).  
19F (CDCl3, 470 MHz) δ: -168.9. 
13C (CDCl3, 125 MHz) δ: 149.2 (d, JF = 236.1 Hz, CF), 138.3 (ArC-CH2), 131.7 (d, JF = 1.8 
Hz, Ar-CN), 131.6 (2C, ArC-H), 130.2 (2C, ArC-H), 128.9 (2C, ArC-H), 128.8 (ArC), 127.3 
(ArC-H), 125.5 (2C, ArC-H), 121.2 (ArC), 113.2 (d, JF = 24.3 Hz, CCH3), 96.9 (d, JF = 16.5 
Hz, CHCF), 47.7 (PhCH2), 8.2 (d, JF = 2.0 Hz, CH3).  
m/z [EI (+ve)] 343.1 [M]+, HRMS found [M]+ 343.0368, C18H15BrFN requires 343.0372.  
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IR (thin film) vmax = 2922, 1683, 1612, 1471, 1352 cm-1. 
m.p. 98-100 ˚C. 
 
1-Benzyl-5-cyclohexyl-3-fluoro-2-methyl-1H-pyrrole, 330. 
 
N
F
 
 
α,β-Unsaturated lactam 325 (32 mg, 0.12 mmol) was reacted with methyl lithium (92 μL, 
0.13 mmol, 1.4 M in diethyl ether) following general procedure J. The crude residue was 
purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 330 (29 mg, 0.11 mmol, 92%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.25-7.13 (3H, m, Ar-H), 6.80-6.76 (2H, m, Ar-H), 5.64 (1H, s, 
CHCF), 4.90 (2H, s, CH2), 2.33-2.24 (1H, m, CH), 1.91 (3H, d, JF = 1.6 Hz, CH3), 1.74-
1.63 (4H, m, CH2), 1.26-1.08 (6H, m, CH2).  
19F (CDCl3, 470 MHz) δ: -170.6. 
13C (CDCl3, 125 MHz) δ: 148.6 (d, JF = 233.9 Hz, CF), 138.7 (ArC-CH2), 134.8 (d, JF = 5.7 
Hz, Ar-CN), 128.7 (2C, ArC-H), 127.1 (ArC-H), 125.5 (2C, ArC-H), 109.3 (d, JF = 24.7 Hz, 
CCH3), 91.8 (d, JF = 16.8 Hz, CHCF), 46.4 (PhCH2), 35.6 (CH), 34.1 (2C, CH2), 26.6 (2C, 
CH2), 26.0 (CH2), 7.8 (d, JF = 2.1 Hz, CH3). 
m/z [EI (+ve)] 271.1 [M]+, HRMS found [M]+ 271.1737, C18H22FN requires 271.1736.  
IR (thin film) vmax = 2926, 2852, 1616, 1446, 1365, 1348, 1112 cm-1. 
m.p. 55-57 ˚C. 
 
1-Benzyl-3-fluoro-2-methyl-5-(2’-phenylethyl)-1H-pyrrole, 331. 
 
N
F
 
 
α,β-Unsaturated lactam 326 (34 mg, 0.11 mmol) was reacted with methyl lithium (91 μL, 
0.12 mmol, 1.4 M in diethyl ether) following general procedure J. The crude residue was 
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purified by flash column chromatography (0 - 2.5% diethyl ether in petroleum ether) to 
yield the desired product 331 (24 mg, 80 µmol, 74%) as a yellow oil. 
 
1H (CDCl3, 400 MHz) δ: 7.24-7.08 (6H, m, Ar-H), 7.04-7.00 (2H, m, Ar-H), 6.80-6.76 (2H, 
m, Ar-H),  5.71 (1H, s, CHCF), 4.83 (2H, s, CH2), 2.76-2.71 (2H, m, CH2), 2.64-2.60 (2H, 
m, CH2), 1.97 (3H, br s, CH3).  
19F (CDCl3, 470 MHz) δ: -170.5. 
13C (CDCl3, 125 MHz) δ: 148.3 (d, JF = 234.1 Hz, CF), 141.4 (ArC), 138.2 (ArC-CH2), 
128.8 (2C, ArC-H), 128.4 (2C, ArC-H), 128.3 (2C, ArC-H), 127.9 (d, J = 6.3 Hz, Ph-CN), 
127.2 (ArC-H), 126.1 (ArC-H), 125.5 (2C, ArC-H), 110.0 (d, JF = 24.6 Hz, CCH3), 94.1 (d, 
JF = 16.8 Hz, CHCF), 46.5 (PhCH2), 35.4 (CH2), 28.4 (CH2), 7.9 (d, JF = 2.1 Hz, CH3).  
m/z [EI (+ve)] 293.1 [M]+, HRMS found [M]+ 293.1581, C20H20FN requires 293.1580.  
IR (thin film) vmax = 2922, 1614, 1496, 1454, 1417, 1363, 1114 cm-1. 
 
2,2-Difluoro-1-phenylbutan-1-ol, 335.161 
 
OH
F F
 
 
3-Bromo-3,3-difluoroprop-1-ene (0.19 mL, 1.9 mmol) was added to a slurry of indium 
(0.22 g, 1.9 mmol) in H2O (5 mL). Benzaldehyde (0.10 g, 0.94 mmol) in THF (0.6 mL) was 
added and the reaction was heated to 60 °C and stirred for 17 h. The mixture was diluted 
with H2O (10 mL) and extracted with diethyl ether (3 × 10 mL). The organics were 
combined, dried (Na2SO4) and removed in vacuo. The crude residue was purified by flash 
column chromatography (0 - 2% EtOAc in heptane) to give the desired product 335 (0.17 
g, 0.92 mmol, 98%) as a colourless oil.   
 
1H (CDCl3, 400 MHz) δ: 7.48-7.42 (2H, m, Ar-H), 7.41-7.36 (3H, m, Ar-H), 5.88 (1H, ddt, 
JH+F = 17.4, 12.4, 11.1 Hz, CHCH2), 5.62 (1H, dtd, JH+F = 17.4, 2.5, 0.9 Hz, CHH), 5.49 
(1H, dd, JH = 11.1, 0.9 Hz, CHH), 4.94 (1H, ddd, JH+F = 10.3, 8.8, 3.9 Hz, CHOH), 2.46 
(1H, dt, JH+F = 3.9, 0.9 Hz, OH).  
19F (CDCl3, 377 MHz) δ: -108.0 (dt, JH+F = 21.2, 10.4 Hz), -109.4 (dt, JH+F = 21.2, 10.4 Hz). 
13C (CDCl3, 100 MHz) δ: 136.0 (dd, JF = 3.4, 1.6 Hz, CF2), 129.4 (t, JF = 25.7 Hz, CHCH2), 
129.1 (Ar-C), 128.8 (ArC-H), 128.2 (2C, ArC-H), 127.6 (2C, ArC-H), 121.6 (t, JF = 9.2 Hz, 
CH2), 75.9 (dd, JF = 30.6, 29.1 Hz, CH). 
The spectral data is in agreement with the literature values.161 
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4-Methyl-N-(prop-2’-en-1’-yl)benzene-1-sulfonamide, 344.162 
 
NHTs
 
 
Allyl amine (1.31 mL, 17.5 mmol) was dissolved in CH2Cl2 (15 mL) and the solution was 
cooled to 0 °C. p-Toluenesulfonyl chloride (3.34 g, 17.5 mmol) and triethylamine (2.44 mL, 
17.5 mmol) were added and the mixture was stirred for 17 h at rt. The reaction was diluted 
with H2O (20 mL) and the aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The 
organics were combined, dried (Na2SO4) and removed in vacuo. The crude residue was 
purified by flash column chromatography (0 - 30% EtOAc in heptane) to yield the desired 
product 344 (3.32 g, 15.7 mmol, 90%) as a white solid.  
 
1H (CDCl3, 400 MHz) δ: 7.78 (2H, d, JH = 8.3 Hz, Ar-H), 7.33 (2H, d, JH = 8.3 Hz, Ar-H), 
5.73 (1H, ddt, JH = 17.2, 10.2, 6.2 Hz, CH), 5.14 (1H, dd, JH = 17.2, 1.5 Hz, CHCHH), 5.11 
(1H, dd, JH = 10.2, 1.5 Hz, CHCHH), 4.82 (1H, t, JH = 6.2 Hz, NH), 3.59 (2H, tt, JH = 6.2, 
1.5 Hz, CH2), 2.44 (3H, s, CH3). 
13C (CDCl3, 100 MHz) δ: 143.5 (ArC-SO2), 137.0 (ArC-CH3), 133.0 (CHCH2), 129.7 (2C, 
ArC-H), 127.2 (2C, ArC-H), 117.7 (CHCH2), 45.8 (CH2), 21.6 (CH3).  
The spectral data is in agreement with the literature values.162 
 
N-[1’-(tert-Butyldimethylsilyl)prop-2’-en-1’-yl]-4-methyl-N-(1’’-phenylbut-3’’-en-
yl)benzene-1-sulfonamide, 358. 
 
TsN
Si
 
 
Diisopropyl azodicarboxylate (0.20 mL, 1.0 mmol) was added dropwise to a solution of 
alcohol 359 (0.17 g, 0.99 mmol), PPh3 (0.35 g, 1.3 mmol) and sulphonamide 191 (0.20 g, 
0.66 mmol) in THF (5 mL) at 0 °C. The resulting mixture was stirred at rt for 17 h. The 
reaction was diluted with H2O (10 mL) before being extracted with diethyl ether (3 × 10 
mL). The organics were combined, dried (Na2SO4) and removed in vacuo. The crude 
residue was purified by flash column chromatography (1% EtOAc in heptane) to yield the 
desired product 358 (0.10 g, 0.22 mmol, 34%) as a white solid.   
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1H (CDCl3, 400 MHz) δ: 8.08-7.69 (2H, d, JH = 8.3 Hz, Ar-H), 7.42-7.23 (7H, m, Ar-H), 
5.89-5.62 (3H, m, CHSi, CHCH2 and CHCH2), 5.24 (1H, dd, JH = 8.8, 6.9 Hz, CHN), 5.18-
5.03 (2H, m, CH2), 3.98 (1H, ddd, JH = 16.7, 4.8, 1.2 Hz, CHCHH), 3.75 (1H, ddd, JH = 
16.8, 6.0, 1.2 Hz, CHCHH), 2.99-2.85 (1H, m, CHCHHCH), 2.77-2.65 (1H, m, 
CHCHHCH), 2.54 (3H, s, CH3), 1.11-0.74 (9H, m, CH3), 0.07– -0.07 (6H, m, CH3). 
13C (CDCl3, 100 MHz) δ: 144.6 (CHCH2), 143.0 (ArC), 138.6 (ArC), 138.0 (ArC), 134.7 
(CHCH2), 129.7 (CH), 129.5 (2C, ArC-H), 128.7 (2C, ArC-H), 128.3 (2C, ArC-H), 127.9 
(ArC-H), 127.4 (2C, ArC-H), 117.5 (CHCH2), 60.5 (CHN), 49.4 (CH2), 36.4 (CH2), 26.4 
(3C, CH3), 21.5 (CH3), 16.5 (CCH3), -6.2 (CH3), -6.4 (CH3). 
m/z [ESI (+ve)] 478.2 [M+Na]+, HRMS found [M+Na]+ 478.2182, C26H37NSSiO2Na 
requires 478.2206.  
IR (thin film) vmax = 2953, 2926, 2854, 1452, 1338, 1159 cm-1. 
m.p. 75-77 ˚C. 
 
1-(tert-Butyldimethylsilyl)prop-2-en-1-ol, 359.163 
 
OH
Si
 
 
Allyl alcohol (0.29 mL, 4.31 mmol) was dissolved in THF (15 mL) and the solution was 
cooled to -78 °C. n-Butyl lithium (1.9 mL, 4.74 mmol, 2.5 M in hexanes) was added slowly 
and the mixture was stirred for 30 min. After this time, tert-butyldimethylsilyl chloride (0.71 
g, 4.74 mmol) was added before the solution was allowed to warm to rt and stirred for 17 
h. sec-Butyl lithium (6.2 mL, 8.62 mmol) was added slowly at -78 °C and the reaction was 
warmed to -50 °C and stirred for 2 h. The reaction mixture was quenched slowly at -78 °C 
with sat. NH4Cl (20 mL) and then extracted with diethyl ether (3 × 10 mL). The organics 
were combined; dried (Na2SO4) and the solvent was removed in vacuo. The crude residue 
was purified by flash column chromatography (0 - 3% EtOAc in heptane) to yield the 
desired product 359 (0.44 g, 2.56 mmol, 60%) as a colourless oil. 
 
1H (CDCl3, 400 MHz) δ: 5.98 (1H, ddd, JH = 17.2, 10.7, 5.2 Hz, CHCH2), 5.06-4.83 (2H, m, 
CHCH2), 4.16-3.99 (1H, m, CH), 0.82 (9H, s, CH3), -0.09 (3H, s, CH3), -0.13 (3H, s, CH3).  
13C (CDCl3, 100 MHz) δ: 140.8 (CHCH2), 109.4 (CHCH2), 67.5 (CH), 26.9 (3C, CH3), 17.0 
(CCH3), -7.6 (CH3), -9.2 (CH3).  
The spectral data is in agreement with the literature values.163 
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2-Phenyl-1-tosyl-1,2,3,6-tetrahydropyridine, 360.164 
 
TsN
 
 
Diene 358 (66 mg, 0.15 mmol) was dissolved in CH2Cl2 (26 mL). Grubbs 2nd generation 
catalyst (6.0 mg, 7.4 μmol, 5 mol%) was added and the mixture was heated to reflux for 3 
h. The solvent was removed in vacuo and the crude residue purified by flash column 
chromatography (0 - 2.5% EtOAc in petroleum ether) to afford the desired product 360 (38 
mg, 0.12 mmol, 81%).  
 
1H (CDCl3, 400 MHz) δ: 7.61 (2H, d, JH = 8.3 Hz, Ar-H), 7.31-7.23 (2H, m, Ar-H), 7.25-7.08 
(5H, m, Ar-H), 5.71 (1H, ddd, JH = 10.2, 5.0, 2.4 Hz, CHCH), 5.55-5.46 (1H, m, CHCH), 
5.25-5.22 (1H, m, CHN), 4.10-3.97 (1H, m, NCHH), 3.38-3.22 (1H, m, NCHH), 2.43-2.20 
(5H, m, CH2 and CH3).  
13C (CDCl3, 100 MHz) δ: 143.1 (ArC), 139.2 (ArC), 137.1 (ArC), 129.5 (2C, ArC-H), 128.4 
(2C, ArC-H), 127.5 (ArC-H), 127.4 (2C, ArC-H), 127.0 (2C, ArC-H), 123.9 (CHCH), 123.8 
(CHCH), 52.8 (CHN), 40.8 (CH2), 26.4 (CH2), 21.5 (CH3). 
The spectral data is in agreement with the literature values.164 
 
6-[4’-(1’’’,3’’’-Benzoxazol-2’’’-yl)phenyl]-3-fluoro-1-[(4’’-methoxyphenyl)methyl]-
1,2,5,6-tetrahydropyridin-2-one, 370. 
 
O
N N
O
F
OMe
 
 
Lactam 220 (30 mg, 77 μmol), benzoxazole (13 mg 0.11 mmol), K2CO3 (24 mg, 0.17 
mmol), PPh3 (12 mg, 40 μmol), Cu(II)OAc2 (3.5 mg, 17 μmol) and Pd(PPh3)4 (10 mg, 9.0 
μmol) were dry mixed. Toluene (3 mL) was added and the reaction was heated under 
microwave irradiation to 128 °C for 4 h. Following this time, the mixture was diluted with 
H2O (5 mL) and extracted with diethyl ether (3 × 10 mL). The organics were combined, 
dried (Na2SO4) and removed in vacuo. The crude residue was purified by flash column 
chromatography (0 - 20% EtOAc in petroleum ether) to yield the desired product 370 (24 
mg, 56 μmol, 73%) as a white soild.  
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1H (CDCl3, 400 MHz) δ: 8.28 (2H, d, JH = 8.4 Hz, Ar-H), 7.86-7.76 (1H, m, Ar-H), 7.68-7.55 
(1H, m, Ar-H), 7.46-7.37 (2H, m, Ar-H), 7.35 (2H, d, JH = 8.4 Hz, Ar-H), 7.16 (2H, d, JH = 
8.5 Hz, Ar-H), 6.88 (2H, d, JH = 8.5 Hz, Ar-H), 5.91-5.74 (1H, m, CHCF), 5.56 (1H, d, JH = 
14.8 Hz, CHHN), 4.65 (1H, dd, JH = 7.7, 2.5 Hz, CHN), 3.83 (3H, s, CH3), 3.51 (1H, d, JH = 
14.8 Hz, CHHN), 3.06-2.95 (1H, m, CHCHHCH), 2.57-2.47 (1H, m, CHCHHCH). 
19F (CDCl3, 470 MHz) δ: -126.3. 
13C (CDCl3, 100 MHz) δ: 162.3 (NCO), 159.7 (d, JF = 31.1 Hz, CO), 159.3 (ArC-OMe), 
150.8 (ArC), 150.4 (ArC), 149.4 (d, JF = 255.2 Hz, CF), 143.1 (ArC), 142.0 (ArC), 129.6 
(2C, ArC-H), 128.6 (ArC), 128.2 (2C, ArC-H), 127.1 (2C, ArC-H), 125.4 (ArC-H), 124.8 
(ArC-H), 120.1 (ArC-H), 114.2 (2C, ArC-H), 110.7 (ArC-H), 109.6 (d, JF = 15.1 Hz, CHCF), 
56.9 (OCH3), 55.3 (CHN), 47.5 (NCH2), 29.2 (d, JF = 6.3 Hz, CH2).  
m/z [EI (+ve)] 428.3 [M]+, HRMS found [M]+ 428.1538, C26H21FN2O3 requires 428.1536.  
IR (thin film) vmax = 2928, 1651, 1512, 1452, 1244, 1199, 1057 cm-1. 
m.p. 117-119 ˚C. 
 
6-[4’-(1’’,3’’-Benzoxazol-2’’-yl)phenyl]-3-fluoro-1,2,5,6-tetrahydropyridin-2-one, 371. 
 
O
N HN
O
F
 
 
α,β-Unsaturated lactam 229 (25 mg, 93 μmol), benzoxazole (13 mg, 0.11 mmol), K2CO3 
(25 mg, 0.19 mmol), PPh3 (12 mg, 40 μmol), Cu(II)OAc2 (3.6 g, 17 μmol) and Pd(PPh3)4 
(11 mg, 9.0 μmol) were dry mixed. Toluene (3 mL) was added and the reaction was 
heated under microwave irradiation to 128 °C for 4 h. Following this time, the mixture was 
diluted with H2O (5 mL) and extracted with diethyl ether (3 × 10 mL). The organics were 
combined, dried (Na2SO4) and the solvent removed in vacuo. The crude residue was 
purified by flash column chromatography (0 - 20% EtOAc in petroleum ether) to yield the 
desired product 371 (20 mg, 65 μmol, 70%) as a white soild.  
 
1H (CDCl3, 400 MHz) δ: 8.32 (2H, d, JH = 8.4 Hz, Ar-H), 7.85-7.77 (1H, m, Ar-H), 7.66-7.60 
(1H, m, Ar-H), 7.57 (2H, d, JH = 8.4 Hz, Ar-H), 7.44-7.37 (2H, m, Ar-H), 6.12 (1H, dt, JF = 
10.9 Hz, JH = 4.5 Hz, CHCF), 5.67 (1H, s, NH), 4.65 (1H, t, JH = 8.6 Hz, CHN), 2.77-2.70 
(2H, m, CHCH2CH). 
19F (CDCl3, 377 MHz) δ: -129.4. 
13C (CDCl3, 100 MHz) δ: 162.2 (NCO), 161.0 (d, JF = 31 Hz, CO), 150.8 (ArC), 149.7 (d, JF 
= 254 Hz, CF), 143.4 (ArC), 142.0 (ArC), 128.4 (2C, ArC-H), 127.7 (ArC), 126.9 (2C, ArC-
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H), 125.4 (ArC-H), 124.8 (ArC-H), 120.2 (ArC-H), 113.3 (d, JF = 13 Hz, CHCF), 110.7 
(ArC-H), 55.8 (CHN), 31.0 (d, JF = 6 Hz, CH2).  
m/z [EI (+ve)] 308.2 [M]+, HRMS found [M]+ 308.0963, C18H13FN2O2 requires 308.0961.  
IR (thin film) vmax = 3205, 2922, 1693, 1654, 1452, 1201 cm-1. 
m.p. 135-137 ˚C. 
 
6-[4’-(1’’,3’’-Benzoxazol-2’’-yl)phenyl]-3-fluoro-piperidin-2-one, 372. 
 
O
N HN
O
F
 
 
A solution of benzoxazole 371 (0.11 g, 0.36 mmol) in MeOH (20 mL) was treated with 
palladium activated charcoal (11 mg, 10% by weight) and the suspension was stirred 
under a H2 atmosphere for 4.5 h. The mixture was filtered through celite, dried (Na2SO4) 
and the solvent was removed in vacuo. The crude residue was purified by flash column 
chromatography (0 - 40% EtOAc in petroleum ether) to yield the desired product 372 (0.11 
g, 0.35 mmol, 99%) as a white solid.  
 
1H (CDCl3, 400 MHz) δ: 8.31 (2H, d, JH = 8.4 Hz, Ar-H), 7.84-7.78 (1H, m, Ar-H), 7.67-7.60 
(1H, m, Ar-H), 7.51 (2H, d, JH = 8.4 Hz, Ar-H), 7.44-7.37 (2H, m, Ar-H), 5.94 (1H, s, NH), 
4.98 (1H, dt, JF = 37.6 Hz, JH = 4.0 Hz, CHF), 4.72-4.69 (1H, m, CHN), 2.39-1.99 (4H, m, 
CH2CH2). 
19F (CDCl3, 470 MHz) δ: -185.2. 
13C (CDCl3, 125 MHz) δ: 167.6 (d, JF = 20 Hz, CO), 162.3 (NCO), 150.8 (ArC), 144.9 
(ArC), 142.0 (ArC), 128.3 (2C, ArC-H), 127.3 (ArC), 126.7 (2C, ArC-H), 125.4 (ArC-H), 
124.8 (ArC-H), 120.1 (ArC-H), 110.7 (ArC-H), 85.6 (d, JF = 176 Hz, CHF), 57.1 (CHN), 
27.2 (d, JF = 6 Hz, CH2), 26.1 (d, JF = 21.1 Hz, CH2).  
m/z [ESI (+ve)] 333.1 [M+Na]+, HRMS found [M+Na]+ 333.0989, C18H15FN2O2Na requires 
333.1010.  
IR (thin film) vmax = 2926, 2854, 1681, 1454, 1244, 1182, 1058 cm-1. 
m.p. 235-237 ˚C. 
 
1-Benzyl-1H-1,3-benzodiazole, 373.165 
 
N
Bn
N
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DMF (5 mL) was added to a mixture of benzimidazole (0.20 g, 1.7 mmol) and K2CO3 (0.35 
g, 2.5 mmol). Benzyl bromide (0.24 mL, 2.0 mmol) was added and the reaction was 
heated under microwave irradiation to 100 °C for 1 h. The mixture was diluted with H2O 
(10 mL), extracted with diethyl ether (3 × 10 mL) followed by repeated washing with H2O 
(3 × 10 mL) and brine (2 × 10 mL). The organic phase was dried (Na2SO4) and the solvent 
was removed in vacuo. The crude residue was purified by flash column chromatography 
(0 - 100% EtOAc in petroleum ether) to yield the desired product 373 (45 mg, 0.21 mmol, 
14%) as a white solid. 
 
1H (CDCl3, 400 MHz) δ: 7.98 (1H, s, NCH), 7.88-7.84 (1H, m, Ar-H), 7.40-7.25 (6H, m, Ar-
H), 7.23-7.19 (2H, m, Ar-H), 5.41 (2H, m, CH2). 
13C (CDCl3, 100 MHz) δ: 143.0 (ArC), 143.2 (NCHO), 135.5 (ArC), 134.0 (ArC), 129.1 (2C, 
ArC-H), 128.3 (ArC-H),  127.1 (2C, ArC-H), 123.1 (ArC-H), 122.3 (ArC-H), 120.5 (ArC-H), 
110.0 (ArC-H), 48.9 (CH2).  
m.p. 114-115 ˚C. 
The spectral data is in agreement with the literature values.165 
 
6-[4’-(1’’-Benzyl-1H-1’’,3’’-benzodiazol-2’’-yl)phenyl]-3-fluoro-1,2,5,6-
tetrahydropyridin-2-one, 374. 
 
N
Bn
N HN
O
F
 
 
α,β-Unsaturated lactam 229 (30 mg, 0.10 mmol), benzimidazole 373 (28 mg 0.13 mmol), 
K2CO3 (31 mg, 0.20 mmol), PPh3 (15 mg, 50 μmol), Cu(II)OAc2 (4.4 mg, 20 μmol) and 
Pd(PPh3)4 (13 mg, 10 μmol) were dry mixed. Toluene (2.5 mL) was added and the 
reaction was heated under microwave irradiation to 128 °C for 4 h. Following this time, the 
mixture was diluted with H2O (5 mL) and extracted with diethyl ether (3 × 10 mL). The 
organics were combined, dried (Na2SO4) and removed in vacuo. The crude residue was 
purified by flash column chromatography (0 - 60% EtOAc in petroleum ether) to yield the 
desired product 374 (39 mg, 96 μmol, 97%) as a white soild.  
 
1H (CDCl3, 400 MHz) δ: 7.80 (1H, d, JH = 8.0 Hz, Ar-H), 7.67 (2H, d, JH = 8.2 Hz, Ar-H), 
7.39 (2H, d, JH = 8.2 Hz, Ar-H), 7.32-7.23 (4H, m, Ar-H), 7.23-7.11 (2H, m, Ar-H), 7.03 
(2H, appt d, JH = 6.5 Hz, Ar-H), 6.00 (1H, dt, JF = 10.8, JH = 4.5 Hz, CHCF), 5.54 (1H, s, 
NH), 5.40 (2H, s, CH2N) 4.78 (1H, t, JH = 8.5 Hz, CHN), 2.64-2.57 (2H, m, CHCH2CH). 
19F (CDCl3, 377 MHz) δ: -129.5. 
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13C (CDCl3, 100 MHz) δ: 161.0 (d, JF = 31 Hz, CO), 153.2 (NCN), 149.7 (d, JF = 255 Hz, 
CF), 143.2 (ArC), 141.8 (ArC), 136.19 (d, JF = 6.9 Hz, ArC), 130.7 (ArC), 130.7 (2C, ArC-
H), 129.2 (2C, ArC-H), 128.4 (ArC), 127.9 (ArC-H), 126.8 (2C, ArC-H), 125.9 (2C, ArC-H), 
123.4 (ArC-H), 122.9 (ArC-H), 120.1 (ArC-H), 113.3 (d, JF = 14 Hz, CHCF), 110.5 (ArC-H), 
55.7 (CHN), 48.4 (NCH2), 31.0 (d, JF = 5 Hz, CH2).  
m/z [ESI (+ve)] 398.2 [M+H]+, HRMS found [M+H]+ 398.1643, C25H21FN3O requires 
398.1639.  
IR (thin film) vmax = 2926, 2854, 1697, 1660, 1454, 1249, 1199 cm-1. 
m.p. 204-206 ˚C. 
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11. Appendix  
 
Crystal Structure and Structural Refinement for 198 
 
 
Chemical Formula: C11H12FNO 
Space Group: P -1 
Cell lengths: a 6.0469(2) b 9.1864(3) c 9.4011(3) 
Cell angles:  a 110.410(2) b 96.980(2) g 92.353(2) 
Cell volume: -483.854 
Z, Z’: Z: 2 Z': 0 
R factor (%): 3.49 
Atoms 
Number Label Charge SybylType Xfrac + ESD Yfrac + ESD Zfrac + ESD 
Symm. 
op. 
1 C1 0 C.2 0.9519(2) 0.69884(14) 0.67740(14) x,y,z 
2 C2 0 C.3 0.9134(2) 0.83934(15) 0.81542(15) x,y,z 
3 H2 0 H 0.955 0.8167 0.9114 x,y,z 
4 C3 0 C.3 0.6782(2) 0.88681(16) 0.80997(15) x,y,z 
5 H3A 0 H 0.6759 0.9931 0.8858 x,y,z 
6 H3B 0 H 0.5806 0.8145 0.8374 x,y,z 
7 C4 0 C.3 0.5895(2) 0.88407(15) 0.65064(15) x,y,z 
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8 H4A 0 H 0.6887 0.9541 0.6215 x,y,z 
9 H4B 0 H 0.438 0.9211 0.6498 x,y,z 
10 C5 0 C.3 0.5803(2) 0.71805(14) 0.53693(14) x,y,z 
11 H5 0 H 0.4674 0.6528 0.5635 x,y,z 
12 C6 0 C.2 0.5099(2) 0.70444(14) 0.37274(14) x,y,z 
13 C7 0 C.2 0.2882(2) 0.65768(15) 0.30661(16) x,y,z 
14 H7 0 H 0.184 0.6333 0.3647 x,y,z 
15 C8 0 C.2 0.2175(2) 0.64625(17) 0.15687(16) x,y,z 
16 H8 0 H 0.0653 0.6149 0.1133 x,y,z 
17 C9 0 C.2 0.3677(2) 0.68038(17) 0.07054(16) x,y,z 
18 H9 0 H 0.3201 0.6706 -0.0327 x,y,z 
19 C10 0 C.2 0.5883(2) 0.72897(17) 0.13642(16) x,y,z 
20 H10 0 H 0.6919 0.7541 0.0783 x,y,z 
21 C11 0 C.2 0.6592(2) 0.74125(15) 0.28633(15) x,y,z 
22 H11 0 H 0.8108 0.775 0.3303 x,y,z 
23 N1 0 N.am 0.79856(17) 0.65529(12) 0.55254(12) x,y,z 
24 H1 0 H 0.831 0.5813 0.4708 x,y,z 
25 O1 0 O.2 1.12428(14) 0.63207(11) 0.68528(10) x,y,z 
26 F1 0 F 1.06059(14) 0.96212(10) 0.81591(10) x,y,z 
 
Bonds 
Number Atom1 Atom2 Type Polymeric Cyclicity Length SybylType 
1 C1 C2 Unknown no cyclic 1.528(2) 1 
2 C1 N1 Unknown no cyclic 1.332(2) un 
3 C1 O1 Unknown no acyclic 1.238(2) 2 
4 C2 H2 Unknown no acyclic 1 1 
5 C2 C3 Unknown no cyclic 1.505(2) 1 
6 C2 F1 Unknown no acyclic 1.406(2) 1 
7 C3 H3A Unknown no acyclic 0.99 1 
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8 C3 H3B Unknown no acyclic 0.99 1 
9 C3 C4 Unknown no cyclic 1.520(2) 1 
10 C4 H4A Unknown no acyclic 0.99 1 
11 C4 H4B Unknown no acyclic 0.99 1 
12 C4 C5 Unknown no cyclic 1.521(2) 1 
13 C5 H5 Unknown no acyclic 1 1 
14 C5 C6 Unknown no acyclic 1.510(2) 1 
15 C5 N1 Unknown no cyclic 1.473(2) 1 
16 C6 C7 Unknown no cyclic 1.390(2) un 
17 C6 C11 Unknown no cyclic 1.391(2) un 
18 C7 H7 Unknown no acyclic 0.95 1 
19 C7 C8 Unknown no cyclic 1.387(2) un 
20 C8 H8 Unknown no acyclic 0.95 1 
21 C8 C9 Unknown no cyclic 1.384(2) un 
22 C9 H9 Unknown no acyclic 0.95 1 
23 C9 C10 Unknown no cyclic 1.386(2) un 
24 C10 H10 Unknown no acyclic 0.951 1 
25 C10 C11 Unknown no cyclic 1.386(2) un 
26 C11 H11 Unknown no acyclic 0.95 1 
27 N1 H1 Unknown no acyclic 0.88 1 
 
All Angles 
Number Atom1 Atom2 Atom3 Angle 
1 C2 C1 N1 118.0(1) 
2 C2 C1 O1 119.0(1) 
3 N1 C1 O1 123.0(1) 
4 C1 C2 H2 109.2 
5 C1 C2 C3 114.6(1) 
6 C1 C2 F1 105.3(1) 
7 H2 C2 C3 109.2 
8 H2 C2 F1 109.2 
9 C3 C2 F1 109.3(1) 
10 C2 C3 H3A 109.6 
11 C2 C3 H3B 109.5 
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12 C2 C3 C4 110.5(1) 
13 H3A C3 H3B 108.1 
14 H3A C3 C4 109.5 
15 H3B C3 C4 109.6 
16 C3 C4 H4A 109.9 
17 C3 C4 H4B 109.9 
18 C3 C4 C5 108.9(1) 
19 H4A C4 H4B 108.3 
20 H4A C4 C5 109.9 
21 H4B C4 C5 109.9 
22 C4 C5 H5 107.7 
23 C4 C5 C6 113.2(1) 
24 C4 C5 N1 110.0(1) 
25 H5 C5 C6 107.8 
26 H5 C5 N1 107.8 
27 C6 C5 N1 110.2(1) 
28 C5 C6 C7 119.3(1) 
29 C5 C6 C11 122.0(1) 
30 C7 C6 C11 118.7(1) 
31 C6 C7 H7 119.6 
32 C6 C7 C8 120.7(1) 
33 H7 C7 C8 119.7 
34 C7 C8 H8 119.9 
35 C7 C8 C9 120.3(1) 
36 H8 C8 C9 119.8 
37 C8 C9 H9 120.4 
38 C8 C9 C10 119.2(1) 
39 H9 C9 C10 120.4 
40 C9 C10 H10 119.7 
41 C9 C10 C11 120.6(1) 
42 H10 C10 C11 119.7 
43 C6 C11 C10 120.4(1) 
44 C6 C11 H11 119.8 
45 C10 C11 H11 119.8 
46 C1 N1 C5 126.8(1) 
47 C1 N1 H1 116.6 
48 C5 N1 H1 116.6 
 
All Torsions 
Number Atom1 Atom2 Atom3 Atom4 Torsion 
1 N1 C1 C2 H2 138.2 
2 N1 C1 C2 C3 15.4(2) 
3 N1 C1 C2 F1 -104.6(1) 
4 O1 C1 C2 H2 -42.8 
5 O1 C1 C2 C3 -165.6(1) 
6 O1 C1 C2 F1 74.4(1) 
7 C2 C1 N1 C5 -6.9(2) 
8 C2 C1 N1 H1 173.1 
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9 O1 C1 N1 C5 174.2(1) 
10 O1 C1 N1 H1 -5.8 
11 C1 C2 C3 H3A -164.3 
12 C1 C2 C3 H3B 77.3 
13 C1 C2 C3 C4 -43.5(2) 
14 H2 C2 C3 H3A 72.9 
15 H2 C2 C3 H3B -45.5 
16 H2 C2 C3 C4 -166.3 
17 F1 C2 C3 H3A -46.5 
18 F1 C2 C3 H3B -164.9 
19 F1 C2 C3 C4 74.3(1) 
20 C2 C3 C4 H4A -57.7 
21 C2 C3 C4 H4B -176.9 
22 C2 C3 C4 C5 62.7(1) 
23 H3A C3 C4 H4A 63.1 
24 H3A C3 C4 H4B -56.1 
25 H3A C3 C4 C5 -176.5 
26 H3B C3 C4 H4A -178.5 
27 H3B C3 C4 H4B 62.4 
28 H3B C3 C4 C5 -58.1 
29 C3 C4 C5 H5 65.1 
30 C3 C4 C5 C6 -175.8(1) 
31 C3 C4 C5 N1 -52.1(1) 
32 H4A C4 C5 H5 -174.4 
33 H4A C4 C5 C6 -55.4 
34 H4A C4 C5 N1 68.4 
35 H4B C4 C5 H5 -55.3 
36 H4B C4 C5 C6 63.8 
37 H4B C4 C5 N1 -172.5 
38 C4 C5 C6 C7 -97.9(1) 
39 C4 C5 C6 C11 80.4(2) 
40 H5 C5 C6 C7 21.1 
41 H5 C5 C6 C11 -160.6 
42 N1 C5 C6 C7 138.5(1) 
43 N1 C5 C6 C11 -43.2(2) 
44 C4 C5 N1 C1 25.9(2) 
45 C4 C5 N1 H1 -154 
46 H5 C5 N1 C1 -91.3 
47 H5 C5 N1 H1 88.8 
48 C6 C5 N1 C1 151.4(1) 
49 C6 C5 N1 H1 -28.6 
50 C5 C6 C7 H7 -0.9 
51 C5 C6 C7 C8 179.0(1) 
52 C11 C6 C7 H7 -179.3 
53 C11 C6 C7 C8 0.7(2) 
54 C5 C6 C11 C10 -179.3(1) 
55 C5 C6 C11 H11 0.7 
56 C7 C6 C11 C10 -1.0(2) 
57 C7 C6 C11 H11 179 
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58 C6 C7 C8 H8 -179.5 
59 C6 C7 C8 C9 0.4(2) 
60 H7 C7 C8 H8 0.5 
61 H7 C7 C8 C9 -179.6 
62 C7 C8 C9 H9 178.7 
63 C7 C8 C9 C10 -1.2(2) 
64 H8 C8 C9 H9 -1.3 
65 H8 C8 C9 C10 178.7 
66 C8 C9 C10 H10 -179.1 
67 C8 C9 C10 C11 0.9(2) 
68 H9 C9 C10 H10 0.9 
69 H9 C9 C10 C11 -179.1 
70 C9 C10 C11 C6 0.2(2) 
71 C9 C10 C11 H11 -179.8 
72 H10 C10 C11 C6 -179.8 
73 H10 C10 C11 H11 0.2 
 
 
